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 i 
Abstract 
 
Interest in patient and public involvement (PPI) in healthcare research has been growing. 
In the UK and internationally there is increasing demand for researchers to demonstrate 
the value of PPI both in their work and to funding bodies. Existing evidence demonstrates 
that reporting of PPI has been limited and inconsistent. In particular, whilst there is 
growing evidence about the use and efficacy of PPI in research processes, little is known 
about how to evaluate the impact of PPI on research outcomes. The aim of this research 
was therefore to evaluate the impact of PPI on cancer research outcomes. 
An interpretivist and pragmatist methodology was adopted to explore how the impact of 
PPI on cancer research outcomes can be evaluated, using a mixed methods sequential 
design. In phase one, 23 in-depth interviews were conducted with patients, researchers 
and stakeholders from the East Midlands region to explore perceptions of the impact of 
PPI on research outcomes and their experiences of involving patients and the public in 
research outcomes. In phase two, a modified Delphi study was conducted with 35 experts 
across England in order to refine and enhance knowledge about the impact of PPI on 
research outcomes. Data were analysed using Braun and Clarke (2006). End user 
involvement was embedded in the study at key stages and evaluated using the GRIPP 2 
checklist (Staniszewska 2017). Limitations to this research study included the paucity of 
black and minority ethnic participants and being only East Midlands focused in phase 1. 
Findings from the interviews and the Delphi study demonstrated that there are several 
factors which shape the impact of PPI on research outcomes. These are: PPI in 
commissioning; PPI in research processes; PPI in dissemination; PPI in implementation; 
information and communication technology; power and leadership; resources and the 
political context; networks; and wanting to make a difference. Data show that the 
evaluation of the impact of PPI on research outcomes was achievable at four stages: pre-
implementation, partial-implementation, during-implementation and post-
implementation. Reflexive analysis of the use of end user involvement within the study 
included a consideration of the challenges of involvement for PhD researchers.  
Drawing on theoretical insights about PPI in research and work from the field of 
implementation science, this thesis makes an original contribution by arguing three main 
points. First, that PPI can be considered as a complex intervention (Craig et al. 2008). 
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Second, that as a complex intervention, the impact of PPI on research outcomes can 
therefore be evaluated using the Consolidated Framework for Implementation Research 
(CFIR) (Damschroder et al. 2009). Third, using the CFIR, particularly the domain of 
‘process of implementation’, enhances understanding about the success or failure of the 
implementation of PPI in practice. The data highlight particular attention should be given 
to the time and resource implications required to conduct effective evaluation of the 
impact of PPI on research outcomes. 
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Chapter One: Introduction 
Introduction 
Patient and public involvement (PPI) in healthcare research has taken centre stage in the 
research landscape in recent years and this is a thesis that aims to explore how its impact 
might be evaluated. PPI in research is defined as ‘doing research with or by people, not 
to, about, or for them’ (INVOLVE 2012). Whilst a great deal of attention has been given 
to evaluation of PPI in and on research processes, less attention has been paid to how 
involving patients and the public in research might shape its outcomes. It has been 
suggested that post research plans frequently fail because the use of PPI is 
underdeveloped in implementation programmes (Savory 2010). Similarly, 
understandings about the impact of PPI on research outcomes are underdeveloped in part 
because of not knowing what and how to evaluate such impact.  
 
This thesis draws on concepts from implementation science to explore the impact of PPI 
on research outcomes. Implementation science is defined as the scientific study of 
methods to promote the systematic uptake of research findings and other evidence-based 
practices into routine practice, and hence, to improve the quality and effectiveness of 
health services and care (Eccles and Mittman 2006). Implementation research attempts to 
understand what implementation plans work for whom and in what context. It uses 
theoretical frameworks that can help to guide data collection, analysis, and interpretation 
of implementation processes (Kirk et al. 2015). Therefore, a question at the heart of this 
study is whether the impact of PPI on research outcomes is evaluable using 
implementation theory.  
 
This chapter establishes the themes that underpin this study. It will introduce PPI in 
healthcare research, how PPI came about, and how it operates in the UK context. This is 
followed by a discussion about research impact and the gap between research and 
practice. Observations are made about the researcher’s practitioner role, which triggered 
ideas for the current PhD study and its particular focus on cancer research. Finally, the 
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chapter offers insights into the end user involvement present throughout this study, a 
justification, the aims and objectives. Lastly it offers a chapter by chapter synopsis.  
 
What is ‘PPI’ in ‘healthcare’ and ‘research’? 
It is important to carefully consider the terms applied throughout this thesis and a brief 
overview is offered here, before terminology is considered in more detail in the next 
chapter. Terms of particular significance (and already used here) are: ‘patient and public’, 
‘involvement’ and ‘healthcare research’. In this study ‘patient and public’ broadly refers 
to ‘non-specialist’ input in healthcare decisions (Frederikkson and Tritter 2017). The 
word ‘involvement’ draws from the INVOLVE (2012) definition, set out above. This 
definition encompasses an active input that people have in the research process. Finally, 
‘healthcare research’ is considered as the NIHR definition: 
Research is about finding out new knowledge that could lead to changes in 
treatments, policies or care.  There are many different types of research from 
studies in a scientific laboratory to those that observe and examine people with 
different conditions or develop new treatments. Research might be concerned 
with preventing disease and promoting good health or finding out people's 
experience of different services and support in the community. 
(NIHR 2018, para. 1) 
 
PPI in healthcare research: an evolving phenomenon  
PPI has been set as a global policy imperative by the World Health Organisation (WHO). 
The declaration of Alma Ata (1978) stated that: ‘…people have the right and the duty to 
participate individually and collectively in their health care’ (WHO Alma Ata 
Declaration 1978 [no page number listed]). Yet in the UK, PPI was not implemented with 
conviction until serious clinical and health service failings occurred (Kennedy Report 
2001). These clinical breakdowns highlighted that PPI could be one way of delivering 
safer care and a method of improving health service accountability via a move away from 
paternalism towards patient empowerment (Ocloo and Fulop 2011). Within the UK, the 
government embraced the following principle from the NHS constitution: ‘The patient 
will be at the heart of everything the NHS does’ (Department of Health 2009). Many other 
countries also involve the patients and the public in healthcare governance and decision-
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making, including Australia (Todd and Nutbeam 2018), North America (Frank et al. 
2014), Canada (Boivin et al. 2014) and countries across Europe (Brett et al. 2010).  
 
Research involving patients and the public will affect all disease areas. PPI can be non-
disease-specific too, e.g. in routine healthcare planning and development or in accident 
and emergency settings (Bridges 2010). PPI operates in primary care (Coulter 2005), in 
secondary care (Doherty and Doherty 2005), and in tertiary care (Carlet et al. 2004). It 
can be found in healthcare audit (Le Var 2002), healthcare evaluation (Gagliardi et al. 
2008) and in healthcare research (Brett et al. 2014). This thesis specifically addresses PPI 
in healthcare research and research evaluation. 
 
Since 1997, the discourse and direction of PPI in UK healthcare has evolved considerably 
(explored in chapter two). PPI has been politicised as a way of servicing a spectrum of 
needs for government, for the patients, and for the public. These needs range from 
increasing peoples’ democratic rights, through to legitimising healthcare services to help 
address public concerns (Forster and Gabe 2008).  
 
In parallel to these wider developments, PPI has become commonplace in research. PPI 
in research is underpinned by what Snape et al. (2014a) defined as ‘intrinsic values’. The 
public have an entitlement to be involved in the research process, they have the right to 
say what research is undertaken and importantly, for this research, they have the right to 
shape how research is used. If we acknowledge that different types of knowledge are 
important, then members of the public will have a unique knowledge to offer healthcare 
practice (Snape et al. 2014).  
 
PPI in research embraces a variety of activities carried out with patients and the public 
(Pandya-Wood and Robinson 2014). Involvement might include participation in one or 
more ways of helping to set a research question (Batchelor et al. 2013), developing a 
research design (Walker and Pandya-Wood 2013), collecting and analysing data (Brett et 
al. 2010; Pandya 2007), and disseminating research and planning for implementation 
(Gray-Burrows et al. 2018; Rivas and Pandya-Wood 2014). These activities are often 
 4 
carried out at different levels with patients and the public, ranging from consultation 
through to deep collaboration or even user-led work (Fleming and Hudson 2007). PPI can 
be ‘spontaneous or planned…invited or sponsored… [people engage in a range of ways], 
by gathering data through to challenging theory’ (Madden and Speed 2017 p1). Despite 
all the different ways that research studies involve people, and the extent to which this is 
meaningful, PPI can run the risk of being ‘insignificant, tokenistic, and overly 
managerialist’ (ibid p.2). Consequently, some studies will thrive whilst others will fail, 
and in some cases, this may be on account of the extent to which PPI is meaningful and 
impactful. This study seeks to better understand what factors might allow for such success 
or failure. 
The research impact agenda 
Through investment in research, development and innovation, the UK aspires to be a 
world class research facility. In 2016 alone, the Office of National Statistics (ONS) 
indicated that expenditure on research and development reached its highest level on 
record at £31.8bn1. At the same time, some £1.37bn was spent by the National Institute 
for Health Research (NIHR) (NIHR 2016), which is the research arm of the National 
Health Service (NHS). In 2017, this figure was supplemented by a research spend of 
£816m for health and social care research managed by the Department of Health and 
Social Care (DHSC 2016).  
 
Health research, by its very nature, is focused on impact and alongside the shift towards 
PPI in research, every funded healthcare research study must now include an impact plan 
that involves patients and the public. To assess the impact of funded research and avoid 
waste, the NIHR uses the Added Value Framework (Chalmers and Glasziou 2009). From 
investigating digital and technological solutions to developing new drugs to perform 
precision medicine, the work of the NIHR is focused on funding health and social care 
research and translating discoveries into practical products, treatments, devices and 
procedures, whilst involving the patients and the public in all of its work (NIHR 2018). 
                                                 
1 Research expenditure  
https://www.ons.gov.uk/economy/governmentpublicsectorandtaxes/researchanddevelopmentexpenditure/bulletins/ukgrossdomestice
xpenditureonresearchanddevelopment/2016 
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The routine involvement of patients and the public affected by the research (or the work 
carried out in research centres) is therefore compulsory for NIHR-funded research. Other 
UK research funding bodies including Wellcome Trust, the Research Council United 
Kingdom (RCUK) and specialist research charities such as Cancer Research UK have all 
dramatically increased their emphasis on the need for PPI (Hughes and Duffy 2018) and 
the need for demonstrating research impact (ibid).  
 
The Higher Education Funding Council for England’s (HEFCE) Research Excellence 
Framework (REF) set out new expectations that academic research needed to demonstrate 
‘impact’, defined as: ‘an effect on, change or benefit to the economy, society, culture, 
public policy or services, health, the environment or quality of life, beyond academia’ 
(HEFCE 2011). It was clear that REF impact and the impact of PPI on research outcomes 
concerned similar issues, i.e. the impact of research at an implementation level in 
healthcare (beyond the research dissemination stage).  
 
However, despite the emphasis on impact, REF has posed a challenge for understanding 
the contribution of PPI, notably since knowledge on PPI outcomes is limited (Caress 
2014). There are also methodological problems in trying to attribute research outcomes 
to the involvement of patients and the public. This present study is therefore exploratory 
in nature, it does not seek to prove a causal link. 
 
The working definition of impact used within this study is any effect or outcome outside 
the research which occurs as a result of the research, usually after some form of 
dissemination has taken place (Rivas and Pandya-Wood). 
The research and practice gap and PPI 
Understanding the impact of completed research studies on health and social care services 
is generally unclear (Morris et al. 2011; Butler 2008; Norman 2010; Bero et al. 1998). 
Implementation science attempts to investigate and address this gap, offering researchers 
a plethora of informed and evidence-based ways for mapping how to instigate change in 
the complex and dynamic healthcare environment made up of interacting components of 
context, people and processes (Campbell et al. 2007). Whilst implementation processes 
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attempt to help close the research and practice gap, there continues to be a challenge. This 
gulf between research and practice mirrors a general implementation problem globally, 
i.e. the ‘know-do gap’ (Pablos-Mandez and Shademani 2006). Specifically, for PPI in 
research, the gap highlights that whilst the literature suggests that PPI helps the research 
process by prioritising what to research, how to research, what the findings mean and 
how they might be communicated (Staley 2009), we know very little about the impact of 
PPI on research outcomes (Brett et al. 2010). Meanwhile, the patients and the public who 
might have helped during the research processes, and who invested their time, do not 
always see change. 
 
There continues to be little evidence on how PPI makes any difference to the outcomes 
of health research (Shippee et al. 2013; Snape et al. 2014; Mockford et al. 2011, Mathie 
et al. 2014; Evans et al. 2014; Brett et al. 2014). Researchers have begun to highlight that 
this apparent lack of evidence may be due to poor quality reporting of PPI in research 
(Staniszewska et al. 2011). Some researchers question whether PPI is really worth the 
effort if it does not achieve anything (Petit-Zeman and Locock 2013). As a result, PPI 
could become vulnerable to poor practice or tokenistic use.  
Conceptualisation of this study and the researcher’s role 
The research idea at the heart of this study first emerged in 2008, when the author was 
new in post working as a PPI in Research Advisor as part of the NIHR-funded regional 
Research Design Service2 based in the Centre for Social Action at De Montfort University 
(a role still held but now based at the University of Leicester). It was felt during frontline 
advising that public sector researchers were yet to fully embrace involvement ideas 
because frequently during PPI advising sessions, researchers would be concerned about 
the added time and resource implications.  
 
Being new in the public-sector role, with a background in community research and 
development (in HIV and substance abuse), it was observed that PPI in research was seen 
                                                 
2 The NIHR funds roles such as the current researcher’s, which focus specifically on ‘front line advising’ on PPI in research design 
and helping researchers to prepare research grant applications for national peer-reviewed funding competitions. with members of the 
public and patients to gain mutual understanding about how PPI can enhance particular research studies. 
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as a burden for some clinical researchers. Although there was an expectation from the 
then Department of Health (DH), now Department of Health and Social Care (DHSC), 
that all researchers were intrinsically in favour of its values (Harrison and Mort 1998), 
this was not always the case in practice. Taking aside the rich value base that underpins 
PPI, for clinical researchers, involving patients and the public was often seen as 
something of an inconvenience (Madden and Speed 2017). Thus, not only were clinical 
researchers having to demonstrate PPI in the planning of research to convince those peer-
reviewing their research application on funding panels, they were also expected to accept 
the ethos of PPI seemingly without question. Some researchers entertained the idea of 
PPI because it was a mandatory requirement, not because they necessarily believed in it, 
nor that they saw its value.  
 
It was decided after these observations that a research study was necessary. Following 
extensive conversations, which were later understood to be consultation work (Fleming 
and Hudson 2007) with public members and academic researchers in social action and 
health, the topic of cancer was deemed as an appropriate area of health and illness as a 
context for the current study. This was appropriate for a number of reasons. Firstly, more 
than one in three people will be diagnosed with a cancer in their lifetime and cancer 
research translation remains an important NHS priority (Cancer Research UK 2011). 
Secondly, cancer research is one area where PPI is already advanced (Stewart et al. 2011; 
Hubbard et al. 2007), meaning there are a plethora of completed research study examples 
with PPI. Thirdly, the choice of cancer as the topic would allow for targeted data 
collection. Finally, the focus on one disease also allowed the current researcher some 
rigour and replicability, as empirical work would be richer, fuller and more detailed, 
building understandings of perceptions and accounts of involvement that professionals, 
patients and the public offered. 
 
Given this PhD was a study about PPI, it was important to involve people who were 
potential end users, such as researchers/academics, healthcare professionals, and patients 
and the public. Inviting input from these groups at key stages offered an opportunity to 
ask important questions about how PPI in research and implementation are connected. To 
keep the work focused on the aims (which are identified below), this study has had 
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deliberation embedded in its design (explained in depth in chapters four and nine). 
Suitable researchers and academics were involved via university research networks. 
Patients and the public were found through working in the PPI role. When involvement 
was planned with patients and the public, the opportunity to input this work was made 
possible by patient forums the researcher had set up in her professional work. Thus, 
members of the public and patients were already interested in the impact of PPI and this 
research. Some were affected by cancer research themselves, they were all geographically 
close in proximity, willing to help, interested in the study and available to offer comments 
at a given time (Dörnyei 2007). A variety of end users were invited to offer their input 
during research design and analysis. Towards the end of the study, end user workshops 
were also held to help untangle the originality of the study. A journal was kept of key 
influences of encounters with end users. No funds were available to carry out the end user 
involvement, but the researcher felt that input from end users has been invaluable to this 
study, by adding a layer of scrutiny and reflection. Further reflections on involvement in 
this study are explored in chapter nine. 
End user involvement has taken place throughout this study. To demonstrate how the 
involvement has shaped the process of research and when, a table in chapter 4. draws on 
the Guidelines for Reporting Involvement of Patients and Public 2. Model (Staniszewska 
et al. 2017).  The table 6 explains who was involved, the stage of the study, the level of 
involvement, the nature of involvement, what was raised by end users, what was used in 
the study, and finally, the context and the application of theory influencing end user 
involvement.  
 
Additionally, in chapters one, four, five, six, seven and eight, a text box has been included 
to show how involvement influenced that particular stage of the research. Finally, chapter 
nine is dedicated entirely to providing a reflection of the dilemmas experienced in relation 
to end user involvement in this study. 
Justification of this research 
As this chapter has shown, interest in PPI in healthcare research has grown significantly. 
At the same time, there has been increasing demand for researchers to articulate and 
demonstrate the value of PPI to national funding bodies. While there is now evidence 
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about the benefits of public involvement on the process of research (Staley 2009), we still 
do not know specifically whether and how PPI makes a difference to research outcomes 
(Mockford et al. 2011), nor do we have sufficient understanding of the types of issues 
which affect the implementation of PPI informed research findings into policy and 
practice (Staniszewska 2011).  
 
There is a dearth of published high-quality research assessing the impact of PPI 
(Staniszewska et al. 2017) and the possible reasons for this include that evaluation may 
be too difficult and that PPI is thought to be of intrinsic value and therefore needs no 
further justification (Snape et al. 2014). At an implementation level, difficulties exist for 
clinicians, patients and managers in healthcare settings in transferring research into policy 
and/or practice (Forbat et al. 2009). The present study was therefore designed to address 
these knowledge gaps.  
Aims and objectives 
This exploratory and inductive social science research study aims to advance knowledge 
about how to evaluate the impact of PPI on cancer research outcomes. The objectives are: 
1. To explore perceptions and experiences relating to the impact of PPI on research 
outcomes amongst patients, researchers and stakeholders involved in cancer 
research  
2. To identify factors which affect the implementation of PPI informed research 
findings in policy and practice 
3. To enhance and refine understandings of factors that shape the impact of PPI 
4. To enhance knowledge and understanding about the link between implementation 
theory and how evaluation of impact of PPI on research outcomes might be 
achieved. 
 
Structure of the thesis 
This thesis is organised into ten chapters including this one. Chapter two presents a policy 
overview of PPI in UK health research, clarifying terminology and exploring debates on 
what PPI in healthcare and research seeks to achieve. It describes the underlying 
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ideologies (democratic and technocratic) that have shaped the politics of PPI. Relevant 
social and healthcare policies are reviewed, leading the author to conclude that PPI sits 
both within a neoliberal agenda but also poses challenging questions for neoliberalism.  
 
Chapter three presents a critical narrative review of what is understood by ‘research 
impact’ along with the ‘impact of PPI on research process and outcomes’. This chapter 
leads the author to argue that progress has been made to understand the impact of PPI on 
research processes, but not on the outcomes. It is argued that implementation science, as 
a field of activity, could advance thinking for the current research question.  
 
Chapter four is a methodological chapter in which the study design, methods selected and 
ethical issues and are discussed. The involvement of end users is described in detail and 
a snapshot of the sample is offered along with information concerning their demographic 
profile.  
 
Chapter five is the first findings chapter, exploring how participants gave meaning to the 
impact of PPI on research outcomes. The chapter presents seven factors thought to shape 
PPI on research outcomes, drawing on 23 interviews conducted with patients and the 
public, researchers and stakeholders. The chapter explores how these factors acted as 
barriers or facilitators towards achieving the impact of PPI on research outcomes and 
identified the importance of context and processes in shaping outcomes.  
 
Chapter six presents the findings drawn from a three-round Delphi survey with 35 
panellists. During the Delphi survey, panellists reviewed and enhanced the seven factors 
set out in chapter five and introduced a further two factors. The collective nine factors of 
PPI were then situated at micro, meso and macro levels and a definition of the impact of 
PPI was formed offering insights into what impact of PPI is enveloped by. 
 
Chapter seven presents six examples drawn from the data. This chapter explores: a) what 
PPI activity enabled the impact within the example; b) why participants felt that factors 
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of PPI influenced the ability to have this impact; and; c) how PPI on research process and 
outcomes are conceptualised for evaluation.  
 
Chapter eight, the discussion, draws the findings together and sets out the original 
contribution to knowledge. The chapter positions PPI as a complex intervention (Craig et 
al. 2008) and one which can be subjected to evaluation as such using Damschroder et al.’s 
(2009) Consolidated Framework Implementation Research (CFIR). This original 
contribution offers new ideas that support the evaluation of PPI and highlights challenges 
for addressing the impact of PPI. It demonstrates that the current study findings can be 
mapped out using the domains of CFIR: intervention characteristics, outer settings, inner 
settings, characteristics of individuals involved, and the process of implementation, but 
pays particular attention to the latter domain. 
 
Chapter nine is a critical reflection of conducting PPI in this PhD study. It explores the 
epistemological tensions of doing PPI in the context of a doctoral research study and 
considers how barriers were overcome. 
 
Chapter ten, the conclusion, describes how the aims have been achieved and the 
implications of the study. The chapter also sets out the limitations of the study. It 
identifies further research and recommendations in the field and argues that the current 
study has advanced the field of PPI evaluation and PPI in implementation. 
 
 
  
 
End user involvement influencing this phase/chapter 
 
December 2009 - Conceptualisation of the study. Involvement in the form of 
consultation took place on a one-to-one basis with 6 people: researchers, PPI staff, 
patients and public. These conversations took place following a national meeting 
about PPI and impact. This led to the development and refining of the objectives of 
the current research and the need to have a specific health area (cancer) as a focus 
for the study. 
 
April 2011 - Conceptualisation of the study. Involvement in the form of 
collaboration via a workshop with 8 academics at De Montfort University. This led 
to understanding the need for having PPI in the study itself. 
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Chapter Two: Overview of PPI in health and research in England 
Introduction 
There are two literature chapters in this thesis.  This chapter is a policy overview of PPI 
in health research and the next literature chapter is a critical thematic narrative review. 
The focus of this chapter is on the policy, practice and theory of patient and public 
involvement (PPI) in healthcare services and research in the UK. The purpose is to 
contextualise the recent and rich evolution of PPI from healthcare to research within the 
political and theoretical landscape1.  
 
There are four broad sections in this chapter which help to set the context for the thesis. 
The first section draws attention to the terms used across the literature and helps to set 
the scene about the roots of PPI and how policy (and with it) terminology has evolved.  
The second section offers understandings about the rationale and ideology of patient and 
public involvement in healthcare arguing that democratic and technocratic principles 
guide involvement policies. The third section of this chapter traces neoliberalism in PPI 
in healthcare policy. The idea of PPI is critiqued, as is the rhetoric used by politicians. 
The fourth section focuses specifically on research policy concerning PPI and offers a 
critique of the Going the Extra Mile (GEM, 2015) recommendations. Through the 
critique, issues about the quality and power-sharing of PPI in research are raised by 
considering theory-based models such as the commonly used Arnstein’s Ladder of 
Participation (1969). The critical theory of Habermas (1987) has been threaded in to this 
last section, as it helps to analyse the GEM report recommendations. It is worthy of note 
that this fourth section is long but highly necessary because the GEM policy is the only 
PPI specific research policy that situates the government’s thinking relating to the current 
thesis. The GEM report recommendations will be analysed to help gain a sense of PPI 
principles and the values placed on PPI in research. Analysing each recommendation 
                                                 
1 The discussion in this chapter uses materials from a mix of sources including select papers from the 
critical thematic narrative review (next chapter), recent policy documents, critical theoretical literature from 
books, funding websites and grey literature from conference proceedings.  
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offers insights into context and process of PPI in research (context and process are 
running themes in the entire thesis). 
 
By collectively exploring these entwined four sections concerning PPI, a concluding 
summary is offered at the end, in which it is argued that PPI in research practice is steadier 
than in health services. It also concludes that the ‘impact of PPI’ question stems from 
neoliberal thinking but also threatens neoliberalism. 
Section 1. Terms used in PPI  
This study uses the widely accepted term ‘patient and public’ but it is important to clarify 
that within the literature sources used, different terminology was referred to for patients 
and the public involved in healthcare and research. Whilst placing people in neat 
categories is not the purpose of the study, it is important to acknowledge the difference 
between those who are professionally involved in health research, i.e. salaried workers in 
healthcare versus those who are people involved in the research because of their illness 
and experience. Thus, a critique is offered about some of the assumptions and 
connotations which are associated with the terms. 
 
Commonly used terms found in the literature included consumer, service user, user, 
client, lay person, expert by experience and expert patient. There were other labels too, 
but these ones particularly were frequently referred to. Each label listed here has positives 
and negatives associated with it and while the label may define someone’s status it also 
carries weight beyond its definition. The term ‘consumer’, whilst implying choice of care, 
has been critiqued as suggesting a market-based consciousness that the patient is a 
customer, that the NHS is a market and the doctor is a provider (Boote et al. 2002). ‘User’ 
or ‘service user’ similarly, at face value, implied ensuring the suitability of the service 
(DH 1998). However, it would commonly be associated only with those who had a history 
of substance abuse or mental health (McLaughlin 2008) leading to confusion about its 
transferability. The name ‘client’ was widely used in the UK to describe a social work 
relationship between social workers (including hospital social workers) and the people 
they protect (McDonald 2006 in McLaughlin 2009). However, client has negative 
constructions associated with it too, mainly to suggest those who are clients are often in 
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need of something (McLaughlin 2008). The label ‘lay person’ may distinguish from 
someone who is not a professional in healthcare, but it also suggests the person is present 
with less knowledge, even though they may have another profession (Thompson 2009). 
Despite this, in the absence of universally accepted terminology, occasionally ‘lay’ will 
be used in this thesis mainly to distinguish between healthcare professionals who are 
salaried workers versus those who are there because of their lived experience. ‘Expert by 
experience’ or ‘expert patient’ are the final terms scrutinised because it makes a claim for 
specialist knowledge about a health condition which is framed from the view of the 
patient with the lived experience (McLaughlin 2008). The term ‘expert patient’ has 
gained currency via the government over the last few years, e.g. the Expert Patient 
Programme (Donaldson 3003). The name implies that ‘…[they] have the confidence, 
skills, information and knowledge to play a central role in the management of life with 
chronic diseases’ (DOH 2001 page no unavailable). The problem with this term however 
is that it paints a picture of a patient who has researched their illness and demands 
improved treatment, which is expensive, unsuitable and one that the clinician does not 
know about (Shaw 2004). But, the term also suggests a degree of power that the other 
terms do not quite capture. In this work ‘expert patient’ will be used in the methodology 
chapter and in the findings (chapter six) to distinguish patient participants from other 
‘expert’ participants. 
Summary of section 1. Terms used in PPI 
In this first section terminology concerning PPI has been explored. Ultimately what each 
of these terms describe is the unequal relationship between those in power and those 
outside it. They demonstrate that terms range from those which are passive to those which 
imply levels of knowledge about health and disease. In the previous chapter a summary 
of key terms used in this thesis and their definitions has been offered. Paying attention to 
terminology matters because underpinning the discourse of labels and names are 
questions concerning ideology, to which we now turn our attention. 
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Section 2. The rationale and ideology behind patient and public involvement in 
healthcare 
Since the 1970s, UK governments have pursued various policies to enable PPI in 
healthcare underpinned by a combination of two stances: democratic (attempting to 
legitimise services), and technocratic (improving services to suit people better).  
 
Democratic 
Abelson et al. (2003) argue that involvement improves the accountability of public 
services, and in turn contributes to addressing a wider but contentious ‘democratic deficit’ 
in public life (Flinders 2015; Warren 2009; Wood 2010). By improving accountability, 
PPI offers a democratising influence, and enhances the legitimacy of public services and 
administration. This accountability in turn offers engagement as a means of tackling often 
entrenched policy problems. Abelson et al. (2003) argue that the trend of involvement in 
governance suggests policymakers want a more sceptical and critical public, where 
involvement provides a way to harness popular rejection of paternalistic healthcare 
models of governing. This basis for involvement would appeal to the principles of 
individualism and autonomy whereby people become self-governing and rely less on the 
state (Schofield 2002), echoing the neoliberal challenge to professional power. Such 
principles are in tension with collectivism. Consumerism, choice and meeting the needs 
of a demanding public in healthcare are framed in ‘market’ terms, rejecting the ‘one size 
fits all’ approach to healthcare provision (Clarke et al. 2007). As a result, participation 
offers both co-operation between services and the ‘demanding public’, and serves as an 
instrument for self-governance within communities (Schofield 2002).  
 
Technocratic 
In contrast, a technocratic rationale for improving PPI in healthcare, as Beresford (2005) 
argues, concerns the intimate link between people’s personal experience of a health 
condition and having a greater say in controlling their own lives. The ideological 
characteristics of this concern the struggles experienced by people regarding unequal 
access to services (a thread running through this chapter), a point which is important 
because it suggests that activism and agency can improve services. The driving factors 
for change are therefore equality and empowerment (Barnes et al. 2004), but the focus on 
service improvement is technocratic by nature.  
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The welfare state has faced criticism as being inflexible and bureaucratic (Hogg 2009), 
and from the 1970s onwards, became increasingly challenged by equality-based 
movements, for example disability activism (Barnes 2003). People’s experiences and 
experiential knowledge became important in offering medicine the lay perspective 
(Popay and Williams 1996: Epstien 1996) but with the issues of lay and professional 
knowledge came questions of who has the power (Milewa et al. 1999).  
 
Both the democratic and technocratic stances have seen a rise in the public becoming 
sceptical because of changing (healthcare) structures and expectations in society 
(Giddens 1991). Some public doubt probably comes from the rising and falling of patient-
and public-focused organisations such as the Community Health Councils (CHCs) and 
Patient and Public Involvement Forum(s) (PPIF) (discussed later). But being involved in 
government dealings beyond voting is attractive to sections of the public and to some 
extent the government too (Martin 2007). Each rationale suggests different outcomes 
attributable to involvement (Montpetit 2008) and people will have different motivations 
for engaging.  
 
Democratically driven involvement expects improved accountability and individualistic 
responsibility (Truman and Raine 2002). In contrast technocratically driven policy 
characteristics concern improving the quality of a service by using people’s experiences, 
ideas and knowledge (Prior 2003). In healthcare research, as the chapter will move onto 
later, the ideas of these rationales extend to the person(s) involved being the co-
producer(s) of research (Greenalgh et al. 2016), as they help to generate useful questions 
to address healthcare problems and potentially improve translation of research into 
practice (Rycroft-Malone et al. 2016).  
 
To whom PPI policies appeal to 
The people to whom technocratically driven policies appeal may well be different from 
those who respond better to the democratically driven ones. In both cases though, the 
issue of representativeness and whose knowledge is being used to inform the services is 
often inadequately addressed (Crawford et al. 2003). Some involvement plans expect 
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elected members of the public, some random selection, and some stratified selection, 
which guarantees ‘representation of different demographic groups, for example those of 
different ethnicities, socio-economic (backgrounds and ages) and election’ (Martin 2009a 
p4). Each of the approaches to representativeness comes with problems of whose views 
are being used and whose views are trustworthy (Martin 2009b).    
 
The democratic ideology is a mixed spectrum of genuine democracy on the one hand and 
a challenge to the effectiveness and efficiency of services on the other. The technocratic 
ideology concerns improving the integrity of healthcare services using people’s daily 
experience and knowledge of struggles. Despite their differences, both ideologies of 
involvement contain within them notions of ‘democracy’ in healthcare services. 
However, this presents one acute challenge, that of ‘representativeness’. 
 
Involvement opportunities are often undermined or controlled by the powerful (Beresford 
and Campbell 1994) and as a result involvement can often be merely an act of tokenism, 
manipulating PPI processes to advance professional interests (Milewa et al. 1999). Martin 
(2008a) has argued that because involvement initiatives are not representative, they could 
be understood as a distortion of participation policy whereby outcomes of who gets 
involved will be contingent on micro-level negotiations. The problem of legitimacy of 
knowledge begins at self-selection because those that come forward are often from 
middle-class cross-sections of society (Church et al. 2002) or ‘pale, male, and stale’ 
(Flinders et al. 2011). Harrison and Mort (1998) call the legitimacy issue a ‘technology 
of legitimation’, implying professionals use certain voices over others to suit their own 
agendas and yet at the same time reject certain views, claiming those voices are rejected 
because they are ‘unrepresentative’ (Barnes 1999. p79). Martin (2008b, p.1758) argues 
that this is a case of ‘acute hypocrisy’ using Beresford and Campbell’s (1994) work to 
confirm his own analysis of representativeness, arguing that this is a ‘no win’ situation. 
Learmonth et al. (2009) summarise this paradoxical situation that people have to be 
‘ordinary’ to represent their community but if they are ordinary, they cannot effectively 
represent their community. 
As already discussed, PPI is delivered via a complex infrastructure of services in England. 
The third sector is a significant contributor to healthcare. Patients and the public 
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contribute to the shaping of health care via the third sector in a number of ways, including 
contributing to the development of health policies and campaigns and by setting research 
priorities and resource planning. Patient groups, set up by the third sector, are also 
involved in identifying ethical and best practice in treating particular diseases (Baggott 
and Jones 2018). However, whilst these tasks and roles are important in the running of 
health services, questions remain about whom these individuals and organisations 
represent and precisely who holds power to exert influence.   
 
Community participation in the third sector offers a way for people and groups to 
legitimise their own knowledge claims and experience of health and disease (Renedo and 
Marston 2011). They may do this for technocratic or democratic reasons, or a 
combination of both, which in turn can potentially lead to disagreement amongst 
advocacy groups. For example, groups might seek to draw on combined experiences of a 
disease or prioritise the needs of an individual citizen with their unique experience of 
disease. Further, Baggott and Jones (2018) suggest that some patient groups may not be 
representative in the absence of formal membership processes. Yet, if such groups can 
draw on the solidarity, expertise and support from the wider public, their knowledge 
claims will be considered more authoritive or legitimate when exerting power and 
influence. Researchers therefore need to be mindful of ‘whose voice’ is represented 
through third sector PPI. Through considering third sector organisations, we can identify 
challenges of representativeness that are very similar to those found in debates within the 
public sector. 
 
Summary of section 2. The rationale and ideology of patient and public involvement in 
healthcare 
In this section of critiquing democracy in healthcare services, the drivers of democratic 
and technocratic policy understandings have been formed. On the one hand problem 
policy attempts to fix a democratic deficit and on the other it serves a purpose to legitimise 
healthcare. The problem of representativeness has been summarised. It is argued that 
people involved may not have the organic (and networked) connections that healthcare 
needs thus people are not representative of the populations affected by the problem issue. 
This may further exacerbate any democratic deficit and health inequalities (later it will 
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be argued that a similar problem exists in healthcare research). In the next section the 
policies and rhetoric around PPI initiatives are considered to understand the evolution and 
reshuffling of such initiatives in England, leading to a claim that a strong neoliberal 
undercurrent runs though policy. 
Section 3. Tracing patient and public involvement in healthcare policy  
The government’s ambition for the health service when it was first set up was to have a 
centrally controlled public service, but policy concerning PPI was limited before 1973 
(Toth 1996). Healthcare began as a collective movement but ended up turning into an 
individualism agenda, resulting in a weaker universal healthcare system, and in turn 
valuing a neoliberal agenda.    
 
Thatcher 
Local authorities managed community health services until 1974. After this point, under 
Prime Minister Wilson, Community Health Councils (CHCs) were introduced in England 
(and Wales) to endorse local community input in health-related matters. When Thatcher’s 
premiership began in 1979, she had ‘different ideas’ about how to tackle the problems in 
the NHS and its relationship to the people using the service (Hogg 2009 p.3). She 
introduced ‘New Public Management’ ideas to healthcare and an internal market, notable 
for its purchaser/provider split). As a result, involvement was increasingly beginning to 
take place within a consumerist health care agenda. In this new model of health delivery, 
CHCs were becoming redundant and health authorities became the ‘consumer champion’ 
(Hogg 1999). Milewa et al. (1999) argue that health authorities in the Thatcher era were 
believed to have all the knowledge about what the public needed and wanted from 
services, but they failed to state who had claimed this position. Thatcher’s government 
saw the possibilities of using individual people to manoeuvre change in her proposed 
business model of the NHS and the language of ‘consumerism’ became fashionable. 
These consumers were understood to help local authorities by expressing their 
dissatisfaction about the quality of services they were receiving. The consumerist focus 
(technocratic ideology) therefore dominated over a democratic focus.  
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Also, during this time, there was a notable move towards people taking responsibility for 
their own health, a direct challenge to state responsibility for collective healthcare. This 
permeated different public-sector policies and began to undermine the collectivist and 
social rights principles of citizenship (Heater 2004). The social rights discourse in 
citizenship enables a relationship of accountability between public service providers and 
their users (Barnes 1999). Consumerist ideologies raise questions of how equal access to 
services and treatments are safeguarded for all users because individual consumers are 
likely to inhibit or prevent collective approaches (Steen et al. 2018). Steen et al. (2018) 
argue that the employment of individualistic policies by government act as a cover-up for 
‘minimizing governments’ responsibilities and accountability in a context of scarcity of 
financial resources […and] in social and health care services most specifically’ (p285). 
Over time, the continual undermining of collectivism has, according to some authors, 
resulted in increased social inequalities and the reinforcement of ideas about the 
‘deserving’ and ‘undeserving poor’ (Hogg 2009; Bambra et al. 2010). 
 
Major 
The turn towards individualism continued under John Major’s leadership of the 
Conservative government in the 1990s, with an increasing focus on individual 
responsibility underpinned by a liberal economic agenda. Government interest in 
community development around this time fitted effortless with its broader aims of 
decentralisation, voluntarism and consumerism (Farrant 1991). As care in the community 
healthcare reforms took hold, so too did new codes of practice.  
 
In 1991, a passive Patient’s Charter was introduced with the aim of defining rights and 
standards that the public could expect from the healthcare they received. This was situated 
as a way for people to be informed about what to expect in order to better benchmark 
their satisfaction (Coulter 1997). Then in 1992, further attempts were made to strengthen 
the purpose of involvement, which outlined plans for how health commissioners could 
involve local people in purchasing agreements (Rhodes and Nacon 1998). This approach 
continued for five years until the announcement was made to reform local commissioning 
under New Labour (see below), and Primary Care Groups were established with 
commissioning responsibilities (Rhodes and Nocon 1998). Public confidence in 
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healthcare was low by this point, but expectations were rising. Perhaps one contributing 
factor for low public confidence might have been the serious clinical failings at Bristol 
Royal Infirmary where 29 babies had died during or after heart surgery (Dyer 1998). 
 
Blair 
When New Labour was elected in 1997, Tony Blair’s agenda for health became one 
concerning ‘modernisation’ of healthcare alongside significant financial investment. The 
term ‘user involvement’ started to gain currency, and many of the reforms were arguably 
a continuation of individualism enacted under Thatcher and Major. Engaging with all 
citizens, and people understanding their social rights, became guiding policy themes. 
Amongst many plans, New Labour introduced Health Action Zones to involve local 
people in decision-making about local health services (Rhodes and Nocan 1998).  
 
Blair’s plans were sometimes controversial, for example replacing, in 2003, 185 CHCs 
with 572 Patient and Public Involvement Forums (PPIF) and Patient Advisory Liaison 
Services (PALS) (Baggott 2005). The reason for the abolition of CHCs rested in fears 
that they attracted the ‘usual suspects’, implying the same people were repeatedly coming 
forward to represent everyone in society (Hogg 2009). Unlike the CHCs, the PPIFs were 
linked to institutions, NHS trusts and Primary Care Trusts. Their stated aim was to 
improve public engagement in NHS organisations but whether and how this happened 
was unclear. Also, in 2003, the Commission for Patient and Public Involvement in Health 
(CPPIH) was set up as a non-departmental public body with many responsibilities, 
including undertaking national reviews of policies and services. However, after just 18 
months the closure of the CPPIH was announced. This was because there were concerns 
about the way in which the CPPIH approached public involvement. Meanwhile PPIFs 
were criticised for not accurately communicating with or reflecting the views of local 
communities (Baggott 2005: Forster and Gabe 2008: Tritter 2009). Then in 2006, another 
new announcement was made that 151 Local Involvement Networks (LINks) would 
replace the 572 PPIFs. LINks were developed to engage with the local communities and 
the voluntary sector organisations, but they had no statutory rights (Hogg 2009). LINks 
focused on commissioning rather than providing services: funding was channelled 
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through local authorities, which commissioned a local organisation to act as a host for the 
relationship to be made with people in that locality.  
 
These numerous and rapid reshuffles could have been interpreted as indicating that 
something odd and unclear was guiding involvement initiatives, perhaps by destabilising 
the structures representing people using healthcare. The changes also destabilised public 
understandings of what government was trying to achieve during this period. 
 
Brown 
For Gordon Brown’s premiership in 2007, the concept of ‘engagement’ became 
commonplace. However, inequalities in participation persisted and relatively few people 
participated in established health forums. More work needed to be done to engage ‘hard-
to-reach’ people. The Darzi Review (2007) emphasised the need to give patients and the 
public better information and more control and influence. However, soon after in 2008, 
the world financial crisis took hold, followed by a sustained global recession. It was a 
time of the economic downturn and consequent restrictions to public funds. Austerity 
took hold with an aim of reducing the budget deficit.  
 
Cameron 
In 2010 David Cameron, who had formed a Coalition government between the 
Conservatives and Liberal Democrats, introduced the ‘Big Society’ agenda and a number 
of reforms designed to stimulate ‘localism’. For Cameron: 
The Big Society is about a huge culture change, where people, in their everyday 
lives, in their homes, in their neighbourhoods, in their workplace, don’t always 
turn to officials, local authorities or central government for answers to the 
problems they face but instead feel both free and powerful enough to help 
themselves and their own communities. 
(Cameron 2010)  
 
Built on his perception of a ‘broken Britain’, the ideas underpinning the Big Society 
echoed a return to individual responsibility, rather than state responsibility. A reduction 
in state ‘interference’ would mean that individuals and communities would need to work 
out issues for themselves, with emphasis on civil society rather than the state (Hogg and 
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Baines 2011). The accompanying localism agenda worked to decentralise power with 
expectation that local governments and communities would take responsibility, yet no 
funds were provided for this ambition. The ideology of the Big Society underpins the 
Liberating the NHS white paper, where decentralisation plans are clear: ‘Too many 
decisions have been made nationally, rather than locally, without enough public 
involvement.’ (Department of Health 2010b). Liberating the NHS led to the abolition of 
LINks, replacing them with 152 local HealthWatch organisations, one for each local 
authority. HealthWatch England was designed to support the work of the local 
HealthWatch organisations and recommended inspections of services which appeared to 
be failing. Reference to HealthWatch was included in the Health and Social Care Act 
2012 too, which was developed to help strengthen public power and involvement in health 
and social care. HealthWatch became established in 2013. After 2013, no public speeches 
mentioned the Big Society (Levitas 2012), suggesting the agenda has failed to gain public 
traction.  
May 
After the resignation of Cameron in 2016, Theresa May became Prime Minister of the 
Conservative government and to date the NHS remains financially unstable and continues 
to dominate public policy debate about its funding and priorities. The Brexit negotiations 
dominate political discourse and meanwhile other social policy has taken a back seat. The 
language of consumerism remains present (e.g. McCartney 2017), thus maintaining 
neoliberal thinking. 
Summary of section 3 Tracing patient and public involvement in healthcare policy  
The purpose of introducing the selected PPI policy initiatives by each government is not 
to ‘skate over’ the different structures of involvement at local, regional and national 
levels. Rather, it demonstrates the continuity and changes in language used and the cycle 
of centrally driven reform, without clarity, by whosoever sits in power. At best, 
involvement policy is confused and muddled (Forbat et al. 2009). Ideological difference 
is demonstrated in tensions between how a policy issue is communicated to the public 
and how the policy issue is achieved. Instability is clearly exemplified between 2003 - 
2013 with three major reorganisations for patient-focused organisations. It seems that no 
structure could stay for too long, in case it become powerful or genuinely questioning of 
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decisions on healthcare. Rather than address any democratic deficit, changes could 
ultimately exacerbate problems of participation. Thatcher’s neoliberal ideology was 
subsequently strengthened and more firmly embedded by her successors (McKee and 
Stuckler 2011). In the next section the literature focuses on healthcare research, the focus 
of the current thesis. 
Section 4. Tracing policy for patient and public involvement in research 
Despite the enduring climate of financial austerity, there continues to be an economic 
imperative to support the development of the UK research and knowledge industry 
(Carter et al. 2013). Legislative developments, such as the Health and Social Care Act 
2012 (DH 2012), have opened the door to the NIHR, working with NHS England and 
others, to increase opportunities for the public to contribute to research (NIHR 2018). The 
origins and development of PPI in research policy shall be the focus of this last section 
in this chapter.  
What is PPI in research? 
It is now commonly accepted that it may be appropriate to involve people in all stages of 
the research process, depending on the research project. There are various points where 
PPI can take place in the research cycle (as shown in figure 1 below). 
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Figure 1 - Research cycle of patient and public involvement 
(Pandya-Wood and Robinson 2014) 
 
The extent to which people are involved can vary significantly, from consultative, through 
collaborative and ultimately to user-controlled involvement (Fleming and Hudson 2009).  
Whichever stages of the research cycle the involvement takes place(s) in, it is important 
to clarify the purpose and identify suitable resources (Boaz et al. 2018). There is a 
growing field of spectra (Hanley et al. 2003), frameworks (Shippee et al. 2013) and 
models (Forbat et al. 2009) to help understand characteristics of PPI in research. PPI has 
been documented in a variety of healthcare research areas to have positive outcomes on 
different stages of the research, for example: winning funding for the research, designing, 
recruitment, and selecting outcomes (Domecq et al. 2014). In chapter three, the impact 
on all of the stages of the research cycle is considered in more depth, including the 
potential for negative impact.  
 
Although from an outsider’s point of view it would seem that PPI has been carefully 
considered and works well in research, at a closer level of scrutiny there are problems of 
delivery (explained later). Prior to this, a brief history of PPI in research is offered to help 
situate involvement in research in healthcare in England. 
Identifying and 
prioritising
Commissioning
Designing and 
managing
Undertaking Disseminating
Implementation
Evaluating 
impact
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How did PPI in research start? 
State funded medical research in England began in 1919 (Medical Research Council 
2017) but involvement of patients in research only really started 80 or so years later. In 
England, clinical trials were inviting patient input around the mid-1990s (see Partridge’s 
contributions in Consumers in NHS Research (now known as INVOLVE) (2000)). 
According to Thornton (2008), AIDS patients had challenged researchers conducting 
trials that overlooked patients’ preferences of outcomes. Thornton (2008) also argues that 
in 1997, after an international conference on breast cancer advocacy, there was a notable 
shift towards ‘consumer participation’ in the UK. Thornton (2008) identified that 1995 
was an important time for PPI in research, as a Health Select Committee report on breast 
cancer services had faithfully offered an entire section to ‘involving patients in research’. 
Select Committee members believed that their recommendations would help to improve 
the standard of care for women in the UK with breast cancer. They also hoped that ‘as 
other specialties follow the lead, they may help to raise the standard of care for all cancer 
patients’ (Thornton 2008, p904). Since the mid 1990s, government policy documents 
referring to involvement in research have steadily established the concept of PPI in 
research (Evans 2014).  
 
Best research for best health policy 
An important research policy set out by the DH was Best Research for Best Health (2006). 
The DH endorsed PPI by suggesting that they knew that PPI in research made research 
more relevant to the needs of the people the research affected. That more reliable 
knowledge was formed thus more likely to be applied into practice (DH 2006). But people 
needed to be involved in all stages of the research: 
priority setting, defining research outcomes, selecting research methodology, 
patient recruitment, interpretation of findings and dissemination of results. We 
have established structures and mechanisms to facilitate increased involvement 
of patients and the public in all these stages of NHS Research and Development. 
[…] We will continue funding and developing INVOLVE […]  
(Department of Health 2006) 
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A blanket expectation of involvement throughout the research process has been critiqued 
on the frontline by researchers because of premature understandings within the policy 
about what is deemed appropriate and meaningful to achieve a useful contribution for a 
study (Bagley et al. 2015).  
 
As the statement above suggests the DH promised to support INVOLVE - established in 
1996. INVOLVE describes itself as world leading for PPI in research and is one of the 
few government funded programmes of its kind globally. They have a national advisory 
group and their role is to bring together insights, expertise and experience to ensure PPI 
is an essential component to research (INVOLVE 2018). As outlined in the introduction 
INVOLVE (2018) defines PPI as: ‘Doing research with or by people, not to about or for 
them’. This definition appeared in over half of the journal papers appraised (in the next 
chapter), suggesting acceptance amongst scholars in the field. Linked to the INVOLVE, 
the DH set up the NIHR. 
 
The NIHR is funded by taxation, and as a result, PPI in research retains an important 
place in healthcare funding. The DH has invested considerably in policy for PPI in health 
research: the NIHR is a large, multi-faceted and nationally distributed organisation 
(Harvey et al. 2011). The NIHR vision is: ‘To improve the health and wealth of the nation 
through research' (NIHR 2013). Its mission is: ‘To provide a health research system in 
which the NHS supports outstanding individuals working in world-class facilities, 
conducting leading-edge research focused on the needs of patients and the public’. The 
NIHR’s aims are to: 
1. Establish the NHS as an internationally recognised centre of research excellence; 
2. Attract, develop and retain the best research professionals to conduct people-
based research; 
3. Commission research focused on improving health and social care; 
4. Strengthen and streamline systems for research management and governance; 
5. Increase the opportunities for patients and the public to participate in, and benefit 
from, research; 
6. Promote and protect the interests of patients and the public in health research; 
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7. Drive faster translation of scientific discoveries into tangible benefits for patients; 
8. Maximise the research potential of the NHS to contribute to the economic growth 
of the country through the life sciences industry; and 
9. Act as sound custodians of public money for the public good. 
(NIHR 2013) 
 
The NIHR is designed around patients and the public (Green 2015). The target diagram 
(Figure 2) demonstrates that the different components of the NIHR (faculty, infrastructure 
and research) all carry out their work plans with the patients and the public at the heart of 
everything they do. The NIHR’s facilities and systems represent an integrated clinical 
research system and, since its establishment, claims itself to have increased the volume 
of applied health research for the benefit of patients and the public, driven faster 
translation of basic science discoveries into definite benefits for patients and the 
economy, and to have developed and supported the people who conduct and contribute 
to applied health research (NIHR 2015).  
 
 
Figure 2 - NIHR Target diagram 
 
To scrutinise just one section of the target diagram helps us to understand the PPI agenda. 
Under the infrastructure organisations, for example, sit the Research Design Services 
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(RDS). As mentioned in the introduction chapter the author works in an RDS as a PPI 
lead. RDS’ have a strong but recent foundation in the NIHR. In February 2016, the 
Department of Health and Social Care (DHSC) via the NIHR, initiated a partnership 
between the RDS and INVOLVE because it was believed that RDS’ had the ability to 
draw on the expertise of research advisers working on the ground with researchers doing 
PPI and using real-world examples. NIHR believed the partnership would help inform 
the development of national policy and guidance, which was technically INVOLVE’s 
sole role before this period. In addition, NIHR believed that the partnership would have 
the ability to rapidly convey new national policy issues to local researchers.  
 
The ten RDS are split by England’s regions and were set up to help researchers to submit 
high quality research applications for national, peer-reviewed funding (NIHR RDS 2018). 
A major work stream for all RDS’ is to help researchers consider PPI at research design 
stage. RDS’ have facilitated this via a ‘Public Involvement Fund’ to help pay for early 
involvement of the patients and public in research design work (Walker and Pandya-
Wood 2013). The work of the RDS raises awareness of what good practice at research 
design stage might look like, with the research community, by considering ethical 
boundaries and the consequences of close patient contact with researchers before formal 
ethical approval has been obtained (Pandya-Wood et al. 2017a).  They also identify and 
assist with the types of issues to consider when inviting the input of public co-applicants 
to help with planning, conducting and disseminating the research study. However, the 
legal position of involving the (lay) public as co-applicants in research and how these 
people will be adequately paid, trained and mentored (like the rest of the research team) 
is under-developed (Pandya-Wood et al. 2017b).  
 
Anticipating the progress made and challenges ahead in PPI in research, and to help plan 
for the next decade, in 2014 an independent panel conducted a review of PPI in research 
to help form an overarching PPI in research policy for the NIHR. The consultation with 
hundreds of public and patients and over 80 national and international organisations, 
provided evidence and helped to scan the horizons of PPI in research for the NIHR to 
consider. The consultation’s name ‘Breaking Boundaries’ implied that the NIHR was 
aware of the barriers that existed between researchers and PPI. What followed was a 
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policy report called ‘Going the Extra Mile’ (NIHR 2015) outlining a new vision, mission 
and set of goals for the next ten years specifically to address research-related PPI 
complexities.  
Going the Extra Mile  
Going the Extra Mile (GEM) raised 11 recommendations, each of which are explored 
here, along with a short critical appraisal of what may have been at the heart of the issue 
that the recommendation is addressing. Critiquing the recommendations individually 
helps to locate arguments and gaps in knowledge about representativeness, equalities, 
resources and leadership around PPI in research that the current study will address.  
 
Recommendation one: Information and communication 
To improve the ways in which the public can learn about and become involved 
in research, the NIHR will work with partners. 
(GEM 2015)  
 
The problem of representativeness and poor communication sits behind this dual 
recommendation. The field of PPI has been described on the ground by frontline workers 
as a ‘battle ground’ of competing interests concerning the diverse needs of a society 
characterised by differences of race, religion, class, disability, sexuality and gender. The 
technocratic and democratic ideas that all these differences can work together to service 
research are nothing short of utopianism (Gibson et al. 2012). But by applying newer 
ways to address the long-standing issue of having the same people come forward, and 
perhaps making it easier for the public to get involved via better communication in a more 
tailored way, helps to address inclusiveness as a democratic value (Bochel et al. 2008).  
 
Perhaps the issue of ‘communication’ could be fostered as a dialogic process, helping to 
harness understandings about people’s motivations of involvement. Bissell et al. (2018) 
argue, in their paper about PPI work in the cancer research setting, that Habermas’ (1987) 
work on communicative rationality and avoiding colonisation of the lifeworld by the 
forces of capitalism and the state is a useful way to help pave mutual understanding 
between those inside and outside of systems. Patients and the public are outside of 
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systems and their lifeworld is governed by communicative rationality, orientated towards 
reasoning and achieving mutual understanding. This recommendation of GEM is an 
opportune way to consider these different but entwined issues. 
 
Recommendation two: Culture (a) 
The NIHR will commission the development of a set of values, principles and 
standards for public involvement, to be co-produced with the public and other 
partners. 
(GEM 2015).  
 
This recommendation addresses the thorny issue of tokenism. Researchers can sometimes 
be suspicious, unwilling to cede control and are dubious about involvement (Carter 2013). 
Having principles and standards can help to overcome challenges such as tokenism. More 
importantly, standards of good practice can clarify for those involved, the expectations 
from both sides. Arnstein’s (1969) ladder of citizen participation focused on power and 
has been used to conceptualise the extent of involvement in research (Tritter and 
McCallum 2006; Gibson et al. 2012; Mc Laughlin 2009; Oliver et al. 2008). The eight 
rungs of the ladder are: manipulation, therapy, informing, consultation, placation, 
partnership, delegated power and citizen controlled. The model demonstrates that 
participation does not come without democratic and technocratic concerns and implies 
that participation processes may often be little more than manipulation. For Arnstein, 
participation was concerned with the power to make decisions and the seizing of this 
power. Each rung relates directly to the degree to which citizens had achieved decision-
making power. Arnstein’s work has been critiqued for being too linear, missing rungs, 
and for focusing too much on one type of power without looking at the dynamics of 
involvement (Tritter and McCallum 2006). The model has been adapted to include 
Mullen et al.’s (1984) reactive and proactive involvement and to help create a matrix of 
involvement (Oliver et al. 2008). McLaughlin (2009) argues that the ladder fails to 
appreciate that involvement evolves in projects, outlining that involvement of the public 
at research application stage will not have the same level of input as at write-up stage. 
The linearity is problematic as it may lead people to be swayed to either starting at the 
highest or lowest points of the ladder rungs, opening potential for tokenism in practice. 
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The ladder analysis demonstrates that since 1969, the application of the ladder 
specifically for research in healthcare is unhelpful, but scholars appreciate it as a starting 
point for addressing principles and standards in of PPI research.  
 
More recently, a Medical Research Council (MRC) study (Gradinger 2015) on values 
associated with PPI, found that there were three value sets. One, normative values 
concerned ethical and political values associated with empowerment, change, 
accountability and transparency. Two, substantive values concerned with consequences 
of PPI in research e.g. quality, validity, relevance, reliability, representativeness and 
evidence. The third set of values concerned processes, e.g. partnership, trust, clarity and 
respect.  
 
Therefore, broad principles and standards of involvement, as the recommendation states, 
offers a common new starting point for researchers and the patients and public involved 
to consider aspects such as decision making, power and the avoidance of tokenism. 
Subsequent to this recommendation, six principles have been developed and are being 
piloted for wider use, covering: respect, support, transparency, responsiveness, diversity 
and accountability, and six standards which comprise: Inclusive opportunities, working 
together, support and learning, communications, impact and governance (NIHR 2017). 
 
Recommendation three: Culture (b) 
Strategic goals identified in the report will be included in the NIHR overall 
strategic plan and become the objectives against which public involvement, 
engagement and participation are planned and reported across the NIHR, 
(GEM 2015) 
 
This recommendation concerns making PPI and engagement meaningful in routine 
research practice. Such an approach would foster a culture which values and encourages 
questions and dialogue between professionals and the lay public. In the report, the 
strategic goal to use and apply people’s knowledge gained through their experience of 
health and social care and research is believed to be a vital component to developing 
treatments, interventions and services required to tackle the health needs and priorities of 
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the population (GEM 2015). This recommendation builds on the previous 
recommendation of culture and the formation of national standards, by creating a culture 
that values lay knowledge working with professional knowledge. This is an important 
point because current systems of lay input into healthcare research do not always function 
well, e.g. people involved are sometimes barely able to express their views (Renedo et al. 
2015). One PhD study, on the impact of PPI in the cancer research context (Thompson 
2009), found that participants highlighted specific forms of expertise in their accounts 
about involvement. These accounts suggested professionalisation of patients, above and 
beyond what may have been regarded as experiential expertise. This professionalisation 
legitimatised their credibility in PPI roles (Thompson et al. 2012). In a further publication, 
Thompson et al. (2014) argued using Habermas’ (1987) systems and lifeworld analogy, 
that in health systems, such as the NIHR, certain rules and practices are more or less 
codified and organised in meaningful ways to deliver outcomes for both professional and 
lay groups. Thus, Bissell et al. (2018) argue that involvement (in cancer research settings) 
is less about the use of experience, and more about lay people watching or supporting the 
professional researchers at work. Despite this criticism, recommendation three in the 
GEM report is commendable, if ambitious. 
 
Recommendation four: Continuous Improvement (a) 
INVOLVE will provide leadership and co-ordination across the NIHR, ensuring 
that the public and researchers are better supported to do public involvement. 
NIHR leaders, researchers and staff will receive an induction in public 
involvement and leads across the NIHR will have their own leadership and 
development programme as well as opportunities to share good practice. 
(GEM 2015) 
 
The NIHR has recognised that PPI in research requires long-term investment, leadership 
and co-ordination. This recommendation echoes the general concerns about leadership 
found in wider literature around research impact and implementation (e.g. Kuruvilla et 
al. 2006) as well as PPI literature (e.g. Jinks et al. 2016). Trust between researchers, 
patients and the public, and staff in PPI leadership roles requires investment. Learning 
about what approaches in PPI work best in different healthcare research settings requires 
detailed understandings about the complex interplay of involvement dynamics. Concerns 
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include: clarity of purpose, defined roles and relationships, organised support and a 
strongly funded infrastructure, which are all components believed to create the spaces for 
strong and supported PPI in research (Jinks et al. 2016).  
 
Since this recommendation, a leadership survey took place between June 2017-January 
2018 amongst PPI leads across the RDS network, which demonstrated that a considerable 
mix of skills and knowledge is needed for those working on the ground, supporting 
researchers and patients and public. The synthesised set of knowledge and skills spans 
academia, management, community development work, healthcare and nursing.  This 
implies that the staff leading in PPI roles need to be highly trained and invested in, to help 
them in PPI in research work duties. (Williamson et al. 2018). 
 
Recommendation five: Continuous improvement (b) 
The NIHR will measure success along these indices: Reach: the extent to which 
people and communities are engaged, participating and involved in NIHR 
research including the diversity of this population. Relevance: the extent to 
which public priorities for research are reflected in NIHR funding and activities. 
Refinement and improvement: how public involvement is adding value to 
research excellence as funded by the NIHR. Relationships: collaborative 
working for the advancement of public involvement across NIHR. 
(GEM 2015) 
 
General research impact has been defined by similar characteristics such as reaching out, 
being responsive, being relevant, disseminating appropriately and ensuring appropriate 
impact (Oliver et al. 2004: Haines et al. 2004).  The focus of this study applies especially 
to this point and the entire next chapter addresses impact. After this recommendation was 
set, a ‘public involvement impact working group’ was developed by the DH to explore 
the usability of such terms in assessing impact of PPI. 
 
Recommendation six: Co-production 
The public, researchers and health professionals will be empowered and 
supported better to work together in the future using the principles of co-
production. 
(GEM 2015)  
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Co-production is a ‘buzz word’ that has gained increasing popularity in the field of PPI. 
Maguire and Britton (2017) explore a Habermasian understanding of the metaphor 
‘spaces’ between professionals and the public (the potential co-producers). They argue 
that it is difficult to keep a productive relationship between those who run the research 
agenda and the people who get involved. Institutions will have an instrumental purpose 
(i.e. pre-set goals), whereas patients and the public will have their own goals, but their 
goals will only be known if they communicate appropriately in the space for sharing their 
experience. Some people involved may be forceful or better communicators, others may 
lack confidence to speak up. Some may speak different languages (literally) or have 
arrived with previous life events which may not fit easily in the knowledge space 
available in a particular setting. Positioning these knowledge spaces in the landscape 
between ‘lifeworld’ and ‘system’ (Habermas 1987) offers understanding towards the 
complex nature of internal and external pressures of PPI in research. Whilst the idea of 
co-production is something of admirable quality, the co-production agenda to some extent 
glosses over and suppresses the heart of the problem that: 
They [spaces] not only connect different worlds, different ways of thinking and 
being, they have often come into existence, like blisters, where these worlds rub 
against each other, or like bruises, where they have collided.   
(Maguire and Britton 2017: 13) 
 
The quotation above suggests a difficult and tense relationship between two clashing 
agendas sharing the space. Despite this, the co-production recommendation challenges 
epistemic values for those on the ground. However, an INVOLVE-led piece of work has 
resulted in the newly formed Guidance on Co-producing Research Projects (2018). 
Recommendation seven: Connectivity 
NIHR will support work that is locally inspired and driven whilst strategically 
consistent with the NIHR overall goals.  
(GEM 2015) 
 
Recommendation seven concerns staying grounded locally amidst a fast pace of evolving 
healthcare needs. PPI is not a homogeneous entity and to work with groups of needs, an 
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organised and collective voice, holds weight. Gibson et al. (2012) and Locock et al. 
(2017) have described Nancy Fraser’s work (1990) on weak and strong publics to help 
understand the strength of organised and collective voices. A weak public is when people 
have little power, whereas a strong public exerts influence. Making efforts to explore 
strong publics or groups chimes with Kelleher’s (2001) work on ‘New Social 
Movements’ which used Habermas (1987) to analyse self-help groups and to study the 
‘way of life’ that these groups captured when describing their daily struggles. Kelleher 
(2001) argues that language has an important function in the analysis of the activities of 
these self-help groups. In his work, Kelleher discusses narrative reconstructions of 
networks and groups, arguing that when people engage in groups, not only will ‘people 
let off steam’ (own experiences) but they will allow people to gain new knowledge by 
listening to others. Such interactions give people confidence, to express themselves but 
more importantly, altering their identity by perhaps considering what doctors think, hence 
balancing and taking forward a collective voice (Kelleher 2001). This recommendation 
attaches appropriate weight to ‘connectedness’ because it offers a lens into some of the 
wider groups of society and how some of these are affected by health issues that are the 
focus of research. 
 
Recommendation eight: Co-ordination (a) 
Leadership and appropriate governance structures will ensure that the future 
development of public involvement in the NIHR has a clear sense of direction 
and is accountable. The NIHR National Director for Patients and the Public in 
Research will establish a leadership group to provide strategic leadership for 
public involvement, engagement and participation activities across NIHR and 
identify clear priorities for resourcing. 
(GEM 2015)  
 
This recommendation concerns strategic direction from central government, which is 
essential for the success of PPI in research. If the government distances itself too much, 
then values for PPI in research might dissolve, and progress and momentum may slow 
down. Therefore, the lead must come centrally, and must be embedded in the structure of 
the NIHR. Subsequently, priorities have been developed and include the following: 
making more help and support available to the lay public and researchers, encouraging 
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local innovation and creativity in PPI, and facilitating greater collaboration in PPI 
including regional ‘patient voice’ forums.  
 
One example of a piece of work supported locally by the NIHR was the Sharebank 
initiative in the East Midlands, focusing on training in PPI (Horobin et al. 2017), which 
is, at the time of writing, being piloted for roll-out across England. The essence of the 
project is to train the lay public in research issues so that they are better equipped to 
challenge researchers and articulate their concerns. Traditionally people have been 
passive recipients of healthcare research, but Sharebank is unique in that the patients and 
public are being upskilled to challenge the medical voice, perhaps as Habermas might 
argue, taking steps towards reigniting the vision of the bourgeois public sphere (1962). 
The public sphere was understood to be a public realm which co-existed with authority 
(i.e. the police, the church and royalty). It was a place where people were seen in public 
such as salons, coffee houses and clubs where there was a shared sense of belonging, and 
people discussed life politics cohesively as equals. Habermas (1962) was inspired by the 
conditions and dialogue of the public sphere, and he attributed the death of open 
discussions to a negatively changing ethos. As certain people became more authoritative 
and influential, unconstrained dialogue and debate was lost. However, it could be argued 
that internet-based platforms such as social media, online forums and blogs offer a new 
way to help re-imagine the public sphere and dialogue (Kellner 2014). Little is known 
about how involvement initiatives can take advantage of such online platforms but for 
now the strategic goals of the NIHR are reasonably flexible to accommodate this newer 
technology – a recent guide addresses PPI in the digital age (Dumper 2018), suggesting 
increased understandings are forming. 
 
Recommendation nine: Co-ordination (b) 
All NIHR Coordinating Centres and infrastructure organisations will have a 
strategy, framework or plan that covers the promotion and advancement of 
public involvement, participation and engagement in research. Leadership 
accountability and funding for this agenda within organisations will be clear and 
transparent. Progress should be reported annually, made publicly available and 
an overview included in the NIHRs annual report. 
(GEM 2015) 
 38 
 
This recommendation links to democracy and reiterates that by involving the patients and 
the public, transparency in research infrastructure becomes more observable, resulting in 
increased research value and a reduction of waste in research as argued eloquently by 
Chalmers et al. (2014). This is discussed further in chapter three. 
 
Recommendation ten: Diversity 
A diverse and inclusive public involvement community is essential if research 
is relevant to population needs and provides better health. 
(GEM 2015) 
 
Although concealed, recommendation ten seeks to address problems of class, power and 
health inequalities. The involvement of underrepresented voices is undermined by 
insufficient mobilisation efforts and a lack of resources to meet the diverse range of needs 
of the population (de Freitas and Martin 2015). The number of ‘how to involve’ manuals 
is plentiful (Beresford 2002: Reed et al. 2004: and Goodare and Lockwood 1999) and yet 
many initiatives fail to reflect the voices of seldom-heard sections of society, and in turn 
may exacerbate inequalities (de Freitas and Martin 2015). The work of Renedo and 
Marston (2011) discusses inclusive participation, community participation and bottom-
up approaches to participation. The authors argue that patients and public struggle to 
assert their identities, that as outsiders of the expert-led system they find it difficult to 
negotiate or even ‘survive’. Further, the lay public are adapting their individual agency 
to a top-down model and have to cope with threats of moving away from their own sense 
of identity. This could be viewed as Habermas’ (1987) understanding of ‘uncoupling’ and 
reflects the professionalisation dilemma discussed above. 
 
Scambler (2001) argues that in the past, social and health policies have failed to reduce 
health inequalities in the UK, signalling the strength of the ‘power elite’ or what he calls 
‘greedy bastards hypothesis (GBH)’. From this perspective, inequalities are interpreted 
as indirect and unintentional by the capitalist elite. Scambler (2001, p91) applies 
Habermas’ understanding of Marx’s theory of class which sits between ‘defensible 
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revision and premature displacement’ (Scambler 2001, p92). Scambler argues that 
Habermas’ study of the uncoupling of system and lifeworld in society has prematurely 
rejected the Marxian claims on the importance of relations of class. 
Habermas (1984, 1987) […] distinguish[es] between the system – comprising 
the economy (which generates money) and the state (which generates power), 
and which is characterized by strategic action (or action oriented to success) – 
and the lifeworld – comprising the private sphere (which generates commitment) 
and the public sphere (which generates influence), and which is characterized 
by communicative action (or action oriented to understanding). He maintains 
that social differentiation has led to an uncoupling of system and lifeworld, and 
to an excessive rationalization of the former at the cost of a colonization of the 
latter.  
(Scambler 2001, p92) 
 
Scambler argues that Habermas’ ‘colonisation of the lifeworld’ thesis somewhat 
addresses issues of class, power and inequalities but without due attention to Marxist 
thinking. What Habermas does offer is a way to study the complex systemic problems 
experienced by people and exercised by the state: 
The intention in the GBH is not to ‘test’ this complex and awkward hypothesis, 
which would be premature, but rather to explore the conditions and extent of its 
plausibility, and to reflect on how effective empirical procedures to test it might 
be devised.  
(Scambler 2001, p92) 
 
Returning to the GEM (2015) report, the importance of diversity and inclusiveness being 
stated as a national recommendation will no doubt be carefully watched and studied. It 
will be of interest to see to what extent the recommendation has made steps to represent 
the research users and to reduce class, power and health inequalities.  
 
Recommendation eleven: Review 
An independent review will be commissioned by the NIHR in three years’ time 
to assess the progress made in taking forward the recommendations in this 
report.  
(GEM 2015) 
 
 40 
Making progress is the what this last recommendation addresses. The expectations for 
PPI in research continues to confuse those working on the ground. Whether the ambition 
of PPI in research is ‘fit for purpose’ with its plans, initiatives, pressures, demands, 
influences, facts and folklores constantly evolving (Gibson et al. 2012) is an important 
question and currently the idea of review relates to this agenda. PPI is gaining fast 
recognition in a critically constructive manner (Madden and Speed 2017). The 11th 
recommendation of the review seeks to ensure that involvement initiatives stay true to the 
people that research affects the most: the patients and the public.  
 
Summary of section 4. 
Under this section the recent context of PPI in research has been described by examining 
specifically what PPI in research is, how it is considered to help research and when and 
why it started. The section referred to Best Research for Best Health, the establishment 
of INVOLVE and the NIHR.  The first and only PPI in research policy GEM was 
scrutinised at depth. The eleven recommendations have demonstrated and situated the 
deep problem points for PPI in research.  
 
The earlier part of this chapter focused on understanding conceptual and theoretical ideas 
about patient and public involvement (PPI) in healthcare more generally, considering the 
democratic and technocratic rationales. The knowledge economy has been stable 
organisationally, in terms of infrastructure to address some of the challenges found in PPI 
in healthcare. Thus, borrowed arguments which apply in research amongst many, include 
representation problems, failing to adequately bring the patients and public perspectives 
into healthcare problems. By focusing on theory offered by Arnstein (1969) and 
Habermas (1987), arguments concerning power were demonstrated as a core reason for 
common failures well known in PPI in healthcare. It is hoped that similar problems can 
be avoided in healthcare research. Thus, involvement in healthcare research is, we can 
conclude, steadier and better invested in than healthcare services.  
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Concluding chapter summary 
This chapter aimed to orient the reader to PPI by sewing together four salient debates 
from healthcare to healthcare research. Section 1. demonstrated that terms for patients 
and the public have evolved and helps to draw attention to the power imbalance between 
professionals and the lay unpaid public who get involved and suggest that evolving terms 
are slowing recognising that people involved are becoming ‘experts’ of their disease, 
rather than just passive patients. Section 2. has drawn on ideology to understand rationales 
to help conceptualise arguments concerning democratic and technocratic knowledge: the 
two driving forces for PPI in healthcare (which can be applied to serve the research 
purpose too). The democratic ideology for involvement is a mixed spectrum of genuine 
democracy on the one hand and legitimisation of services on the other. A critique of 
democracy in healthcare services found that the problem of representativeness can be 
summarised as lacking organic connection, meaning those who get involved are often not 
representative. By carefully observing PPI in healthcare policy, it was made possible to 
see that healthcare development in PPI has been subject to mass restructuring, resulting 
in loss of direction and lack of public trust. Healthcare policies and rhetoric connected 
with PPI initiatives highlighted the dominance of neoliberal thinking.  
 
In section it was argued that most governmental activity is framed within neoliberalism. 
Liberalism concerns choice and economic gains, while democracy concerns equality and 
collectivism. Both ideological positions appeal to individuals in the growing neoliberal 
population. These ideological positions are reflected in the language used by politicians 
too, to strike appeal across the population. The differing ideological beliefs of each 
political party fall under the principles of conservativism, liberalism and socialism but 
have merged into a culmination of neoliberalism. 
 
In section 4. the focus was offered to PPI in healthcare research examining what the 
research process with PPI looks like, when it all started and how government has invested 
in it. The focus on one particular policy – GEM – enabled a critical review of some of the 
challenges faced in PPI and research. 
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Politics is sometimes described as ‘the deliberate shaping of future society’ (Dorlen 1998, 
p129) and what the policy overview presented here means for current study is that 
politically there is an ideological constraint between the governing force and those being 
governed which can destabilise healthcare. Underpinning the governing force is the desire 
to carefully manipulate and, only at certain opportunities, encourage public input into 
health and research decision-making. But a desired behaviour can only be reached if the 
governing forces can relate to its people on the ground, e.g. meet the diversity and co-
production challenges, and have transparent and open conversations about what matters 
to public. There are some fundamental gaps and challenges that this policy review has 
highlighted. What we have yet to understand is the role the lay public have in shaping 
healthcare after research ends and how government policy affects the impact of PPI on 
research outcomes. This policy overview suggests that PPI in research is a blend of 
democratic and technocratic ideology. PPI in research is regarded as something relatively 
new but appears to be an extension of government promoting new approaches to 
citizenship (Barnes et al. 2004) and at the same time intended to shape and improve the 
organisation and delivery within the health service (Tritter and Lutfey 2009). The policy 
cycle shows great fluctuation and potential tension for the development of PPI, as we 
have seen from the various healthcare PPI initiatives. However, within healthcare 
research, notably through the GEM policy, it appears that ambitions are well intended. 
Moving on from the foundations of this work, the next chapter considers questions of 
impact of PPI in healthcare research. 
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Chapter Three: Understanding the impact of research and the 
impact of PPI on research outcomes: a critical narrative review  
 
Introduction 
This chapter aims to review key literature on the impact of research generally, as well as 
on the impact of PPI on research. The literature is presented in a form of a critical 
narrative review (Culley et al. 2013), which allows for different themes to be discussed 
and interpreted from a range of disciplines and which considers qualitative, quantitative 
and mixed methods research. The review asks the following questions: What is the current 
state of evidence on the impact of research in general? What is the current state of 
evidence on the impact of PPI? 
Background 
The question of whether PPI has any effect on health research first began to be asked by 
scholars as early as 2002 (Boote et al. 2002). More recent insights have considered how 
we might evaluate the impact of PPI on research outcomes (Brett et al. 2010) including 
how context, process and mechanism shape impact (Staley 2014). The last eight years 
have been witness to high quality funded research on the impact of PPI e.g.: how to 
measure the impact of service user involvement by taking consideration of values (MRC 
study, Grant ID:G0902155, awarded to Popay); evaluating CLAHRCs in action (NIHR 
study, Grant ID HS&DR/09/1809/1072 awarded to Rycroft-Malone); two studies 
applying realist evaluation (Pawson and Tilley 2004) to PPI (both NIHR, Grant ID: 
HS&DR/10/2001/41 awarded to Evans, and Grant ID: HS&DR/10/2001/36 awarded to 
Wilson); then a further study to optimise methods of PPI in clinical trials in HTA (NIHR 
Grant ID: HS&DR/10/2001/29, awarded to Gamble); and most recently, to understand 
knowledge mobilisation concerning PPI and the gap between knowledge generation and 
its implementation in practice (Grant ID: KMRF-2016-05-014, awarded to Maguire).  
 
These studies matter because PPI in research has been suggested as one way to address 
the gap between knowledge generation with PPI and research implementation in practice 
(Savory 2010; Boaz et al 2018). Links between PPI impact and impact of research are 
very recently starting to form in literature reviews (Hughs and Duffy 2018). Hughs and 
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Duffy formed a concept analysis (a way of formally defining attributes to a concept) to 
link understandings about the impact of research and the impact of PPI, Other than their 
work, and anecdotal observations about dominant structures of impact and how they may 
relate to PPI (McKenna 2015), few scholars have explicitly in the PPI literature formed 
any links between the two bodies of knowledge. 
 
To date, no review has explicitly explored how the two aspects come together: 1, the 
distinct academic literature on research impact and: 2, the role that PPI as a phenomenon 
has on research outcomes of PPI. Including the two areas under one review will help to 
map out newer understandings about the most recent thinking about how they might link. 
Therefore, the two questions for the current critical narrative review are: 1) What is the 
current state of evidence on the impact of research in general? (are there explicit or 
applicable connections to understanding the impact of PPI on research outcomes?) and 
2): Can any knowledge be applied from the impact of research and implementation 
science literature (concerned with knowledge translation) help to form newer 
understandings about the impact of PPI on research outcomes?).  
Together these two questions will help to address the current state of evidence on the 
impact of PPI on research outcomes. 
 
Methods 
To address the two review questions, the critical narrative review method of reviewing 
literature was used. This involves: interpreting the knowledge gained; and acknowledging 
the diversity of studies from a range of disciplines from both qualitative and quantitative 
research (Culley et al. 2013). Inclusion and exclusion criteria, and search screening and 
selection will be considered next. 
 
Electronic search strategy 
The first challenge faced when conducting the electronic searches was ensuring to use the 
correct terminology because, as described in the previous chapter, there is a debate of 
terminology (McLaughlin 2009). With personal experience of working in the field of PPI 
and reading around the topic as advocated by Harlem and Schlapp (1998), it became clear 
that certain terminology was used more widely (Aveyard 2010). Therefore, the following 
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terms, in common usage by healthcare researchers and professionals, were included: 
‘user’, ‘patient’, ‘carer’, ‘lay’, ‘public’, ‘client’, ‘consumer’, ‘citizen’, ‘stakeholder’ 
‘participation’, ‘involvement’, ‘engagement’, ‘research’ and ‘impact’. Conducting 
literature searches on such ambiguous concepts also meant that search results covered a 
mix of professional settings, ranging from social work research to laboratory-based 
scientific health research. Additionally, impact was variously defined: for example, from 
individual impact on a person, through to impact on healthcare service delivery. Special 
attention was applied to health research, as principally the focus of this research was 
concerning research in the NHS which had PPI. Electronic searches were conducted in 
specialist databases: Medline, Scopus, Cumulative Index of Nursing & Allied Health 
Literature (CINAHL) (NHS), PubMed, Health Management Information Consortium 
(HMIC) (NHS), ASSIA, Web of Science and PsycINFO. 
 
A second stage for literature searching was also applied, a point supported by Greenhalgh 
and Peacock (2005) who argue that electronic robotic methods are not sufficient and that 
other systems are necessary to add scrutiny in generating results. Thus, five tiers were 
added as follows: 
1. Reference chaining using the articles generated from the electronic searches.  
2. Known academic and professional contacts were emailed asking for particularly 
relevant sources for the current study. 
3. Relevant websites which had a focus on public involvement in research were 
checked regularly for any new reports, e.g. the INVOLVE and NIHR websites. 
4. Zetoc alerts and Google Scholar alerts were set up from 2010 to help keep abreast 
of any new articles about the topic. Both alerts were particularly useful when a 
new journal entry was added on the World Wide Web. These alerts are without 
charge and were sent once a week, every week during the course of study 
5. University libraries (DMU and Leicester) were searched for suitable books. 
Particularly where the focus of the content matched the current research, e.g. 
impact of PPI on research outcomes, theorising PPI on research and/or impact of 
PPI on research. 
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Inclusion and exclusion criteria 
The inclusion and exclusion criteria set in table 1 were adopted.  
 
Table 1 - Inclusion and exclusion criteria 
Inclusion Criteria Exclusion Criteria 
Peer reviewed and focusing on patient 
and public involvement theory, practice, 
policy and research 
Training and Patient Reported Outcomes 
Measures (PROMs) 
 
Since 1997 unless reference chained Pre-dates 1997 unless found via chaining 
 
Research policy focused websites on 
patient and public involvement in 
research policy such as INVOLVE, 
Department of Health, NIHR and RCUK  
 
Not NHS or research-focused websites 
discussing patient and public involvement 
in research 
Books and PhDs with a focus on impact of 
patient and public involvement in cancer 
research (identified by known contacts) 
 
PhDs which focused on involving patients 
and the public outside of cancer research 
Any other information building 
understandings to help conduct the 
current work found through reference 
chaining 
Anything outside of social sciences, 
health sciences and implementation 
sciences fields e.g. business and 
commerce  
 
Eligibility of sources 
Sources discussing: training, service development, PROMs, or participation in trials were 
not relevant. These foci were beyond the scope of the study and these articles were 
rejected. 
 
Results 
A total n=704 sources were identified from the combined searches. Duplicates were 
removed and upon reading the titles and keywords it became clear that some of the articles 
were not relevant to the current study. This process brought the number down to n=386 
sources. However, Evans (2002) noted that journal article titles would not always 
accurately reflect the content covered, therefore important articles could have been 
missed out, for example studies describing ‘co-production’ or ‘community-led’ research. 
Special efforts were made to keep up to date and scan carefully. 
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Table 2 - Literature search stages 
Stages  Number of sources found  
Stage 1 to search: 
Medline, 
CINAHL (NHS) 
HMIC (NHS) 
ASSIA 
Web of Science 
PsychINFO 
SCOPUS 
n=704  
Duplicates found and removed (n=182)  
(n=704 - n=182 = n=522 )  
Non-relevant articles found and removed (n=214) 
(n=522 – n=214 = n=308) 
 
 
Sources to be longlisted n=308  
Stage 2 Five-tiered system:  
o Reference chaining 
o Emailed known contacts 
o Websites checked 
o Zetoc alerts 
o Library searches for 
books and PhD’s  
 
 
 
 
 
 
Sources to be longlisted n=78  
Total number of longlisted 
articles 
Which involved checking 
abstracts and keywords and 
content scrutiny 
 
 
 
n=308 + n=78 = n=386  
251 articles removed in this process 
Total number of shortlisted 
articles to include 
 
n=135 to include 
 
Characteristics of sources 
Of the n=135 sources identified, the earliest sources dated from 1997, and n=47 studies 
had been published since 2014. Publishing output increased, which suggests literature 
was starting to gain recognition about PPI and impact. A database was created and 
updated on an ongoing basis/as required so that the topic, type of involvement, the type 
of impact (process or outcome), methodology, theoretical position and key messages 
could be assessed and recorded. The headings in the database created were:  
o Source, author, date and title; 
o the topic or health condition the article was discussing; 
o sort type of involvement that had taken place being described in the article 
(consultation, collaboration or user controlled); 
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o whether the authors were discussing the impact of public involvement on the 
research process or outcomes;  
o any mention of research impact generally; 
o the methodology that was employed to help understand the topic; 
o theoretical position applied; and 
o any key messages. 
 
 
Table 3 - Grouping of 135 sources 
Sources categorised  From n=135 
Empirical studies on the impact of PPI n=55 
Evaluations of PPI n=14 
Opinion pieces and commentaries on impact of PPI n=13 
Generalisable lessons on PPI (and theory) n=13 
Policy of PPI 
(the majority of which were used for the previous literature 
chapter) 
n=10 
Research impact and implementation science n=11 
Book chapters on health policy and Habermas 
(some sources were used in the previous chapter) 
n=8 
Systematic reviews on PPI n=7 
PPI related websites 
(all three used for the previous chapter) 
n=3 
PhD Studies (PPI related) 
(used in the previous chapter) 
n=1 
 
It became clearer after developing a database (see table 3) that the impact of research 
literature (n=11) focused on four issues. 1) Defining impact 2)‘Research context’ within 
which research problems are defined, 3) the ‘application of new knowledge’ and how it 
is applied, 4) ‘Research evaluation-tracing tools’ these are impact tracing ideas, and 5) 
that implementation theories help to tie context, process and outcomes together to help 
‘implementers’ apply new knowledge to real-world issues.  
 
Of the remaining n=124 articles the majority of sources (n=87) were discussing not just 
one but multiple types of impact of PPI. Further, that various health conditions spanned 
the content, in the body of the article e.g. in systematic reviews about impact of PPI or 
when a study was focusing on a combination health conditions and groups such as: 
arthritis and older people, sport and exercise in young people, and palliative care in the 
community. However, some articles had a clear focus on PPI and impact, for example 
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n=9 mental health, n=10 cancer, n=5 children and maternity, n=6 health networks, n=2 
dermatology, n=8 clinical trials and n=3 primary care.  
 
Hence two related but academically distinct bodies of literature inform this chapter. One 
concerned ‘the impact of research’ and the other concerned ‘impact of PPI on research 
healthcare and process and outcomes’. What was most striking from looking at the two 
bodies of literature was that impact of PPI was never explicitly discussed in the impact 
of research literature, although input of ‘end users’ or ‘stakeholders’ was. Similarly, in 
the impact of PPI on healthcare research process and outcomes literature, the dominance 
of higher education impact strategies such as Research Excellence Framework (REF) 
were largely absent. 
 
Table 4 - Critical Narrative Review content summary 
Summary of two bodies of 
literature found 
Impact of research Impact of PPI on research 
process and outcomes on 
healthcare research 
Type of source Empirical studies 
Systematic reviews 
Literature reviews 
(Systematic, policy) 
empirical studies 
Countries of origin UK-based (n=3), American 
(n=2), Canadian (n=2), 
European countries (n=2) 
and Australia (n=1). 
Mainly from the UK 
(n=118), from Europe 
(n=4) and Canada (n=3). 
Aimed at  Policy makers, university 
leaders, healthcare 
managers and 
commissioners 
Researchers, policy 
makers and scholars 
Themes of evidence 1)Meaning of impact 
2)Research Context 
3)Application of new 
knowledge, Research 
evaluation tracing 
4)Implementation science 
and Summary of gaps 
 
 
1)The impact of PPI on 
healthcare research 
2)The impact of PPI on 
research processes 
3)The impact of PPI on 
people involved in the 
research process 
4)Impact of PPI on 
research outcomes 
5)Poor quality reporting 
on PPI 
Absence of evidence on Discussion of PPI in 
research during 
implementation 
Discussion of PPI on 
impact of research 
(outcomes) 
 50 
Findings 
Body of evidence 1: ‘The impact of research’ 
 
Introduction 
From ‘the impact of research’ body of literature (review question one), articles came 
from: UK (n=3), America (n=2), Canada (n=2), European countries (n=2), and Australia 
(n=1). It was noticeable that the information was aimed at policy makers, university 
leaders, and healthcare leaders. Almost every article since 2013 discussed the words 
‘impact’ and ‘REF’, indicating their emerging importance. The content described in the 
literature often consisted of comparisons of existing and/or new models/frameworks 
developed by authors to help assess impact, based on empirical work (e.g. Rivera et al. 
2017). Content also spanned implementation theory (e.g. Damschroder et al. 2009). 
Impact of research papers confirmed the gap between research and policy (Haines et al. 
2003), needing more research on impact of research itself (Penfield et al. 2014) and other 
factors affecting impact of research, such as the media (Eysenbach 2011) or political 
agendas affecting decision-making (Gold 2016). Competing local priorities (Brownson 
et al. 2017), conflicting expert opinion (Milat et al. 2015), and powerful lobbying groups 
were also discussed (Campbell et al. 2007) as affecting the impact of research. There was 
only very recent evidence about the role that stakeholders can have in implementation 
work (Boaz et al. 2018) and evidence from Kirk et al. (2016) to suggest that Damschroder 
et al’s. (2009) implementation theory was flexible enough to help evaluate 
implementation processes. One very early government report referred to PPI as a complex 
intervention (Farrell 2004). These aspects will now be discussed in turn. 
 
Meaning of impact 
The word ‘impact’ is defined as ‘marked effect or influence’ (Oxford English Dictionary 
2004). Internationally, there is a growing interest in demonstrating the impact of research 
(Morrow et al. 2017). Demonstrating impact is important because it helps to minimise 
research waste (Ioannidis et al. 2014), helps allocate resources efficiently (Pang et al. 
2003), and maximises the benefits of research (Rivera et al. 2017). But there is a 
difference between ‘academic impact’, assumed as the intellectual contribution to one’s 
field of study within academia, and ‘external (socio-economic) impact’ beyond academia 
 51 
(Penfield et al. 2014). Exploring impact in the context of research verses practice showed 
that the word impact was generally understood to mean the consequences of research 
(Donovan 2011), implying effect, change or influence of research on various complex 
phenomena, including policy (Oliver et al. 2014), society (Bornmann 2013) and/or the 
economy (Deloitte Access Economics 2011). The impact of research has also been 
explicitly defined by REF as ‘any identifiable benefit to, or positive influence on, the 
economy, society, public policy or services, health, the environment, quality of life, or 
academia’ (HEFCE 2011). But evaluating this type of impact is complicated. The 
definition above given by HEFCE to some extent implies linearity, similar to the Research 
Council United Kingdom (RCUK) definition which discussed the contribution that 
research makes to society and the economy, embracing a diversity of ways that research 
affected individuals, institutions and different countries, including: 
fostering global economic performance, and specifically the economic 
competitiveness of the United Kingdom; increasing the effectiveness of public 
services and policy; enhancing quality of life, health and creative output. 
(RCUK 2013) 
 
The most important aspect of RCUK’s definition was that impact needed to be 
demonstrable. However, RCUK also acknowledged that policy and service development 
from social science research is not direct or linear, contradicting its impact statement by 
suggesting that impact is not straightforward and policy processes are not linear either 
which they said made it: ‘difficult to pin down the role that an individual piece of research 
has played’ (RCUK 2013). They argued that the timing of evaluation also presented 
problems because after research has ended it may be too soon to judge whether impact 
has yet to fully develop. Conversely, it can be too late, when impact may no longer be 
traceable as people involved had moved on (RCUK 2013). But Davies et al. (2005) 
suggest that problems arise when trying to track and demonstrate immediate impact of 
research because research can directly influence or indirectly influence policy, practice 
and behaviour. More subtly, impact can help to change ‘peoples knowledge, attitudes and 
understandings towards social issues’ (p2). They finished by saying that: ‘Tracking these 
subtle changes can be difficult, but it is perhaps more important in the long run’ (p2) and 
that extra problems arise about: 
 52 
knowing where to look, for research impacts (who are the research users?); 
knowing when to look for these impacts (how long is sufficient for research to 
take effect?); and knowing how to assess the specific contributions made by 
research (was the research really the key factor in any changes observed?). 
(Davies et al. 2005p2) 
 
The statements above help to describe the sensitive nuances of trailing impact of research. 
The quotations set the tone of three aspects concerning impact of research: the research 
context; the application of new knowledge; and evaluation tools.  
 
Research context 
The literature showed that the research context needs to be advantageous for the 
investigation issue (Owen et al. 2012) and is necessary for impact to generate. An 
advantageous research context concerns favourable conditions for research collaboration 
to occur, i.e. recognition of the problem, question or issue (Morrow et al. 2017), along 
with alignment with the wider socio-economic and political factors which are usually 
important influences for the ‘research design stage and providing momentum for 
research that was underway’ (p420). They concluded that: 
Political, professional or public agendas had helped to promote research studies 
by directly linking research outputs to political figures or campaigns by 
professional bodies on issues. 
(Morrow et al. 2017 p420) 
 
Morrow et al. (2017) argue that research design and conduct is sensitive to the political 
climate that the research is conducted within. However, Eccles et al. (2009) have argued 
that there are uncertainties about the relationship between the context and intervention. 
The challenge of the actual context for some researchers may lean against prevailing 
orthodoxies of political priorities which are pre-set. Guthrie et al. (2013) argued that the 
wider political, economic and social context must suit the climate at the time new 
knowledge is shared, implying that impact of research is dependent on its end users and 
the likelihood of them adopting the new research evidence or products (Boaz et al. 2009). 
Thus, individuals, groups and organisations need to ‘buy in’ and value the new 
information, in order to adapt and apply it. Thus, Guthrie et al. (2013) is pointing to the 
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context after the research has finished, which Morris et al. (2011) argued would be on 
average 17 years for impact to be experienced. 
 
The literature on impact of research ‘context’ failed to connect how PPI affects the 
context of research. The question the current study is addressing, the impact of PPI on 
research outcomes, requires us to address how the research context assists or limits 
alignment from ‘bench to bedside’ (Callard et al. 2011). The rationales (described in the 
previous chapter) outline common drivers for PPI in research. It can be argued that 
alignment ensures that research is patient-centred (Martin 2008a; Greenalgh et al. 2016) 
and thus findings generated will be convertible into relevant answers for users (Gold 
2016). Further, the importance of a live dialogue about what patient and public users, and 
professional users, want from the research findings, will aid its potential application.  
 
Application of new knowledge 
According to Graham et al. (2006), there are at least 29 terms that refer to acting on 
findings. This presents a challenge for researchers and policy makers in applying new 
knowledge because no single term is used post-dissemination. For example, in the 
literature the terms ‘knowledge creation’ (Nonaka 2000), ‘knowledge brokerage’ (Van 
Kammen et al. 2006) and ‘knowledge mobilisation’ (Levin 2008) were found. Though, 
the three main terms found in literature were ‘knowledge translation’, ‘knowledge 
exchange’ and ‘knowledge transfer’. Knowledge translation concerns a dynamic and 
iterative process that includes synthesis, exchange and application of knowledge to 
improve and provide more effective health services and products and strengthen the 
healthcare system (Straus et al. 2009). ‘Knowledge exchange’ involves collaborative 
problem-solving between researchers and decision makers, which happens through 
linkage and exchange of knowledge. Effective knowledge results in mutual learning 
through the process of planning, producing, disseminating and applying existing or new 
research in decision making (Lomas et al. 2005). The third term to consider was 
‘knowledge transfer’, which is used to represent the process of moving research-based 
knowledge or ideas from one area to another, supporting a culture of evidence-based 
decision making in healthcare (LoBiondo-Wood and Haber 2005). However, a problem 
with this term is that it suggests that knowledge can be ‘rolled out’. Moreover, the 
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applicability and usefulness of the term ‘knowledge transfer’ is increasingly being 
questioned because the knowledge-base is itself diverse and the agents or professionals 
who are supposedly using new knowledge are also diverse. The agents cut across sectors 
from health research to health management, health policy makers, through to clinicians, 
service users and the public, and the nature of these ‘agents’ is fragmented across 
healthcare (Walker 2007).  There are two reasons that have been offered to why 
knowledge transfer can present difficulties. Firstly, knowledge messages can be ‘sticky’ 
or difficult to share beyond the immediate setting (Szulanski 1996; 2000). Secondly, this 
sticky knowledge may also lead to problems associated with ‘absorptive capacity’ when 
trying to transfer the knowledge to healthcare staff to maximise the new knowledge 
(Cohen and Levinthal 1990), implying the new knowledge may not suit the staff or the 
setting it which it is being offered. 
 
Each term described acting on findings after dissemination. Yet, introducing the three 
main terms, which have very slight difference in meaning is important as it helps to 
highlight that language is inconsistent across the sectors. It was also documented in the 
literature that research knowledge will depreciate significantly before it makes its way 
into real life (Hanney et al. 2004). Some argued that knowledge will slowly ‘creep’ into 
a decision maker’s mind (Pawson et al. 2005). The subtle issue such as knowledge ‘creep’ 
is largely invisible and therefore impact-tracing becomes even harder to assess (Molas-
Gallart 2004). Consideration of how completed research study findings are applied into 
real healthcare settings demonstrates that difficulties already exist in trying to understand 
how new knowledge is used or even described in its use. Therefore, attempting to assess 
the impact of PPI presents further difficulties.  
 
However, to plan for the application of new knowledge, research funders increasingly 
expect researchers to submit impact plans as part of their proposals (Lyall et al. 2015; 
Smith et al. 2011). Typically, researchers include in their impact plans: forums for debate 
(Walshe and Davies, 2013), public engagement (Grand et al. 2015), dissemination and 
communication plans for different audiences (Rivas and Pandya-Wood 2014), or 
partnerships with research users to implement research evidence in practice (Meagher et 
al. 2008). Some argue that impact of research is generated through multiple processes, 
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including knowledge creation, exchange, transfer and translation between researchers and 
research ‘end users’ (Donovan and Hanney, 2011; Kuruvilla et al. 2006). Yet, 
interestingly no funders explicitly required researchers to demonstrate plans for the 
involvement of patients and the public at implementation stage nor how research impact 
will be traced. 
 
Research evaluation tracing 
There was an array of ways to assess the impact of research. In some cases, assessing 
impact was described as burdensome and intrusive and there was no overall consensus as 
to which evaluation tool should be used (Martin 2011). In a recent systematic review 
conducted by Rivera et al. (2017), the authors summarised n=24 health research impact 
frameworks to help researchers and policy makers understand how a research study might 
examine impact. Rivera et al. considered assessing ways to study impact and at which 
point potential impacts could be assessed.  They generated a research impact framework 
which focused on academia, society, economy, and cultural outputs using narrative and 
quantitative metrics. Assessment approaches included: using a combination of interaction 
processes between stakeholders and researchers; the use and importance of partnerships 
between researchers and policy makers; understanding the pathways to impact; as well as 
the ability of health technology assessments to influence efficiency of healthcare systems 
(Raftery et al. 2016). Rivera et al. (2017) identified through their data synthesis five tiers 
across a range of short-, medium- and long-term time periods, although they do not 
explicitly state how many years each tier could take. The time taken in each tier is 
potentially highly important when considering that some research funders, e.g. Research 
for Patient Benefit (RFPB) fund, who explicitly stated once that impact should be 
demonstrable five years post completion of study (Ashby 2017). The first-tier proposed 
by Rivera et al. (2017) was primary-research related impact, which the authors argued 
were immediate research outcomes. Their second tier focused on influencing policy; the 
third tier involved health systems impact; the fourth tier was health-related and societal 
impact; and the fifth tier was broader economic impact. Their framework is summarised 
in table 5. 
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Table 5 - Tiers of impact 
Tiers of impact and their 
focus 
Subgroups of impact  Time 
1) Primary research-
related-impact 
 
Research and innovation outcomes (publication and 
citation rates) 
Dissemination and knowledge transfer (talks, media 
coverage) 
Capacity building, training, and leadership (further 
research) 
Academic collaborations, research networks and data 
sharing 
Short 
term 
2) Influence and 
involvement in 
policy making 
Type and nature of policy impact (presentations to 
decision makers) 
Level of policy impact (influencing policy makers, 
changes in legislation) 
Policy networks (collaborations between policy and 
industry)  
Medium 
term 
3) Health and health 
systems impact  
 
Quality of care and service delivery (improved 
prognosis/diagnosis) 
Evidence-based practice (improved patient experience) 
Improved information and health information 
management 
Cost containment and cost-effectiveness 
Resource allocation (targeted) 
Health workforce (fewer days of loss of earnings) 
 
 
Long 
term 
4) Health-related 
and societal 
Impacts 
Health knowledge, attitudes and behaviours (public 
engagement) 
Improved equity inclusion, cohesion and human rights 
Health literacy (changed behaviours for the better) 
5) Broader economic 
impacts 
Attracting research investment  
Income from intellectual property  
Spin-out companies 
Adapted from Rivera et al. (2017)  
 
Rivera et al’s. (2017) work is helpful in offering an overview of impact categories but 
challenges are presented when considering the research context, and the application of 
knowledge and tools for evaluating impact. Rivera et al. (2017) advances from short- to 
long-term impact without the explicit mention of PPI. There was mention of ‘end users’ 
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at an engagement level, but engagement does not constitute involvement because public 
engagement is arguably often concerned with informing the public about something, 
rather than seeking their active involvement in research outcomes. Thus, tools for 
evaluating impact of research has revealed a gap that overt PPI in the process of research 
evaluation was a missing link because the n=24 impact assessments had failed to identify 
the use of patients and the public for long term impact, thus missing it out as a thread 
running through their entire framework. There could be many reasons for this: 1. that 
others may have implied though the term ‘end users’ that all stakeholders, including the 
patients and the public, fall under this category; 2. that Rivera et al. (2017) may not have 
explicitly considered the practical knowledge of patient and public in their work, hence 
they had chosen not to comment; 3: because there is limited evidence about PPI in shaping 
healthcare policy and practice (Mockford et al. 2011), the issue did not translate fully into 
the work of Rivera et al. (2017).  
 
Yet, if we look at the core goals of PPI, it is associated with improvement beyond the 
medium term. Such improvements include reducing health inequalities (see Greenhalgh 
2009); improving patient safety (Gauvin et al. 2010); making better use of resources 
(Minogue and Wells 2016, Fudge et al. 2007); and the better management of healthcare 
knowledge by both the professionals and the public (Garfield et al. 2003, Greenhalgh 
2009). These examples all comfortably rest on the fourth tier of the Rivera et al.’s (2017) 
framework, so the absence of PPI as a thread running through their framework implies a 
gap in knowledge. Having PPI in the five tiers could alleviate some of the challenges 
between research and practice (including understanding negative research and why the 
research should not be applied (Chalmers 1995; Goldacre 2014). After all, the ultimate 
goal of healthcare research is: ‘to advance knowledge for the good of society; to improve 
the health of people worldwide; or to find better ways to treat and prevent disease’ (The 
Lancet 2013 p1315). 
 
However, it is of interest that the field of implementation science has paid attention to the 
people and processes that affect the routine uptake of knowledge; this is explored next. 
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Implementation science 
Implementation science is a growing field of activity which attempts to study the 
processes promoting the uptake of research and evidence into routine practice as 
described by Eccles and Mittman (2006). In a recent review about engaging stakeholders 
to support improvement, the study focused on multiple stakeholders, which included 
patient and public, but not exclusively. Boaz et al. (2018) produced a set of indicators 
which could be used to identify stakeholder engagement with the potential for impact. 
Boaz et al.’s (2018) work is the only study which partially comes close to what the current 
thesis is examining about the impact of PPI on research outcomes. They found 
organisational factors, values and practices for future researchers. Their study reports on 
15 indicators which were observable for stakeholder engagement impact. They did not 
consider implementation processes specifically for patients and the public. Also, the work 
of Damschroder et al. (2009) is of significant value because they analysed 19 existing 
theories on implementation of research into practice and created a meta-framework which 
they called ‘The Consolidated Framework for Implementation Research (CFIR)’. They 
identified five domains in this meta framework: These where: 
1. the intervention that the research focused on needs adapting to the setting;  
2. the inner settings must recognise that people on the ground will be affected by the 
issue, therefore policies must be ready for change; 
3. the outer settings (contextual aspects e.g. politico-social issues) need to be aligned 
to the inner settings; 
4. the individuals involved in making the change must include all end users; 
5. careful thought must be offered to the process by which implementation is 
accomplished.  
(Damschroder et al. 2009) 
 
Together the five domains of Damschroder et al. (2009) are home to list 36 conceptual 
definitions which they call constructs. The use of the CFIR (Damschroder et al. 2009) in 
implementation processes and research was reviewed by Kirk et al (2015). Their review 
attempted to address three objectives: 1. to determine the type of studies which use the 
CFIR, 2. how the CFIR has been applied (including depth of application), and 3. to 
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determine the contribution of the CFIR to implementation research. 26 studies met their 
inclusion criteria for their review. The range of studies included came from a mix of 
qualitative (n=10), quantitative (n=3) and mixed methods (n=13) implementation 
research. They found that the CFIR was applied at pre (n=2), during (n=8), and post 
(n=15) implementation phases. Almost every study focused on facets of implementation 
where the intervention had already been developed and tested for feasibility and 
effectiveness.  
 
They found that the objective of more than two thirds of these studies (73.1%) was to 
gain insights of practitioners’ experiences into barriers and facilitators of implementation. 
This is potentially important for the current study. The settings in which the CFIR was 
adopted in was healthcare delivery, health promotion, the management of disease and 
process redesigns. Once again, for the current study, this is important as it suggests 
flexibility in the model’s applicability. The topics of health covered in the CFIR ranged 
from mental health to obesity. In n=20 of the studies reviewed by Kirk et al. (2016), 
analysis occurred within the healthcare system, healthcare programmes (n=2), 
departments (n=2) and the patients (n=2). Of these 26 studies, n=15 stated specific 
constructs of the CFIR that were used for implementation. While n=9 studies specified 
only the domains, n=3 reported using domains and constructs and n=2 studies specified 
no domains or constructs. Some studies used the constructs to guide interviews whilst 
others used the CFIR as coding templates, though a disadvantage raised was unmeasured 
implementation factors. Different authors who used CFIR raised advantages such as it 
acting as an aid memoir. But Kirk et al. (2016) found that little attention was offered by 
other researchers using the CFIR, about the terminology in the CFIR. They found that 
Ilott et al. (2013) critiqued the implementation process domain for prematurity as it failed 
to take account of longer-term change. Kirk et al. (2016) offered a short discussion on 
how the CFIR might advance theoretical direction, and they argued that further research 
was needed to develop measures to propose and test models that predict implementation 
they concluded by saying that the CFIR acted as a foundational strategy for 
implementation. 
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What Kirk et al.’s (2016) review conveys to the current researcher is that the CFIR is 
useful in a variety of settings and more importantly all domains and constructs are useable 
across different areas of health and units of analysis (e.g. departments, projects and 
programmes). However, it does not tell us how the CFIR can be used specifically towards 
evaluating the impact of PPI on research outcomes. None of the studies reviewed by Kirk 
et al. demonstrated its usability for understanding the impact of PPI. But the review of 
Kirk et al (2016). tells us that the CFIR is potentially a valuable tool to help understand 
PPI on research outcomes and understanding its complexities. 
 
In an early DH report concerning PPI and implementation, Farrell (2004) offered a 
diverse look at the nuances of implementation in healthcare projects which had PPI. Of 
the n=12 PPI projects reviewed, Farrell reported four ingredients to successful outcomes:  
1. enhancing communication and interaction between professionals and patients;  
2. recognition and clarification of the problem, by specifically stating questions and 
comments about a particular research project and its benefits and problems;  
3. preparing for difficult situations, particularly relating to resource allocation 
decision-making and;  
4. building relationships and partnerships so that local partners can be aware and 
help to share the knowledge.  
 
Farrell’s four ingredients link to aspects of the CFIR, because Farrell (2004) suggested 
that PPI is a ‘complex intervention’. A complex intervention, according to Brett et al. 
(2014 p388), is ‘where impact needs to be evaluated alongside broader factors, in order 
to identify what works, for whom and in what circumstances’. Understanding such 
complexity helps to shed light on why some studies thrive whilst others fail. Snape et al. 
(2014) also formed consensus in their work on impact barriers and drivers that are central 
components to implementation work with PPI which required research team cohesion and 
suitable resources. Thus, implementation processes are key to understanding the impact 
of PPI on research outcomes.  
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The remaining section of this review attempts to understand more specifically what is 
known and not known about the impact of PPI in healthcare and research on process and 
outcomes (review question two). After exploring the next body of evidence, how the 
author’s thinking has been advanced about the two distinct areas is knowledge is 
considered in the form of a conclusion.   
Body of evidence 2: ‘The impact of PPI healthcare research on process and outcomes’ 
 
Introduction 
The remaining body of literature discussed in this review focuses on the impact of PPI on 
healthcare research in process and outcomes (i.e. review question two). The articles were 
primarily aimed at researchers, policy makers and scholars. They were mainly UK-based, 
whilst some were international (see table 4 for details). These articles offered descriptions 
of impact of involvement on research processes.  
 
Eight literature or systematic reviews (Oliver et al. 2004; Nilsen et al. 2006; Daykin et al. 
2007; Staley 2009; Boote et al. 2010; Mockford et al. 2011; Brett et al. 2014a; and Brett 
et al. 2014b) on the topic of impact of PPI were found and used in this review to 
demonstrate growing thematic knowledge since 2004. Very little was found on the impact 
of PPI specifically on research outcomes (Wilson et al. 2015). This is evidence that the 
literature has at least considered the impact of PPI on: healthcare (Daykin et al. 2007; 
Mockford et al. 2011); researchers, patients and public (Brett et al. 2014b); and the 
research process (Staley 2009). Only one isolated example from healthcare research 
evaluation observed that no evidence was available towards understanding impact of PPI 
on research outcomes (Wilson et al. 2015). The literature also demonstrated a gap in the 
quality of reporting of PPI (Staniszewska et al. 2017). 
 
The impact of PPI on healthcare 
To understand the impact of PPI on healthcare, a systematic review by Daykin et al. 
(2007) set out to evaluate the Patient Advisory Liaison Service (PALS). Daykin et al. 
(2007) assessed n=8 PALS groups across England. Whist acknowledging their work did 
not focus on outcomes, they argued that their review offers a comprehensive account of 
wider PPI literature. Four themes were present in the work: the impact of organisational 
culture; leadership and change management; the impact of PPI; and the need for robust 
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research on impact. Daykin et al. articulated that an organisational culture in support of 
PPI initiatives was a key component for successful PPI outcomes, stressing the need for 
shared understandings between staff and patients. Daykin et al. identified a range of 
‘outcomes’: 
The studies report a diverse range of outcomes, from enhanced subjective 
experiences to discrete initiatives at the collective level, including a mental 
health charter (Hodge, 2005), a counselling service targeting black and minority 
ethnic communities (Crowley et al. 2002) and the establishment of a flagship 
health centre (Kashefi and Mort, 2004).  
(Daykin et al. 2007 p57) 
 
Daykin et al. (2007) go further and state that whilst there was a tendency to report on 
positive outcomes of PPI initiatives, there was less discussion of negative outcomes, even 
though most authors reviewed reported barriers to the development of PPI. Daykin et al. 
(2007 p57) also identified that: ‘One of the difficulties in assessing this evidence is that 
there is often a time lag reported between an intervention and the outcomes.’ This echoes 
the point made by Rivera et al. (2017) and is discussed later in the review of Wilson et al. 
(2015) later. 
 
Similarly, a systematic review by Mockford et al. (2011), focused on healthcare rather 
than research that had PPI, identified n=42 papers which showed that PPI had a range of 
impacts. Their work described that there was little evidence of economic analysis of the 
costs of PPI and found reporting limitations of the evidence base due to poor quality 
reporting on impact. In their review, only a few studies defined what was meant by PPI 
but with little theoretical or conceptual insights. Mockford et al. (2011) identified a gap 
in robust measurement of impact, and that descriptions lacked detailed evidence. Only 
n=15 reported impacts of PPI on outcomes. Mockford et al. (2011) themed these impacts 
into seven areas: 1) the design of new healthcare buildings; 2) the location and access to 
services; 3) the provision of additional services; 4) re-organisation of existing services; 
5) improved changes of organisations in acute trusts; 6) improved dialogue between 
health professionals and patients; and 7) improved dialogue between patients and 
managers. Interestingly, all seven themes are important markers of significant change and 
yet they all are very different. 
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In summary, when discussing the impact of PPI on healthcare services, Daykin et al. 
(2007) and Mockford et al. (2011) highlight a range of improvements. However, 
capturing the audit trails of these improvements are notably absent in their discussions. 
 
The impact of PPI on research processes 
There were many examples of impact at all stages of the research process where members 
of the public and patients had been involved. The patient and the public have been 
involved in: setting the health research agenda (Entwistle et al. 2008); initiating research 
projects (Terry et al. 2007); deciding what research to fund (Lindenmeyer et al. 2007); 
determining the focus of a research study (Mosavel et al. 2005); and choosing the methods 
and tools used in the research (Barnard et al. 2005). In a Health Technology Assessment 
(HTA) review by Oliver et al. (2004), they identified n=286 documents that mentioned 
‘consumer’ involvement helping to identify areas for research. Oliver et al. (2004) also 
addressed barriers to involvement which included negative attitudes and poor working 
relationship; difficulties in communication and time constraints. They argued that these 
aspects could be reversed with leadership and outreach to the community. 
 
Other research studies have reported on the positive impact of PPI in research studies on 
recruitment (Viswanathan et al. 2004); data collection (Pandya 2007); analysis (Best et 
al. 2017); and writing up and disseminating (Pandya 2007). A Cochrane review by Nilsen 
et al. (2006) on n=6 randomised controlled trials, reported that one of the main outcomes 
from PPI on the research processes leads to more readable and understandable research 
materials. 
 
PPI in the research process had also resulted in improving the research process itself and 
had led to positive outcomes (and negative, discussed below) whilst conducting the 
research. For example, Langston et al. (2005) conducted a randomised controlled trial on 
patients with Paget’s disease. Patients in this trial joined the peer-review process, and 
attended the trial steering committee, provided advice to study participants and promoted 
the work of the trial. There are other examples too, in the work of Rhodes et al. (2002) 
which worked with people in setting up a diabetes service for patient and public advisory 
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groups. Byas et al. (2002) conducted a study on mental health in young service users, 
who acted as co-researchers; Walmsley (2004) similarly reported involving people with 
learning disabilities in their research. Other researchers have reported impacts such as 
research quality improving governance and ethical acceptability of studies (Marsden and 
Bradburn 2004). Boote et al. (2010) reviewed n=7 case examples of PPI in primary 
research design and reported that group meetings were the most common method of 
engagement. Contributions made by the public were largely in the areas of review of 
consent procedures and patient information sheets, outcome suggestions, and 
recommendations on participant recruitment. 
 
Brett et al. (2014a) identified n=66 studies which reported on PPI and its impact on health 
and social care research. Again, positive impacts on the process of PPI were reported, 
including: enhanced quality and appropriateness of the research focus and questions; 
development of accessible research information; better recruitment in studies; public-
member-focused interpretation of results; and better dissemination. But the authors 
concluded that the evidence base behind the impact of PPI still remained weak and needed 
significant enhancement.  It is fair to summarise thus far that the impact of PPI on the 
research process is well documented but understanding of its impact on outcomes is 
insubstantial. 
 
Staley’s (2009) review which also focused on the impact of PPI in research found that 
n=89 studies offered information regarding impact. Most of the evidence on impact was 
based on the views of researchers and members of the public who had worked together 
on research projects. Her review reported that there was inconsistency regarding how 
impact was described in journal entries. This inconsistency was because there were no 
guidelines about reporting PPI impact until 2017 (Staniszewska et al 2017). Whilst there 
is not a consistent approach to defining and assessing impact, the benefits of doing so, 
and added time and costs reported, were similar across the studies. Staley (2009. p5) 
identified that there were impacts reported ‘… on the research (at all stages and levels), 
on the members of the public who were involved, on the researchers, on participants, on 
community organisations and the wider community’. Staley also found that people 
involved had ‘influenced whether the results of research have been used to bring about 
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change’. This latter point was precisely what the current study was designed to further 
understandings about. Staley (2009) added in her report:  
 
 
the individuals involved in research have on occasion formed new relationships 
with key policy makers and local agencies. They have then been able to use their 
new skills and confidence to continue to affect community action and change 
(Staley 2009, p83).  
 
It seems that Staley was referring to an important part of the jigsaw for this current study, 
suggesting that for PPI to impact on research outcomes the people involved had strong 
agency and leadership traits which helped maintain the implementation agenda after the 
research. 
 
The impact of PPI on people involved in the research process 
A systematic review (Brett et al. 2014b) using n=65 studies reported impacts on the 
patient and public feeling valued and gaining confidence and life skills. Researchers 
reported that such involvement led to greater understanding and insight into their research 
area, gaining respect and a good rapport with the community. The communities reported 
becoming more aware and knowledgeable about their condition. Other studies found that 
through PPI, people acquire new skills (Donà 2006); have more confidence (Rhodes et 
al. 2002); have better supported networks (Faulkner 2004); gain a sense of enjoyment 
(Barker and Weller 2003); and ultimately could gain sufficient experience from the 
studies to result in employment (Allen et al. 2006).  
 
But impacts can also be negative and there was a reluctance among researchers to admit 
this (Staley 2009). A few cases have been documented during PPI in research which led 
to emotional difficulties with immigrant women (Meyer et al. 2003), work overload 
(Clark et al. 2004) and unwanted media exposure about socially taboo areas, such as 
teenage pregnancy (Pertrie et al. 2006). Brett et al. (2014b) identified that a lack of 
preparation and training led to some feeling unable to contribute to the research and 
became too overburdened with the work involved. Similarly, researchers reported 
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difficulties in incorporating the public in meaningful ways due to lack of money and time. 
Possibly the most difficult lasting negative experience of impact could be feelings of 
anger and frustration at being powerless to make changes (Rowe 2006). The work of 
Pandya-Wood et al. (2017) found that PPI in research design work was sometimes 
unintentionally carried out in an unethical manner (i.e. before studies are funded and 
formal ethical processes begin). 
 
Impact of PPI on research outcomes 
The literature review revealed a major gap in information about the evidence base 
concerning the impact of PPI on research outcomes. Wilson et al. (2015) applied realist 
evaluation (which focuses on context, mechanism and outcomes and was developed by 
Pawson and Tilley 1997) to PPI’s evaluation and found that across n=6 topic areas using 
a scoping exercise, online survey and case studies, researchers reported no evidence of 
any immediate outcomes of PPI: ‘Among the eight that were completed, we found no 
evidence of any immediate outcomes of PPI for the research findings …’ (Wilson et al. 
2015, p110). The RAPPORT study was designed specifically to meet the gap in 
knowledge about impact of PPI process and outcomes. So, the conclusion was important 
as it showed that ‘no evidence of immediate outcomes’ was reported. They used 
Normalisation Process Theory (NPT) (May and Finch 2009) which uses four mechanisms 
to help identify how interventions are embedded and ‘normalized’ within routine care. 
These mechanisms of NPT are: coherence; cognitive participation, collective action and 
reflexive monitoring (May and Finch 2009). Whilst NPT offers a helpful possible 
framework for the evaluation of PPI, it has also been used extensively in the evaluation 
of health care interventions and therefore its efficacy is becoming increasingly well 
established (McEvoy et al. 2014, May et al. 2011).  
 
When reviewing the limitations of their study, Wilson et al. (2015) identified, as Daykin 
et al. (2007) also did, that a longer time period was needed to understand and see the 
outcomes related to PPI in research: ‘Outcomes of PPI on research findings and impact 
on services and clinical practice requires a longer-term follow-up study’ (Wilson et al. 
2015 p.171).The study by Wilson et al. was the only work to have tried to address what 
this current research is focused on, and yet its inconclusive evidence points to a further 
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reason for why the current study is necessary. An earlier paper by Mathie et al. (2014) on 
the RAPPORT study found that even though PPI processes were well described in grant 
applications, there was a lack of monitoring on how PPI operates as the study develops, 
providing a glaring difference of what happens during study planning and conducting, i.e. 
research governance is lacking when a study is running.  
 
Poor quality reporting in the field is well established as a possible reason for the lack of 
literature on the impact of PPI on research outcomes. Furthermore, currently there is no 
consistent language to identify what is meant by impact of PPI on research processes or 
outcomes (Brett et al. 2010; Mockford et al. 2011; Staley 2009).   
 
Poor quality reporting on PPI 
Several authors have commented that reporting and assessment of PPI by researchers was 
poor (e.g. Brett et al. 2010). Mockford et al. (2011. p28) argued:  
 
There is, surprisingly, a dearth in research about the impact of PPI on services 
…and how services have changed (the outcomes), because of it [or] the extent of 
changes, or how much it costs….  
 
Staniszewska et al. (2011) point out that the difficulty in assessing the impact of PPI 
outcomes is due to poor methods of reporting how impact was understood as a marker of 
change.  
 
However, the non-appearance in the literature about changes observed, costs and other 
issues does not equate to no impact: ‘…the absence of evidence does not indicate an 
absence of impact, rather it indicates inadequate reporting with a lack of valid and 
reliable tools to capture the impact of public involvement’ (Mockford et al. 2012 p396). 
In some situations, the impact may easily be noticeable, while in most cases impact of 
PPI is much more elusive (Popay et al. 2014). However, Staniszewska et al. (2011) raised 
that descriptions of impact by their nature were insufficient because:  
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The main ways in which PPI impact is represented is through short descriptions. 
No standard formats exist for describing or capturing these impacts, and so they 
tend to vary in content, structure, and presentation.  
(Staniszewska et al. 2011 p396) 
 
Mockford et al. (2011) argued for a need for tools to help form an evidence base for the 
impact of PPI in research outcomes, with clear concepts, economic guidelines, and 
guidelines for reporting. The Guidelines for Reporting Involvement of Patient and Public 
(GRIPP) (Staniszewska et al. 2011) were subsequently devised from systematic reviews. 
In response to the above anomalies, there was a sense of urgency for common definitions, 
for tools and theoretical models: 
While there are some helpful definitions of involvement, the conceptualization 
or theorization of PPI has generally been poor. There have been some attempts 
to develop conceptual or theoretical frameworks, but there is no overall 
conceptual model of PPI impact that captures the essence of the concept and has 
been empirically tested.  
(Staniszewska et al. 2011 p394) 
 
Staniszewska et al. (2011 p389) made a further point and explained that identifying the 
necessary components to create the much-needed tools was important: ‘…[to] enable a 
greater understanding of what works, for whom and in what circumstances.’ They argued 
that context might concern conditions for PPI to make an impact such as support, training 
and resources. In relation to circumstances, they argued for the need to have insights into 
the PPI process, such as the methods used to undertake the PPI. The authors highlight 
that PPI is a complex process that has many different angles of assessment connected to 
it: ‘the importance of context and process suggests that PPI should be viewed as a 
complex intervention that requires multi-layered reporting.’ (Staniszewska et al. 2011 
p394).  
 
Staniszewska et al. (2017) devised an international checklist with consensus on what 
researchers should be reporting about on PPI processes (and to some extent, outcomes). 
The checklist came in two forms, a short format (SF) and a long format (LF) outlining 
guidelines eliciting comment on the impact of PPI. Not intentionally perhaps, the LF 
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offered pointers to the implementation process. It is worth reminding the reader that 
usually reporting or publishing occurs retrospectively, as does assessing impact. But 
perhaps one distinctive aspect of PPI is that it could help bring a unique focus to 
implementation work because it could concern prospective and retrospective thoughts, as 
patients and the public remain patients and the public, before and after research studies 
end. Thus GRIPP 2 can help in planning PPI and reporting PPI (Chapter 4 and Chapter 9 
demonstrate this). 
 
Gaps and important knowledge identified 
The two bodies of literature relating to impact of research, and the impact of PPI on 
healthcare and research, have both discussed the importance of context, mechanism and 
outcomes. In the impact of research literature, writers have not fully acknowledged the 
growing work in the field of PPI. Similarly, in the impact of PPI on healthcare research 
on process and outcomes, scholars, until recently, have regarded dominant impact 
structures such as the REF to be something that does not warrant comment regarding the 
impact of PPI on research work. These points will now be expanded and considered in 
relation to the current study. 
 
Summary and gaps: ‘The impact of research’ 
 
Exploring collectively the broader literature on impact of research particularly, ‘research 
context’, ‘application of new knowledge’, ‘research evaluation tracing tools’ and 
implementation science, has helped to confirm that PPI as an agenda for health research 
implementation is largely absent. This might partly explain why the impact of PPI on 
research outcomes appears to be an underdeveloped area of knowledge. Thus, the 
implications for the current study from the impact of research literature demonstrated six 
gaps: 
1. When considering the impact of PPI on research, timeliness must be taken into 
account because population needs evolve and doing the right thing at the right 
time appears to make a difference (Bensing et al. 2003). 
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2. There has been a lack of effort on creating consistent language, how engagement 
efforts with patients and the public could help usability of new knowledge. There 
was also no explicit mention of PPI in the application of new knowledge. 
3. The tabulated framework of Rivera et al. (2017) helped to identify that knowledge 
on impact frameworks available does not include the impact of PPI. And although 
there was mention of ‘end users’, this was not at involvement level, it was at an 
engagement level. 
4. The CFIR provided by Damschroder et al. (2009) has the potential to help 
establish how the impact of PPI outcomes could be better understood by offering 
attention to adapting the intervention, considering alignment between inner and 
outer settings, using the insights of people and then making the change. 
Application of the work by Damschroder et al. (2009) is unique because it 
inherently considers the ideas of complex interventions which can help PPI in 
implementation work.  
5. Broader factors pointing to PPI being a complex intervention also related the three 
challenges that the impact of research literature has identified. I.e. the importance 
of context equates to a favourable PPI climate; the need for clarity about how 
research will be applied will equate aligning appropriate PPI processes; and what 
impact tools to use may equate to how PPI can be evaluated.   
6. Guidelines and frameworks such as those of Rivera (2017), Damschroder et al. 
(2009) and Staniszewska et al. (2017) could be useful not just retrospectively but 
perhaps also during the research process planning as ‘...[guidelines and 
frameworks] can help to understand the conditions or features which support 
intervention effectiveness, its implementation and ideally, how to achieve 
sustained practice change’ (Brocklehurst et al. 2017. p333). Thus, following 
implementation guidelines during research conduct offers the research context up-
to-date knowledge, and offers the application of the research timely information. 
Therefore, impact can be assessed and traced more easily as the impacts emerge 
over time and yet the perspectives remain fresh. Though in the real world, funding 
does run out and so too can people’s motivations.  
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Summary and gaps: ‘The impact of PPI in healthcare research on process and outcomes’ 
 
On the impact of PPI, studies report a diverse range of outcomes including, 1. the design 
of new healthcare buildings; 2. the location and access to services; 3. the provision of 
additional services; 4. re-organisation of existing services; 5. improved changes of 
organisations in acute trusts; 6. improved dialogue between health professionals and 
patients; and 7. improved dialogue between patients and managers (Mockford et al. 
2011), There were also specific improvements in mental health services and 
improvements for BME communities. (Daykin et al. 2007).  
 
The impact of PPI on research processes was better documented than outcomes (Staley 
2009) but understandings about the impact of PPI on outcomes was underdeveloped. 
Staley (2009) argued that patients and the public who had strong agency and managers 
with strong leadership were in a firmer position to affect community action and change. 
Thus, here it seems that Staley is implying that implementation and impact may be 
achievable with individual agency and good leadership. The impact of PPI on people 
involved in the research process was documented by Brett et al 2010 but the impact of 
PPI on research outcomes was a major gap. Wilson et al. (2015) applied realist evaluation 
and NPT and found no evidence of impact. Others revealed that reporting and assessment 
of PPI was poor (e.g. Brett et al. 2010; Mockford et al. (2011). Robust evidence of impact 
is needed for a variety of reasons concerning process and outcomes:  
 
1. PPI in research-process related reasoning might encourage researchers to commit 
to the process of PPI (Staley et al. 2014). It would help to ensure that research is 
carried out with integrity (Snape et al. 2014a). Thus, overall would improve 
research quality (Morrow et al. 2010; Wright et al. 2011) and reduce negative 
ethical implications for patients and public, and for the research process itself 
(Pandya-Wood et al. 2017). Moreover, PPI in the research process would help to 
justify resources allocated to PPI (Staniszewska 2011). 
2. In relation to impact of PPI on research outcomes, understanding the impact of 
PPI on services and policy will help to strengthen the link between research and 
practice (Brett et al. 2011; Mockford et al. 2011).  
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3. Staniszewska et al.’s. (2017) framework of GRIPP 2 will be piloted and over the 
next few years and providing researchers use it, poor-quality about the impact of 
PPI reporting could become a diminishing problem.  
4. PPI context, PPI mechanisms and PPI outcomes need to be considered in 
understanding the impact of PPI on research outcomes, echoing ideas of realist 
evaluation (Pawson and Tilley 1997) 
5. Implementation theory such as NPT has been used to understand how to embed 
PPI into routine healthcare, thus suggesting that implementation science as a field 
of academic knowledge may offer new ideas for the current study, the CFIR has 
never been used. 
 
What this tells us is that there is a vague and not explicit link between the two distinct 
bodies of literature. The concept of PPI is not on the ‘radar’ of research impact literature 
but literature on impact of PPI on research are starting to form links in the way of a 
concept analysis which takes us from what research impact means to what impact of PPI 
means (Hughs and Duffy 2018). 
 
Methodological limitations 
In this critical narrative review there are methodological aspects which require 
acknowledgment. The terminology used to specify the people who use or are meant to be 
served by healthcare was broad. The meaning of the term ‘impact’ was also broad and 
was rarely addressed in the PPI literature.  
 
The articles were grouped to help understand whether they were concerned with empirical 
or theory-based writing. The literature presented here came from a mix of qualitative, 
quantitative and mixed methods approaches used by others to study the impact of PPI and 
impact of research, thus generalisability in the qualitative studies is not possible to 
determine as samples were often small.  
 
The reporting of PPI, as Staniszewska et al. (2017) note, has been poor and this has no 
doubt affected the content of the critical narrative review, especially that which concerns 
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the impact of PPI. In the current review it was found that PPI in research is multi-layered 
and cuts across a diverse number health conditions and different disciplines. This means 
that what may seem to work as a plausible explanation for one study, may not work in 
another. Hence a further reason why the need for understanding context, mechanism and 
outcomes (principles of realist evaluation) has been a popular choice for some (Wilson et 
al. 2015).  
 
Mason (2002 p154) argues that no research or story can be ontologically neutral (ontology 
is a point which is explored in the next chapter). The main focus of this review was to 
generate an understanding about the impact of PPI on research outcomes. The data in 
articles presented varied from primary and secondary sources, meaning that these sources 
have already been interpreted once before, by others who compiled and presented its 
arguments, thus taking these as evidence requires a degree of caution. To help gain an 
overview of knowledge it was helpful to use several literature reviews compiled by others 
since many of the key messages about the area under investigation were already 
summarised. They also offered the research enquiry details about insights into how to 
approach fieldwork for the current study (which is in the next chapter).  
Conclusion 
This critical narrative review has identified many studies, from a range of health 
disciplines, which address the 1. The impact of research and 2. The impact of PPI on 
healthcare research on process and outcomes. Various themes have emerged for 
consideration for the current study which have been summarised.  
 
The appraised literature problematised the impact of PPI in that more time and money 
was needed to enhance it. Better training, leadership and communication processes are 
also needed to help embrace its value. Collectively, the impact of PPI in the processes of 
research is understood better than impact of PPI on the outcomes of research and 
healthcare. This finding mirrors the previous chapter: achieving outcomes at 
implementation stage is an enduring challenge for PPI. The above impacts are diverse 
and rich in information about how they affect, mostly positively, healthcare services, the 
research process itself, the topic of interest being researched, and the people involved. 
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However, most of the impacts found did not focus upon the issue this study is concerned 
with, which is the impact of PPI on research outcomes. This is an important point because 
it implies that PPI evaluation needs to take account of stages of PPI evaluation, as 
reporting is poor. Perhaps efforts need to be placed on planning evaluations of PPI at 
certain points of time in order to understand smaller steps of achievement after a study 
has ended with PPI. Methodological limitations describe some of the challenges 
identified in using the literature particularly around using systematic reviews. In the next 
chapter, the methodological decisions made for the current research study are set out. 
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Chapter Four: Research Design and Methodology 
Introduction 
The aim of this study was to advance knowledge about how to evaluate the impact of PPI 
on cancer research outcomes. This social science inductive inquiry used a combination 
of interpretivist and pragmatic approaches, resulting in qualitative, mixed methods design 
(using interviews and a Delphi survey with patients and the public, healthcare researchers 
and stakeholders). At key stages of the research, the study utilised the principles of 
involvement with ‘end users’. 
 
This chapter explains decisions that were made to ensure that the methodology was 
congruent with the research aims and objectives. It begins with a discussion about 
research strategy concerning understandings of empiricism, epistemology and ontology 
because through these understandings of the researcher’s world view, methodological 
decisions were made. The ‘involvement section’ follows because involvement was 
threaded throughout the research design and involvement often resulted in 
methodological decisions. As involvement with end users was a large part of this study, 
it needed to be presented separately because those encounters were carried out before or 
after a key stage of research (e.g. data collection) therefore the involvement section 
demonstrates precisely what its aim was, how the involvement happened and what it 
resulted in before the researcher describes ‘her side of the story’. After this, an 
overarching design is presented, followed by detailed information about the approaches 
used in both phase 1 and phase 2. The chapter then reviews quality assurance and ethics.  
 
‘Participant’ and ‘panellist’ distinction 
Throughout this thesis in relation to the current research the author will be using the terms 
‘participants’ to mean (only) interview participants (phase 1), and ‘panellists’ to mean 
those taking part in the Delphi (phase 2). 
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Methodological stance and theoretical orientations 
Personal values inform the methodology chosen by a researcher (Crotty 2003). Under this 
section the epistemological, ontological and involvement influences on the researcher are 
outlined.  
 
Fundamentally, there are two main and opposing epistemological positions, positivism 
and interpretivism. A positivist position implies that one reality exists, and that the 
researcher will discover this reality (Robson 2002). The positivist position offers 
measurements of human opinion, suiting numeric answers, working out physical theories 
or hypotheses (Bryman 2012). Positivists see the researched world as independent of the 
researcher. On the other hand, interpretivists believe that the social world is understood 
differently from the natural world, i.e. we are born into a gendered, cultured and 
politicised world in which all experiences have meanings to each individual which are 
unique to them. Interpretivism offers room for difference and disputes, valuing varied 
perceptions and opinions (Dyson and Brown 2006). Initially, because this thesis’ aim was 
exploratory, an interpretivist epistemological position was adopted. ‘Perceptions of 
impact’ implied richer understandings based on people’s experiences, accounts and 
reasons behind their thoughts. However, early involvement work, clearly identified that 
something useful and tangible should come from the current study to help shorten the gap 
of understandings about impact of PPI on research outcomes and impact of research. 
Thus, the current research also needed to be pragmatic. Pragmatism in this research study:  
“… accepts, philosophically, that there are singular and multiple realities that 
are open to empirical inquiry and orients itself toward solving practical problems 
in the ‘‘real world”  
(Feilzer 2010, p8)  
 
Linked to the idea of epistemology is the question about social ontology, which refers to 
the nature of social entities: 
Whether social entities can and should be considered objective entities that have 
a reality external to social actors, or whether they can or should be considered 
social constructions built up from the perceptions and actions of social actors.  
(Bryman 2012, p32) 
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There are two main competing concepts for ontological grounding: objectivism and 
constructivism. Objectivism implies that people in the world are recipients to rules and 
regulations beyond reach or influence and tasks are carried out to maintain procedures. 
Facts and values are inseparable (Robson 2002). In contrast constructivists believe that 
meanings are constantly being revised to build a body of knowledge (ibid). 
Constructivism associates well with interpreting social phenomena. The current 
researcher’s social ontology aligned to the constructivist view because new meaning 
unfolds every day about aspects affecting the current research question, and together these 
opinions and theories build knowledge. The current study also aligned to the idea of 
inductive enquiry, rather than deductive enquiry. Inductive enquiries explore how the data 
generated relate to theory, allowing researchers to generalise interpretations from data 
followed by deduction (Bryman 2012). Whereas a deductive inquiry is when a researcher 
begins with a theoretical position and tries to gather and analyse data according to the 
theory (Brett Davis 2007). 
 
The use of qualitative data collection, then analysis, followed by further data collection 
was necessary to help the pragmatic angle. Traditionally, this has not been compatible for 
some researchers (Denzin and Lincoln 1998, p8). However, increasingly there is a 
growing view that mixing methods offer tangible benefits to social research because one 
of two datasets could serve as an explanation towards the other (Bryman 2012). By 
employing two approaches to data collection, data integrity and credibility could be 
enhanced because findings would help to build further understandings (Max Burgman 
2008).  
 
Thus, data refinement would offer pragmatic understandings that were needed for the 
richness of the data collected (Cresswell 2003). However, to use two methods – both of 
which were mainly qualitative – required careful consideration. There is an emerging 
field of thought that combining qualitative with more qualitative data can be classed as 
mixed method research (Morse 2009). The qualitative findings could offer context to the 
external validity or broader variables uncovered through the counted data (Creswell et al. 
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2008). In turn these aspects would help to generate understanding towards a diversity of 
views across the groups (Bryman 2012). 
 
And there is room in qualitative work for counting. Autonomous counting in qualitative 
research is used when, for example, ranking may help demonstrate the significance and 
importance of a particular (set of) issue(s) (Hannah and Lautsch 2011). Now that the 
epistemological and ontological position has been established, a description is offered 
about involvement informing the study. 
End user Involvement 
This section outlines why and how end user involvement was carried out. There are two 
entwined aspects that require explanation as they impacted upon the thinking behind this 
study. Firstly, the researcher’s own reflexivity on the topic being studied and secondly, 
critical consideration of the involvement of others and their impact on this study. Mindful 
of this, it was decided that an involvement reporting tool would be used called GRIPP 2 
(Staniszewska et al. 2017) as described in the previous chapter. 
 
This tool was designed to help researchers to report on the involvement aspects carried 
out in their studies. Table 6 (below) demonstrates the application of GRIPP 2 to this 
present study. A deeper reflection on end user involvement is offered in chapter nine. 
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Table 6 - GRIPP 2 adapted to report end user involvement in the current study 
Title (Staniszewska 
et al. 2017p3) 
Application to this study 
A) Provide a clear 
description of 
methods by which 
patients and the 
public were 
involved; 
 
Consultative level of involvement was maintained throughout the study (Hanley 2005). Consultation is when people are 
asked for their views about the study and then these views inform the researcher’s decision making in the study. Several PPI 
consultation meetings occurred whenever the researcher felt there was a strong purpose or need for clarity in the research 
(see below in sections G, H and I). In summary, workshops had between 5-17 attendees. Sometimes the focus was just 
patient and public input, other times the focus was researcher or stakeholder input. The input depended on who the focus 
of the study was on at a given time and on the availability of people and the researcher’s availability to ‘piggy back’ onto 
existing events that were being planned by her affiliated universities. Where possible an email was sent out in the form of a 
summary of the research and the reason for PPI input to whoever was planning the event to allow for a PPI workshop. The 
reason for sending out a summary was so that people who chose to be involved were briefed beforehand. At the end of the 
workshops the researcher would summarise what had arisen from discussions and ask for clarity, followed by explaining to 
those present how the content or people’s input might be used in the study. 
 
On reflection choosing consultation as a method of involvement had pros and cons. Consultation was useful as it provided 
flexibility to this PhD. As this is a PhD study, no funds were provided to run PPI workshops. Consultation was sometimes 
difficult to manage because ideally people involved would have liked to have known how their input changed the research 
but in reality, this did not happen unless people explicitly asked. People rarely did ask – which sometimes made the 
involvement in this work feel slightly publicly isolated and disconnected from what they had raised. It was also difficult for 
the researcher to keep up with emailing everyone who was present. 
 
B) Provide a 
description of 
patients, carers, and 
The ‘researched’ in the current research spanned the experiences of patients and public, applied healthcare researchers, 
healthcare policy staff and clinical staff. Thus, the involvement in this study reflected the above range of people (See details 
below in D).  
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
the public involved 
with the PPI [patient 
and public 
involvement] 
activity in the study; 
 
 
On reflection it is important to note that the patients and the public involved in this study were sometimes experienced 
individuals who were on occasion highly verbal about the training that they had been exposed to in their PPI roles. At 
shorter workshops (45 mins) it felt as if the focus of the current research needed a longer time for them to digest the 
content and frustratingly just as content became useful the workshops were almost over. Over the course of the study 
sometime the same groups of people came to workshops and their knowledge on the topic had evolved or grown partly 
because the researcher was able to articulate better on the topic and partly because they had been exposed to more impact 
of PPI related information through their own networks. 
 
Researchers were often the hardest group to help understand the focus of the study because they were not attuned to PPI 
in research all the time or sometimes they felt that PPI was about participants in the study. This confusion often diverted 
valuable time allocated for discussion on the topic, away from it. Not surprisingly the theoretical discussions which were 
held in 2017 were most fruitful amongst academic researchers.     
 
C) Report on how 
PPI is used at 
different stages of 
the study  
 
The principles behind the researcher’s deliberative design aligned with reflection and critical feedback on methodological 
decision making, and to help with conceptual clarity, both at the following stages of the current work:  
- study aims development;  
- research design – both phases;  
- piloting questions for fieldwork – both phases;  
- analysis – both phases; and  
- discussion planning. 
 
D) Report the level 
or nature of PPI 
used at various 
stages of the study. 
Involvement took shape in the form of mostly planned face-to-face meetings, workshops, telephone calls, Skype calls and 
email exchanges. Impromptu involvement also influenced this work and a research diary that was kept recording details of 
these occurrences. 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
E) Report the 
methods used to 
qualitatively explore 
the impact of PPI in 
the study;  
 
Regular supervision discussions, an audit trail, a reflective diary and a poster on this very topic were used, applying Lincoln 
and Guba (1985) (see Appendix 1). This helped the researcher conceptualise what impact meant for the current work. 
Below in section G, H and I a summary reflects how useful each encounter of planned and unplanned involvement was, 
documenting direction and change for the current work. 
 
F) Report the 
methods used to 
quantitatively 
measure or assess 
the impact of PPI; 
 
This study used mixed methods sequential design. But input from end users was in dialogical ways, see below in section G, 
H and I, but from a numeric assessment in summary: 12 consultations occurred (on average, twice yearly) over the course of 
the research process with over 110 people spanning a range of academic and patient and public involvement backgrounds.  
 
G) Report the rigour 
of the method used 
to capture or 
measure the impact 
of PPI; 
 
H) the results of PPI 
in the study, 
including both 
positive and 
negative outcomes; 
 
I)the positive and 
negative impacts 
G), H) and I) are combined below in 1-13 ‘influential meetings’ which describe the rigour and impact of the involvement 
encounter and whether it was positive or negative. 
 
1)December 2008 - organic discussion prior to the study starting - favourable context  
Observations on the front line and a discussion at a national Research Design Service (RDS) meeting presented the 
challenges of understanding the impact of PPI on research outcomes. The idea of studying the impact of PPI on research 
outcomes was discussed as a potential useful piece of work to help current debates on why researchers should engage with 
patients and the public in applied health research studies.  
 
The PhD was registered in April 2009 and initial literature reviews started in 2010.  
 
2)April 2011 - relevance of question/aims via a workshop 
A workshop held with academics at the Health Policy Research Unit (HPRU) at De Montfort University (which is a cluster of 
professionals interested in academic research concerning the topic of this work).  
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
that PPI has had on 
the research, the 
individuals involved 
(including patients 
and researchers), 
and wider impacts; 
 
 
Outcomes and impact from the workshop 
- Brainstorming led to the aims and objectives of this study. 
-The research needed to develop tangible and pragmatic outcomes from it.  
-The importance of having PPI in the study itself was unveiled by the workshop attendees. 
-It became apparent that the ‘end users’ of this research were not just patients and the public but also the researchers and 
academics interested in this work.  
-The importance of focusing on one topic area was raised at this workshop and as a result, the disease of cancer was 
selected over other topics of health (autism, substance abuse and HIV were the researcher’s background before the current 
role in the NIHR RDS).  
 
-The workshop resulted in early peer review of the proposed design of the study. 
 
3)November 2011 - ethical clarity was needed for phase 1 via two face-to-face meetings 
During the ethics approval process from De Montfort University, clarification was needed about whether NHS ethics 
approval was needed for this study; an ethics committee member and a Research and Development office manager were 
approached for a discussion. 
 
Outcomes and impact from the two meetings 
They confirmed that NHS ethics approval was not necessary for this study as people involved as participants would be 
offering their expertise of research and not concerning their cancer. They raised that recruitment for participants was to be 
carried out via publicly searchable and approachable means. After this, ethical approval was successfully attained (before 
the researcher began maternity leave for 13 months).  
 
4)June 2013 - data collection tool (patient and public sensitive) 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
The questions developed needed to be piloted to ensure that there was flow and that they were serving their purpose. Two 
members of the public offered opportunity for piloting the work. Both were in remission. Piloting took place face to face. 
 
Outcomes from the pilot interviews with patients 
Certain questions were omitted from the interview guide as a result of the pilot. For example, it was felt that a probing 
question about involvement in prior cancer research studies should be reworded. Because of this suggestion, the question 
was altered on the interview guide. 
 
5)June 2013 - data collection tool (researcher appropriate) 
Two pilot interviews with academics from the Faculty of Health and Life Sciences at De Montfort University were carried out 
to ensure that the questions were researcher appropriate  
 
Outcomes from pilot interviews with researchers 
Feedback indicated some of the questions were too long and wordy, which helped the researcher to adjust the interview 
guide for the current research. 
 
6)August 2013 - data collection tool (stakeholder appropriate)  
Two pilot interviews with healthcare professionals from the University of Leicester were held (to ensure that the questions 
during interview were applicable for the stakeholders. 
  
Outcomes from pilot interviews with stakeholders 
For consistency, impact of research needed to be explained within the interview itself.  
The interview guide was adapted to include this point. 
They said some questions were not suitable for stakeholders and should be phrased differently e.g. original question was 
‘can you describe the study you were involved in’ changed to ‘how were you connected to the … study’? 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
7)May 2014 – data analysis focus workshop with researchers 
A seminar at the HPRU was held to present the researcher’s analysis of the interview data. The key themes were presented. 
Workshop attendees were also asked for suggestions for the focus of the Delphi ‘stimulus paper’. 
 
Outcomes of the data analysis workshop with researchers 
At this seminar, a discussion took place about how the data were very varied and broad. The main reasons for the variations 
were because of the various types of studies that the different groups (patients researchers and stakeholders) has focused 
to speak about during interviews, their real-life examples of studies ranged from clinical trials to qualitative interviewing in 
the community (palliative care).It was suggested that common themes running across the three groups needed to be 
focused on rather than other aspects from the data. 
 
8)May 2014, data analysis focus workshop with stakeholders 
A seminar at the University of Leicester SAPPIRE group was held on data analysis focusing on common themes across the 
three groups. Workshop attendees were asked specifically about Delphi ‘stimulus paper’. Feedback was offered from the 
previous workshop too. 
 
Outcomes from the data analysis workshop held with stakeholders 
An important point raised here was also concerning the vastness of the data and that the researcher should try and simplify 
the data (there were seven themes) these needed to be the focus. Attendees posed the question of why refinement was 
necessary if the work was interpretivist, to which the researcher’s response was that something applicable needed to come 
from this study to help further the field. Workshop attendees agreed that the study needed to be pragmatically focused.  
 
9)June 2014 data analysis focus workshop with patients and the public 
At the Research Engaging with Patients and Public (REPP) forum a summary of findings was presented in a lay format.  
 
Outcomes from the workshop held with patients and the public 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
Small group discussions were arranged. Those present (45 patients and public) had concerns that the findings were too 
‘broad and quite academic’. Hence, the issues relating to PPI in research processes were in their words a ‘red herring’ for 
this research and some if it needed to be carefully sifted out of the analysis, so that the stimulus paper issues related to the 
outcomes rather than processes. Public members at the workshop also said it was ‘very hard to think about impact of PPI 
without a definition’.  
 
Attendees were asked to comment on what they would like to find out through the Delphi if they were conducting the 
research. The main messages were that impact of PPI needed defining, and that process issues were already known about, 
so the Delphi needed to be ‘very outcomes focused’. 
 
These three workshops (points 7,8,9 in this section) impacted on this work considerably because it helped the researcher 
gain clarity that the focus of the Delphi needed to be on the seven factors identified from the data (PPI processes, 
Dissemination, Power and leadership, Resources and the political context, Networks, Information and Communication 
technology and Wanting to make a difference). The Delphi needed a starting point about what impact of PPI on research 
outcomes meant for the current study. The stimulus paper developed reflected these aspects. 
 
10)August 2014 - October 2014 Phase 2 Delphi study planning, checking and piloting over six weeks  
Questions for phase two needed planning, checking and piloting within the intensive six weeks. A carer agreed to pilot all 
three rounds of questions. 
 
Outcomes from planning, checking and piloting Delphi study 
Rounds one, two and three questions were all piloted with a carer. Wording was adjusted on all three rounds some 
questions were made more ‘lay-friendly’. After data collection was complete, results were recorded in a journal and a 
discussion workshop was needed to gain theoretical and conceptual clarity.  
 
(A second maternity break followed after data was collected for phase 2. in September 2015, for 14-months  
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
 
11)May 2017 - Theoretical clarity workshop 
A workshop was held with HPRU members on theoretical clarity and the focus of the Discussion from this study.  
 
Outcomes of theoretical clarity workshop 
It was suggested that the researcher needed to focus on the pragmatic use of theories 
 
12)May 2017 - Theoretical clarity workshop 
A final workshop was held with the SAPHIRRE group on the theoretical clarity and the focus of the Discussion chapter. 
 
Outcomes of theoretical clarity workshop 
Workshop attendees raised that the researcher needed to be mindful that the work needed to have a pragmatic focus   
These conceptual workshops later led the researcher to the work of Damschroder et al (2009). 
 
J) The influence of 
any contextual 
factors that enabled 
or hindered the 
process or impact of 
PPI; 
 
There were various influential factors, concerning the context of this research which enabled and hindered the process of 
the study and the impact of the planned involvement for this study. 
 
Between 2009-2012, MRC and NIHR funded five studies on the impact of PPI on research. As a result, momentum on the 
topic started to gain pace. Thus, the context began to shift, and the impact of PPI began to feature regularly in national 
conferences and meetings. This in turn initiated several conversations between the researcher and others (e.g. one 
prominent conversation in February 2011 was with a rheumatologist researcher who challenged the researcher by asking 
‘how are you researching the impact of PPI without involving people?’ This conversation contributed towards the idea of 
having focused discussions at the HPRU seminar with end users about how this current study might involve people and who 
the end users were. 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
In November 2016, upon returning from a second maternity leave, several new publications had been published on the 
topic being researched. As all the national funded studies had finished, this suggested that the field was gaining 
sophisticated momentum from scholars. 
 
K) The influence of 
any process factors, 
that enabled or 
hindered the impact 
of PPI; 
 
Involvement in this work has often felt reactive. The goodwill of people who have been involved has been partly because of 
the researcher’s professional work in the field. In hindsight this work could have explored whether two or three consistent 
people could help plan the involvement as did Robinson (2012) in her work on Asperger’s syndrome and Thompson (2009) 
in her work on PPI in the cancer research setting. Despite this observation and the length of time taken to conduct this 
work, meaningful involvement at the highest standard has been achieved due to the researcher’s own values and interest in 
the topic. Thus, the impact of the approach of involvement used in this work has been successful as people involved offered 
a diverse critical and constructive sounding board. More on reflections about end user involvement is offered in chapter 
nine. 
 
L) Any conceptual or 
theoretical 
development in PPI 
that have emerged; 
testing of theoretical 
models; 
The work of Damschroder et al. (2009) has been applied to the study discussion to help consider PPI at an implementation 
level. 
M) Aspects of 
instrument 
development and 
testing (e.g. validity, 
reliability, feasibility, 
acceptability, 
responsiveness, 
The following models were used: The work of Lincoln and Guba (1985) was used for reliability and validity understandings - 
see section on Research rigour in this chapter.  
The five domains that Damschroder et al. (2009) identified have been used to understand interpretability of how data from 
the current study which is about advancing knowledge about the impact of PPI, can be considered via the domains of 
adapting the intervention, the inner and outer settings, offering thought to the types of people involved in making change 
happen (their individual agency) and actually carrying out the change. The use of GRIPP 2 itself (Staniszewska et al. 2017) 
has been adapted and used retrospectively to help respond to the gap in specially designed tools for recording PPI work. In 
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Title (Staniszewska 
et al. 2017p3) 
Application to this study 
interpretability, 
appropriateness, 
precision)  
 
this work, in the absence of other tools GRIPP2 LF and SF has been adapted and used as a tool to record how involvement in 
this study has resulted into change (impact) and this table demonstrates that, with flexibility and adaptation, a 
methodology can reflect the GRIPP 2. 
  
Adapted from ‘Guidelines for Reporting Involvement of Patients and Public 2’ Long Format (GRIPP 2 LF) (Staniszewska et al. 2017) 
 
 89 
As table 6 demonstrates, the involvement of potential ‘end users’ had an impact on the 
current study’s research design from a pragmatic point of view, to help methodological 
decision making, and to aid conceptual clarity. Involvement occurred during: study aims 
development; research design for both phases; piloting questions for fieldwork in both 
phases; analysis in both phases; and discussion planning. Involvement encounters 
occurred mostly in face-to-face and sometimes remotely (over email and telephone). 
Overall, 12 key influences of involvement occurred over the course of the study (on 
average, twice yearly) and over 110 people were involved at a consultative level (Hanley 
2005). The context for the study was favourable because numerous studies were funded 
nationally on the topic at the time (implying momentum of new knowledge was gaining 
pace). The following scholars’ work was applied and influenced the conceptual clarity of 
involvement for the researcher. Lincoln and Guba (1985) Damschroder et al. (2009) and 
Staniszewska et al. (2017). Table 6 demonstrates that deliberation was woven through the 
work. However, whilst theories are important to help demonstrate what had influenced 
the researcher, it is worth remembering, they are only after all hopes and aspirations and 
not strict guidelines (Platt 1986).   
Overarching study design 
This work adopted an exploratory sequential design for data collection (Creswell et al. 
2008). Data were collected in two phases, through interviews and a Delphi survey. Phase 
1 took place between June 2013-February 2014 with a total of n=23 participants who took 
part in qualitative interviews. Interviews were chosen to form rich accounts of 
understandings about perceptions of impact of PPI on research outcomes. Patients, 
researchers and stakeholders took part and provided information about research studies 
which had finished. Themes identified from the interviews were fed into a unique paper 
which was called the ‘stimulus paper’ in this study. Prior to the interviews, literature 
reviews were carried out (and parts of these were published in book chapters: Pandya-
Wood and Robinson 2014, Rivas and Pandya-Wood 2014 and Pandya-Wood et al. 2018).  
 
Phase 2 of the research was carried out in the form of a three-round modified Delphi 
survey (interview data themes formed the preliminary work for the Delphi) with experts 
from the field. The Delphi survey’s purpose was to offer a sophisticated yet practical 
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understanding of the complex social issues that the interviewees had identified from their 
accounts of understandings and perceptions concerning the impact of PPI on research 
outcomes. This phase was carried out between September 2014 and December 2014 with 
n=35 panellists (those working in leading charities and large non-government 
organisations, policy-makers, academics, independent consultants, government 
department leads, and ‘expert patients’/patient champions).  Figure 3 demonstrates the 
data collection process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase 1 - Qualitative interviews 
The interview is a well-used research method chosen usually by qualitative researchers. 
They are essentially a conversation with a focus, bringing in rich and thick descriptions 
about the phenomenon being researched. Interviews are useful because they can be 
structured in their style, semi-structured or totally unstructured, offering varying degrees 
of information (Britton 2006). Ives and Damery (2014) argue that the real strength of an 
interview is the flexibility of the research encounter to be both proactive to obtain the 
data, and also reactive to the data obtained, probing more questions. They allow for views 
Figure 3 Data collection process 
Interview data collection  
Analyse 
Collect (round one) Analyse 
Collect (round two) Analyse 
Themes: Stimulus paper 
Collect (round three) Analyse 
Seeking examples using phase 2 data to inform phase 1 data 
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to unfold by asking the participants to consider using their own thoughts, perceptions and 
feelings driven by their own experiences.  
The aim of this qualitative research was to understand the experiences of others, inviting 
them to describe their own perspectives. Semi-structured interviews, through probing, 
also enable follow-up questions for further clarification and detail. They can allow a space 
and opportunity to talk, rather than being constrained by pre-identified categories of 
response, using people’s own vocabulary about what they find significant and important 
to them (Brett Davies 2007). Interviews were therefore planned to be conducted face to 
face, rather than remotely. 
 
Limitations of interviews 
The author was mindful of interviewing being a skill that required practice and constant 
reflection. Roulston (2010) found that four problems were encountered by novice 
researchers, summarised as: 1) difficulty in dealing with unexpected participant 
behaviours; 2) managing the researcher’s own prejudice and beliefs; 3) difficulty in 
constructing and delivering questions; and 4) difficulty handling sensitive topics. By 
carefully planning and piloting (described in table 6) each of these problems were 
overcome. 
 
But there are further challenges to interviews because they were always retrospective 
accounts (Taylor 2005) and past events can be misremembered, implying inaccurate data 
might be collected. To mitigate this, participants with recent experience were sought. 
With interviews there are subtle power dynamics between the researcher and the 
participant (Robson 2002).  The issue of power may be connected to participants feeling 
intimidated by researchers, and power dynamics could well be present between a 
researcher and elite interviewees (Littig 2009). In this work, interviews were planned with 
professors, senior investigators and those holding significant public office, titles or in 
receipt of national recognition. Therefore, being confident in interviewing was deemed 
important for the current researcher right from the outset. Similarly, the interview pilot 
phase needed to ensure that research questions were accessible to reduce any intimidation. 
 92 
 
Preparing an interview guide 
An interview guide was developed by the researcher so that a list of appropriate and 
focused questions could be asked about people’s experiences and knowledge about the 
impact of PPI on research outcomes. When preparing the interview guide, the main issue 
kept in mind was: ‘just what is it that is puzzling me?’ (Lofland and Lofland 1995 p78) 
because this raised a sense of inquisitiveness in helping to ask the necessary questions 
needed from each group (patients, researchers and stakeholders). From reading the 
literature on the topic of impact of PPI on research outcomes, the researcher was aware 
of where knowledge was limited. The planned involvement channels of this work also 
helped with potential questions. National meetings, such as INVOLVE conferences, 
helped the researcher consider frontline issues that patients, researchers and stakeholders 
were struggling with in relation to impact on outcomes. At the time when data collection 
was being planned, five national studies had been funded on – the impact of PPI. These 
studies became public knowledge on the funders’ websites. Efforts were made to ensure 
the current study remained uniquely focused on the impact of PPI on research outcomes. 
Finally, discussions with colleagues were also considered when generating questions.  
 
The interview guide questions were designed in a way that was suitable for any of the 
three groups being interviewed. Topics for questions followed a logical and chronological 
structure. The interviews opened with two familiarisation questions: 1) information about 
the study and 2) what the motivations were for involvement in the study. Then it was 
necessary to ask, 3) how patients and public were supported for their roles in the research 
(mindful that this would also generate research process issues – but necessary, as it added 
more context). The interview then proceeded to ask questions about the outcomes from 
the study, including 4) key messages disseminated, 5) what had happened since the study 
had finished and lastly, 6) how participants understood impact. A copy of the interview 
guide is set out in Appendix 2. Within the current study, the interview schedule (appendix 
2), was not used verbatim but as a topic guide. 
 
Pilot interviews 
Once developed, the interview questions and interview process needed to be piloted with 
individuals from each of the three groups; two people from each group were involved. 
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The pilot phase was invaluable for many reasons: the six pilot interviews helped the 
researcher to gain confidence; ensure that the questions followed a logical flow; adjust 
wording of certain questions; and monitor the smooth running of time. The length of time 
for an interview ranged from 45 minutes to two hours although adjusting the interview 
guide and the pilots helped to ensure that questions could be completed in one hour. Minor 
changes were made to suit each of the three groups and cues for questioning certain 
groups. Data from pilots was not used in the analysis. 
 
Sampling framework 
Data should continually be collected until data saturation has been reached, i.e. when 
information generated becomes repetitive and nothing new is being raised (Ives and 
Damery 2014). In the current research, participants were identified using purposive, non-
probability sampling (Tansey 2007). In this study, finding a range of views and 
perceptions about the understandings of the impact of PPI on research outcomes was the 
primary concern. Using academic and professional networks, three groups were recruited: 
patients and the public, researchers and stakeholders. 
 
To help the current study retain its unique focus, the following inclusion and exclusion 
criteria were applied: 
• Researchers and patients interviewed were required to be able to discuss a cancer 
research study from the last five years2 which had patient and public involvement 
in the research design and conduct. 
• Preference was given to finding participants from the East Midlands. Focusing on 
one regional geographical boundary enabled convenience and snowball sampling 
approaches to be used by the researcher (Denscombe 2014).  
• Participants needed to be over the age of 18 and able to speak in English. 
Excluding non-English-speakers was a limitation for this research but was 
necessary because there were no funds available for translation services. This 
limitation was magnified given that Leicester, from where most participants were 
recruited, is a diverse and multicultural city where over 130 languages and dialects 
                                                 
2 According to the Research for Patient Benefit funding stream it is possible to demonstrate patient 
benefit between 3-5 years of a study finishing. 
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are spoken (Census 2011). Sheldon and Parker’s (1992) work on race and 
ethnicity highlighted problems associated with health research and its limitations 
for not integrating aspects of race and ethnicity into health research strategies that 
include all groups.  
 
Recruitment, consent and arranging interviews 
All potential participants were identified through the researcher’s professional networks 
as Regional Lead and Senior Advisor for Patient and Public Involvement for the Research 
Design Service, East Midlands. Emails were sent with a poster to people (Appendix 3) 
the researcher was aware of and those who fitted the sampling framework. In addition, a 
professional virtual network was contacted via an email advertising this research. The 
professional virtual network cuts across health and social care sectors. It celebrates a 
broad membership list, where members can select which subgroups they want to join for 
targeted information to be sent to them. Interest areas, to list a few, range from: ‘PPI’, 
‘Cancer’, ‘Better care without delay’ and ‘Service improvement’. See Table 7 for targeted 
recruitment for each group. 
 
Table 7 - Targeted recruitment (Phase 1) 
Patients  Researchers Stakeholders 
NIHR Cancer Research 
Network 
Cancer Support groups in the 
East Midlands 
PPI forums at Leicester, 
Nottingham, Derby, Lincoln 
and Northampton 
CHAIN Network 
3 Twitter tweets resulted in 7 
retweets 
Snowballing (word of mouth) 
Public Face Newsletter (East 
Midlands wide) 
Existing contacts 
CHAIN (Contact, Help, Advice 
and Information Network) 
DMU staff newsletter 
 
 
Existing contacts 
CHAIN 
INVOLVE 
 
If potential participants put themselves forward and if they fitted the criteria, an 
information sheet (Appendix 4) and consent form (Appendix 5) were provided. Some 
people requested a telephone conversation, others took part in an email conversation, to 
find out more about the research. This initial contact was a valuable opportunity to allow 
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people to ask any questions about the research, and to arrange potential interview dates, 
times and venues.  
 
Interview sample and data collection process 
Interviews were carried out with n=23 participants. Details of their demographics and 
background information are set out in Table 8 and Appendix 6 demonstrates how this 
information was collected. 
 
Table 8 - Participant demographics and key information (Phase 1) 
Category  Patients  Researchers Stakeholders 
Sex F (n=4) and M (n=2). F (n=3) and M (n=5). F (n=4) and M (n=5). 
Age range 60 – 65 across group. 40 – 60 across the group. 22 – 60 across the group. 
Ethnicity All White British (n=6). All White British (n=8). All White British (n=9). 
Religion All Christian (n=6). Christian (n=5), and 
No religion (n=3). 
Christian (n=4), 
No religion (n=3), and 
left bank (n=2). 
Experience Breast Cancer (n=3), 
Oesophageal Cancer (n=1), 
Non-Hodgkin’s Lymphoma 
(n=1), and 
Stomach Cancer (n=1). 
Clinical geneticist (doctor) 
(n=1), and Clinical and 
Academic Professor (n=7). 
Broad and varied ranging 
from junior policy staff in 
charities, to professors 
and directors of research 
centres and a hospice. 
Two had been awarded an 
OBE. 
Some had PhD and 
Professor in their title. 
Locations  Northamptonshire (n=1),  
Nottinghamshire (n=1), 
Leicestershire (n=1), 
Lincolnshire (n=2), and 
Derbyshire (n=1). 
Nottinghamshire (n=3) and 
Leicestershire (n=5). 
 
Nottinghamshire (n=4), 
Leicestershire (n=3), and 
East Midlands in general 
(n=2). 
Type of cancer 
study involving 
PPI 
Randomised Control Trials 
(RCTs) (n=2), 
Community research (n=1), 
Surveys (n=1), 
Service improvement/ 
redesigning a service (n=1), 
and 
Improving cancer experience 
(n=1). 
Randomised Control Trials 
(RCTs) (n=4), 
Palliative care (n=1), 
Cancer health provision 
inequalities (n=1), and 
Community care (n=2). 
Community research 
(n=2), 
Palliative care (n=2), 
Participatory Action 
Research (n=1), and  
Improving cancer 
experience (n=9). 
Funder Research for Patient Benefit 
(n=2),  
Cancer Research UK (n=2),  
and unknown (n=2). 
Marie Curie (n=1),  
Macmillan (n=1),  
European Union and Sanofi 
(pharmaceutical company) 
(n=1), 
Economic and Social Research 
Council (n=1), 
Research for Patient Benefit 
(n=3), and unknown (n=1). 
Health Technology 
Assessment (n=1),  
Service Delivery 
Organisation (now Health 
Services and Delivery 
Research) (n=1), 
Cancer Research UK 
(n=2), 
Marie Curie (n=1),  
Macmillan (n=1),  
Collaborative Leadership 
for Applied Health 
Research Care (n=1),  
 96 
Category  Patients  Researchers Stakeholders 
Breast Cancer UK (n=1), 
and  
Prostate UK (n=1). 
 
Interviews with patients took place in their own homes and were generally ‘social’ and 
relaxed in style, typically lasting 90-120 minutes. Interviews with researchers took place 
in hospital settings and university offices and lasted just under an hour - these interviews 
were the shortest. Interviews with stakeholders took part in university offices, hospital 
offices and hospital cafes all over the East Midlands, for a duration of 90 minutes. After 
all of the interviews were completed, each participant was informed about the potential 
next stages of this work. Later, a handwritten card was posted to each participant to 
express gratitude for their time. 
 
Data analysis  
This section demonstrates how two overarching themes with seven subthemes were 
identified using Braun and Clarke’s (2006) model of analysis. The first theme was the 
‘Impact of PPI in research processes’ (two subthemes under this were ‘PPI processes’ 
and ‘Wanting to make a difference’). The second overarching theme was ‘Impact of PPI 
on research outcomes’. Under the latter theme, the main focus of the PhD, the subthemes 
generated were: Networks; Leadership and power; Resources and the political context; 
Dissemination; and Information and Communication Technology.  
 
All the interviews were recorded and transcribed verbatim. Braun and Clarke’s (2006) six 
stages of data analysis was applied to this process. The process entails: data 
familiarisation, generation of initial codes, searching for themes, reviewing themes, 
defining and naming themes, and producing a report. The stages are now described: 
1) Data familiarisation  
This stage for Braun and Clarke (2006 p2) involves ‘the researcher immersing themselves 
in their dataset by reading and re-reading each and every data item (and listening to any 
audio data at least once), to learn the content of the dataset ‘inside out’’. Once all the 
data were transcribed, the audio recordings were heard, and corrections were made to the 
 97 
Microsoft Word files. Once the transcripts were ready for analysis, these files were 
grouped according to the participants (patients researchers and stakeholders). These files 
were all printed and also uploaded onto NVivo.  
2) Generation of initial codes 
For Braun and Clarke (2006) this phase concerned coding data to help generate initial 
codes. The idea behind coding is to find interesting data which relate to meaningful 
information. At the very least a code can signify surface level information but at a deeper 
level a code might have hidden meanings such as assumptions that participants may have. 
Using NVivo, familiar and recurring issues raised were coded (Robson 2002 p274). See 
Appendix 7 for coding frameworks for phase 1. n=122 codes were identified and applied 
in this stage. For example, three codes were: ‘Rewards and incentives’, ‘Stretched 
resources’ and ‘Involving charities’  
3) Searching for themes 
For Braun and Clarke (2006 p2) the analysis here ‘shifts to a wider focus. A theme 
identifies a meaning patterned across the dataset, which is important for illuminating the 
research question’. Despite efforts to minimise data content on the impact of patient and 
public involvement on research processes, more than half of the overall data appeared to 
be on this topic (see Figure 4 - process codes map). Briefly, this large theme was useful 
because it grounded the data they provided during interview. At any opportunity 
participants eloquently spoke about their experiences of PPI processes (and in the case of 
researchers how they were (mostly) pro-involvement), they discussed from how 
opportunities about research were advertised to how what the work had led to since. 
Patients spoke of what it felt like to be a patient, what skills researchers were looking for, 
what skills they brought to the research process and the sorts of things that motivated 
them to get involved. Stakeholders described the unique value of research which had 
involved patients and the public, suggesting that the respective research study’s they were 
describing were ‘better quality because of PPI elements’. It was decided that this 
information was key to understanding the outcomes of research.  
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After PPI processes were grouped as a theme in their own right providing background 
information to help consider ‘contextual issues’, they were placed to one side to revisit 
later. Once all the remaining codes were themed, 15 ‘parent codes’ were identified as 
relating to impact (see Figure 5) and 20 codes identified as relating to barriers and/or 
facilitators of impact (see Figure 6). (To see full breakdown of these codes, along with 
their tiers of information, ‘parent’, ‘child’ and ‘grandchild’ codes that were also identified 
in NVivo, please see Appendix 7). 
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Figure 4 - PPI processes discussed during interviews (map) 
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Figure 5 - Perceptions of impact of PPI mentioned during interviews (map) 
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Involvement within the current study helped at this stage as the codes identified were grouped using the knowledge of workshop attendees. 
 
Figure 6 - Barriers and facilitators of impact of PPI (map) 
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4) Reviewing themes  
Braun and Clarke (2006) argue that in order to review the themes, there are two levels:  
checking that the themes work in relation to the coded data and; checking that they work 
across the entire dataset. The researcher will check to see that the theme is distinct, 
coherent and has distinct boundaries. To ensure that the analysis so far was an accurate 
reflection of the emerging themes, a sample of transcripts were sent to the researcher’s 
supervisors to help ensure consistency. This acted as a quality check of the researcher’s 
analysis technique. Themes identified by the supervisors helped to clarify that some 
themes overlapped, e.g. ‘networks’ and ‘dissemination’.  
5) Defining and naming themes  
This was an important stage for the analysis. Braun and Clarke (2006) state that the 
researcher will produce detailed and complex definitions of each theme which capture 
the uniqueness of the theme and how it relates to others, clearly addressing how the data 
reflect the research questions. To ensure this process was carried out carefully, three 
‘making sense of the data’ workshops were held with ‘end users’. They were asked to 
help broadly categorise the data. They were not shown the coding framework generated 
on Nvivo, they were only shown the Inspiron generated maps (Figures 4, 5 and 6). 
  
This process along with the researcher’s own demonstrated that there were seven 
overarching themes: ‘PPI process’; ‘Wanting to make a difference’; ‘Networks’; 
‘Leadership and power’, ‘Resources and the political context’; ‘Dissemination’; and 
‘Information and communication technology’.  
6) Producing a report (to serve as a ‘Stimulus paper’) 
This stage of the Braun and Clarke (2006) model concerns using clear language to 
describe the themes. A short description was written by the researcher about each of these 
themes to help identify the area of focus for the next stage of the study. The content 
developed was used towards the ‘Stimulus paper’ (see Appendix 8) for the Delphi in 
phase 2. 
 
The seven major themes here form the basis of the first data chapter (chapter five). 
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Phase 2 - Delphi survey  
This phase used the Delphi survey to help data refinement and enhancement. The broad 
themes generated during the interviews needed data refinement to understand how the 
findings reflected the real lives of policy makers, politicians and other experts. This 
section sets out why the Delphi technique method was selected and what the process 
entailed. Crucial to the success of the Delphi technique was the use of a ‘stimulus paper’. 
 
Stimulus paper 
The literature on Delphi surveys provides no definition of a stimulus paper, but the use 
of ‘stimulus text’ in interviews is well documented. Silverman and Brull (1993) suggest 
a stimulus text offers context, more than just a question or a sentence making a 
proposition. A stimulus text is a description about an ‘outline or story of an event or 
action, seen or experienced from a viewpoint, uttered by an identifiable or unidentifiable 
narrator’ (Silverman and Brull, 1993, p91–92). The description of the stimulus offering 
context fits with this research, as the data that were generated in phase 1 provided initial 
contextual information about the impact of PPI on research outcomes. For Törrönon 
(2002), a stimulus text presents important analysis of what has been studied and found: 
The stimulus text …are expected to articulate the phenomenon under 
examination to make it perceptible in such a way that the…[those]… 
interpreting the stimulus text, are ‘empowered’ to express their social 
experience and cultural knowledge of the issue under question: 
(Törrönon 2002p345) 
 
Adapting Törrönon (2002) line of thinking in this work meant that the ‘stimulus text’ 
needed to be succinct and articulate, summarising the data themes from phase 1, with the 
Delphi questions. In determining how long the paper should be, the researcher followed 
guidance on developing executive summaries, which suggested that many writers 
produce a summary under three pages (Custom Writing and Research website 2013). The 
paper needed to be short enough to be read by busy professionals but long enough to be 
a stand-alone document. The final stimulus paper was two pages long and addressed the 
seven major themes (also known in the data chapters as Factors of PPI): ‘PPI process’; 
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‘Wanting to make a difference’; ‘Networks’; ‘Leadership and power’, ‘Resources and the 
political context’; ‘Dissemination’; and ‘Information and communication technology’. 
 
The Modified Delphi technique 
The Delphi technique is a consensus building method that collects data sequentially 
through two or more rounds of questionnaires (Campbell et al. 2004). The modification 
means that prior data was collected (Custer et al. 1999) through phase 1 in this study.  
 
Panellists are often experts in their field (Snyder-Halpern et al. 2000). Panellists either 
develop statements or are given the statements by a researcher(s) (Martino 1983) which 
in the current study took the the form of a two-page stimulus paper.  
 
The questions in a Delphi survey are completed anonymously as panellists do not meet 
face-to-face (Hasson et al. 2000). As part of the process, each questionnaire response is 
fed back to the panel in a controlled way by the researcher (ibid). The panel will usually 
be dispersed geographically (Snyder-Halpern et al. 2000). Thus, the Delphi technique was 
superior because it had four key features: anonymity, iteration, controlled feedback, and 
statistical aggregation (consensus forming/voting) (Rowe and Wright 1999).  
 
The Delphi survey is designed to ‘obtain the most reliable consensus of opinion of a 
group of experts…by a series of intensive questionnaires interspersed with controlled 
opinion feedback’ (Dalkey and Helmer 1963 p458). The Delphi technique allows for 
panellists to interact with each other in a controlled way, i.e. the researcher pooling their 
combined knowledge into the controlled feedback (Rowe and Wright 1999), without 
physically coming together i.e. not allowing dominant members of a group to taint the 
views of others (Bolger and Wright 2011). The technique reduces chances of powerful 
professionals with seniority manipulating others (Jairath and Weinstien 1994). Thus, 
people taking part would not feel obliged to conform to fellow participants (Murphy et 
al. 1998). In the field of impact of PPI on research, the Delphi survey has been used 
successfully by Boote et al. (2006) on the principles and indicators of successful PPI in 
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research. The study found that a common understanding was reached across all 
stakeholders on manifestations of positive service user involvement in research.  
 
Phase 2 of the research was concerned with confirming the importance of the themes 
identified in phase 1, enhancing their credibility and offering external validity using a 
diversity of views. Therefore, a modified Delphi was useful for the current study as the 
themes provided panellists the context required for their particular opinions (Snyder-
Halpern et al. 2000).  There are a number of strengths identified in using this approach. 
 
The Delphi provides a means of interaction between experts who cannot physically come 
together but whose participation may increase the credibility of the information gathered 
Linstone and Turoff (1975). From a financial point of view the Delphi was inexpensively 
facilitated. Another strength of the Delphi was that all communication was carried out via 
email and using the Blind Carbon Copying (BCC) rule which meant anonymity was 
achieved. This anonymity aspect proved useful if something important but controversial 
was raised by a panellist. Including controversial responses in the controlled feedback 
was important.  
 
Snyder-Halpern et al. (2000) found that email responses, compared to posted responses 
were more legible, eased data entry and enhanced communication. Another advantageous 
feature of the Delphi survey was iteration. Between each questionnaire, controlled 
feedback was offered, through which the researcher presented a summary of the range of 
opinions in a numeric way highlighting voting patterns of themes, helping the group see 
where there was emerging importance, consensus and disagreement, allowing panellists 
an opportunity to reconsider their views.  
 
Consensus and voting 
The Borda count is often described as a consensus-based voting system rather than a 
majoritarian one. The Borda count is named after the French mathematician and political 
scientist Jean-Charles de Borda, who devised the system in 1770 (Emerson 2013).  The 
Borda count allocates points corresponding to the number of options ranked lower. Once 
all votes have been counted the option with the most points becomes the winner and the 
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order of preference for the remaining issues being voted on is also achieved e.g. 1st, 2nd, 
3rd etc. This method was used for the consensus-building-aspect of the study (Lakhanpaul 
et al. 2014). The method was useful for the current research because it determined which 
of the seven (which later became nine) themes were deemed most to least important. 
Figure 7 illustrates an example of the Microsoft Excel spreadsheet used for counting and 
developing graphs to share in the controlled feedback between rounds.  
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Figure 7 - Borda Count (Delphi Round 1 - Example) 
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Limitations of the modified Delphi technique 
There are limitations to using the Delphi technique as the survey is reliant upon the use 
of ‘expert’ knowledge. The term ‘expert’ has been critiqued (Green et al. 1999) because 
it suggests that the involvement of a ‘layperson’ may be unacceptable for a study 
(Meyrick 2003, p10). On the contrary, in the Delphi survey by Boote et al. (2006) the 
research teams involved ‘lay’ as well as ‘expert’ people to make the study reflective of 
its focus, demonstrating PPI, and arguably this may well have contributed to the study’s 
success. Gutierrez (1989) argues that participants in a Delphi survey should be a group 
of knowledgeable people, not necessarily ‘experts’. Panellists should be those who can 
provide relevant input to the process, potentially have the highest authority possible, and 
be committed to and interested in the research aims.  
 
Another known problem with Delphi surveys is participant attrition as rounds progress 
(Mayaka and King 2002). To reduce attrition rates in the current study, participants were 
reminded of the commitment needed for the study and the time window for the Delphi 
was kept short (six weeks) in order to retain panellists. Analysis for each round was 
undertaken in just one week (there were three rounds). According to Hasson et al. (2000) 
rates of attrition also depended on how much preparation the current researcher did 
beforehand. Therefore, when a potential panellist offered to take part in the Delphi, a 
visual Delphi process diagram was also sent to every panellist so that they could 
understand the dates they were needed and the process to which they were signing up to, 
showing when each round opened and closed.  
 
Delphi surveys can become very intense, especially between rounds (Pandya 2005). The 
researcher was mindful that people recruited into the Delphi were busy professionals. A 
word limit for each question was not set so that panellists could, if they wanted, provide 
examples to help further contextualise their response. It was also decided that busy 
professionals were unlikely to read controlled feedback which was longer than two sides 
of A4 paper (applying the same principle as for the stimulus paper length). There were 
three rounds to this work but there could have been more (Keeney et al. 2006), or fewer 
rounds (Hasson 2000). After the panellists had read the stimulus paper this work needed 
to establish: 1) how relevant the themes were to panellists in terms of order of importance, 
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and why; 2) whether anything new should warranted a theme of its own, and why; and 3) 
how impact of PPI on research outcomes could be better understood. Therefore, it was 
anticipated that three rounds would suffice for the current study.  
 
Sampling framework Delphi 
Keeney et al. (2006) argue that a researcher conducting the Delphi must decide on the 
inclusion and exclusion criteria before the study commences, such as the gender, 
professional experience, educational background and employment background of the 
panellists. As argued already, to reduce Delphi limitations professional and non-
professional (lay) people were considered as useful for this study. Panellists would have 
a broad range of skills and knowledge spanning a range of groups covering policy, 
practice, academia, patient experience to list a few. A theoretically informed set of 
inclusion and exclusion criteria was devised. 
 
Participants could take part in the study from anywhere in England. They needed access 
to the internet during the data collection phase of six weeks. They needed to be able to 
read and write English and they were selected on the basis of their particular specialist 
expertise for this study from one of six groups: 
1. Working in leading health charities and large non-government organisations 
because, according to Tritter et al. (2003), the voluntary sector plays an 
increasingly large role in the funding, provision and delivery of services and 
nowhere is this more apparent than in cancer care. 
2. Policy-makers, because they provide insight and understanding regarding the 
broader set of economic, administrative, managerial, or policy-related factors that 
may influence the implementation of cancer care (Cotterell et al. 2011) at a 
political level. 
3. Academics, as they have insight into why evidence-based healthcare has featured 
as a policy concern in many healthcare systems over the last decade, driven by a 
growing recognition that healthcare delivery does not always reflect what is 
known to be best practice. Studies suggest that up to 30-40% of patients do not 
receive care which complies with current scientific evidence (Schuster and 
McGlynn 1998; Grol 2001). 
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4. Independent consultancies dealing with PPI and service improvement because 
these types of organisations provide additional business-driven insights into why 
involvement is important. 
5. Government department leads and politicians, who help build further knowledge 
on how legislation is being used/not being used to support the case for PPI in 
policy and practice in health and social care (Hughes et al. 2009). 
6. ‘Expert patients’/patient champions, to help further understand their knowledge 
of services affecting them and the extent to which they can challenge 
professionals' assumptions toward those with chronic illness (Wilson 2001).  
 
Sample size and recruitment Delphi 
According to Reid (1988) there are variations in sample sizes for Delphi surveys 
depending on the type of research being planned. Sample sizes can range anywhere from 
10 to 1,500 people (Reyens and Hehn 2000). Murphy et al. (1998) suggest that larger 
samples are likely to provide more reliable datasets when research questions have a 
limited range of answers. This work relied on some qualitative responses and therefore 
too many participants would have become too complicated to manage for one researcher. 
Any fewer than 20 participants would have been likely to lead to incomplete 
understandings of this complex research area. Recruiting at least six people from each of 
the six backgrounds seemed manageable and realistic.  
 
To recruit the Delphi participants, purposive and convenience sampling strategies were 
applied (Proctor and Allen 2006). The researcher approached known academics, cancer 
charities, consultancies and policy networks. An poster (see Appendix 9) inviting people 
to participate were sent. The study was also advertised via INVOLVE’s advisory group 
meeting. Individual letters were sent to local Members of Parliament, Department of 
Health leads and to members of European Parliament. For a full list of participants please 
see the virtual panel composition in Table 9. Basic demographics and roles of participants 
were collected before the Delphi survey commenced (see Appendix 6) to help identify 
their ethnicity, age, religion and professional/social background (also presented in Table 
9). Any interested people who came forward were telephoned first to check that they met 
the criteria for selection, were available when the Delphi survey was planned and that 
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potential participants understood that they needed to be committed to the entire six-weeks 
process. If they met the criteria, they were then emailed an Information sheet (see 
Appendix 10), a Delphi process diagram with dates (Appendix 11) and a Consent form 
(Appendix 12). This initial contact was also an important opportunity for potential 
panellists to ask questions. 
 
Table 9 - Participant demographics and key information (Phase 2) 
Category Patients and carers Academic and clinical 
researchers 
Policy and 
commissioning work 
Stakeholders/ 
Healthcare 
professionals and 
PPI work  
Sex  F [n=5]  
M [n=2]. 
F [n=5]  
M [n=3]. 
F [n=10]  
M [n=7]. 
F [n=5]  
M [n=2]. 
Age Range 55 -70 [n=7] 
across group. 
40-65[n=8] 
across group. 
35-60 [n=17] 
across group. 
40-65 [n=7] 
across group. 
Sexual  
preference  
Heterosexual [n=6] 
and Gay[n=1]. 
Heterosexual [n=8]. 
 
Heterosexual [n=17]. Heterosexual [n=7]. 
Ethnicity White British [n=7]. White British [n=6], 
Asian British [n=1], and 
Black British [n=1]. 
White British [n=15], 
Asian British [n=1], 
and 
White and Black 
African [n=1]. 
White British [n=6], 
Asian British [n=1]. 
Religion Christian [n=4], 
No region [n=2], 
and 
Atheist [n=1]. 
 
Christian [n=4], 
Hindu[n=1], and 
No religion [n=3]. 
Christian [n=8], 
Sikh [n=1], and  
No religion [n=9]. 
Christian [n=4], 
Spiritual [n=1], 
Sikh [n=1], and 
No religion [n=1]. 
Disability 
 
No disability [n=6], 
Physical and 
mobility impairment 
[n=1]. 
No disability [n=6], 
Long term illness or 
health condition [n=1], 
and Learning 
disability[n=1]. 
No disability [n=16], 
Learning disability 
[n=1]. 
No disability [n=7]. 
Experience Cancer [n=5], 
Carer [n=2]. 
 
Professor status [n=5], 
Independent researcher 
(Dr) [n=2], and 
Unknown [n=1]. 
Commissioning [n=3], 
Government [n=7], 
and 
Cancer policy work 
[n=7]. 
PPI work [n=5], 
Communication 
[n=1], and 
Quality [n=1]. 
Locations Northeast [n=1], 
London [n=1], 
South Central [n=1], 
Southeast [n=2], 
Southwest [n=1],  
East of England 
[n=1], and of these, 
[n=7] covered all of 
England.  
Northeast [n=1], 
Northwest [n=1], 
Yorkshire and 
Humber[n=1], 
East Midlands [n=1], 
West Midlands[n=2], 
London[n=2], and of 
these [n=3] covered all 
of England. 
Yorkshire and 
Humber[n=1], 
East Midlands [n=5], 
West Midlands[n=1], 
Southeast[n=3], 
Southwest[n=2], 
No region just national 
[n=5] and of these 
[n=15] covered all of 
England. 
East Midlands [3], 
London[n=2], 
South Central[n=1], 
Southeast [n=1] and 
of these [n=4] 
covered all of 
England. 
 
Recruitment was relatively straightforward, and the researcher was satisfied with the 
broad range of expertise people brought with them. The Delphi survey was carried out 
via email, apart from when the MPs were involved, where two physical meetings were 
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scheduled to answer the Delphi questions. During the Delphi period, for the major 
political parties, it was conference season – hence them requesting an interview rather 
than email. This adjustment to the planned data collection (a face-to-face-meeting rather 
than electronic email response) was necessary as the MPs were too busy to take part in 
some of the rounds and reading the controlled feedback. To mitigate dropout the 
researcher offered verbal controlled feedback and asked the questions directly. This may 
have impacted on the data collection as others on the Delphi (although each participant 
had direct access to the researcher’s telephone number to call if they had any questions) 
did not have the opportunity to discuss their answers. 
 
In addition to the steps set out in the process (Figure 8, below), the researcher mitigated 
against attrition by sending email reminders midway through a round, and text reminders 
for those who had not submitted on the final day of each round. As a result of this 
thorough strategy of retention, of the 39 people recruited only four people dropped out (a 
Member of the European Parliament, a representative from an independent political party 
focused on health, one patient and one academic). The analysis process between rounds 
was intense and took on average 80 hours, making the whole process very demanding. 
Supervisory input was essential to help the researcher remain focused. 
 
Delphi analysis and controlled feedback  
Each Delphi round was analysed in real time. The system of analysis was similar to phase 
1, using the approach to thematic analysis set out by Braun and Clarke (2006). As most 
of the data produced were not too long in content, at the end of each round the key points 
made by participants about emergent themes were noted. Qualitative data generated were 
often descriptive and NVivo was used to manage data. Turoff and Hiltz’s (1996 p71) 
technique was used to ensure that clarity, issues of bias, missing information, patterns, 
hidden disagreements and issues to focus the answers upon should were considered 
throughout. They outline the following: 
1) The data analysed and offered in the feedback needed to present a range of views 
and considerations; 
2) That hidden disagreements and judgemental biases needed to be exposed to 
further clarification; 
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3) To detect and clarify any missing information or cases of ambiguity in 
interpretation by different participants; 
4) To analyse complex situations only by analysis procedures (e.g. such as using 
Braun and Clarke 2006); 
5) To detect patterns of information and of sub group positions (e.g. whether patients 
took a certain stance in their ranking preference); and 
6) To detect critical items that need to be focused upon in the subsequent rounds (e.g. 
raising further questions about the themes or about impact of PPI on research 
outcomes). 
 
The first and second points were clarified through round two of questions but point three 
was clarified by email with participants as soon as responses started to come in, 
particularly if responses seemed ambiguous to the researcher. Points four and five used 
Braun and Clarke’s (2006) thematic analysis process to understand patterns (see coding 
framework for phase 2, Appendix 13). 
 
Once responses were received to each set of questions within the specified deadline, a list 
of answers was drawn up to keep in mind that the best opinion may have become ‘watered 
down’ (Sackman 1975) or that the survey might generate ‘bland statements’ (Rennie 
1981). Researcher awareness of these criticisms reinforced the notion that analysis was 
important in Delphi surveys as it needed rigorous attention to detail concerning each 
participant’s opinion for each answer. Where possible, quotations were offered in the 
controlled feedback so that the original tone was retained, and any important messages 
were not misrepresented.  
 
During the Delphi analysis, the supervisory input was key as it offered support in reading 
a sample of opinions and confirmed or queried the researcher’s decisions. The supervisors 
were helpful in raising any concerns about any points that the current researcher may have 
missed and offered critical suggestions any new questions that the researcher felt needed 
to be explored in the new rounds of questioning to help the refinement process. 
Involvement from an independent academic and a carer helped too in this stage. 
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Round one 
In round one the Delphi panellists were asked to read the stimulus paper and then to 
answer the questions posed in the email (see Appendix 14 for a summary of the questions 
that were generated for each round based on issues raised from previous rounds). 
Panellists were asked to reflect on the findings, then drawing on their own work 
background and specialist topic knowledge they were asked to rank the themes in order 
of importance, and to add any new themes they felt were missing.  
 
Controlled feedback - round one 
In the second round, controlled feedback was offered on the ranking exercise consensus 
thus far, demonstrating the ‘order of importance’ generated, along with a description of 
the two ‘new themes’ they had identified (‘PPI in commissioning’ and ‘PPI in 
implementation’). Panellists had also raised that importance was hard to rank without 
appreciating the micro, meso and macro levels that the themes were situated within. 
Finally, round one had raised that there was not a definition for the impact of PPI.  
 
Round two 
For round two, panellists were asked to rank the nine themes this time, along with their 
understanding of whether the themes were micro, meso or macro level factors. They were 
also asked to provide in their words a definition of impact of patient and public 
involvement. 
 
Controlled feedback – round two 
In the controlled feedback, data were pooled together, and the knowledge generated was 
shared, helping the next round (Reyens and Hahn 2000). Items for which there was a lack 
of agreement among participants were also included. A synthesised definition (impact of 
PPI) was developed by the researcher, capturing the panellists’ combined efforts and this 
definition was shared in the controlled feedback.  
 
Data synthesis can be conducted for different purposes (Mays and Pope 2008). For the 
current study it served the purpose of formulating a definition of the concept of impact of 
PPI. The data that was used to form the definition came from an open-ended question 
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asked to the panel: to provide in their own words, a definition of impact of PPI. Based on 
the 35 answers received a list of typologies were devised using the help of NVivo 
software. Characteristics of the impact of PPI were drawn up mapping focal issues 
demonstrated in Appendix 13. 
 
Panellists were asked to indicate to what extent the proposed definition captured their 
responses from round two. The ranking exercise was also summarised to demonstrate 
how the themes sat at the sociological positioning of micro, meso and macro levels. 
Panellists were asked to comment on whether the findings would apply to other disease 
areas. Panellists commented on future use and applicability of the findings, along with 
further research questions the work may have raised for them. 
 
Round three 
By this point the two controlled feedback summaries had raised vital points, channelling 
the discussion towards impact of PPI on research outcomes, in light of the views of the 
group as a whole (Reyens and Hahn 2000). Consensus was reached on the order of 
importance for the nine themes. Participants also commented on the transferability of the 
findings and future research on the topic.  
 
Final controlled feedback – round three 
When the Delphi process was complete, participants were informed of the convergence 
and divergence of opinions that had occurred during the course of the study (see Delphi 
findings, chapter six). Figure 8 summarises the entire Delphi study. 
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Figure 8 - Illustration of the Delphi process 
 
Outcomes of the Delphi survey 
In this research, the use of the Delphi survey was successful because it refined and 
developed the seven themes to become nine themes. It was reassuring that the two areas 
that panellists felt should be themes in their own right were originally within two other 
themes.  
 
The Delphi also helped to rank order of importance and furthered understanding about 
whether the themes were situated at micro, meso or macro level. The information about 
Round 1 - 39 panellists read stimulus paper and asnwered questions.
Along with ranking the seven factors, in the first round, panellists 
were also asked to raise any additional issues that should be added to 
the seven factors. The panel raised two further themes: PPI in 
Commissioning and PPI in implementation, and suggested two further 
issues: that the themes sit as micro, meso and macro issues, and that  
they wanted a definition of 'impact of PPI'
Round 2 - 35 panellists read controlled feedback and answered 
questions.   
The two new factors were added to the existing seven factors and the 
panel was asked again to rank the issues but also across concepts such 
as micro, meso or macro issues.
They were also asked to define impact of patient and public 
involvement.
Round 3 - 35 panellists read controlled feedback and answered 
questions.
Consensus was found across the order of importance. Micro meso and 
macro issues formed a matrix enhancing understanding of impact of 
PPI on research outcomes.
A synthesied definition was offered about impact of PPI on research 
impact.
Panellists were asked to what extent the collective definition formed 
by the author reflected/captured their individual definition and their 
view of what PPI impact was.
Panellists were asked if the nine themes identifed were transferable 
or not.
Researcher sent a final controlled feedback one week later, 
summarising the final round responses.
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micro, meso and macro level influences raised was highly useful for considerations of 
how the (themes) findings could be presented under implementation frameworks such as 
Damschroder et al. (2009).  
 
Forming a definition of the impact of PPI was not part of the plan for the Delphi, but by 
‘going with the flow’ of what panellists were raising in the first round, the opportunity 
was exploited. With some quick thinking, panellists were asked to define impact 
themselves, and a definition was also achieved through data synthesis. 
 
Once the Delphi survey was complete, a thank you card was sent to all participants. Two 
senior people contacted the researcher afterwards to say that they felt the research had 
been conducted very well and efficiently and that the text reminders acted as a personal 
touch, as did the thank you card.  
 
The data gained from phase 2 forms the basis of chapter six. After the Delphi data 
collection was complete, further analysis was carried out and the next section explains 
this process.   
Seeking examples of PPI on research outcomes – A method adopted for chapter 
seven 
Exclusion criteria 
This analysis part was concerned primarily, to seek understandings of impact of PPI on 
research outcomes by applying the nine major themes identified. A further analysis was 
necessary to understand what impact of PPI on research outcomes actually meant. 
Thirteen of the 23 interviews demonstrated impacts of PPI on research process but not on 
research outcomes. Of these 13 interviews it was noted that:  
• Interviewees were speculating, guessing or hoping the research would have an 
impact, rather than offering concrete examples.  
o On two circumstances interviewees were describing the impact of PPI on 
research outcomes from the drug industry and not a government funded 
national peer reviewed piece of research.  
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o On five occasions the interviewees were discussing community 
engagement, but this was a more training and development-based impact 
rather than research-based impact. 
o In one case, impact was purely academic knowledge generation, were the 
person interviewed was attempting to advance the field for PPI. 
o Finally, on five occasions, it was too early to judge the impact of a study. 
 
This seeking examples section formed the basis of six examples which chapter seven 
discusses concerning evaluation. 
Ethics processes followed 
Whilst conducting this research, ethically conscious working standards were adhered to 
at all times. Ethical approval for phases 1 and 2 was conferred by the Faculty of Health 
and Life Sciences Research Ethics Committee (FREC) at De Montfort University (see 
letters from the FREC in Appendix 15). Additionally, The Wellcome Trust (WT) Good 
Research Practice Guide (2007) was adopted for use in this study.  
 
The WT guide discusses researchers needing to be ‘honest in respect of their own actions 
in research…’ in relation to this point, the posters (Appendix 3 and 9) information sheets 
(Appendix 4 and 10) and consent forms (Appendix 5 and 12) were all developed with full 
transparency. Regarding ‘Openness’ the WT guide stated: ‘the Trust expects the 
researchers …to be as open as possible in discussing their work with other scientists and 
with the public in order to help foster an informed public climate’. This study developed 
a climate of openness by involving people in the work to offer an opportunity to discuss 
the direction of the study. Also, a paper was developed about ethical practice of PPI 
(outside of this study see Appendix 16) which the researcher led. (Pandya-Wood et al. 
2017). 
 
In relation to ‘guidance from professional bodies’ the WT: ‘expects researchers to 
observe the standards of research practice set out in guidelines published by scientific 
and learned societies…’ thus for the current study this was understood as following the 
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researcher’s own institutional code of ethical practice (DMU’s own ethical standards) i.e. 
using the FREC as the anchor process. For ‘leadership and cooperation’ the WT stated 
that: all members of a research team are encouraged to develop their skills and in which 
the open exchange of ideas is fostered’. Where possible, when research groups were 
requiring research students, the researcher would offer seminars, e.g. one such talk was 
about the Delphi technique. The WT guide requires ‘supervisors to supervise all stages 
of the research process’ and regular supervisions took place between the researcher and 
her supervisors. For ‘training’ WT stated that: ‘researchers should undertake appropriate 
training’. All training courses offered by the doctorate college at DMU were attended 
including using NVivo to help with analysis and coding. For ‘primary data/samples’ it 
stated that ‘Researchers should keep clear and accurate records of the procedures 
followed’. This study kept clear audit trails that monitored carefully when research 
direction changed. In relation to ‘ethical practice in Research involving human 
participants’ WT stated: ‘Researchers should ensure the confidentiality of personal 
information relating to the participants in research, and that the research fulfils any legal 
requirements such as those of the Data Protection Act 1998’. Research data was kept safe 
by using a password protected PC, using a lockable filling cabinet and ensuring that all 
participants information was given an alias name (see table 10, p119). Lastly the WT 
discusses ‘publication practice’. Although papers from the current study are yet to be 
published, papers are underway (see chapter ten).  
 
Confidentiality 
Conducting research using the focus of the cancer disease, and within the East Midlands 
region, requires a brief discussion of how researching participants in one geographical 
location led to ethical issues identified by Goodwin (2006).  There were occasions when 
confidentiality issues arose. For example, when interviewing patients, three of the 
patients knew that the researcher had already interviewed two others. They each discussed 
with the researcher that they knew that the researcher had spoken to the other participants, 
one of whom made disparaging comments about another participant’s reasons for 
participating in the current study. The researcher was careful not to delve into a 
conversation about who had been involved and reminded each of them to respect 
confidentiality. Pseudonyms were used by the researcher in the findings chapter (see table 
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10 for a list of participants and panellists and their alias names). In similar fashion, there 
was a time when a certain oncologist researcher participant also spoke of her colleague 
(a researcher) who had already been interviewed. She spoke about how he was ‘anti PPI 
in research’ and that he was the ‘devil’s advocate of PPI’, again implying that she knew 
the researcher had already interviewed this particular oncologist (suggesting the 
researchers had had a conversation about the current research study). Another clinical 
researcher referred to a young patient of his (who he did not name but the current 
researcher knew personally). Perhaps if the current research (phase 1) had been conducted 
nationally, then participants would not have so easily known about each other’s input. 
Also, if the researcher had chosen to explore more than one disease area then these 
instances might not have happened. 
 
During analysis, the researcher was mindful that at times people’s names and sensitive 
material were being disclosed. To ensure confidentiality and anonymity all transcribers 
were asked to complete a confidentially agreement. 
 
During phase 2, a very close family friend of the author had just died from ovarian cancer 
and a close colleague had lost his mother to cancer. The researcher’s own emotional 
awareness was an unidentified issue but became apparent during the data collection stage 
when the issue of how distressing the disease of cancer is and its effect on people’s lives. 
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Table 10 - Study participants (n=62)  
Patients  
(n=13) 
Stakeholders/ Healthcare 
Professionals and PPI work 
(n=14) 
Academic and Clinical 
Researchers  
(n=16) 
Policy and Commissioning 
work 
(n=19) 
(IP1) Sarah  
Breast cancer 
(IP2) Jane   
Breast cancer 
(IP3) Helen 
Lymphatic cancer 
(IP4) Paula 
Breast cancer 
(IP5) Gary  
Non-Hodgkin’s 
Lymphoma 
(IP6) Ben 
Stomach cancer 
 
(DEP1) Reese 
Expert patient 
(DEP2) Della 
Expert patient 
(DEP3) Louise 
Carer 
(DEP4) Olivia 
Expert patient 
(DEP5) Grace 
Expert patient 
(DEP6) George 
Carer 
(DEP7) Daisy 
Expert patient 
(IS1) Dennis  
Implementation science 
lead 
(1S5) Jenna 
Trials coordinator 
(IS8) Patsy 
Hospice senior staff 
(IS7) Michael  
Academic department lead  
(IS3) Steven 
Hybrid role (national PPI 
policy work) 
(IS4) Barry  
PPI lead 
(IS6) Hannah 
National PPI policy role  
 
(DPPIL1) Alice 
PPI lead 
(DPPIL2) William 
PPI lead 
(DPPIL3) Dean 
PPI lead 
(DPPIL4) Patricia 
PPI lead 
(DPPIL5) Kim 
PPI lead 
(DPPIL6) Marian 
PPI lead 
(DPPIL7) Pam 
PPI lead 
 
(IR1) Priscilla   
Oncologist professor 
(IR2) Joanne  
Social science professor 
(IR3) Janine 
Palliative care professor  
(IR4) Philip  
Oncologist professor  
(IR5) Robert  
General practitioner professor 
(IR6) David  
Geneticist doctor 
(IR7) James  
Oncologist professor 
(IR8) Gerald  
Social science professor 
 
(DAC1) Mark  
Academic doctor 
(DAC2) Ajay 
Clinical professor  
(DAC3) Rebecca 
Clinical academic 
(DAC4) Kylie 
Clinical academic 
(DAC5) Carolyn 
Academic doctor 
(DAC6) Ranjit 
Healthcare commissioner and 
doctor 
(DACTT7) Jean 
Academic doctor 
(DAC8) Matilda 
Clinical academic 
(IS7) Katy 
National cancer policy staff 
(IS2) Nick 
Cancer charity 
 
(DONHS1) Anna  
Senior NHS policy  
(DONHS2) Caroline 
Senior NHS communications 
(DONHS3) Denise 
Senior NHS communications 
(DONHS4) Janice 
Senior cancer nurse with policy 
(DOCom5) Felicity 
Research commissioner 
(DOCom6) Hersha 
Commissioner of health 
education 
(DPCh1) Holly 
National cancer charity policy  
(DPCh2) Hallie 
National cancer charity policy 
(DPCh3) Marina 
National cancer charity policy 
(DPCh4) Luke 
National cancer charity policy 
(DPCh5) Stan 
National cancer charity policy 
role 
(DPCh6) Bob 
National patient champion body 
(DPG7) Stuart 
Member of Parliament 
(DPG8) Keely 
Member of Parliament 
(DPQG9) Shane 
Senior Department of Health 
and Social Care official 
(DPQG10) Jonny 
Senior member of national 
research ethics service 
(DPTT11) Mat 
Policy thinktank of health 
research 
(Key: Pink = Interviewees and Blue = Delphi panellists) 
Research rigour 
Reliability and validity are terms generally associated with measurement whilst this 
research was interpretivist with a pragmatic focus. By employing mixed methods, the 
credibility of the findings was enhanced because they furthered the internal and external 
research rigour process (Le Compte and Goetz 1982). The two datasets helped to serve 
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as an explanation for each other. The qualitative findings provided sufficient accounts of 
rich and thick descriptions, helping to firmly establish the context of the themes for the 
Delphi survey. Similarly, themes were confirmed as valuable in the importance order 
ranking exercise. Context was offered to the themes when Delphi panellists were asked 
to rank the themes and each panellist confirmed the themes’ validity, linked to personal 
experience and understanding of the topic. This meant it was highly likely that the 
qualitative data collected did reflect the diversity of panellists’ views. Therefore, the two 
methods used complemented internal and external validity.  
 
To further assess research rigour, Lincoln and Guba (1985) list four areas: credibility, 
transferability, dependability and confirmability. These will now be discussed 
individually and were previously presented as a poster at the national INVOLVE 
conference (see Appendix 1).  
 
Credibility  
Credibility concerns having confidence in the ‘truth’ of the findings. There are several 
aspects that have helped the credibility of the current study. Firstly, the section on 
involvement, outlines the influence that end users have had on this research and a chapter 
on reflections about this is also offered (Chapter nine). 
 
Through mixing methods, the two phases of the research design helped to contribute 
towards the validity of the knowledge created and increased understanding about the 
types of knowledge that people had about impact of PPI on research outcomes. Phase 2 
refined the findings about impact using consensus-building methods. This double 
layering of data collection acted as a quality measure for internal validity (Morse et al. 
2011). The interviews were carried out across three groups of people, drawing on a variety 
of viewpoints and experiences. Furthermore, in the Delphi survey elicited a range of 
views from central government through to patients, resulting in consensus of the themes 
generated. A further assertion of credibility is via the list of publications generated outside 
of this study but show the researcher’s awareness about the topic being studied (Walker 
and Pandya-Wood 2014; Pandya-Wood and Robinson 2014; Rivas and Pandya-Wood 
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2014; Pandya-Wood et al. 2017; Pandya-Wood et al 2018). Finally, the thesis largely 
reflects the broader literature base. 
 
Transferability  
The concept of transferability implies that the findings have applicability in other contexts 
and settings. Lincoln and Guba (1985) have suggested that qualitative researchers should 
be encouraged to produce 'thick description' which provides a strong foundation to make 
a judgement about transferability of the findings. Thick descriptions were produced 
during the interviews. These descriptions became the themes studied in the Delphi survey. 
Furthermore, during the Delphi survey, panellists ranked the information, suggesting that 
the data themes reflected a sense of reality for the panellists. Not one panellist questioned 
the content of the themes’ descriptions which were provided. Also, panellists were asked 
a direct question about the applicability of the current research in other contexts of health 
and disease (i.e. how transferable the findings were). Their responses demonstrated that, 
largely, data from this work were transferable beyond the disease of cancer, for studying 
the impact of PPI on research outcomes.  
 
Dependability  
Dependability concerns the findings being consistent and reproducible. Lincoln and Guba 
(1985) suggest that an audit trail be kept by researchers as an aid memoir. During the 
current research notes on involvement meetings, fieldwork pilots, supervision meetings, 
discussions with colleagues and all versions of data collection tools and analytical 
procedures were kept. This criterion demonstrates transparency and that the decisions 
made about the research are justifiable.  
 
Confirmability  
Confirmability is about the degree of neutrality, which concerns being mindful of the 
researcher’s own identity. Throughout the thesis, where possible, the researcher’s own 
values and experiences are outlined to show awareness of confirmability. Working for 
the National Institute for Health Research, Research Design Service East Midlands 
(NIHR RDS EM) has placed the researcher in a unique position to conduct this doctoral 
study. Other approaches that have helped with confirmability include having regular 
involvement meetings in this work. Involvement has occurred in various stages, as 
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already outlined in this chapter. The researcher argues that involvement enables better 
research and achieves the confirmability feature of Lincoln and Guba’s (1985) model.  
Summary 
This chapter focused on the research process, describing how data collection was planned 
and executed. It also outlined in detail the involvement process and described how the 
two datasets were analysed. Over the next three chapters, the research data are presented: 
Chapter Five presents interview data about the seven factors (major themes) presented in 
phase 1. Chapter Six concern presentation of the Delphi study and Chapter Seven presents 
analysis of both phases of data collected together – which attempts to deepen 
understanding about evaluation of PPI. 
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End user involvement influencing this stage 
 
November 2011 – To confirm ethical processes to adopt in the study. Involvement in 
the form of consultation, n=2 separate email and telephone meetings took place 
with people from ethics and research development backgrounds on whether NHS 
ethical approval was needed for phase 1. It was clarified that NHS ethical approval 
was not necessary for the current study as patient participants would be found 
outside of the NHS system, via publicly searchable means and the patients would be 
participating in a voluntary capacity. 
 
June 2013 – Development of data collection tools. Involvement in the form of 
collaboration took place with n=2 patients individually in a face to face meeting in 
Leicester. To ensure that the data collection tool developed (interview topic guide) 
was patient sensitive, the two meetings helped to ensure that there was flow to the 
questions and some questions were changed in light of suggestions these patients 
made. 
 
June 2013 – Development of data collection tools. Involvement in the form of 
collaboration with n=2 academics individually in a face to face meeting in 
Leicester. Feedback from these academics showed that some of the questions were 
too long and that some questions should be shortened. As a result, the interview 
topic guide was adjusted. 
 
June 2013 – Development of data collection tools. Involvement in the form of 
collaboration with n=2 stakeholders individually in the form of face to face 
meetings in Leicester. Feedback offered by these stakeholders suggested that an 
impact explanation should be offered during interviews to help with consistency of 
meaning. As a result, the interview guide included a statement on impact which was 
used as a guide to explain what impact meant (appendix 2). 
 
It is important to note that during the process of engaging and involving end users, 
dilemmas about how much end user input to utilise was becoming a question for the 
researcher because the PhD requires independent critical thought and inviting input 
meant that the knowledge and expertise of others was shaping the study. This point 
is discussed in the Chapter nine. 
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Chapter Five: Factors that contribute to the impact of PPI on 
research outcomes  
Introduction  
As the literature review identified, there was a significant shortage of evidence in 
understanding the impact of PPI on research outcomes. The views and opinions of 
participants on these aspects was therefore critical to capture across the two phases of 
data collection. Prior to the Delphi study with experts (which is discussed in the next 
chapter), the researcher conducted 23 in-depth interviews with: patients who have been 
involved in cancer research; researchers who won national peer reviewed cancer research 
funding which required them to involve patients in the study; and stakeholders who have 
used or considered applying cancer research findings. The studies discussed in the 
interviews were required to have been completed in the last five years3 at the time of 
conducting interviews. These interview findings are presented in this chapter.  
 
This is the first of three chapters that present findings from the study. In order to locate 
this first chapter in context, an overview of how the entire data is presented is offered 
here to assist the reader. 
 
During data analysis of interviews it became apparent that participants unproblematically 
described the impact of PPI on research outcomes as being achieved through the PPI in 
research processes. It was clear that untangling the beliefs that participants had about the 
impact of PPI on research outcomes was much harder to achieve because impact on 
outcomes, they each felt, were linked to the processes of PPI. Therefore, the current 
chapter’s purpose is to set out the key factors of PPI identified by interview participants 
as contributing to and shaping the impact of PPI on research outcomes, either by 
strengthening or by hindering the impact of PPI. These are called ‘factors of PPI’ 
throughout the data chapters.  
 
                                                 
3 Some research funders believe that research impact can be demonstrated between three and five years after a 
research study has been completed. 
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However, at the end of this chapter it is argued that as data presented as factors of PPI 
were so diverse and varied, refinement was necessary. Thus, the Delphi survey’s role was 
to refine and where possible enhance understanding about these contributory factors of 
PPI. Thus, chapter six’s purpose is to complete the identification of contributory factors 
shaping the impact of PPI on research outcomes, and to rank these in order of perceived 
importance, by setting out the refinement process undertaken through the Delphi study.  
 
Thus, chapter seven presents an analysis of six examples of the impact of PPI on research 
outcomes extracted from the interviews. The examples enable us to examine which of the 
nine contributory factors of PPI can be seen to have shaped the reported impact, and to 
highlight challenges about how such impact might be evaluated. It is important to note 
that chapter seven was based on re-examination of the combined data. The three findings 
chapters can be summed up as shown in the Table 11. 
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Table 11 - How three data chapters are organised 
 Chapter five  Chapter six 
 
Chapter seven  
 
Which 
data and 
what is 
the title 
of the 
chapter 
Interview data 
 
Factors which contribute to 
impact of PPI on research 
outcomes  
Delphi data 
 
Refinement of factors 
which contribute to 
impact of PPI on 
research outcomes 
Integrated use of Delphi and 
interviews  
 
Examples of PPI on research 
outcomes and challenges for 
evaluation  
Purpose Purpose is to set out the key 
factors identified by 
interview participants as 
contributing to and shaping 
the impact of PPI on 
research outcomes, either by 
strengthening the impact of 
PPI or by hindering it. These 
are called ‘contributory PPI 
factors’. 
 
 
Purpose is to complete 
the identification of 
contributory factors 
shaping the impact of 
PPI on research 
outcomes, and to rank 
these in order of 
perceived importance, 
by setting out the 
refinement process 
undertaken through the 
Delphi study. 
Purpose is to set out six 
examples of the impact of PPI 
on research outcome identified 
by interview participants and to 
examine, in each example, 
which of the nine contributory 
factors can be seen to have 
shaped this impact. 
 
To highlight challenges in 
evaluating the impact of PPI on 
research outcomes? 
Content 
covered  
in the 
chapters 
Factors identified as shaping 
the impact of PPI on 
research outcomes 
1.  Wanting to make a 
difference 
2. PPI in research processes 
3. Information and 
Communication Technology 
(ICT) 
4. Networks 
5. Dissemination 
6. The significance of power 
and leadership  
7. Resources and the 
political context 
1. Ranking the seven 
factors plus ‘PPI in 
commissioning’ and 
‘PPI in 
implementation’). 
 
2. Situating the factors 
of PPI as micro, meso 
and macro levels 
 
3. A definition of the 
impact of PPI 
 
 
1. Examples against analysis of 
the nine factors of PPI 
specifically exploring: 
 
a) what PPI activity brought 
about the impact within the 
example 
 
b) why participants felt that 
factors of PPI influenced the 
ability to have this impact; and; 
 
c) how PPI on research process 
and outcomes are 
conceptualised for evaluation 
 
 
Introducing the contributory factors of PPI 
This current chapter uses data from the interviews. Interviews were carried out with 
patients, researchers and stakeholders who were in a position of speaking in hindsight 
about completed cancer research studies which had PPI in the process of the study. During 
thematic analysis of the transcripts there appeared to be seven complex factors of PPI. 
These factors were embedded in interviewees’ discussions of particular projects. These 
factors of PPI were the major themes identified in the ‘making sense of data workshops’ 
by end users of this study. These factors of PPI are labelled as: 1. ‘Wanting to make a 
difference’; 2. ‘PPI in research processes’; 3. ‘Information and Communication 
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Technology (ICT)’; 4. ‘Networks’; 5. ‘Dissemination’; 6. ‘The significance of power and 
leadership’; and 7. ‘Resources and the political context’. The reason these factors of PPI 
are central is because they acted as a foundation of understanding the impact of PPI on 
research outcomes. All interviewees perceived these factors as acting as barriers and 
facilitators. 
Factor 1. Wanting to make a difference 
Wanting to make a difference concerned people’s motivations for PPI. Participants spoke 
about: hope for change, the idea of democracy, having equality and better services, the 
pragmatic knowledge that patients and the public brought to research and accountability. 
 
Hope for change 
All six patient participants stated their individual experiences for PPI in research began 
with the significant and life-changing event of their own cancer diagnosis. It was after 
they became well (in remission) that they were able to consider helping future cancer 
research. For Jane, her cancer led her to devote the rest of her life to cancer research: ‘I 
mark my experience as what led me into becoming involved…’ (Jane, cancer patient, IP2). 
Helen, talked about how there was ‘hope in trials’ (Helen, cancer patient, IP3) implying 
cure as the central reason for why she decided to get involved in research. For Ben though, 
he wanted to transform his bad experience into something positive. Ben used words like 
‘our’ and ‘we’ indicating that he had identified with other patients previously, about their 
collective poor experiences of cancer diagnoses and prognoses: 
…being told the diagnosis, being told the prognosis, and based on our experience 
we felt that …our experiences, …Without going deeper into it, …the way I was 
told, and the way it was initially handled, was quite poor.  
(Ben, cancer patient, IP6) 
 
For Helen and Jane, becoming involved in cancer research concerned offering insights 
about how a new drug trial could be set up, implying technical insights. But for Ben, he 
appeared to have knowledge about how negative experiences of oncology could be 
avoided, so what Ben was offering was a different type of championing role from that of 
Helen and Jane. 
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Democracy  
Sarah responded independently to a national newspaper advert inviting the public to join 
a research study. Sarah demonstrated democratic principles for her reason of wanting to 
make a difference, implying intrinsic values relating to citizen duties, accountability and 
moral consciousness in her PPI role. This opening part of the interview summarises these 
points: 
One day I was reading the newspaper and I noticed an advert which said ‘are 
you interested in cancer research?’ …so I applied…. when I was working I 
couldn’t but now it’s time to because research is paid for by public money and I 
have a duty to offer my views. Do you know, hand on heart, I feel strange at 
meetings when they offer us tea and biscuits, let alone a payment for our time.  
(Sarah, cancer patient, IP1) 
 
Sarah’s involvement was driven by helping cancer research through her practical insights, 
led by her own cancer experience to improve things for others. These examples 
demonstrated that patient motivations concerned wanting to make a difference by helping 
researchers to improve cancer treatment, improving standards of care, improving the 
oncology consultation experience and ensuring democratic rights.  
 
Equality and better services 
Unlike other researchers, Joanne (a research professor) was strongly motivated by 
working towards equality for LGBT communities in cancer services. One particular 
aspect which made Joanne passionately motivated to conduct PPI in research was that 
when women were going through a breast cancer diagnosis process there would be a 
review of their medical history and during this time, their family and sexual orientation 
would be likely to be captured on file. Joanne’s work was driven by particularly negative 
accounts of oncology experiences from lesbian women. For example, one woman told 
her that she had to disclose her sexuality over and over again: 
if you’re a lesbian wanting to be treated holistically for cancer and you have to 
come out to 79 people, it is exhausting…. So, it’s bringing those experiences 
closer to you, …One lady said she was asked, hello Mrs Smith where’s your 
husband today? You know that kind of thing is what these women experience.  
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(Joanne, academic, IR2) 
 
Joanne maintains links with her PPI group to keep herself grounded. These regular 
conversations with women, she argues, is what helps lead to subtle directional research 
changes, as they offer up to date and real understandings about what LGBT women are 
going through. She articulated: ‘I don’t know why anyone would do research without 
embracing PPI principles’ and that her job will not be over until she witnessed equality 
in the health service.  
 
Pragmatic knowledge 
Researcher motivations were often driven by the practical insights that PPI offered to the 
research process. For example, Philip (research professor) stated that cancer trials often 
under-recruited and for this reason he could see, from past experiences, that there was 
great value that PPI contributed to making research run more effectively. In the trial he 
spoke about during interview, the PPI group had practical patient insights and 
suggestions:  
They would say things like, drop that blood test that would save an extra trip to 
the hospital. As an oncologist those are the things that we might miss but are 
valuable to patients …these insights make or break research.  
(Philip, oncology professor, IR4) 
 
In one study Robert (research professor), stated the funder expected PPI, which prompted 
him and his team to ask a cancer charity to join the team. Robert said that the funding 
panel had been impressed with his application because the charity became a co-applicant 
and that when the study was actually taking place they asked helpful questions during the 
entire process, offering a ‘reality check’ to the research:  
… They pulled us in the right direction …Saying, for example, if we do an 
interview, what do you ask; if you get a result, what do you interpret; if we put 
some questions in a questionnaire, well – those don’t make sense,… 
(Robert, GP and professor, IR5) 
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Generally, across the researchers it seemed that intentions for PPI in their respective 
studies was channelled by experiences from previous work and that patients had helped 
research and the winning of research funding.  
 
But not all interviewees who were researchers were as positive and embracing of PPI. 
James for example, had an alternative understanding and his belief was that PPI offered 
little to the research process, attributing the phenomenon itself to ‘political correctness’. 
Similarly, he felt that patient knowledge was limited and not helpful to research: 
Patients don’t make a huge contribution, it’s just political correctness all this 
patient involvement…. Even our lay summary was put together by our academic 
secretary. …I have sat for 15 years on research committees that have got public 
involvement and frankly [they]don’t contribute much. I think you’re kidding 
yourself if you think they do… 
(James, oncology professor, IR7) 
 
The interview with James was insightful. He was open about how he felt PPI added little 
to medical research. James said in his interview that the research grant for had requested 
links with wider cancer charities and expected that a ‘lay summary’, which James said he 
called a ‘non-specialist summary’, not a lay summary or a plain English summary.  
 
Other than James, most researchers spoke of PPI being something of positive value but 
there were examples of ‘tokenism’ and ‘self-selection’, identified by Priscilla: 
 
Priscilla: I am PI for 20 studies at the moment ….one or two of them might have 
a bit [of PPI], but these are drug trial studies. So, I have got a study at the moment 
where ….we have got …on the application form for the grant …a nominated 
patient but actually in practice they are not really. 
RP-W: are you saying that their involvement is tokenistic? 
Priscilla: Yes, but then you could argue actually does it warrant more input? 
…The only thing that patients can do really is have a look at the protocol and 
decide whether [it’s]reasonable. …they are a self-selected group because they 
volunteer to do this. So, they may well say oh absolutely its ok to have two extra 
endoscopies because they are motivated and they are committed. Whereas Mr 
Smith in the street may well think very, differently.  
(Priscilla, oncology professor, IR1) 
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Priscilla was referring to an important point about representation, that PPI is not 
representative. Another interesting point was made by Patsy (hospice senior staff), who 
said that patients are seen on a daily basis in clinics and yet the problem with PPI is that 
the focus is on the one person who comes forward in the PPI capacity, not the very many 
other patients who have been seen. She said PPI placed too much emphasis on those one-
off encounters which are not representative: 
I suppose the other thing that happens in people’s minds is that you know how 
many thousands of patients I have seen in my career compared to the person that 
comes largely with their own experience, which may be just them, it might be 
their family, it may be they come from a group of other patients that they are 
kind of representing. But it’s unrepresentative, [and] always quite personal isn’t 
it?  
(Patsy, hospice senior staff, IS8) 
 
Accountability 
Overall, stakeholders, generally felt that PPI addressed in cancer research, strategic and 
accountability issues. Steven (who was once a cancer patient and now working in cancer 
policy work thus had a hybrid role), offered insights about a strategic review of cancer 
research funding, questioning policy-makers about future funding and previous spending 
on cancer. His motivations for PPI focused on ensuring that cancer research spending was 
carefully considered across all cancers, not just some: 
So me and others amongst us… Through our input we found out where the 
cancer spending was going, Breast and leukaemia spending was huge but 
pancreatic and lung cancers had nothing, so … the facts and figures were being 
exposed and we could start to challenge them [the funders].  
(Steven, hybrid role, IS3)  
 
Jenna’s view (trials manager, IS5) also reflected that patients have a strategic role in 
cancer research work. Jenna recollected that over the last 25 years there had been a 
steadily growing view that PPI could help cancer research planning. Her experience of 
engaging with patients in trials reflected that patients not only comment on plain English 
summaries and patient information sheets, but PPI also helps with prioritising what 
should be funded in the first place.  
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For Barry, a PPI lead, researchers move on to new pieces of work, but patients carry on 
being patients. They are changed by their experience of cancer and are therefore in a 
unique position to see outcomes through: 
When the researchers finish a piece of research they go on to another piece of 
research.  But the people involved in that project might not, they…have a 
personal involvement in wanting to see it happen…so they will be able to see, 
well we’ve suggested this and five years later these guidelines are out and that 
has had implications from the research.  
(Barry, PPI lead, IS4) 
 
Factor 2. PPI in research processes 
Participants described the PPI in the research processes that they had been involved in 
either setting up or had experienced. Under this factor, PPI in commissioning, PPI in 
research design, managing individual agendas during PPI work, PPI in the research 
conduct and appropriate and meaningful PPI are discussed. 
 
PPI in commissioning 
More than half of the interviewees had commented that PPI in commissioning had added 
significant value to research. But participants struggled to give examples. Research 
planning with the people it affects was believed as vital in transforming services and 
improve outcomes of cancer care as Paula explained: 
I had a telephone interview to hone in about my diagnosis with a 
commissioner.... I was also able to give them information that I’ve suffered late 
effects, which is common with my type of cancer and treatment.  
(Paula, cancer patient, IP4) 
 
Research commissioning panels were able to question the research team if they had 
doubts about PPI. Priscilla spoke about how she was asked by the funding panel to make 
significant PPI related changes to her application: 
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We had to change our plans, so it started off with four [patients on the steering 
committee], when we got our grant they suggested we increased it to a minimum 
of six, which we did.   
(Priscilla, oncology professor, IR2) 
 
Another issue discussed at a commissioning level was how public members could become 
public co-applicants on research grants. To help the funders have confidence that the 
study was capable of recruiting despite having ethical issues: 
I am a co-applicant for a study [of which Paula explained ethical implications] 
… So, in a way it could be a little bit controversial in terms of recruitment. And 
that’s really where, … us as advocates […] can help. And [the Principal 
Investigator] has engaged me as a member of [charity] to be a co-applicant.  
(Paula, cancer patient, IP4) 
 
Clearly these examples demonstrate that commissioners wanted to see how research calls 
were being carefully planned, that researchers were considering different ways to involve 
people and that if the commissioning research panel were unsatisfied they could ask for 
more PPI.  
 
PPI in research design  
Just as commissioning processes were perceived as being important in research impact 
generation, proactive PPI in research design was perceived to lead to more focused and 
relevant research, which in turn was seen as being more likely to achieve impact later. 
However, finding suitable people to involve first was often seen to be problematic. More 
than half of the interviewees spoke of how they found it difficult to involve people, from 
finding suitable people to struggling to support their training and payment. 
 
Patient Sarah talked about how her skills and knowledge increased over time, however 
initially she confesses to knowing very little about PPI in research. Sarah said as time 
went by, she felt she was able to make useful suggestions. She also expressed that being 
involved in research is not for everyone and requires a level of basic skills and confidence 
to do the role: 
What I found is that I knew nothing about anything when I started, but gradually 
[…] you start to make sensible comments, […]it’s obviously not everyone’s cup 
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of tea to do this [PPI in research], you’ve got to be able, … have some sort ability 
to read, write and speak up and more than anything else not be intimidated by 
30 professors in the room!  
(Sarah, cancer patient, IP1)  
 
Sarah, by describing the essential skills of reading and writing, highlights that those who 
struggled to read and write were at a disadvantage immediately. Sarah’s continuity of 
being involved in research led her to having confidence towards PPI.  
 
But continuity appeared to serve other purposes. Phillip (a research professor) believed 
that if a certain group of patients are involved at earlier phases of trials then the same 
group should follow the work through because they are knowledgeable about that 
particular piece of work: 
I think the same users need to be involved in follow-up trials. So, for phase 1, 
phase 2 etc., the same users could be involved, with sequential studies etc., as 
they will be better equipped to advise and guide for the second and third 
[phases]and so on…This helps with continuity and it helps with buy-in too.  
(Philip, oncology professor, IR4) 
 
However, there was tension in the data about PPI in research benefitting from patients 
who have been involved for a long time versus those who felt PPI needed fresh 
perspectives. Four participants felt that using the same group of people meant that people 
became too acclimatised to research systems and moved away from their original 
experience of cancer which led them to becoming involved in the first place. This point 
was raised by patients particularly. Here is an example from patient Jane: 
What you really want is… new people because we’ve got too many old ones. 
We need to manage some of the old ones off, who are now a long way away 
from when they first had cancer or had experience of cancer as a carer.  
(Jane, cancer patient, IP2) 
 
Another patient, Helen, raised that there simply are not enough people to get involved in 
research. She said that there are lots of trials currently running and they all expect PPI, 
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but the task of finding people is difficult because there are not enough sufficiently trained 
numbers of people willing to help: 
 
 
The trouble is, PPI is embedded …there’s hundreds of these research trials and 
if you haven’t got enough[trained] people to actually be involved in them, then 
it’s actually quite difficult for researchers to find people.  
(Helen, cancer patient, IP3) 
 
Seven participants raised a connected problem, one of retention. In cancer research, PPI 
might not survive the length of the research study, or patients may withdraw their 
involvement due to deterioration of their health. Ben explained how he witnessed this: 
… the last couple of meetings I went to, there were only three of us, …one 
person wasn’t too well… another had decided that they would like to go and do 
a bit of travelling… because, they felt that their cancer was progressive …so it 
did slightly dwindle but I wanted to see it through.  
(Gary, cancer patient, IP5) 
 
Janine said one way in cancer research to fulfil PPI aspects was by involving carers or 
those better. This was particularly important in palliative care, as carers’ perspectives 
were perceived as a useful secondary insight into patients’ lives as well as those who were 
not palliative patients: 
The difficulty in cancer research is people don’t live long enough …That’s why 
we asked relatives and carers and people who have [been] cured from their 
cancer but not people who are on active treatment or those who have got 
secondary disease.  
(Janine, palliative care professor, IR3) 
 
Managing individual agendas during PPI 
The effect patients feeling intimidated was acknowledged by researcher professor Janine: 
…some people haven’t a clue on what professionals around them are doing. 
They dare not say anything and feel very uncomfortable about having all these 
medics about.  
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(Janine, palliative care professor, IR3) 
 
Janine’s view raised an important question about how this negative effect of confidence 
resulted in managing patient agendas. Several interviewees spoke about the issue of 
individual patient agendas being difficult to manage. This was especially the case when 
patients became too dominant about their own cancer experience: 
The trouble is A finding someone, and B finding someone who hasn’t got an axe 
to grind, you see …there’s a patient representative, …he brings up his diagnosis 
in every possible meeting….  
(Janine, palliative care professor, IR3) 
 
But it seemed that patients’ needs changed over time. Priscilla explained that agendas of 
patients are in transition during their cancer experience and this can affect their ‘state of 
mind’ relating to PPI: 
… in that awful time when you have just been told, your brain doesn’t work. … 
her head wasn’t in a place where she could have made any real decisions. 
However, now a few years down the road it’s very different, …she wants to lead 
all the decision making but at that stage she just couldn’t  
(Priscilla, oncology professor, IR2) 
 
Priscilla’s point reminds us that patients’ feelings evolve as research progresses, and 
whilst sometimes people might not be at their best during one phase of their cancer 
research PPI experience, as their health and prognoses change their input will change too. 
The challenge therefore may be that gaining the best input from people is highly 
dependable on their situation at the time.  
 
PPI in research conduct 
In each interview, the broad issue about difficulties of conducting PPI were discussed. 
Conducting PPI work involved training issues, supporting and ensuring that people where 
paid for their time doing PPI. Four patients received training for their PPI role. Most 
researchers and stakeholders also had opinions about training. Patients linked up to larger 
organisations described the sorts of training they had been offered. 
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I’ve got a really good mentor… if my comments are not relevant he’ll explain 
why and if they are, he’ll encourage me to put them forward.  
(Paula, cancer patient, IP4) 
 
Helen, talked about her experience of a cancer biology study day that she was sent on 
through a charity that she was involved in, which helped her understand why cancers 
generally were not detected sooner. She also explained how gaining access to this training 
resolved her inner anger of being diagnosed late. This helped her to move her own 
bitterness towards cancer to one side, enabling her to focus on the PPI role: 
I was angry that they hadn’t picked it up. And it wasn’t till shortly afterwards I 
went on this biology [training]that I realised how minute the pinprick is of the 
cancer cell and when it gets to a certain size that’s when it has to get its own 
blood supply and that’s when they can pick it up. …And then that clarified a lot 
in my mind.  
(Helen, cancer patient, IP3) 
 
But training could be highly specialised and involved significant travel. Patient Paula 
recounted how she was awarded a scholarship to go to California to learn about breast 
cancer and patient advocacy work. 
Luckily, I got a scholarship to go to California, a breast cancer science course 
…they provide a training course for breast cancer advocates …I was sponsored.  
(Paula, cancer patient, IP4) 
 
However, for some patients not connected to larger patient groups, reimbursements were 
all that they were offered, and one patient refused payment.  
They offered us money … and most of us said no …keep the money. We just 
want to do it for the good of other people that are coming behind us.  
(Gary, cancer patient, IP5) 
 
Joanne simply gave ‘a bouquet of flowers’ to each of her PPI because there were not any 
funds to pay for honoraria from the grant; these flowers were bought from her own 
money. Most researchers spoke of comprehensive payment systems that they had worked 
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out ahead of the study starting. For example, Katy described a payment system, she listed 
the amounts that the group members could expect from attendance for PPI work: 
…if it’s half a day …we pay them around £50. If they are doing …maybe 5 or 
6 hours meeting and they are having to prepare and read lots of papers and maybe 
do a presentation, we have a rate of £150. 
(Katy, national cancer policy staff, IS7) 
 
It is clear to see that training was sometimes offered to PPI but also as an 
acknowledgement through the form of a ‘thank you’. But there was no consistency across 
the examples of how and, indeed, how much patients were being paid. 
 
Appropriate and meaningful PPI 
19 interviewees commented on the different roles for PPI from reviewing patient 
information sheets, plain English summaries, to helping with data collection. Examples 
were offered about how PPI had led the research studies to be more ‘appropriate and 
meaningful’. Research-related issues were raised to improve or change the research 
process/ focus. The next set of quotations display this.  
 
Gerald articulated that if someone has experienced cancer then they may find it hard to 
separate out their individual issues and experiences from what is being researched and 
therefore they should not be collecting or analysing data as this could lead to data bias: 
I think people who maybe have had cancer are very changed by their experience 
and therefore may have very strong views about what should or shouldn’t be 
done. Which may make it very difficult for them to be impartial in how they 
collect or interpret data….  
(Gerald, social science professor, IR8) 
 
Many interviewees (half of whom were stakeholders and researchers) felt that patients 
can help with recruitment. But Gary (patient) made the following observation: 
There’s nothing like someone who’s done the study [i.e. participated] saying to 
someone else it was really important, very straightforward, I’m glad I did it. So 
that helps recruitment, as an advocate for the study I suppose. In a way the 
researchers can’t twist people’s arms like that (laughs) can they?  
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(Gary, cancer patient, IP5) 
 
Echoing Gary’s opinion was Steven’s (hybrid role) who discussed that whilst patients 
may not be developing cancer research trials, they do impact on the way trials are thought 
out. He offered the example of targeted access to a new trial: 
So, one of the areas they hadn’t thought of in the trial was raised by the PPI 
person on their steering committee, they said ‘oh no, I think this is a really 
important question for people with breast cancer….’ And they opened that trial 
locally because of that. So, whilst we don’t develop the trials… I think people 
do have more of an impact on things that you wouldn’t necessarily think of.  
(Steven, hybrid role, IS3) 
 
Helen discussed how she was able to influence a trial management committee to change 
the upper age limit because she had turned 60 that year and aside from the cancer, she 
was fit. Helen had wondered why the trial had a cut-off age of 60: 
I’d turned sixty. And, course, a lot of the cut-off dates for a trial is sixty. My 
question was; well, hang on a minute! A healthy sixty-year-old is probably a lot 
healthier than somebody who’s been abusing their body in their forties. So why 
is there a cut-off date at sixty? Surely it should be up to how the individual 
patient is, and not just a blind cut-off date. That made ‘em sit up and think.  
(Helen, cancer patient, IP3) 
 
There was a sense generally that patients can help with ethical issues in research and 
Priscilla explains how this happened for her study. 
We were wanting to try and get patients to sign up to take part in the study before 
they had been seen in oncology. So, at a time when they were really vulnerable. 
Were really struggling ethically to decide how we could actually encourage 
[and] invite them to attend without upsetting them further. The patient group 
were very helpful in logistics, in the end the patient group wrote the letter of 
invitation, not us. So, they basically wrote the letter to say we are a group of 
patients we have been here, this work is being done that we are helping with, we 
would very much like to invite you to participate. If you would like to take this 
further, then one of our researchers will be in touch.  
(Priscilla, oncology professor, IR1). 
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Factor 3. Information and Communication Technology (ICT) 
We live in a technological world and this was conveyed in many ways during interviews. 
Patients, researchers and stakeholders all talked about various ways that technology is 
being used and applied in everyday PPI in research work and this factor of PPI reflects 
using ICT. The use of smartphones for emails about PPI, google groups also known as 
virtual platforms, social media and blogs as well as sharing information on video 
streaming channels were all discussed. 
 
Smartphone use for emails about PPI 
Four patients discussed the use of their smartphones for PPI work. Paula throughout the 
day checked her smartphone for new public involvement requests/tasks, implying both 
that checking her emails was a big part of her day and also that requests from researchers 
were routinely coming in:  
… I’m dealing with requests on my smartphone, I’m always, having cheeky 
looks at my smartphone most of the day because I’m getting stuff in from… the 
trial I mentioned I am co applicant for, most of the day.  
(Paula, cancer patient, IP4) 
 
Virtual platforms for PPI 
Three patients explained how they were part of a virtual platform where patients could 
comment on studies that researchers were planning: 
…. there’s a Google group… and people will comment on this group and so they 
[researchers] can collect together comments and get comments from quite a 
number of patients.  
(Sarah, cancer patient, IP1) 
 
Smartphone applications being developed by PPI work in research processes 
Barry a stakeholder in a PPI role described a smartphone application that a PPI group had 
developed to help a research study, demonstrating impact on the research process because 
Barry recollected that researchers had adopted the ideas generated by the PPI group. The 
study has not yet been completed but shows how PPI work can help with technological 
ideas:  
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…the medics [researchers] have real-time reporting now, …the smartphone app 
is a quick way of doing it. They took the proposal to the PPI group that I chair, 
and the PPI group, in half an hour had generated some possible applications and 
uses of this thing that the researchers hadn’t contemplated; and the researchers 
wrote back to the panel to say, here are four things that we hadn’t thought of, 
that you did, and we’re now going to work on them.   
(Barry, PPI lead, IS4) 
 
Social media and blogging 
15 participants emphasised the use of social media to help generate interest about a study 
and a subsequent campaign from the study. The ease of using social media such as 
Twitter, Facebook, blogging and crowdsourcing was raised as a way of further reaching 
people about new research and improvement initiatives:   
It’s a lot easier now with things like social media, Twitter, Blogging, 
…crowdsourcing, that kind of stuff. People are interested in what’s been done 
and how it’s changed services…  
(Katy, national cancer policy staff, IS7) 
 
Katy then went on to explain the reach of a campaign generated through cancer research 
with PPI:  
… there is an evaluation report published about the reach of that campaign and 
the difference it’s made [and] how many clinicians it’s reached, and the patients 
and the public were involved. So, we had the TV and radio interviews 
…thousands of people Twittering [sic] and you name it.  
(Katy, national cancer policy staff, IS7) 
 
But for researchers like Robert, they expressed concerns about not knowing who was 
using the findings that were produced. He expressed that social media can help with 
dissemination, but that it was difficult to know how far findings can travel or how they 
might be used: 
…. I suppose it’s like people who tweet and then people who retweet tweets, 
you do something but you don’t know how far it is going to go and who’s going 
to end up with it.  
(Robert, GP and professor, IR5) 
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Three participants had a blog. Steven, who had a hybrid patient and professional role, 
described how his blog, which he wrote in his dual capacity of patient and a professional, 
impacted positively on research work: He felt he was able to assert and challenge policy 
through this medium:  
There is something about the way we are strategically linked virtually, the way 
we have got our networks, the way we are beginning to alter policy. The way we 
have stopped just being the quiet voice within…, [by using online platforms] we 
are challenging, we are assertive, we are known. … my blog’s an example, 
where we are actually speaking out and becoming leaders.  
(Steven, hybrid role, IS3) 
 
Steven discussed blogging but at the heart of what he was saying was about leadership, a 
point which will be revisited in the factor of ‘power and leadership’ (below). Steven then 
said that social media and new technology offered a way to share what PPI has achieved 
for research: 
I think we can use social media and new technology, we can use them to actually 
say here is some of the discussion around this [the impact a study has made].  
(Steven, hybrid role, IS3) 
 
The use of YouTube and hyperlinks 
The traditional use of YouTube is to allow users to upload, view, rate, share, add to 
favourites, report and comment on video clips. But it seemed that YouTube was being 
used for PPI work. In the interviews with David and Katy, they offered examples of 
impact of PPI on research outcomes and described the use of YouTube to help with cancer 
genetics research work:  
I am delighted that we have got the first YouTube channel in the world for 
clinical genetics, that’s just under 10,000 views and it’s been viewed in 12 
countries.  
(David, geneticist doctor, IR6)  
 
Katy discussed that they asked their PPI group to comment on YouTube clips that 
researchers had developed: 
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 [….] if you look on their website they have got a seven-minute clip and we sent 
that out to all our lay networks to say have a look at this, what do you think, does 
it help?  
(Katy, national cancer policy staff, IS7) 
 
Almost all researchers and stakeholders validated how easy it was to inexpensively send 
information about a study using their email and sending documents presented in Portable 
Document Format (PDF) and hyperlinks to the other side of the world, at the click of a 
button, to help generate impact: 
Having a PDF or a hyperlink …these days it’s so easy [and inexpensive] you 
can zing it over to New Zealand or Australia,  
(Nick, cancer charity, IS2) 
 
Factor 4. Networks 
This factor of PPI was about the importance of networks, and the richness of different 
perspectives that come from working collaboratively, building and forming partnerships. 
Patients all described networks they were connected to. Stakeholders and researchers 
described how professional networks impacted on them and their work. 
 
Patient networks 
All patients identified how their own networks helped them with their PPI roles. Paula 
was involved in a number of other PPI research related activities, these other roles helped 
her more generally in PPI work: 
If the patients are already members of charities, they are not just coming in blind 
to one area. They normally, …like me, are involved in other areas so understand 
wider issues of PPI.  
(Paula, cancer patient, IP4) 
 
Steven, was actively involved in other work which researched long-term effects of life 
after cancer. Steven shared how he and other patients like him are connected to a stream 
of influential patient networks. Steven explained that he was invited to the House of Lords 
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at Question Time to discuss the networks he represented and what they wanted to be the 
focus of research:   
I have just been invited again to the House of Lords at Question Time… one of 
my questions was about improving the research for long-term survivors of 
cancer, like me.  
(Steven, hybrid role, IS3) 
 
But Steven believed that this visit to the House of Lords was not the only place where he 
was able to make impact; he also had his own networks to share research and make 
impact. He believed collaborative working amongst patient networks could potentially 
demonstrate ‘reachability’ of his networks 
We have got our own networks of people. And they then influence other people 
because they are all sitting as members of Breast Cancer Campaign, Ovarian 
Cancer Trust etc. So, if you did a Venn diagram, …mapping all the circles of 
the patient’s community you will see…we find our own ways of making change 
happen.  
(Steven, hybrid role, IS3) 
 
No example of change was provided by Steven despite the point made. However, Jane 
also talked about how she was involved in patient networks via a charity that she was 
involved in. She discussed how the charity offered her ‘clout’ when approaching political 
figures. Jane had contacted local MP’s to gain political backing for the charity she was 
part of to help improve cancer patient care in a rural part of the country:  
So, we [Jane and the charity she was part of] are contacting our local MPs, we 
are talking to MPs who are interested in this topic [improving cancer patient 
care]’.  
(Jane, cancer patient, IP2) 
 
Several patients mentioned that charities helped to keep the cancer patient voice alive. 
One unique charity, which is a network of cancer patient survivors the charity develops 
links between cancer researchers and patients, by training patients to become confident 
advocates in cancer research.  
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I came across a charity [and] decided to become a full member of this national 
group, which specialise in training advocates to be effective voices in research, 
and that’s right at the cutting edge of research. It’s mainly, looking at proposals, 
research questions and protocols prior to going on to funding for study. So, it’s 
actually helping with funding and fundamentally that’s what a lot of [members 
in this charity] are doing.  
(Paula, cancer patient, IP4) 
 
Stakeholder networks 
Stakeholders spoke of a UK-wide partnership between government, charity and industry 
which promotes co-operation in cancer research, where partners can achieve greater 
progress by working together. Jenna spoke of how this cancer network is highly dedicated 
in the role of co-ordinating cancer research: 
… for cancer …we haven’t just got the research networks with the clinicians 
doing the work and the research staff helping them run it, we’ve got these 
national groups and these regional groups, …and the national clinical studies 
groups. I think we are in a better place than any other disease area... So, [this 
network] would call that like a whole systems approach. …they are trying to 
make sure that the key people nationally are in a group, they’re developing the 
right studies…where there’s gaps, and they then making sure that they go out 
there and are being implemented after. …But I think we are unusual in cancer 
because we have got that whole structure behind it.  
(Jenna, trials coordinator, IS5)  
 
Katy described the same partnership as Jenna but in more detail (note the excerpt is long 
but necessary to illustrate cancer networks in the UK):  
…we partner very closely with the [network]. NCRI is a partnership of all the 
key funders for cancer research in this country, so people like Cancer Research 
UK, Macmillan etc., etc., the key charities. You have got all the key government 
bodies …key pharmaceutical industry [and] they all work together and put 
money into a pot and agree on funding and prioritising for research in this 
country. ….We have got patients going into that, directly advising that group, 
…And a few years ago, when [the network] was redoing its strategy for 
…[patients] said well actually it’s great that people are looking for a cure for 
cancer, …but actually cancer is a much more long-term condition now, people 
are living with this day to day, month to month. We would like to see more 
research on the effects of living with cancer, not just… physically but 
psychologically, on our economic situations, being able to work etc. And their 
voice was taken into account, it informed the strategy. 
(Katy, national cancer policy staff, IS7)   
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Researcher networks 
It seemed that networks were significant and each researcher spoke about how they 
worked in collaboration with others. Some regarded networks as relationships, signalling 
respect and perhaps unspoken support for the work, based on trust and working together: 
I’ve got some pretty good relationships in the palliative care field, in the end of 
life care strategy field. I will make sure that I take this work to quite a lot of 
different forums.  
(Janine, palliative care professor, IR3) 
 
Although Janine is discussing dissemination plans, it is included here as it reflects the 
essence of networks. She then went on to explain that when knowledge is shared it should 
not be uncritically accepted because: ‘in a relationship you work it out because lots of 
other things need to happen too’. Researcher Philip said that he was involved with a 
charity and through this role he had a significant group of people whom he could connect 
with to encourage them to lobby government. 
Factor 5. Dissemination  
In this factor dissemination is explained. Participants believed that before research studies 
made an impact at implementation stage, several dissemination aspects needed to be 
carefully considered. They discussed the limits of academic dissemination, the 
importance of disseminating information more widely, the importance of PPI in the 
dissemination process and that dissemination cannot carry on for ever. 
 
Limits of academic dissemination 
Every researcher discussed the effects of open access journals, writing journal papers and 
speaking at conferences, but some more interesting issues were also raised which were 
felt to affect the impact of PPI on research outcomes. Effective dissemination was about 
getting the findings of research to the people who can make use of them, to maximise the 
benefit of the research without delay. Most patients, researchers and stakeholders 
commented on the limits of academic dissemination, acknowledging that academic 
dissemination practices often have only reached a few people. For example, posters, Patsy 
said, were not ‘proper’ dissemination:  
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… Quite frankly the number of people that look at a poster is very, small, that’s 
not proper dissemination.  
(Patsy, hospice senior staff, IS8) 
 
Another point about the limits to academic research dissemination was made by a head 
of an academic department, who said that journal papers quite possibly only reach a 
relatively small number of people: 
If you’re publishing in a journal it is quite possible that only two hundred people 
will ever read that research paper.  
(Robert, GP and professor, IR5) 
 
Disseminating information more widely 
There was a consistent message across the interview findings that information needed to 
be produced in a variety of ways, for a series of audiences: 
…part of dissemination is trying to get it put into practice, so …it means 
producing [information]in different ways for different audiences.  
(Nick, cancer charity, IS2) 
 
Nick offered an example, saying that he emailed the information, he presented a poster at 
a conference, he shipped out hard copied of the reports and he tweeted about the report 
using a link. He then made a point about dissemination being an on-going process: 
My dissemination tactics have been emailing it to people, going to conferences, 
presenting posters, leaving copies on tables. […emails and tweeting] as well.  
(Nick, cancer charity, IS2) 
 
Patients and the public in the dissemination process 
PPI in the dissemination process itself was believed to make an impact on research 
outcomes. It was believed if patients and the public were involved in dissemination 
delivery itself, they can convey the message in a captivating way.: 
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…I think it’s very emotive… listening to a patient’s story is very powerful. And 
what we are looking at is something that might require doctors to change their 
practice and that’s a really hard ask. But actually, if you have got a patient who 
is telling you the results of this study which show it makes a difference rather 
than me I think that’s very, compelling.  
(Priscilla, oncology professor, IR1)  
 
Helen discussed that if patients have been involved in the study, then the person 
disseminating must raise that in the content: 
If you’re involving patients …you’ve got to be telling policy makers and all-
important bodies, telling them and others ‘look, you’ve got to take this seriously, 
patients were involved in this’.  
(Helen, cancer patient, IP3) 
 
Patient Paula said that: ‘If the patients are involved they can disseminate…. Widely’. 
Patients Ben and Gary’s view chimed with Paula’s, even though Ben spoke less of his 
connections to charities. He said for the study he was involved in, he felt charities would 
find it valuable to hear about what the next stages of the work might entail: ‘what mustn’t 
be forgotten is dissemination to patient groups. You know, to charities etc. about this 
work [his input in the study]’. Steven asserted that patients are usually connected to other 
patients, so for that reason they are likely to reach other patients quickly:  
We can no longer just sit around a table …that’s insufficient. It’s a two-way 
process, when we get involved it is incumbent on us to tell others. So, I spend a 
lot of my time [talking to] patient groups, patients’ communities, self-help 
groups, to talk to them about research. …Because the more we spread the word 
out into those communities the better it is.  
(Steven, hybrid role, IS3) 
 
Dissemination cannot carry on forever 
Four researchers said during their interviews about the reality of the situation that 
researchers are faced with. It is a researcher’s imperative to apply for more research grants 
to keep them in a job: 
I don’t think it is anything sinister in what the academics are doing in relation to 
dissemination, …they can’t do everything. They’ve got to draw a line in the 
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research and when it stops paying their salary and …staff they have an 
imperative to get more funding so that they don’t all become unemployed.  
(Robert, GP and professor, IR5) 
 
Factor 6. The significance of power and leadership  
Having the leadership in research of someone with a position of power and influence was 
brought up by 10 participants. Leadership sometimes meant commitment and influence 
and organisational support for PPI, for others it was management in research willing to 
support the PPI. It also meant influential figures, such as MPs, celebrities, champions and 
experts, supporting and even leading the PPI work. Ultimately, there was a belief that if 
the institution hosting the research grant was ‘PPI active’ then the impact of PPI on 
research outcomes would be far greater. 
 
Having patient influence 
Paula described in her interview how one particular patient was very inspiring for her to 
learn from at the charity she was part of. Paula spoke about how this one woman was 
routinely approached by oncology researchers, with the mind-set of asking her to lobby 
for their work. Researchers would use her name to other researchers and healthcare 
professionals saying: ‘something must happen about this, because [name] has told them!’ 
Paula went on to explain that this woman was very formidable in a positive way because 
of her family links to a particular Baroness in the House of Lords:  
… [A] Baroness …who campaigns [for a cancer research charity] and is … in a 
very good position in healthcare …is a formidable person [many people follow 
her work and values of PPI] … and a lot of researchers, clinicians, oncologists 
across the UK know [her]. You just need to say her name, you don’t need to say 
her surname and they are with you on the PPI. 
(Paula, cancer patient, IP4) 
 
Having celebrity influence 
The significance of power and leadership also included influences from celebrities, 
according to four participants. Reference was made to Jade Goody, Peirce Brosnan’s 
wife, Kylie Minogue and Angelina Jolie, who was found to have a gene that caused 
cancer. Ms Jolie, chose to have preventative surgery. Around the time of the media 
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attention this celebrity generated, English hospital referral rates hit record numbers. 
David said that his work became busier after the story of the actor reached the news, 
rather than his own efforts of PPI. He suggested therefore that celebrity backing for 
particular cancer research had influence on research uptake and understandings amongst 
the general public: 
We know that since Angelina Jolie mentioned …she’d had preventative surgery 
it’s doubled our referrals rates and, in some cases, trebled in different parts of 
the country.  
(David, geneticist doctor, IR6) 
 
Having Government support 
Having the backing from powerful people was helpful in manoeuvring campaigns 
according to Katy, who described a campaign that has been successful in generating 
research impact. The campaign was created through her work. Katy explained how she 
has managed to reach Whitehall.  
…The message ‘It’s Ok to Ask’ was a direct result of the [survey], patients 
helped to get questions in, those questions came up with the finding that most 
people want to be asked and expect to be asked about [cancer] research. 
(Katy, national cancer policy staff, IS7) 
 
Katy described the leaders present and their backing of this particular campaign:  
all the key political groups - the All Parliamentary Group on Cancer… the 
Secretary of State for Health …politicians, the decision makers - people like the 
cancer tsar… all coming together… 
(Katy, national cancer policy staff, IS7) 
 
Katy said that when they were presenting the findings to the government about the patient 
driven questions, they had an opportunity to ask a direct question to the then, Health 
Secretary, Jeremy Hunt:  
…we talked about the patient-driven work …and its impact and we asked if he 
could reassure us that the government would take seriously about supporting 
patient services …for the future to help drive service change. … being a typical 
politician he didn’t give a direct answer, but he did say, he thought [our survey] 
was a very positive piece of work and he would like to see that kind of work 
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carried forward. …So that was good that we had the opportunity to talk to 
someone at the top … 
(Katy, national cancer policy staff, IS7) 
 
Katy’s example demonstrates that cancer research and cancer patient experience work, if 
created through established channels, generates political interest at the highest level. 
 
Organisational power and leadership 
Strong organisational leadership was also seen to have an inextricable link with impact. 
An interesting aspect of ‘power’ was organisational support for PPI; it was believed that 
if the institution conducting cancer research was active in PPI work then the impact from 
that research would be far greater:  
So… in an environment where staff are routinely part of a PPI in research culture 
and environment, where there is an expectation that research takes place …there 
seems to be a statistical link with better outcomes for patients. 
(Michael, academic department lead, IS7) 
 
Organisational PPI respect 
One researcher, Janine, described her highly respected and reputable charity organisation, 
based in a university hospital setting. Janine’s research centre had firm support for PPI in 
their palliative care research work. Janine explained that the organisation that she was 
part of had a strong PPI ethos and in her opinion the university was keen to keep a strong 
relationship with patients at the heart of their work: 
…so, we are part [a charity] and we sit inside the brand-new school [within the 
university] So, this is a philanthropically funded research and education 
department, …we’ve got a range of funded research …without exception every 
single one of our studies has got a degree of user involvement [PPI]. We have a 
regular meeting planned …three times a year and, in that way, we can keep a 
continuing relationship… with [PPI] and we can also plan engagement …about 
studies that are ongoing or new studies that we want to develop. But then there’s 
also particular studies which might have an advisory group where we invite 
particular research partners to join that advisory group and so that study will 
decide its own schedule of meetings.  And there might also be some individual 
consultation that goes on.  So, we tend not to be hard and fast about this is the 
way we’re going to do it, it’s on needs must basis.  And we have had studies… 
which have been at the participatory end of the spectrum where we’ve actually 
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worked …closely with maybe five or six patient research partners and they’ve 
been an integral part of the research team,.  
(Janine, palliative care professor, IR3) 
 
Although the above quotation from Janine overlaps with ‘PPI processes’, it is shared here 
to demonstrate the value of having an organisation with strong PPI in leadership.  
 
It seemed that other researchers such as Robert were striving for this ethos that Janine 
was describing. Robert, who was once the Head of Department but since is semi-retired, 
came to work for an ongoing project he was principal investigator for. He raised the issue 
that the department still needed to work more closely with patients to form a partnership 
between the department and the community, but the department had not been able to 
achieve this as yet. Robert made the comparison that colleagues from other teams, such 
as cardiovascular research, had already developed a strong relationship with 
cardiovascular patients: 
I think as a department …we’ve probably got a way to go. I have tried suggest 
…that we have to have some sort of patient partners…the community, …that we 
could talk to about various things. … but you know, that didn’t really get taken 
up. … it’d be really nice to have a group of people with whom we interacted. 
Yet you know, …other Departments [cardiovascular]… they’ve already got, 
…patients who they talk to … but we don’t.  
(Robert, GP and professor, IR5) 
 
James, who felt generally uneasy about PPI practice in research anyway, was not too 
concerned that his hospital seemed to lack leadership regarding PPI. James showed the 
researcher, during his interview, how the hospital’s monthly briefing report raised nothing 
about PPI: 
…what’s he [the chief executive of the hospital] fussed about? Nursing staff 
review. …this venue from GemaSim4 risk, are we hitting targets …on …waiting 
times for cancer treatment, …Local Supervising Authority …Emergency care 
performance, are we hitting the four-hour deadline, adopt discharges, financial 
                                                 
4 GemaSim is a computer-based, 'non-technical skills' training- and assessment tool. A laptop-based 
simulator, GemaSim is designed to demonstrate, and to give experience of the 'real human factor'. It 
allows for the experience, observation, analysis, modification and consolidation of authentic behavioural 
patterns. 
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performance of the various divisions, clinical management group dates, 
executive team portfolios, listening in action, update from IT – that’s this 
month’s briefing. Can you find anything in there about patient involvement? No!  
(James, oncologist professor, IR7) 
Similar to hospitals, it seemed that some universities were developing the wrong kind of 
leadership. REF complicated the impact of PPI because it was driven by academic outputs 
rather than actual change:  
Public involvement impact is not helped by the REF…There’s impact in 
academic [work] which is all about getting in the journals that are read most, 
…So that’s impact number one.  
 (Michael, academic department lead, IS7) 
 
Michael called this the ‘REF bastardisation of impact’, implying a muddle and conflation 
of real values about what impact of research should be rather than what it currently is. 
Similarly, Robert said that despite having a strong desire to make efforts to inform the 
patients and the public, researchers are bound by what they can and cannot do. Once a 
study has finished, if the institution the researcher works in does not value efforts to 
engage the public then that will act as a strong barrier. He implied that academia continues 
to value papers in high impact journals, rather than supporting a culture where researchers 
hold community events: 
…often the outcomes of research are papers and presentations because that’s 
what’s valued by the employers/universities and therefore that’s how people 
respond… you know, you don’t get promoted because you held a patient 
dissemination event, but you might get promoted because you’ve written a paper 
in the BMJ [British Medical Journal]. So where do your efforts go? 
 (Robert, GP and professor IR5) 
 
Michael raised a similar point: 
I don’t like to reduce people to being sort of rational self-interested homo 
economicus-es [sic], but the incentive structures …are not designed to try to 
break down the walls to the ivory towers.  They are designed to maintain the 
institution …and make the academics speak to other academics… 
(Michael academic department lead IS7) 
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Patsy said impact of research is what is countable: 
…in order to keep their jobs, they’ve got to comply with what’s asked of them, 
which is quantifiable, measurable things about how many papers you produce, 
what money’s come in and how many times you’ve been cited. because you can 
only measure the measurable  
(Patsy, hospice senior staff, IS8). 
It seemed that impact from health research was being forced uneasily into neat audit trails. 
Undoubtedly, the REF criteria for impact offers the dominant benchmark for researchers 
in academia.  
  
There were examples in the data to demonstrate the existence of an aloof culture of 
academia, and that often researchers’ salaries and careers depended on creating audit 
trails, rather than demonstrating meaningful and active engagement. These issues were 
believed to add to the complexities regarding how the impact of PPI could be evaluated.  
 
Barry, a PPI lead, discussed how easily a lack of leadership can lead to ‘mission drift’. 
Even with the best intentions initially, when people move on to new roles a loss of 
direction is unavoidable for the organisation:  
there’s a kind of natural tidal flow of values, passion and commitment around a 
particular organisation.. [they start with] clarity of vision, there’s a distinct 
purpose, everybody knows …what they’re trying to do and there’s an alignment 
of what that organisation is about to that single purpose; and then stuff 
happens…quickly and sometimes it happens slowly …things leak; values get 
buried, passion ebbs away, the pioneering innovative leader hands over the job 
to somebody else who doesn’t quite get it.  There’s an ebbing away of clarity, of 
focus, there’s a mission drift, there’s the loss of purpose and direction. …I 
…take this organic view of organisations which is …as real as seasons following 
one another.   
(Barry, PPI lead, IS4) 
 
Barry explained how easy it is for organisational values to dissipate regarding PPI. 
According to Barry, if all research is conducted in an environment with strong PPI 
leadership then the work is more likely to have a positive start. But weakening of 
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leadership will inevitably affect the impact of PPI on research and therefore, impact as a 
whole.  
 
Connected to leadership and power were organisational issues which were believed to 
affect impact. For example, Janine articulated the importance of organisations being led 
by senior researchers who can help with facilitating and minimising bureaucracies. These 
include enabling payment for PPI, using plain language when engaging patients, and 
training students and staff so that PPI can flourish over time: 
I think it’s very unfortunate that universities make us jump through so many 
hoops in order to get the money to people [who get involved in research], 
[because of] hugely bureaucratic and difficult rules.  …I’ve learnt also that 
you’ve got to teach other people to engage with users.  …some of the PhD 
students just go in there and they talk to them in either a patronising language or 
they talk to them in terms that they’re simply not going to understand.  And of 
course, there’s a balance to be reached, …these are mature people who’ve lived 
a life and they’ve probably had a different life to the one that we’ve had….  
(Janine, palliative care professor, IR3) 
 
Factor 7. Resources and the political context 
Resources and the political context concerned the range of contextual factors which, 
despite having good PPI in the study, might affect or diminish the successful production 
of impact. It included policy making challenges, priorities changing, the effects of 
restructuring from NHS budget cuts, short staffing, the impact of wider socio-political 
factors and uncertainty of the new knowledge gained from research. 
 
Policy making challenges 
The uptake of research findings, with or without PPI, was not straightforward or linear. 
For example, Robert described that when new information is found and analysed in the 
scheme of existing knowledge available it becomes problematic and harder to see how 
information will be used in practical ways. He recalled an example from NICE:  
I was involved in the cancer referral guidelines that were produced at NICE in 
2005, and they’re up for being updated …And there’s actually quite a bit of new 
work on the cancer referral guidelines… but even then, you can produce your 
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recommendations and there’s evidence but what do people do with it and how 
do they use it in practical ways is …not clear.  
(Robert, GP and professor, IR5) 
 
Patients agreed. Helen articulated that in drug trials the decision will always come down 
to NICE and the costs associated with the drug being adopted widely. 
 …It’s NICE guidance who say …“Yes, we’ll accept that drug and give it out to 
NHS patients,” or “No we won’t, it’s too expensive,” …I know some of our 
trials …it’s got right to the …end and then NICE have said – “on your bike, 
we’re not using that.” …you know- and some of the consultants, they’re 
absolutely gutted because they’ve spent years on it…. Long term the drug has 
got to be cost effective to the NHS.  
(Helen, cancer patient, IP2) 
 
However, David felt that sometimes decisions made by policy makers were wrong and 
based on short term solutions of cost saving rather than long term costs. He gave the 
example of his research saying that, in screening, the implications of making savings by 
far outweigh the cost of treating cancers and ongoing cancer screening. 
So, if you have got a person who is 30, who we prove has not got a very high 
risk of breast cancer, they won’t need 30 more years of high level screening, 
then if it costs £1000 a year to screen them, …that’s saved £30,000. 
Chemotherapy …drugs can become extremely expensive. [Also]…there are 
huge social and economic costs of losing people in their thirties, forties and 
fifties and leaving young families behind. So, for me it’s about trying to reduce 
the burden of cancer on families. Which is quite straightforward if you have 
someone at high risk of bowel cancer and you remove their bowel they are not 
going to get it… But there isn’t a formal assessment of either the financial or the 
medical aspect… 
(David, geneticist doctor, IR6) 
 
Apparently though, grant committees do have evaluation processes where expectations 
and resources are weighed up side by side and the job for the policy maker is providing 
best value. James stated that the role is not an easy one when policy makers have to make 
decisions: 
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For a policy maker, …they have a dreadful job …trying to manage expectation 
against resources and by in large what they want is the best value for their 
resource, and that’s why we have huge research evaluation committees to 
evaluate grants. They’re trying to evaluate demands against resource.  
(James, oncology professor, IR7) 
 
Robert also tried to sympathise with the role of the policy maker, saying that policy 
makers are not being illogical. They are considering pros and cons of change: 
to make something generalizable …it might be expensive, …time consuming, 
…but then other factors may have changed ….before your findings come out. 
…the fact that it is difficult is because it is difficult. It’s not because some people 
are being stupid or irrational.  
(Robert, GP and professor, IR5) 
 
Priorities change 
Changing political priorities, especially in connection to PPI, had negative effects because 
people had invested their time, energy and emotions. Dennis, Robert, Priscilla and Joanne 
all shared this feeling but also accepted that environmental circumstances change when 
there is a change in government: 
 
When this …study ended which involved patients through the process, …Not in 
the design of the project I have to say but in the conduct. …There were no clear 
dissemination plans set by the funders, …they had funded the project, they’d set 
the title so they wanted this piece of work, but it wasn’t something that we 
suggested. …We did it and then they did next to nothing with it at the end. …I 
was left in the position of suggesting to their communications manager how it 
might be disseminated, they seemed to have no ideas of their own and very little 
interest and as a result the questionnaire that we designed which was never fully 
used in the NHS… So, an awful lot of effort went in to produce something that 
was never really used.  
RP-W: And how much was that funded for? 
Err in an excess of £300,000 
RP-W: What a waste, 
Yeah, yeah it is. …sometimes the piece of research you are doing is important 
but by the time you have produced the findings ….the games moved on. 
(Dennis, implementation science lead, IS1) 
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Sometimes research required further funding to understand the implementation process, 
as in Priscilla’s case, but follow up funding has not been secured: 
 
We’ve been writing grant after grant after grant for this work but it has not got 
through, we just have to accept. …it’s just very very difficult work to fund in 
this current climate.  
(Priscilla, oncology professor, IR1) 
 
The effects of restructuring from NHS budget cuts 
When governments change, restructuring and reorganising takes place and a direct effect 
of this on ongoing research ventures was seen to be highly problematic. In Joanne’s case, 
a senior person was made redundant and this had a knock-on effect on her research 
endeavours: 
I want [my research on LBGT work] to have a direct impact on people’s lives 
and on practice and that is so difficult to achieve this goal because there are so 
many external circumstances as a researcher you don’t have control over. …the 
coalition won the election, austerity measures kicked in as a result of that [name 
removed] lost her job and there was a whole redesign and restructuring of 
services. So, there are some barriers to understanding what the impact has 
been…We might have had a follow up piece of work and you would know how 
my research was applied.  
(Joanne, social science professor, IR3) 
 
The effects of funding cuts were a critical aspect of understanding impact of PPI on 
research outcomes. Dennis explained that, when it came to implementation in the health 
services, the outcomes were highly sensitive to finances, with profound effects: 
You know there was another project that we were involved with which showed 
some promise in terms of changing service delivery but then it was up to the 
Trust to review that and decide whether or not they wanted to reorganise their 
service accordingly. That project finished a couple of years ago and …they’ve 
not made a decision yet. …Business cases often have to be made.  
RPW: What for? 
… if it involves more money …Part of the problem has been that they’ve all 
undergone massive reorganisation.…PCTs …abolished, …and Clinical 
Commissioning Groups start up. …community health services moved from PCT 
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to the mental health trust, so they had a massive increase in their function. So, 
they had to cope with a lot of new services as well. … hospitals …affected I 
think by the funding squeeze … the increase in A&E - attendance which is 
draining …ever-increasing parts of their budget. And they’re finding it very 
difficult to manage. …the NHS …is under very severe financial pressure and 
it’s very difficult for them to maintain a clear and sustained focus on getting to 
grips with research evidence and getting it into practice. …people are changing 
jobs rapidly and yes, they may say getting evidence into practice is very 
important, …but it’s not a quick process …we’re in a time of great uncertainty 
and reorganisation and we don’t have the time to focus on that [research 
findings] at the moment.  
(Dennis, implementation science lead, IS1) 
 
Dennis described financial pressure, clinical chaos, staff shortages and lack of focus. 
Together all of these issues have implications for the uptake of research evidence. Dennis 
ended by saying that the political importance given to a piece of research evidence 
changes when governments change:  
So, you might think job done and then you have a change of Secretary of State 
…So those sort of things, even with good PPI, you can’t foresee… 
(Dennis, implementation science lead, IS1) 
 
Short staffing 
Gary believed that short staffing affected the ability to make use of new knowledge 
derived from PPI, especially when medical and nursing staff were being pulled in 
different directions: 
… there are numbers of conferences about PPI, … lots of meetings and lots of 
people, trying to keep up to date with the latest information. But when you have 
one nurse look after 12 patients …The poor girl, man, or doctor, are probably up 
to their eyeballs with today’s battles, with not having time to find out about 
tomorrow’s weapons. I don’t know how you fix it.   
(Gary, cancer patient, IP5) 
 
The impact of wider socio-political factors 
Michael pointed out that expecting PPI to have an impact on practice is asking for too 
much, because the socio-political aspects will influence research more than anything else, 
and perhaps evaluation needs to consider these ‘other aspects’ rather than the PPI: 
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all those people who are looking for impacts on practice from PPI are probably 
being… unfair…, aside from whether or not it has the impact there’s the socio-
political imperative …why not have some people looking at it from a different 
perspective. Overseeing what is being done in the name of, …public funds and 
how they are being spent …different perspectives, different experiences… 
(Michael, academic department lead, IS7) 
 
Uncertainty of the new knowledge gained from research 
Participants recognised that other factors play a part in research knowledge use and 
uptake. The gradual nature of evidence use was something that eleven participants 
interviewed raised. They described that thorough knowledge-gathering took place over 
time and taking account of other research was very important: Janine: ‘How does your 
research with PPI fit into that rich tapestry of the community of concern?’.  
 
But resistance to change is also important; if the fit is wrong, insufficient knowledge 
should never be applied as we were reminded by Michael:  
…well they might be the wrong findings, it might require resources that we don’t 
currently have, or they have got to fit into systems that we already have …and 
there are all sorts of stakeholders that are going to be resistant to change. I might 
not believe you, I might think that is all very well but that you have missed this 
really important point. You know there are figures about, about there being a 
seventeen-year lag between generation of findings and putting them into 
practice, I think it is much worse than that. I think that most evidence never finds 
its way into practice, and thank God because a lot of it shouldn’t ever find its 
way into practice, and even when it does, you probably wouldn’t recognise it 
from when the research was originally done.  
(Michael, academic department lead, IS7) 
 
Michael then said when a research study is being conducted, an interface is useful 
between those who are likely to use the knowledge and those who are researching it as 
the work will have more up to date questions and answers, as well as reveal the pressures 
of adopting change. 
a better process would be a more integrated knowledge translation process. an 
interface between, while the research is taking place, or before the research is 
even initiated, …those who might use the knowledge and those who might 
inform it. And I use “inform” advisedly because there is all sorts of knowledge 
that we are pulling into this research process… If this research venture, 
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…involves end users then you are more likely to get the right questions, …more 
likely to understand the clinical context in which that evidence has got to fit, 
…more likely to understand the human resource pressure and the financial 
pressures on the organisation. 
(Michael, academic department lead, IS7) 
Summary of the seven factors of PPI  
This chapter has revealed seven factors contributing to the impact of PPI on research 
outcomes. 1. ‘Wanting to make a difference’ reflected ideas around hope for change, 
democracy, equality and better services, pragmatic knowledge and accountability. 2. In 
‘PPI in research processes’ further areas were identified. These were PPI in 
commissioning, PPI in research design, and PPI in research conduct. 3. ‘Information and 
Communication Technology (ICT)’ highlighted the digital nature of PPI in the form of 
smartphone use for emails about PPI, virtual platforms for PPI, smartphone applications 
being developed by PPI work in research processes, social media and blogging, the use 
of YouTube to generate the impact of PPI on research outcomes, and the ease of sharing 
evidence online. 4. ‘Networks’ comprised vast structures of formal and informal 
collaborations. Patient networks, stakeholder networks and researcher networks were 
described. 5. ‘Dissemination’ explored the limits of academic dissemination, 
disseminating information widely, the involvement of patients and the public in the 
dissemination process, and that dissemination cannot carry on forever. 6. The significance 
of ‘power and leadership’ including the importance of having patient, celebrity and 
government influence was discussed by interviewees. Organisational power and 
leadership was also discussed here, how leaders and powerful people can help 
organisations reduce bureaucracy concerning PPI processes. 7. Finally, ‘resources and 
the political context’ which concerned policy making challenges, priorities changing, the 
effects of restructuring from NHS budget cuts, short staffing, the impact of wider socio-
political factors and uncertainty of the new knowledge gained from research.  
 
Each of the factors of PPI described in this chapter demonstrate that PPI outcomes are 
entwined with motivations, circumstances and context and thus outcomes are difficult to 
determine without paying close attention to the PPI processes themselves. In the next 
findings chapter, this study’s Delphi process is described, which refines these findings to 
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complete the identification of contributory factors shaping the impact of PPI on research 
outcomes. 
  
 165 
 
  
End user involvement influencing this stage 
 
May 2014 – Developing themes from the data. Involvement in the form of 
collaboration with n=10 researchers at a workshop at De Montfort University. 
Key themes from the interviews were presented, and workshop attendees were 
asked for suggestions for the focus of the Delphi stimulus paper. The workshop 
helped the researcher to see that that data were broad because of the different 
types of studies discussed (from randomised clinical trials to community-based 
social science research) and that the backgrounds of interviewees ranged from lay 
to professional. It was at this workshop that attendees suggested that common 
themes needed to be the focus of the Delphi study. 
 
May 2014 – Developing themes from the data. Involvement in the form of 
collaboration with n=9 stakeholders at a workshop at the University of Leicester. 
Slides used for the previous De Montfort University workshop and feedback from 
its attendees was presented at this workshop. An important point raised at this 
workshop was that seven themes were present, and these seven themes should be 
the focus of the Delphi process. 
_______ 
 
June 2014 – Developing themes from the data. Involvement in the form of 
collaboration with n=45 patients and the public at a workshop which was tagged 
on to an existing PPI event in the East Midlands. At this event data from the 
study as well as feedback from the previous two workshops were offered. Those 
in attendance raised that the data were too focused on research processes and to 
help this current study the stimulus paper needed to be focused on outcomes. The 
patients and members of the public suggested that some process related content 
should be placed to one side as it acted as a ‘red herring’. They also said that 
importance of themes is tricky to rank if a common definition is not agreed first. 
This was a general comment and observation they made which later influenced 
round two of the Delphi by asking panellists to offer their own definitions of the 
impact of PPI. 
 
These three workshops impacted considerably on this phase of work because it 
was decided here that the Delphi needed to focus on the seven factors identified 
which were: PPI processes, dissemination, power and leadership, resources and 
the political context, networks, wanting to make a difference, and information 
and communication technology. 
 
The running of these workshops was made possible because of existing PPI 
events already paid for by the NIHR and the university I was funded by. Without 
these opportunities the end user involvement would have been compromised or 
not possible  See chapter nine for details about the limitations and reflections 
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Chapter Six: Refinement of factors which contribute to impact of 
PPI on research outcomes – a modified Delphi Study 
Introduction 
The purpose of the Delphi study was to enhance and refine the understanding of the seven 
factors of PPI discussed in the interviews, by presenting an expert panel with these. The 
factors were: ‘PPI in the research processes’; ‘Wanting to make a difference’; ‘Power 
and leadership’; ‘Networks’, ‘Resources and the political context’; ‘PPI in 
dissemination’; and ‘Information and communication technology’. These were identified, 
through the interviews, as contributory factors shaping the impact of PPI on research 
outcomes. 
 
This chapter will set out how, through the Delphi survey, the seven factors expanded to 
include a further two factors: ‘PPI in commissioning’ and ‘PPI in implementation’. It 
presents the order of importance of these factors, as ranked by the Delphi panellists who 
drew on their professional and personal expertise. The chapter highlights how Delphi 
panellists situated these nine factors of PPI at micro, meso and macro levels, which could 
potentially help the study to understand how each PPI factor could be better understood 
(i.e. whether it was more about PPI processes or PPI outcomes) for evaluation purposes. 
Panellists in the Delphi found it difficult to consider the meaning of impact of PPI but a 
common definition was formed via consensus. 
 
A total of three rounds were undertaken during the Delphi study, and each is summarised 
in this chapter. The panel began with an active group of n=39 panellists. By the third 
round only four panellists had left the study. The combined response rate at the end of 
Round 3 was 89%. The panel’s composition is outlined in table 9 in chapter four.  
 
Each round’s questions, responses, analysis and controlled feedbacks are summarised in 
this chapter (using tables, graphs, figures, quotations and typologies). Information is 
presented in chronology of occurrence and excepts from the ‘controlled feedback reports’ 
have been used to present the data in this chapter.  
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Delphi round 1  
Panellists were asked to read the stimulus paper (discussed in chapter four) an extract of 
which, covering the summary of the seven factors, is produced in table 12 (the full paper 
appears in Appendix 8): 
 
Table 12 - Description of seven factors of PPI 
Factors  Description 
‘PPI in the 
research processes’  
As a foundation for the production of impact the need for 
effective PPI during the planning and conduct of the research 
study. Challenges related to involving patients and the public 
were described as: where and how to find people to involve; 
individual patient agendas; patient-led research ideas; patients 
feeling inspired about research; patients feeling experienced 
enough to get involved in research; and PPI being assessed by 
funding panels. Participants suggested that the point of PPI in 
the research process was to help ‘iron out’ the non- medical 
assumptions of what patients want or need. Successful 
involvement was perceived to lead to more focused and relevant 
research, which in turn was seen as being more likely to achieve 
impact. 
‘Wanting to make 
a difference’ 
How personal motivations and a desire to contribute to change 
or improvement facilitated the production of impact. Patient 
stories included a desire to give something back to society, in 
order that others wouldn’t go through the same (negative) 
experiences, or would not be faced with losing a loved one. 
There was a desire to achieve complete equality in cancer care. 
Some participants felt that the use of public money to fund 
research implied a moral obligation to make improvements. 
Some researchers described this motivation to make a 
difference in terms of career aspirations 
‘Power and 
leadership’ 
The idea that support or input from particularly influential 
individuals or organisations could enhance the likelihood of 
achieving impact, increasing the power of the patient voice. 
Participants discussed what having influential people added to 
research, celebrities, MPs, national policy figures and 
influential patients. An aspect of power was about 
organisational PPI support, it was believed that if an 
organisation was PPI active then the impact of PPI would be far 
greater. 
‘Networks’(non-
virtual) 
The use of networks to share information. Physical meetings 
were seen as a place where people shared new research findings 
and discussed its importance within current healthcare systems. 
Patients talked about the networks they are connected to via 
charities, patient user groups and the social circles that their 
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involvement roles linked them to. Stakeholders and researchers 
talked about how professional networks impacted on them and 
their work, making contact with the right people, chance 
encounters, networking at meetings etc 
‘Resources and the 
political context’ 
A range of contextual factors, which (despite having good PPI 
in the study) might affect or diminish the successful production 
of impact. These included a lack of funding or stretched 
resources affecting staffing, equipment, training, ability to 
purchase certain drugs, and choice of implementation of 
interventions. It included wider policy which effectively 
‘moved the agenda on’ leaving the research apparently no 
longer relevant 
‘PPI in 
dissemination’ 
To whom, where, how, what, when and why research findings 
are disseminated. Participants felt that the link between 
dissemination and impact was fundamental. Dissemination 
plans should involve patients in developing the strategy: 
Messages were seen as needing to be targeted and made easier 
to understand. Participants also discussed how generating 
impact was about the timeliness of research and doing “the right 
research at the right time for impact generation 
‘Information and 
communication 
technology’ 
Of the use of technology to aid impact generation, for example 
the use of smartphones and computers to search for and share 
information by sending important new research knowledge far 
and wide. It was also about blogging and using social media to 
keep informed at the “zing of a button”. Some participants 
suggested that their PPI work required them to be confident and 
regular users of Twitter and Facebook. Blogging was perceived 
as a way of helping people stay connected 
 
After reading the text, panellists were asked the following: 
1. How important is the factor for generating impact from research which has 
included PPI (please use your professional/personal experience as appropriate)? 
Rank the factors please. 
2. Please explain why you ranked them in the order you did. 
3. Please explain if you felt anything was missing. 
 
Delphi round 1 responses 
The Borda count ranking method (see chapter four) was used to determine the order of 
importance of the factors that shape the impact of PPI on research outcomes based on the 
first round’s responses. Table 13 presents the results in round 1, followed by a 
consideration of panellist responses. 
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Table 13 - Ranking order of factors of PPI - Delphi Round 1 
PPI factors Borda count ranking value 
N=39 (panellists) x 7 
(factors) = 273 (273 being 
the highest possible score) 
 
Round 1 
Factors ranked at 
positioning 
‘PPI in the research 
processes’ 
205 1st 
75.9% 
‘PPI in dissemination’ 175 2nd  
64.1% 
‘Resources and the 
political context’ 
173 3rd  
63.37% 
‘Power and leadership’ 167 4th  
61.17% 
‘Wanting to make a 
difference’ 
142 5th  
52.1% 
‘Networks’ 141 6th  
51.65% 
‘ICT’ 88 7th  
32.23% 
 
 
1 – ‘PPI in the research processes’ came first in the ranking with 75.9% of panellists 
believing this to be the most influential factor to generate PPI impact. Many panellists 
said that PPI in the research process adds quality to the research and this is followed 
through to the outcomes of the research. A panellist who gave this factor a high ranking 
said:  
Consumers are able to represent and promote the voice of patients to the NHS 
and its partners such as the NCRI [National Cancer Research Institute] and DH 
[Department of Health] etc.  NICE have acknowledged that two agents for 
sarcoma … were unlikely to have been approved for NHS use without 
involvement from lay members of the Sarcoma Clinical Studies Group.  
(Reese, cancer patient, DEP1) 
 
Whereas a panellist who gave this factor a low ranking expressed the following reasons:  
Good PPI is important and can ensure the research is appropriate in its methods, 
relevant to patients. …However, even though I think PPI is desirable and can 
maximise the impact of research, there are examples [where] it is not critical.  
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(Holly, national cancer charity, policy role, DPCH1) 
 
PPI leads and patients gave this factor a high ranking whereas none of the charities ranked 
it above second place. 
 
2 – ‘PPI in dissemination’ came second, scoring 64.1%. Many panellists felt that 
dissemination was important in a general sense but were not always able to offer concrete 
examples:  
…patients are passionate about disseminating especially if they have somehow 
been involved.  
(Janice, senior cancer nurse, policy role, DONHS4) 
 
But generally, it was understood that patients were seen to make a better impact during 
dissemination:  
Hearing it from the horse’s mouth has greater impact.  
(Carolyn, academic, independent PPI consultant, DAC5)  
 
However, one of the few examples offered demonstrated how dissemination is important 
in generating impact of PPI:  
I led an SDO [Services Delivery Organisation] funded study which was entirely 
co-produced with older people, and we had a hugely successful and well 
attended final dissemination event. I believe that this was, in no small part, down 
to the co-research methodology which people were curious/interested to hear 
more about, as much as the findings. What was incredibly striking at this event 
(and others we held) was the power of research findings being shared by 
‘everyday’ people and service users, not just ‘stuffy’ researchers like me. …We 
wrote up this project as an impact case study for the REF [Research Excellence 
Framework] and I do think that the various examples of impact we could point 
to were largely because of the co-research approach.  
(Jean, academic researcher at a thinktank, DACTT7) 
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Lastly, the quotation below captures the essence of ‘active’ dissemination, i.e. giving a 
message about something that will help to pinpoint where and how professionals might 
improve services: 
I think the inevitable aim of all research should be translation into service.  So 
it’s anything that helps translation into service or to improving services rather.... 
So really for me dissemination is anything that can do that.  
(Hersha, commissioner of health education in HE, DOCom6) 
 
 
3 – ‘Resources and the political context’ was ranked third at 63.37% by the panel. 
Panellists tended to base their ranking on concrete examples and beliefs that generally, 
not just exclusively to PPI, NHS budget restrictions shape the outcomes of any research 
study. Many said that without resources none of the other issues listed mean anything. 
One panellist said that the allocation of resources in relation to access to treatment in the 
cancer field is literally about life and death:  
I am a lay member at [region] Cancer Drug Fund5 ...  It is sad to see the numbers 
of individual patients coming through to the panel (anonymously of course from 
their consultants) who are at a crucial stage in their cancer disease and cannot 
get treatment to extend their lives.  All because of cost, and having to choose 
who does and who does not, through applying certain criteria, to get the drug 
(Olivia, cancer patient, DEP4) 
 
Those that ranked it last gave reasons that echoed this MPs response:  
You can throw resources into something and it might still not change and you 
can be short of resources and can achieve change. Everyone thinks throwing 
money into something makes change: actually it depends on the conditions 
around the resources. E.g. in the NHS there was a huge increase of money put 
in in the last decade and it achieved very little, because there wasn’t the 
leadership, there wasn’t the engagement, there wasn’t the dissemination to make 
a difference 
(Stuart, MP, DPG7) 
 
                                                 
5 Now redundant, the Cancer Drugs Fund was for cancer drugs that were not routinely available on the NHS. This may have 
included drugs that had not been approved for funding, were yet to be approved for funding or were not approved for a specific type 
of cancer. 
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4 – ‘Power and leadership’ was ranked fourth (61.17%).  
…the All Party Parliamentary Group on Cancer produce reports relating to 
patient experience of the NHS on a yearly basis and they have the infrastructure 
behind them, political support and the Britain Against Cancer conference to 
disseminate the results of their research very effectively 
(Luke, national cancer charity, policy role, DPCh4)  
 
Yet, a panellist representing a patient champion body reported having:  
witnessed projects fail because someone of influence was not involved.  
(Bob, national patient champion body, DPCham6)  
 
An academic who ranked it last said that ‘power and leadership’:  
is an outcome of the other factors.  
(Kylie, academic doctor, DAC4)  
 
This factor was given a high ranking by an MP and two panellists from governmental 
organisations.  
 
5 – ‘Wanting to make a difference’ This factor divided the panel. 52.1% of panellist who 
ranked it higher conveyed a similar message to this one:  
Whilst patients and the public should be actively involved throughout the whole 
process of a research study, this [motivation] becomes very important when 
wanting to generate impact and sharing this impact in the most suitable way. 
(Kim, PPI lead, DPPIL5)  
 
Others who ranked it lower said that:  
While it may be useful, I am not sure whether the fact that involved individuals 
wanted to make a difference would ultimately affect impact of a study, at least 
not in any direct way. 
(Mark, academic professor, DAC1)  
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And:  
Although having someone’s motivation is a nice thing, it doesn’t actually make 
a huge difference. 
(Ajay, clinical professor, DAC2) 
 
6 – ‘Networks’ This factor also divided the panel and just over half (51.65%) ranked it 
sixth. Those that ranked ‘Networks’ high, said:  
Cancer networks in England are highly respected.  
(Marina, national cancer charity policy role, DPCh3)  
 
And: 
networks help in channelling the findings of a study as they are seen as 
‘opportunities’ for sharing.  
(Felicity, research commissioner, DOCom6)  
 
Networks help to identify the:  
next steps and changes that may be needed as a result of the research.  
(Stan, national cancer charity policy role, DPCh5)  
 
A panellist who ranked it last said that:  
networks are important for getting patients during clinical trials but not as 
influential when it comes to implementing findings of research.  
(Anna, senior nurse, DONHS1)  
 
In the few concrete examples that were offered, panellists discussed successful 
collaborations they were aware of:  
charities such as Sarcoma UK run a “voices” project encouraging patients and 
carers to be heard in the NHS. Leukaemia & Lymphoma Research has a 
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Prioritisation of Patient Need Programme which includes a key activity to listen 
to and engage patients. 
(George, carer of a cancer patient, DEP6) 
 
7 – ‘Information and Communication Technology’ (ICT) came last in the ranking 
(32.23%). This was the only factor that was ranked consistently low across all groups. 
Some said that ‘ICT’ acted as a barrier. Yet in some situations panellists praised the use 
of ‘ICT’, for example in paediatric research: 
[a] young people’s group will often explain [to researchers] how the use of 
technology was important as a way of generating impact rather than meetings… 
(Alice, PPI lead, DPPIL1)  
 
New factors to consider for Round 2 
As well as commenting on these seven issues above, panellists raised new issues for 
consideration in the next rounds. These were: ‘PPI in commissioning research’, ‘PPI in 
implementation’, ‘the lack of definitions of impact of PPI’ and ‘working out the level of 
problem’. A brief description of these new factors was offered to the panel in the 
controlled feedback when round two started:  
 
1. ‘PPI in commissioning’  
This factor, panellists suggested was about by whom and why the research is funded.  
I would have thought prioritisation of research or determining what research 
should receive funding in the first place is an important factor. 
(Dean, PPI lead, DPPIL3) 
 
And: 
Who has commissioned the research, as potentially this will determine the power 
of implementation.  
(Felicity, research commissioner, DOCom6) 
 
 
2. ‘PPI in implementation’ 
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This factor concerns how the evidence from PPI informed research actually translates into 
practice and policy in the real world: 
Dissemination is not enough, implementation is missing. You have the challenge 
of the second translational gap. 
(Matilda, clinical academic, DAC8) 
 
And ‘PPI in implementation’ was is about the detailed understanding, insights and 
intelligence that PPI brings to implementation. One MP said:  
The detail is what’s missing. Change management [in the health service] usually 
fails because people haven’t checked out all of the details. Being straightforward 
about what is realistic [and likely] to work. Most change management that 
doesn’t work that I know about is concerned with having a big vision and then 
not working out the finer details about how you get from this side of the river to 
that side – you can’t do change management from 50,000ft – it’s not possible, 
you have to be in there working with the people to work it out, understanding 
how and what situations they face. 
(Stuart, MP, DPG7) 
 
 
3. The lack of definition of ‘impact of PPI’ 
Several panellists raised the problem of there being a lack of commonly understood 
definitions of impact of PPI. It was felt by the panel that this made it difficult scrutinise 
because it was contextual and sometimes process-driven. 
A definition of impact of PPI is missing.  
(Ranjit, healthcare commissioner, DAC6) 
 
And another panellist stated: 
How are we all talking about the same thing? You need a definition about 
measuring success or impact.  
(Rebecca, clinical academic DAC3) 
 
  
4. Working out the level of problem 
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A few panellists said that they found difficulty in ranking the issues. They were: ‘quite 
confusing’ (Denise, Senior NHS communications, DONNHS3). Another panellist said:  
I appeared to be ranking against two factors: the significance of the factor on 
helping create impact at the ‘project level’ or micro level v’s the macro level 
impact. 
(Dean, PPI lead, DPPIL3) 
 
Another panellist felt that the factors were: 
…all meshed together, they need unpicking because they are evolving and a 
multi-faceted challenge to understanding the impact of PPI. 
(Della, cancer patient, DEP2) 
Delphi round 2 
In Delphi round 1, the panellists identified two new factors which they felt needed to be 
added to the ranking: ‘PPI in commissioning’ and ‘implementation’ Of note, these two 
factors were included for ranking in round two. Round two was therefore guided by four 
questions: 
 
1. To re-rank the nine factors (the seven original factors together with two new 
factors: ‘PPI in commissioning’; and ‘PPI in implementation’). 
2. To indicate if they felt the factors reflected micro, meso or macro level issues 
3. To explain any thoughts about 1 - in relation to the impact of PPI on research 
outcomes (this would ensure phase 1 data was similar to what Delphi panellists 
were raising about the two areas) 
4. Define the ‘impact of PPI’. 
 
35 Panellists ranked the seven original factors along with PPI in ‘PPI in commissioning’ 
and ‘PPI in implementation’ and were asked to explain their choices. Panellists were then 
also asked to indicate whether they believed the factors were largely micro, meso or 
macro issues. All panellists were then asked to offer a PPI impact definition. The 
following short description was developed for micro, meso and macro levels:  
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• Micro issues – small-scale interactions on individual projects, such as 
conversations, between individuals, or group dynamics that influence something.  
• Meso issues – (the middle of micro and macro) which includes the consideration 
of organisations and communities. For example, hospitals, care settings and health 
education settings which may be the structures that influence something.  
• Macro level – these are large-scale social processes, such as social change, 
political movements, patterns and trends that are influential. 
 
Round 2 responses 
Ranking of the nine factors showed the order of importance. In addition, the factors were 
also ranked on whether they were perceived as micro, meso or macro factors. Table 14, 
below, presents the results from the counting exercise in round two6, followed by the 
consideration of panellists’ responses.  
 
Table 14 - Ranking order of factors of PPI - Delphi round 2 
Factors of PPI Borda count 
ranking value 
N=35 (panelists) 
x9 (factors) = 315 
(315 being the 
highest possible 
score) 
Round 1  
 
(based on 39 
panelists) 
 
Round 2  
 
(based on 35 
panelists) 
 
‘PPI in research processes’ 
 
249 1st  
75.9% 
1st 
79.05% 
‘PPI in dissemination’ 
 
216 2nd  
64.1% 
2nd 
68.57% 
‘Resources and political 
context’ 
208 3rd  
63.37% 
3rd 
66.3% 
‘PPI in implementation’ 200 Was not a factor in 
its own right 4
th  
63.49% 
‘Power and leadership’ 184 4th  
61.17% 
5th  
58.41% 
‘PPI in commissioning’ 
 
148 Was not a factor in 
its own right 6
th  
46.98% 
‘Wanting to make a 
difference’ 
147 5th  
52.1% 
7th 
 46.67% 
‘Networks’ 
 
146 6th  
51.65% 
8th  
46.35% 
‘Information and 
communication technology’ 
72 7th  
32.23% 
9th  
22.86% 
                                                 
6 4 panellists chose not to vote but still wished to be part of the exercise 
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Analysis of Table 14 shows that, interestingly, even with the two new factors (‘PPI in 
commissioning’ and ‘PPI in implementation’), the green on the table shows that 
positioning for ‘PPI in the research processes’ (1st), ‘PPI in dissemination’ (2nd), 
‘Resources and the political context’ (3rd), and ‘ICT’ remained in the same ordering from 
the first round, implying strong consensus on the three most influential factors and the 
least influential factor. These four factors scored consistently 1st, 2nd, and 3rd and last. The 
yellow boxes show how the two new factors relate to the rest of the factors, thus, 
suggesting that implementation was considered more influential by expert panellists than 
perhaps the uncontrollable elements around a research study such as the significance of 
‘Power and leadership’. The pink boxes show where a factor had a strong competitor 
with a one-point difference in the Borda count value between ‘PPI in commissioning’, 
‘Wanting to make a difference’ and ‘Networks’.  
 
The most interesting finding from the ranking exercise is found in the blue boxes with a 
Borda count value of 200 or more (just under 2/3 of the panel), suggesting that to turn 
research into action there is a direct level of understanding about impact being associated 
with dissemination and implementation processes on PPI. After ‘PPI in the research 
processes’ (designing and conducting a study) when research studies end, the 
dissemination and implementation plans are controllable (providing there are resources 
in place) and thus is directly concerned with the impact of PPI on research outcomes.  
 
Implementation came fourth in the ranking (63.49%), perhaps because of reasons in this 
statement:  
“I thought of placing this item into 2nd spot. I felt that evidential proof in its 
entire format (the success of clinical outcomes in a research study) would 
influence commissioners in terms of funding either a continuance or variation of 
similar studies in the future (if both health and economic benefits are shown). 
However, as we are talking about evidential proof of PPI informed research 
translating into practice, I felt 4th place was appropriate….”  
(William, PPI lead, DPPIL2)  
 
Whereas, another panellist who ranked implementation high said:  
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…there is a lot of PPI research in cancer that has focused on patient experience, 
and national patient experience surveys are run in most areas of the UK to inform 
politicians on what is or isn’t working in the health service for patients and to 
inform incremental changes. This has an impact on practice…particularly 
relating to the national cancer plans 
(Hallie, national cancer charity policy role, DPCh2)  
 
A panellist who ranked implementation lowest said that:  
‘PPI in implementation’ is misleading as if you do your PPI well involving both 
end users and potential implementers of your research as the key stakeholders, 
the implementation will follow. 
(Pam, PPI lead, DPPIL7) 
  
Several panellists said that they saw this factor being key work for the thirteen funded 
Collaborations for Leadership in Applied Health Research in Care (CLAHRC). This 
factor concerned how the evidence from research translates into policy and practice in the 
real world. From a PPI point of view, public involvement in the implementation processes 
was about the detailed understanding, insights and intelligence that such involvement 
brings to implementation. There was an example in the data of how patients had 
contributed to NICE approval of drugs of sarcoma to be offered on the NHS.  
Consumers are able to represent and promote the voice of patients to the NHS 
and its partners such as the NCRI [National Cancer Research Institute] and DH 
[Department of Health] etc.  NICE have acknowledged that two agents for 
sarcoma … were unlikely to have been approved for NHS use without 
involvement from lay members of the Sarcoma Clinical Studies Group. 
(George, carer of cancer patient, DEP6) 
 
A nurse also believed that implementation required people inside the NHS to be ready to 
get involved in change:   
In order to make change happen you need to be part of it. You can’t expect 
people to change if you are not willing to demonstrate and lead that change…. 
You need to be prepared to get your hands dirty. 
(Janice, senior nurse with a policy role, DONHS4) 
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‘PPI in commissioning’ came sixth in the ranking (46.89%). A panellist who ranked this 
lowest said:  
Having commissioned research with PPI, from my experience PPI in 
commissioning seems a bit of a tackle … in reality on the ground it simply 
doesn’t happen… meaningfully. 
(Ranjit, healthcare commissioner, DAC6)  
 
An academic who ranked ‘PPI in commissioning’ higher said:  
there is a big difference between a researcher-led and a commissioned call from 
an independent research funder; there is also a difference between calls issued 
by research funders and calls issued by policy/service delivery organisations 
(e.g. Department of Health or an NHS provider organisation, versus NIHR or a 
research council). Calls issued by policy / service delivery organisations might, 
on the face of it, have more potential for direct impact, but this cannot be 
guaranteed as sometimes research will have been commissioned for appearances 
rather than for substantive role in developing policy and services. 
(Mark, academic doctor, DAC1)  
 
Five panellists raised that whilst PPI at commissioning level is fundamental, details about 
funding decisions are missing:  
…more explicit and detailed information [is needed on] how the funders assess 
the PPI elements…what [application] passes and what fails. 
(Dean, PPI lead, DPPIL3)  
 
Some patient panellists said that they were familiar with priority setting partnerships to 
help deal with this concept in a better way:  
The James Lind Alliance7 goes some way towards this and offers a useful model.  
(Louise, carer of cancer patient, DEP3) 
 
                                                 
7 James Lind Alliance is a research priority setting partnership between patients and researchers. 
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There was a split in opinions about the extent to which public or stakeholder involvement 
at the commissioning stage generated impact later, illustrated when one research 
commissioner argued that: 
Public involvement in commissioning is a powerful driver for pushing 
implementation but this by no means guarantees it…  
(Hersha, commissioner of health education in HE, DOCom6) 
 
A patient also felt that involvement at the commissioning stage was not influential 
(especially outside of National Institute of Health Research (NIHR) funding 
programmes): 
If commissioning means all forms of funding committees then in theory it is 
important. However, the reality is that most UK cancer research trials are funded 
by CTAAC [Clinical Trials Awards and Advisory Committee], with Pharma a 
closing second place. Most other cancer research in the UK is by charities or by 
government, and although there may be PPI presence there is no significant PPI 
impact on those bodies/organisations at that level of decision-making. NIHR 
programmes are the exception, but even here, where there are PPI reps on 
committees and a requirement to show PPI in the application, there are no 
judgements about the effectiveness (or even appropriateness) of the PPI in the 
research. PPI in commissioning ought to be more important and more significant 
than it is. Moreover, CTAAC and HTA/RfPB committees decide what is 
fundable, not what gets funded, another reason why PPI in commissioning is not 
as influential as people believe. 
(Reece, cancer patient, DEP1)  
 
There were no observable patterns in which groups on the panel (clinicians, charities, 
patients etc.) ranked which of the two factors high or low. The nine factors were also not 
intended to be exhaustive and there was a strong sense across the two rounds so far that 
some factors overlapped and were closely connected. The two rounds also demonstrated 
a need to explore the nine factors in isolation. 
 
Micro, Meso and Macro question responses 
In Delphi round 2, panellists felt that the ranked factors were very broad and by 
categorising them as Micro, Meso or Macro issues would help. As a result, it became a 
question concerning the scale of the challenge in enhancing our knowledge about how 
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the factors are understood better. Some panellists found it difficult to answer this 
question. The cluster bar chart below captures how the panellists perceived the factors to 
be situated as micro, meso and or macro levels (figure 9).  An interesting but perhaps 
unsurprising finding here was how ‘Wanting to make a difference’ (longest red line), 
‘Networks’ (longest yellow line) and ‘Resources and the political context’ (longest green 
line) were strongly associated at ‘micro’, ‘meso’ or ‘macro’ levels. Yet ‘PPI in the 
research processes’ and ‘PPI in commissioning’ divided the panel.  
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Figure 9 - Micro, meso and macro ranking of factors of PPI - Delphi round 2 
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Definitions of PPI impact  
Panellists were asked to give a definition of PPI impact and every definition was coded 
using Braun and Clarke’s (2008) procedures. Some panel members gave extensive 
definitions, whereas others gave shorter answers to this question and not in the form of a 
definition. Some panellists gave academic/critical definitions, while others offered 
clinical research process focused definitions. Most panellists said in their response that 
this question was challenging to answer because one definition cannot encompass all PPI 
impacts a study might have. A synthesis of these definitions and statements were formed 
(see figure 10, below). Nine examples from the data are offered here, to demonstrate the 
variety of views. 
 
Example one presents three key words concerning impact (policy, theory and practice) 
which were frequently mentioned in related discussions about the topic by panellists in 
their definition text: 
patient and public involvement impact is the specific impact on practice, theory 
or policy that arises from a research project, which would likely not have arisen 
had PPI not been included. 
(Mark, academic doctor, DAC1) 
 
Example two offered another type of impact, concerning ‘patient outcomes or 
experience’:  
patient and public involvement impact is about how far evidence-based 
recommendations from PPI research have been implemented and directly 
improved patient outcomes or experience.  
(Holly, national cancer charity policy staff, DPCh1) 
 
Example three used words such as ‘likelihood’, ‘drivers’ and ‘barriers’ suggesting subtle 
and nuanced issues, with competing interacting components: 
Does involving patients and the public in the research increase the likelihood of 
research being implemented? Or What are the drivers and barriers to research 
being implemented and does involving patients and the public in research have 
any effect on them? 
 185 
 (Jonny, senior member of national research ethics) 
 
Example four was more of a list of useful questions to consider when thinking about the 
effect of impact on the research process. It used the words ‘multiple layers’ and the ‘entire 
research journey’. It was felt important that the synthesised definition should reflect those 
elements: 
Defining PPI Impact is multi-layered. This is dependent upon which part of the 
clinical research process you are referencing. For example: Did PPI reps work 
with researchers in determining which ‘unanswered’ research question was 
prioritised? Did the study design benefit from meaningful PPI? Did the study 
documentation benefit from meaningful PPI lay assessment? Did the 
dissemination of the study findings involve PPI reps in any way? And ultimately, 
was the PPI impact a fundamental factor in the: Success of the funding 
application Helped to sustain participants in a study(ies) Translation of research 
into clinical practice. If you can answer ‘yes’ to all of the above, then each in 
their own right (and this is far from an exhaustive list), defines ‘PPI impacts’. 
Maybe what you need is a universal term that covers ALL of the elements in the 
research cycle that benefits from PPI impact e.g. ‘Clinical research will benefit 
across the board when meaningful PPI interventions are embraced and enabled 
at any point of the clinical research cycle journey as appropriate. Commitment 
to such approaches is likely to demonstrate positive PPI impacts in your 
research.  
(William, PPI lead, DPPIL2): 
 
Example five captured the difficulty associated with assessing the impact of PPI: at least 
four panellists expressed a similar view that any single definition could not capture all 
types of impact. Importantly, whilst the following statement identifies the complexity of 
assessing impact, none of the panellists said that PPI made no impact. 
It is impossible to come up with one size fits all ‘metric’ to measure/ assess 
impact therefore it is pretty unlikely that we will come up with a similar one size 
fits all definition of what should be defined and measured as PPI impact in the 
first place.   
(Dean, PPI lead, DPPIL3): 
 
Example six raised another aspect that came up in other panellists’ definitions, the word 
‘meaningful’. It was felt important that the synthesised definition should reflect this word: 
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I have liked and adopted the term ‘meaningful PPI’ in my own work but if I was 
asked what does ‘meaningful PPI’ look like I would probably have to say it 
depends on all the things that we all know well now that have been highlighted 
in the various impact reviews etc., including placing importance on context etc., 
asking ‘what works for whom, when why and how?’ but perhaps in a more 
qualitative way. […] this may give us an idea of what meaningful PPI may look 
like to different people in different situations and for different types of study.  
(Kim, PPI lead, DPPIL5): 
 
Example seven referred to the socio-political terms ‘micro, meso and macro factors’. 
Although the words are not in lay usage, they were deemed important to reflect the 
essence of what these terms mean in the definition:  
[the definition should include] … micro, meso and macro factors and the role 
they will play in that possible impact.  It is important that we capture the impact 
of the PPI but also to recognise the other factors involved.  
(Felicity, research commissioner, DOCom5): 
 
Example eight concerned ensuring that PPI is observable and transparent. The aspect of 
pellucidity concerned being able to see clear examples of how far PPI has shaped the 
research, and the extent to which involvement will continue to shape future work:   
It is about being able to slice through the research at any point in its cycle and 
be able to clearly identify how it has been shaped by patients and the public up 
to that point and be clear about the future role they will be playing.  
 (Shane, senior DHSC official, DPQG10) 
 
The last example, nine, was unique because it acknowledged that context is rich and 
varied. New research findings are only useful to people and environments that are 
receptive to change. The definition identified that the impact of PPI in research can be 
greater if end users are involved earlier. It accepted that impact depended on a blend of 
internal and external research study factors: 
PPI impact is the extent to which what research does and what practice is looking 
for aligned. Research findings make a difference in situations where the context 
(and those who are decision-makers within it) are receptive to change, are 
research literate, want to challenge themselves to do things differently, have the 
freedom and support to do things differently. In addition to these factors, where 
research includes PPI, impact may be greater where the ‘end user’ of the research 
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(be that policymakers, professionals, health system leaders etc.) really values 
what matters to patients, their carers and families and wants to improve services 
to better meet their needs and expectations. So, it’s a blend of factors internal to 
a study and factors external to it (which are features of the wider contextual and 
decision-making environment) which are important.  
(Jean, academic doctor at a thinktank DACTT7): 
 
Drawing on these, a collective definition was formed via a process of data synthesis. This 
resulted in the statement set out in figure 10: 
 
Patient and Public Involvement (PPI)8 impact is something that is not only controlled 
by people and processes but also through the structures that we are part of and live in. 
PPI impact can be made transparent by understanding four aspects: of which the first 
three are: 1) taking account of whether the research was consultative, collaborative or 
PPI controlled9; 2) knowing the motivations for involvement, which vary and can be a 
mixture of experience, values and task focused; and 3) noting the subtle or significant 
changes as they happen to the direction of something because of PPI. This change of 
direction can ripple in many ways on the surface or behind the scenes in some or all 
tasks on the research cycle10. PPI impact is not linear, but something that is contextually 
multi-layered, relational and developmental. It might be qualitative (seen/experienced) 
and or quantitative (countable/measurable). The changes might lead to something 
positive (or negative). PPI impact is resource-sensitive, enveloped by the immediate 
surrounding and the socio-economic climate. As a result, 4) is about working 
collectively to understand where and when to look at the relevance and focus that the 
meaningful PPI helped to create: sometimes PPI impact is complex to pin down, not 
because it isn’t there, but because it translates in a combination of ways over time into 
the ‘real world’ on patients and public, the professionals, the given research, the health 
systems (policy and or practice) and society. 
Figure 10 - Combined definition of impact of PPI -Delphi round 2 
 
                                                 
8 “INVOLVE defines public involvement in research as research being carried out ‘with’ or ‘by’ members of the public 
rather than ‘to’, ‘about’ or ‘for’ them.” 
9 Hanley et al. (2004) Involving the Public in NHS, Public Health and Social Care Research: Briefing notes for 
researchers. Eastleigh: INVOLVE Support Unit. 
10 Research Cycle: identifying and prioritising, commissioning, designing and managing, undertaking disseminating, 
implementing and evaluating impact. 
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The statement from figure 10 went into the controlled feedback to start Delphi round 
three. Other issues that were raised in Delphi round two, which needed further clarity in 
the final round, concerned the usability and transferability of the current study.:  
An observation – given the focus of this study is on PPI in cancer research and 
usability, cancer is somewhat missing from the context of these questions.  
(Rebecca, clinical academic, DAC3)  
 
The panel was selected for their expert knowledge of cancer research, PPI and 
implementation science experience, cancer policy knowledge and cancer experience. 
Therefore, whilst the word cancer was not in the questions, it formed the lens through 
which this research was conducted. For the author this observation alluded to a discussion 
on transferability, which in turn was connected also to the validity and reliability of the 
data (across the two project phases). The observation also linked to how the findings from 
this research might be used by others in other fields of health and illness and knowledge 
generation on impact of PPI. Therefore, these aspects were considered for the final round.  
 
Delphi round 3 
In round three, the following questions were put to the panel: 
 
1. To what extent does the combined definition of the impact of PPI definition reflect 
your definition/statement? Panellists were asked to keep in mind the nine factors when 
they answered and to indicate their agreement on four point scale of 
completely/mostly/slightly/not at all. 
2. What might be the next steps for this work? 
3. Which of the nine factors are unique to the disease of cancer? Can and should they be 
transferable to other areas of health and disease research with PPI? 
 
By the third round, the seven factors were refined to nine factors. The panelists had helped 
to situate these factors at micro, meso and macro levels. Panellists had already had offered 
their understandings about the definition/statement of the ‘impact of PPI’ and these had 
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been synthsised to form a combined definition. This was presented to panellists as 
controlled feedback to prepare for round three. Figure 11 shows that: seven panellists 
completely agreed with the definition; 19 mostly agreed; seven slightly agreed; one said 
it sat somewhere between mostly/slightly and one panellist found it did not capture their 
submitted definition at all. 
 
 
Figure 11 - Extent to which panellists accepted the combined definition of impact of PPI - Delphi round 3 
 
Table 15 (over) summarises an overview of the panel responses to the combined 
definition, presenting the responses as ‘endorsements’ or ‘critiques’ of the statement. 
 
7
19
1
7
1
Completely Mostly Between Mostly
and Slightly
Slightly Not at all
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Table 15 - Responses to the combined definition of impact of PPI  - Delphi round 3 
Endorsements Critiques 
• A great discussion starter about 
PPI impact. 
• Captures the steps to record/assess 
and measure PPI impact. 
• Broad and hard to disagree with. 
How can anyone argue with it? 
• Articulates that PPI interventions 
translate over time in a 
combination of ways into systems. 
• Non-linearity and its complexities 
described well. 
• PPI impact is an evolving state. It 
is both a perception and evidence. 
• The definition captures that PPI is 
not just a tick box exercise. 
• Once we understand how to assess 
it, we will understand the factors 
that influence it. 
• It encompasses everything 
possible. 
• Pleased that the word ‘meaningful’ 
appears in it. 
• Very detailed and far reaching. 
• Impact is qualitative and 
quantitative.  
• It captures different motivations 
for PPI. 
• Too long. 
• Too academic and not lay enough 
– it could be in plain English. 
• Not a definition. 
• Not straightforward enough. 
• Limited to just research rather 
than involvement activity. 
• Not clear whether it is about PPI 
impact or PPI impact on 
research.  
• The bit about consultation, 
collaboration and user controlled 
is unhelpful as this could all be 
happening in one meeting. 
• PPI Impact is a lot more 
straightforward than its 
influencing factors. 
• The bit about change being 
positive (and negative) is unclear 
because the presence of impact is 
the presence of change. 
• Too ‘process driven’ rather than 
‘principles’  
• Covers how rather than what it is. 
 
One panellist did not respond, stating that: 
This question has confused me considerably because I thought that the stimulus 
paper set out quite clearly what the focus of the research is and defined this term 
as follows: “..what difference PPI makes to the research outcomes and how it 
affects implementation of research findings into policy and practice (hereafter 
referred to as the ‘impact of PPI’)”. So, I was confused by the statement in the 
paper for this round saying that some of the other participants found the lack of 
a clear definition made it difficult to talk about the issue because for me it was 
clearly defined in the stimulus paper.  (Jonny, senior member of national 
research ethics panel DPQG10) 
 
A PPI lead, who said the definition only slightly aligned with his, made this point: 
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…[Who’s the measurement for]… One definition probably is not adequate 
…My attempt to answer this question previously made reference …[to]…PPI as 
a complex social intervention.  Several of these ‘bandwagony’ studies are 
reporting now or will shortly do so at the forthcoming [name removed] 
conference.  Perhaps we need a fresh approach looking at what PPI impact is not 
(rather than what it is)? I was pleased (but not surprised) to see that the phrase 
‘meaningful’ appears there but ask again, meaningful to whom, when and how?  
It feels sometimes as though ‘meaningful’ is simply a pseudo technical word to 
give weight or credence to PPI work but in actuality it is fairly meaningless.  
How do we measure ‘meaningful’? lastly, …[why do we not assess the impact 
of others]…e.g. stats; Health Economics, in quite the same way as we 
continually do for PPI.  
(Dean, PPI lead PPIL3) 
 
And: 
It is difficult for me to see how this definition can be applied to the real world. 
(Daisy, cancer patient, DEP7) 
 
And: 
Very complex, not clear.  
(Bob, national patient body champion, DPCham6)  
 
And: 
The definition I gave was about commissioning in research this is much broader.  
(Hersha, commissioner of health education in HE, DOCom6) 
 
The panellist who said that she somewhat agreed with the definition raised the following 
point: 
Pawson and colleagues 2005 helps to consider factors that shape and influence 
impact drawing attention to subtle contextual conditions that influence impact.  
(Jean, academic doctor at a thinktank, DACTT7) 
 
 
 
Initially, arriving at such a definition was not the purpose of the Delphi study. However, 
the lack of working definition was identified in round 1 responses and the opportunistic 
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moment of exploring this further through the panel was exploited. N=26 responses 
suggest that the definition developed mostly (n=19) or completely (n=7) captured the 
responses, thus suggesting strong support for the formed definition. By drawing attention 
to the more negative comments the researcher is demonstrating that the presented 
definition does require further work. 
 
Panellists were then asked if they felt the nine factors were considered unique to the 
context of cancer. Their responses were presented in Table 16.  
 
Table 16 - Views on transferability of factors of PPI beyond the cancer disease - Delphi round 3 
 
 
Overall most panellists felt that all nine factors are largely transferable to other research 
contexts and areas of priority. However, there was some ambivalence around some of the 
factors: a small number of panellists felt that cancer research is an example of applied 
health research which has unique characteristics that differentiate it from other disease 
areas. This was often linked in the comments to cancer being positioned as a leading 
priority disease and to its related embeddedness is national research systems and 
infrastructure. For example, with regard to ‘Resources and the political context’ it was 
felt that cancer is particularly well placed to benefit from government funding and that 
cancer research charities attract large sums of money from public donations.  
 
Funding issues were also seen as important in terms of commissioning research with PPI 
since it invariably follows national priorities. The particular success that cancer charities 
Factors facilitating PPI’s influence in 
enhancing research impact 
Are they unique to the cancer context? 
‘PPI in the research processes’ Yes – 0,  No – 35,  Maybe – 0  
‘PPI in dissemination’ Yes – 0,  No – 35,  Maybe – 0  
‘Resources and the political context’ Yes – 0,  No – 29,  Maybe – 6  
‘PPI in implementation’ Yes – 0,  No – 31,  Maybe – 4  
‘Power and leadership’ Yes – 1,  No – 31,  Maybe – 3  
‘PPI in commissioning’ Yes – 0,  No – 31,  Maybe – 4  
‘Wanting to make a difference’ Yes – 0,  No – 33,  Maybe – 2  
‘Networks’ Yes – 2,  No – 30,  Maybe – 3 
‘Information and Communication 
Technology’ 
Yes – 1,  No – 32,  Maybe – 2  
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have in advocating the patient voice was also highlighted as important for ‘PPI in 
implementation’ of findings. The existence of the National Cancer Patient Experience 
Survey (conducted across England annually) was felt to be a unique feature of the well-
developed leadership in this research field. The well-established ‘Networks’, and the use 
of ‘ICT’ in cancer research, were both felt to be more advanced than in other areas of 
disease research. 
 
The last question posed to the panel was about what the next stages of this work might 
look like and table 17 summarises the suggestions that were made on future possibilities. 
 
Table 17 - Future possibilities - Delphi round 3 
• Fine tuning the language used to describe the nine factors, through dialogue 
and (physical rather than virtual) discussion to see if the factor ranking-order 
changes. 
• A Delphi study explicitly about PPI impact definition forming. 
• Applying the nine factors to some real exemplars in the context of cancer 
research. 
• More work on how to assess/measure PPI impact. 
• Understanding the boundaries and crossover of boundaries of factors existing 
at micro meso and macro levels. 
• Understanding the significant obstacles/problems for PPI in research impact. 
• Developing a PPI impact framework based on this work. 
• Understanding whether the factors apply to other long-term chronic 
conditions. 
• Breaking down the PPI work into different types of research (health services, 
health policy, clinical trial design, and genomic/genetic research) to see the 
varying degrees of impact. 
• Sharing that the nine factors affecting PPI impact are an original contribution 
to knowledge. 
• To develop practical guidance for researchers about the nine factors. 
• Explore the nine factors (as far as possible) against studies that haven’t had 
PPI to see if those studies make impact. 
• Explore the most obviously existing factors at micro, meso and macro levels 
to see what priority action can be taken to influence it. 
• Developing a toolkit/training programme for managers, commissioners and 
researchers about the nine factors that influence PPI impact. 
• Groups that should know about this work are INVOLVE, National Institute 
for Health Research (NIHR), Breaking Boundaries Review (Department of 
Health), the National Institute for Health and Care Excellence (NICE) and 
Clinical Commissioning Groups (CCGs). This work can give them some clues 
on how to influence healthcare. 
• All major cancer charities need should be briefed on this work. 
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• Publish findings and then invite a debate: it is clear this work has interested 
the panel and has relevance to the health service. 
• Use normalisation process theory to help shape thinking. 
• Present the nine factors at conferences 
 
The information presented in this chapter provides a verbatim account of what was 
presented in the controlled feedback to panellists. The only aspect which was not 
explained in the controlled feedback was how the synthesised definition was created, due 
to word count limits set for the controlled feedback. 
Summary 
This chapter has shown how data collection in this study has revealed nine factors 
contributing to the impact of PPI on research outcomes and how these factors are ranked 
in order of importance. The Delphi also demonstrated that the PPI factors were considered 
to operate at micro meso and macro levels. For example, ‘Wanting to make a difference’ 
was dependant on micro level negotiations. Thus, the impact of people ‘Wanting to make 
a difference’ needed to factor in how people perceived what had changed since the study 
ended. The Delphi has demonstrated that the impact of PPI on research outcomes can be 
a mixture of direct and indirect, or seen or experienced impact. Impact was definitely not 
perceived as linear and was seen as being highly resource-sensitive with resources coming 
in at 3rd place. Panellists felt that impact was translating in a combination of ways over 
time. The definition which was developed also reflected the factors which had emerged, 
i.e. motivation, values, processes for PPI, resources, and how change can be subtle. 
 
What the Delphi findings have demonstrated is how each of the nine factors were 
understood in terms of importance. ‘PPI in the research processes’ were clearly 
important in understanding the impact of PPI on research outcomes, which could explain 
why phase 1 data had a lot of information about this point and why interview participants 
struggled to disentangle the two areas (‘PPI in the research processes’ from ‘PPI in 
commissioning’).  
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The Delphi data show is that ‘Wanting to make a difference’, ‘PPI in commissioning’, 
‘PPI in the research process’, ‘Networks’, ‘Resources and the political context’, ‘Power 
and leadership’, and ‘ICT’ were all factors of PPI which were concerned with indirect 
impact of PPI on research outcomes. ‘PPI in dissemination’, and ‘Implementation’ can 
be seen as direct impacts of PPI.  
 
Just under two thirds of the panel rankings demonstrated a high value for these factors 
which were not concerning ‘PPI in research process’ or wider contextual issues that were 
indirect. For dissemination, Carolyn, Jean and Hersha explained that patients and the 
public are able to articulate in a unique way what needs to happen in terms of action. For 
implementation similarly, Matilda, Stuart, Hallie and George all offered insights into this 
factor of PPI by saying that for cancer services in the UK, PPI in the implementation 
process is at an advantageous position. 
  
‘Resources and political context’ and ‘PPI in research processes’ are already understood 
in terms of impact of PPI affecting the research design in Brett et al. (2010), and Staley 
(2015), but ‘PPI in dissemination’ and ‘PPI in implementation’ were deemed as meso 
issues implying control and influence was achievable directly. 
   
Whilst there may be an unclear boundary here between direct and indirect impact of PPI 
on research outcomes, it is clear from this Delphi data that the later stages of research 
which include the use of PPI helps the generation of impact of PPI on research outcomes, 
according to the experts on the panel. The next chapter presents an analysis of the nine 
factors of PPI, by presenting examples of PPI on research outcomes extracted from the 
interviews by applying new knowledge gained from the Delphi study. 
  August – October 2014 – Checking accessibility of language used in Delphi rounds. 
Involvement in the form of collaboration. Each Delphi round needed planning and 
executing carefully to help this process. Over the intensive six weeks process a 
carer of a patient with cancer agreed to pilot each round to help ensure that the 
questions were lay friendly and accessible. This was done over the telephone and 
by email. The wording on the questions was adjusted on all three rounds after 
receiving helpful feedback via this process. 
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Chapter Seven: Examples of PPI on research outcomes and 
challenges for evaluation 
 
Introduction 
After the Delphi was complete, the transcripts from the interviews were re-read against 
the nine factors of PPI, and evaluation aspects for PPI impact were considered. The 
purpose of this chapter is to set out six examples of the impact of PPI on research 
outcomes and to examine them in relation to the role of each of the nine factors of PPI 
identified through the interviews and the Delphi process as contributing to the impact of 
PPI on research outcomes. The chapter will consider which factors appear to recur as 
contributory factors of PPI and whether any of the nine factors identified through the 
interviews and Delphi process were absent from these examples. The second purpose of 
this chapter is to demonstrate what the participants felt about the evaluation of PPI and 
its impact, whether there was a linearity (or not) from when research ended, and impact 
started. In doing so, the chapter offers insights into how these contributory factors of PPI 
might be evaluated.  
 
This chapter sets out the six examples of PPI on research outcomes. An analysis of these 
examples is offered, considering the presence of the nine factors of PPI and the stage at 
which the research study was described to be in: pre-implementation, partial 
implementation, during-implementation and post-implementation. It will also consider 
how the factors of PPI may be regarded as ‘direct’ or ‘indirect’ for impact building. 
Finally, the chapter considers further excerpts from the interviews to illustrate what the 
evaluation of PPI impact needs to consider. 
The chapter concludes with a summary of key findings.  
Six examples 
Six examples of PPI on research outcomes were found in the data. Each of these examples 
arose from completed studies and time had passed from when the respective studies had 
ended. Interviewees were able to retrospectively form judgements about the PPI work 
that was undertaken for their respective studies. The studies were as follows: 
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1. Oncology consultation aid – although developed it has never been adopted.  
2. Cancer patient experience survey – results have led to many areas of improvement 
in cancer services. 
3. Palliative cancer care – A new connected study has started as a result of this. 
4. Prostate cancer care – A questionnaire has never been adopted but the 
recommendation of more workforce in prostate care has led to an increase in 
workforce. 
5. Cancer genetics testing – Referral rates for genetic testing have increased in BME 
groups. New studies are being planned. 
6. LGBT cancer services – Some policy recommendations have been adopted. New 
studies are being planned. 
 
Each of the examples is now explored in detail, followed by a summative analysis. 
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Table 18 - Example one: Oncology consultation aid 
Example one: Oncology consultation aid developed but not been adopted. 
interviews with: Ben (cancer patient) and Priscilla (oncologist professor) 
 
Study context: From 2009 until 2012, almost £250k worth of funding was awarded 
to help develop a consultation aid to an ‘acceptable format’, to be later used by 
oncologists across the NHS and patients newly diagnosed with cancer. The 
consultation aid came in the form of a questionnaire to help doctors and patients to 
discuss diagnoses and prognoses in the first meetings. The consultation aid’s aim was 
to reduce the mismatched agendas between patients and oncologists. The patient 
would fill out the questionnaire at home before the first meeting with the doctor and 
discuss with their families what they needed to ask during the initial consultation 
meeting. The filled-out questionnaire would be sent back to the doctors, giving the 
doctors a chance to consider what the patient knows about the growth (i.e. whether it 
is cancerous or not). This initial understanding would also ease the doctor’s job about 
potentially having to give patients bad news about the cancer and move on to more 
pressing things such as treatment pathways for the newly diagnosed patient.  The 
consultation tool had shown positive effects, as it has been trialed locally. The team 
now needed to ‘scale-up’ the project, so that patients, nationally, could benefit from 
its use. The research aim was to develop the aid to an ‘acceptable format’, but the 
next level was always going to be an intervention study to validate its use more 
widely. Since completing the study, the team had failed to obtain further funding. The 
‘climate’ meant obtaining funding was challenging, and applications kept getting 
rejected. 
 
Type of outcome achieved: The problem identified by patient Ben about the way his 
cancer diagnosis miscommunication was handled was taken seriously by oncologist 
Priscilla and as a result a research study was funded to develop a consultation aid for 
using in oncology work. However, since the aid had been developed in an acceptable 
format, further funding for an intervention study has not been found, which was the 
whole point of the consultation aid developed in the first place. 
 
The reported role of PPI in shaping the outcome of the research: The research 
team was asked by the commissioners to have six members instead of four members 
which the team did. A PPI group was established comprising of six patients, post-
cancer treatment. Some members of the PPI group helped design the study including 
Ben, others joined after the funding was obtained. The group expressed the sensitivity 
that oncologists needed during the initial time of someone’s cancer diagnosis. 
Patients were reminded what the doctors needed to know about the patient’s 
treatment plans. They co-produced the aid. PPI helped recruit participants locally to 
trial out the work. Patients in the PPI group were reimbursed for out of pocket 
expenses and no training was provided. When the study finished patients were 
involved in dissemination plans. They produced information about the study for 
cancer patient groups. The next stage of this work requires a pilot study of its use but 
subsequent funding has not been found. Since the study has finished, patients have 
written letters of support to funders endorsing its use, but so far, the team of 
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researchers and patients have not been unsuccessful in securing funding for a follow 
up intervention study. 
 
Table 19 - Example two: Cancer patient experience survey 
Example two: Cancer patient experience survey - findings implemented to improve 
services  
Interviews with: Steven (hybrid role) and Katy (national cancer policy staff) 
 
Study context: The Department of Health annually funds a Cancer Patient 
Experience Survey for England. The survey reaches 70,000 cancer patients in 
England and has a high response rate. One cancer network works with private 
researchers on the development of the survey. This network has national partners 
from cancer research funders and together they develop a five-year strategic plan for 
cancer research in England. The network is renowned in cancer research. All of the 
major cancer charities and the cancer tsar support its work. PPI is woven through the 
infrastructure of the network and within the member organisations. When studies are 
funded by the charities which are part of the network, PPI is expected in the 
application and patients are involved in scrutinising bids. This network covered 22 
distinct cancer study areas. There were 32 cancer research sites, and all of these were 
performance managed by this network. The survey results were used in many ways. 
For example, patients with network staff had developed a presentation of six slides 
which were sent to the different sites about their results. The last slide was left blank 
so that each site could respond when they were asked what they would do differently 
to improve cancer research services by the following year. The blank slide was filled 
out by each hospital and sent back to the network (from all 32 sites). The information 
provided fed into the annual reporting of the network, suggesting immediate impact 
about how the survey results may lead to specific changes. Other outcomes from the 
survey included a campaign about cancer research clinical trials. Furthermore, the 
survey led to more and newer questions to be included in future surveys suggested by 
patients, e.g. life after cancer and employment. Broader links the network had with 
particular study areas e.g. a sarcoma research group, helped to feed into NICE 
guidelines about sarcoma treatments. Finally, government and parliamentary attention 
was achieved. The network’s PPI group was invited to the All Party Parliamentary 
Group on Cancer and to Question Time at the House of Lords. Results of the survey 
were also fed back to the Chief Medical Officer. A direct question was asked to 
Jeremy Hunt to continue supporting the work of the network. 
 
Type of outcome achieved: Implementing national cancer survey results for 
improved patient experience of cancer, e.g. improved cancer care across hospitals, 
amended NICE guidelines, a new campaign and policy attention. 
 
The reported role of PPI in shaping the outcome of the research: The network 
had PPI woven into their work. Each clinical study area had an established PPI group 
which offered input into the design of the survey. Each PPI group was well resourced. 
Survey results were analysed with the help of PPI members of the groups and a 
suggestion was made by a patient to develop a campaign about it being ok for patients 
to ask about cancer clinical trials to their doctors. PPI members were bloggers, 
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tweeters and avid users of social networks. A specific PPI group for the survey 
lobbied Government for the 2011 survey to introduce cancer research trial questions 
in the following year’s survey. All of the PPI members were offered out of pocket 
and honoraria payments and appropriate training. The team had established systems 
for paying members of the public who help in this way. 
 
 
Table 20 - Example three: Palliative cancer care 
Example three: Palliative cancer care – further research studies started 
Interviews with: Patsy (senior hospice staff) and Janine (Palliative care professor)  
 
Study context: This study was awarded nearly £300k in 2009 (with two other 
countries) looking at palliative care practices of different healthcare professionals. 
The study was qualitative and involved understanding the perspectives of those 
involved (a physician, a nurse, and the bereaved relatives after somebody had died). 
The research team was based in a large academic institution with a charity part 
funding its work. The researchers were renowned in this field. Palliative care is a 
controversial area and policy on palliative care frequently divides public opinion. 
After the research study was complete it struck the research team that decision-
making processes about palliative cancer care were only discussed as a medical 
matter. In England, it was the community nurses primarily, not the (doctors) who had 
responsibility of patients who lived out in the community and were dying. Thus, 
prescriptions were written up in advance of difficult symptoms that patients may 
experience when they were dying, and it was these community nurses who contacted 
the doctors to move onto decisions to change the drugs [to help palliatively]. So, after 
disseminating the results widely with the help of patients and cancer networks, to 
further this work, a grant was awarded for two further related issues. This work was 
presented by the researcher at a conference, where a local hospice practitioner was 
present. When the researcher was presenting the data from the study, the PPI in the 
study was also described. As a result of this work, one team of hospice staff has had 
meetings with their consultants and registrars about what the findings mean for their 
hospice practice. They have looked at the evidence via different mediums about this 
work (journals, social and mass media). 
 
Type of outcome achieved: Policy attention has been achieved and has led to further 
debate and more research on palliative care. Practitioners are yet to be convinced. 
 
The reported role of PPI in shaping the outcome of the research: 
Various ethical and methodological aspects of the study had been helped by a pre-
study PPI group of 16 bereaved older people. The group were sensitised to the area of 
death and dying in cancer and helped researchers to find suitable ways to overcome 
ethical and methodological problems around recruitment. The group met regularly 
and were offered training, expenses and honoraria payments. They helped to develop 
and write research the studies protocols. The team had established systems for paying 
members of the public who help in this way. 
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Table 21 - Example four: Prostate cancer care 
Example four: Prostate cancer care – more workforce funded 
Interviews with: Dennis (implementation science lead) and Robert (GP and 
professor)  
 
Study context: In 2009 a prostate study was funded for around £300k. The study had 
a pre-arranged research brief, with research aims set to meet an identified gap in 
prostate cancer service provision. The aim was to develop a quality of life 
questionnaire and understand the role of community cancer nurses. Since the study 
ended more community nurses have been funded in response to a recommendation 
made by the researchers but government priority had shifted about the use of the 
quality of life questionnaire and as a result the questionnaire had not been adopted. 
The researchers who secured the funding would not have chosen the development of 
the questionnaire themselves, had it have not been in the funding brief. The team of 
researchers were new to PPI. They asked a large national charity to be a co-applicant 
on the work and this element helped considerably to make the funders have 
confidence that the research would meet its aim. The project outcomes have been 
mixed. Whilst positive change has been witnessed since the study finished, resulting 
in more community nurses as recommended by the research, a negative outcome from 
this work has resulted in the non-adoption of the quality of life questionnaire which 
was part of the initial commissioning brief set by the funder. There are no plans for 
follow up work. 
 
Type of outcome achieved: Better prostate cancer care in the community through the 
increase in resources. 
 
The reported role of PPI in shaping the outcome of the research: 
The funders expected PPI in the study and were impressed with the PPI planned for 
the study. A new PPI group was developed and four patients/public members were 
involved in the research. One of the reasons the research team were awarded the 
funding was because of the novel aspect of a charity co-applicant having links to 
wider patient groups. No training was provided for the PPI in the study. Although out 
of pocket expenses had been offered to patients and the public involved, no honoraria 
payments were offered to patients and the public as PPI was relatively new for the 
institution that the researchers were based in. When the study finished PPI were 
involved in the dissemination work. Information was also cascaded about the study to 
various cancer networks via the charity involved. 
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Table 22 - Example five: Cancer genetics work 
Example five: Cancer genetics work - increased referral rates 
Interview with: David (cancer genetics doctor)  
 
Study context: A small grant had been obtained by David in 2009 for under £30K 
and some further funds from a charity were also obtained. Both of these grants 
expected PPI in the design of the study. The work aimed to address three problems 
with the help of patients and the public to increase referral rates from BME 
communities. At the time the study was running, several high-profile celebrities had 
undergone preventative surgery to reduce their chances of breast and ovarian cancers. 
David’s referral rates from BME communities have risen. The researcher believes 
that he and his team were doing the right research at the right time. 
  
The study had three aims, to increase referral rates within BME communities 
presenting for cancer genetics testing, as those presenting for testing were often 
white, middle class and highly educated. The researchers wanted to target those who 
were traditionally harder to reach. Secondly those who were coming in for testing 
were often presenting themselves too late, when most people in their family had 
already died from cancer and so there were no bio markers for testing which made it 
difficult to understand why the cancer had occurred in the family. The third reason for 
this study was that when people were referred to cancer genetics testing, researchers 
wanted to address if there was anything which could have been improved for the 
patient e.g. access to other services: physiotherapy, dietetics, psychotherapy and 
support groups. 
 
Type of outcome achieved: Increased referral rates in BME communities. The work 
led to a ‘medical supermarket’ idea where all the patients had access to 25 facets of 
holistic care. A chance celebrity story had helped the referral rates increase. 
 
The reported role of PPI in shaping the outcome of the research: 
Although no consistent group of patients and the public were part of the study, the 
work involved various streams of engagement including working with different 
patients which the researcher argued was better than using the same group as they 
could have a wider reach to different communities. The researchers have involved 
different communities in writing to local newspapers; running community events; 
local radio call in shows; piggybacking off community events directed at BME 
communities; and working closely with various high-profile cancer charities and 
susceptibility support groups who raise awareness of hereditary genes of cancer. 
BME community members have been involved in developing a YouTube video about 
hereditary cancers and how to raise awareness.  
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Table 23 - Example six: LGBT cancer services and policy change 
 
Example six: LGBT cancer services and policy change 
Interview with: Joanne (academic professor) 
 
Study context: The researcher had won a grant for around £15k to translate findings 
about a previous piece of work on the experiences of LGTB women undergoing 
routine assessment for diagnoses of cancer in the NHS. The researcher has a strong 
relationship with the LGBT community. This researcher felt that LGBT women had 
an unjust experience of cancer care due to their sexuality. Joanne was aiming to 
challenge the homophobic attitudes of clinicians treating LGBT women. Whilst 
translation was taking place, momentum started to change in direction, as a result of 
the coalition government coming into power. There had been a reduction in how 
much support the researcher was able to achieve from government about this work. 
Although some policy attention had been achieved. The researcher says that one 
person who was senior in a charity and who had a strong relationship with someone 
who worked in government was able to influence government decisions about the 
researcher’s work. However, that person had since left, leaving certain areas of the 
researcher’s work underdeveloped. 
 
The type of outcomes achieved: Health services professionals were better informed 
about health inequalities in the treatment of women with cancer from LGBT 
backgrounds. The researcher had written policy for the DHSC, describing how to 
support LGBT groups during cancer service provision, but more work remains to be 
done. 
 
The reported role of PPI in shaping the outcome of the research: 
An active and regular PPI group had been involved from the start of this researcher’s 
career. This same group had been involved in the subsequent work carried out by her. 
There had been keen support from national charities and the LGBT community. No 
funding for PPI input was available to the researcher. No training was offered to the 
PPI group for their input. Joanne used her own funds to pay people their out of pocket 
expenses. As a thank you to the woman who helped the research, she bought them 
flowers. They continue to be involved. 
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D = Perception that the factor directly affects impact of PPI on research outcomes 
I = Perception that the factor indirectly affects impact of PPI on research outcomes 
✓= Perception of the factor’s presence in the example 
X = Perception of the factor not being present in the example 
 
Colour code 
Red: Pre-implementation (i.e. PPI were part of the study’s commissioning, research and 
dissemination process. No further work has happened in relation to that study since it 
finished, and the PPI group has dissolved) 
Purple: Partial pre-implementation (some recommendations from the research have been 
taken up. The study has ended and no further implementation work is planned. PPI group 
has dissolved)  
Blue: During implementation (i.e. the researchers with PPI are planning the next stage of the 
work) 
Green: Post implementation (i.e. the researchers with PPI are actively working on the next 
phase of the work) 
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Figure 12 - Analysis of the nine factors across the six examples 
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Analysis of examples 
Participants had backgrounds in running/being involved in/utilising the results of: 
randomised controlled trials (RCTs), social science research, community research on 
palliative care, emancipatory research with LGBT groups and on training for healthcare 
practitioners. Therefore, the outcomes of each of these studies and the driving forces 
behind each of them varied immensely. Figure 12 demonstrates that the six examples 
have some common ground, which might explain some of the nine factors of PPI found 
from the current research. Each of the examples described had: ‘PPI in commissioning’ 
of the research; ‘PPI in the research processes’ in the studies; they each had ‘PPI in the 
dissemination’; as well as people involved who were ‘Wanting to make a difference’. At 
a closer look at the table, the red (study 1) and purple (study 4) had questionnaire 
development as part of the research focus and due to changes in government, the uptake 
of these questionnaires did not materialise. Similarly, both red and purple did not have 
pre-existing PPI groups, which suggest that the researchers were not so experienced in 
PPI or that resources for PPI were not available before the funding. Data show that the 
red and purple studies hardly referred to ‘Networks’ nor the use of ‘ICT’. Whilst the 
cancer genetics study (blue) appeared to have data representing each of the factors of PPI, 
the implementation process was helped by the celebrity story. This highlights that timing 
and serendipity can affect impact of PPI. 
 
But timing can hinder outcomes too. The LGBT cancer study was a good example of how 
‘Resources and the political context’ as well as ‘Power and leadership’ can have an 
unfavourable effect on the ability of PPI to have an impact on research outcomes. The 
researcher from this study described how austerity was affecting the impact of her work. 
She and her PPI group had ideas for follow up research, but the work was struggling due 
to people in power not being available to listen to, and act upon, her findings on how 
people from LGBT communities could experience better care. However, she had 
achieved some policy change and the grant that she was describing during her interview 
was a knowledge translation grant to help pay for translation aspects of the bigger study. 
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The examples in green on the table are examples of studies that are flourishing. These 
two studies had pre-existing PPI groups with PPI payment systems, demonstrating that 
organisationally, the studies were situated in departments within universities with strong 
PPI values and experience. Both studies had the resources in place to support training for 
PPI. There was support of established cancer networks, the backing of political groups, 
strong leadership and strategic steer in how they operated and generally these seemed the 
most organised in relation to PPI from all the other examples presented. 
 
Overall, two aspects can be determined from reviewing these six examples that help 
illuminate understanding of the impact of PPI on research outcomes. The first is that the 
impact of PPI on research outcomes can be a fluid phenomenon, underpinned by various 
interacting components. Most examples (green and blue studies) had more work to do 
and because of this, the impact of PPI needed to be understood as ongoing. One study 
was ‘stuck’ in pre-implementation phase (red study). After the prostate study, more 
community nurses were funded but the quality of life questionnaire was not adopted in 
the NHS. The ones in blue were during implementation and some were post 
implementation (green studies). The second aspect is that all six of these studies were 
enveloped by various motivational, contextual and circumstantial factors. These factors 
acted as favourable or unfavorable conditions for developing direct or indirect impact of 
PPI on research outcomes. 
 
‘Wanting to make a difference’ was indirectly connected to the impact of PPI on research 
outcomes as change does not automatically take place after a study ends despite peoples’ 
motivation to want to see change. ‘PPI in the research processes’ was indirect as 
although PPI ensured appropriate and meaningful design and delivery, the messages from 
the research still needed translating and policy makers still needed convincing. 
‘Resources and the political context’ was also indirect as researchers and PPI could not 
control the political climate. The conditions for change include the need for leadership 
and commitment. Similarly, having the help or influence of important people, whilst it 
offers favourable conditions which later might affect implementation, this was not 
directly connected to the impact of PPI. Using information and communication 
technology (‘ICT’) to enhance PPI outcomes was useful through social networks such as 
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twitter and blogging but this would not create change itself, so was also indirect. 
‘Networks’ were indirect because whilst they were important they could not guarantee 
change, but they could create mass support for the findings to be adopted. Finally, whilst 
‘PPI in commissioning’ provides a strong foundation that the research is needed, 
commissioned research does not always have a role in policy making, thus is also indirect. 
Therefore, seven of the nine factors are indirect, creating either favourable or 
unfavourable conditions for impact of PPI on research outcomes.  
 
Conversely, ‘PPI in dissemination’ was likely to achieve direct impact because people 
would have an active role in informing policy makers and decision makers. And ‘PPI in 
implementation’ was also likely to achieve direct impact as patients and the public were 
involved in the delivery of making change. It is important to note that there is an unclear 
boundary here because if PPI is not carried out well, or if the other factors of support are 
missing, then ‘PPI in dissemination’ and ‘PPI in implementation’ would also potentially 
fail. 
Use of the terms ‘direct’ and ‘indirect factors’ suggests they were tightly bound and 
specific. In reality the factors contributing to research impact are more fluid, sometimes 
absent and of greater or lesser strength when present. The direct and indirect factors found 
in this study may not apply to all contexts in the same way on each occasion. For example, 
in co-produced research patients and the public are working much more closely with 
researchers and therefore it may become much easier to unpick together, through 
observations and discussions, how impact was achieved because at a micro level, 
negotiations are being carried out constantly. 
 
What re-examining the data has demonstrated was that ‘PPI in the research processes’ 
and outcomes are linked, but not in a linear way. Interview data found that the relationship 
between process and outcomes was unclear and highly complex to track. Some data from 
revisiting the interview codes was identified and has been presented next to highlight the 
interaction between PPI in research processes and outcomes.  
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The relationship between PPI in research process and outcomes 
Twenty participants from the 23 interviewed described that PPI in research processes 
helped to achieve impact of PPI on research outcomes. For example, Janine explained 
that change is achieved by working together during dissemination events and with the 
help of networks. She felt that the impact of PPI on research outcomes is not something 
that metrics could solve. For her, communities, networks and other research work going 
on around the topic being researched, are all influences on each other and their 
dissemination paths:  
…PPI impact …it’s absolutely non-linear and sometimes [trying to] reduce it to 
a set of metrics is fatally flawed.  …in the end it’s about communities of activity 
or …practice and I think it’s probably better to try to give an account of how 
your work is situated in a wider set of activities going on.  To understand that, it 
is networks and collaborations that drive the ability to do research and the ability 
to disseminate research and that research has to happen at lots of different levels.   
(Janine, palliative care professor, IR3) 
 
Janine went on to say that once research findings were out we should not postulate that 
the findings are usable in their current form just because patients and public were involved 
in the study. Janine concluded her point by stating there is no linearity between research 
process and outcomes but it was more like ‘ripples of effects’.  
So there’s no linearity, it’s more like dipping a toe in the water and then some 
sort of chain reaction occurs.  
(Janine, palliative care professor, IR3) 
 
In similar fashion, Michael’s view was that the impact of PPI outside of academia was 
complex to see, judge and trail: 
the impact that they [PPI] have outside the academic field is always going to be 
…defused, indirect .[and…] mediated through all sorts of other  things very 
difficult to see, trace and audit …its ideas and ideas don’t belong to any one 
person.  
(Michael, academic department lead, IS7) 
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Michael then went on to describe why there was not a perceived linear relationship 
between ‘PPI in the research processes’ and outcomes, on account of a number of other 
factors: 
I think that there is unlikely to be a linear relationship because there is a lot of 
confounding variables. …Carefully thought through [PPI] is likely to improve 
the quality of the research, potentially the validity of the research….  Will it lead 
to more or better impact? I just think there are so many extraneous variables, 
there are so many confounders and control variants that you could never tell for 
sure. 
(Michael, academic department lead, IS7) 
 
Helen did not discuss non-linearity in the same way the others did. She felt that the 
relationship between process and outcomes of PPI was about asking the right questions 
and then pursuing something until the end. In her mind, PPI influenced many aspects 
important for research and those suggestions remained in the researchers’ minds when 
they move on to newer research studies: 
if they [researchers] haven’t done [PPI] before, then some of them find actually 
it makes a huge difference to them [indirectly] and generates things they hadn’t 
thought of, they then put those suggestions forward in all their research in the 
future and… that influences other types of research and topics.  
(Helen, cancer patient, IP3) 
 
Helen went on to say that PPI influences dissemination processes in an automatic way. 
Patients and the public have a personal reason of wanting to see something happen as a 
result of the work. She explained that PPI widens the thinking on who the work should 
go to, and how it might be important for those people the work gets disseminated to. She 
referred to having the perseverance to seeing change through: 
…if you’ve got good PPI throughout the project, then they [PPI] help to get it 
into practice. Because the PPI people on board understand the practical aspects 
affecting the new knowledge. PPI people have already made their connections 
mentally before disseminating/ they have already thought about who this work 
will influence. Because again, we’re on the ground, so able to see, we’ve 
suggested this and five years later these guidelines are out and that has had 
implications from the research. We make sure something is spoken about, its 
talked until we are satisfied.  
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(Helen, cancer patient, IP3) 
 
Robert made an interesting point about the appropriateness of PPI and its connection to 
the link between process and outcomes of PPI. He believed that PPI only works if patient 
experience is at the centre of the research study. Thus, implying that PPI is not for every 
study but for only those with patient focused outcomes: 
PPI works well when you are actually interested in what the experience of 
patients are or the outcomes for patients are. Where the interventions are 
possibly available for patients then that’s probably very appropriate. [those 
studies ]would produce more relevant output. More rounded findings.  
(Robert, GP and professor, IR5) 
 
Robert explained that as every study had such different outcomes the relationship of ‘PPI 
in the research processes’ was influenced by these potential outcomes. In RCT research, 
there was a tendency for clear messages, whereas in other studies it becomes much harder 
to equate that the research led to the change not attributable to other factors: 
Robert: …It will always be ‘this research in the context of other things going on 
led to that’. Ultimately, …if the finding is easy to distinguish, …something quite 
straightforward. So – just – drug X is fantastically better. You know, it’s a really 
crisp simple message. Where it becomes a complex whole system change, as a 
process for research is where… you are connecting up the dots about patient 
care/patient experience - it is rather more challenging. 
(Robert, GP and professor, IR5) 
 
Hannah, who worked in PPI policy role, said that there was difficulty with tracing the 
impact of PPI because of the everyday possibilities that facilitate impact: 
…actually the impact might be small, and it might snowball, and it might not, 
one person might say, the impact might just be in a conversation, …say, and that 
might trigger off a thought process, that, has a huge impact, but you would never 
capture that. So a lot of impact, isn’t always possible to capture it [or]track it 
because it might have been invisible, it might have been a relationship that two 
people had, it might have been a specific group of people within a specific 
context that built something and to actually separate that from everything else is 
going to be really hard.  
(Hannah, national PPI policy role, IS6) 
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Hannah then went on to say that the problem with demonstrating impact of PPI was that 
when ‘PPI in the research processes’ were in place, with strong people in the roles, 
attributing impact can be difficult: 
I think the trouble with all of this is most of the evidence is saying, that …it’s an 
opinion. …The trouble is, that once you’ve got really good public involvement 
…it’s integral to the whole process, determining what their influence was on the 
research and on the design can be very difficult to pull out… 
(Hannah, national PPI policy role, IS6) 
 
Patsy was the only participant who suggested that too much emphasis is placed on PPI 
and actually, clinical encounters should also be weighed up with PPI encounters. Patsy 
eloquently explained that she sees patients every day and for her PPI must add value to 
the study, otherwise the PPI interaction is no different to her everyday encounters: 
…what comes out at the end is added value to the study. … does it really make 
a difference? … clinical researchers are with patients all the time! So,… they are 
interacting to a lesser or greater extent every day. So that level of service user 
involvement [PPI] may be going on all the time. So, does having an additional 
separate entity like a PPI group really add anything to my conversations with 
patients in clinic on a daily basis?  
(Patsy, hospice senior staff, IS8) 
 
Patsy said that she could see value in PPI when it came to researching and reaching the 
‘hard to reach’ communities because without them researching could not be possible:  
… for me it [PPI] is about reaching hard to reach people both in language terms 
but also willingness to talk in this subject area. Then it’s going to be vital to have 
people who can open those doors… 
(Patsy, hospice senior staff, IS8) 
 
She finished the point she was making by saying that she was involved in a piece of 
research looking at non-invasive ventilation. The study idea did not come from patients, 
but the PPI has been vital in eliminating research barriers for her: 
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So, I’m involved in a piece of research to look at the withdrawal of non-invasive 
ventilation …sometimes I think biomedical intellectual curiosity is a really 
important driver as well. It may not have been a patient who had planted that 
idea in my head, but you know …they’ve [the PPI group] offered to be a catalyst 
in this work and have removed some hurdles. 
(Patsy, hospice senior staff, IS8) 
 
For David, the relationship between PPI in research processes and research outcomes was 
an on-going one. For him, because patients were already part of other groups and 
charities, there would be a feedback cycle, where patients informed other patients which 
are then sent back to the researcher via the PPI. Thus, the process and outcomes of PPI 
was not linear but cyclical: 
The other interesting idea is that if you have patients that take part in research 
who are involved in support groups it’s possible in the longer run that as and 
when new developments occur that you might be able to get a feedback loop 
going.  
(David, geneticist doctor, IR6)  
 
It was becoming clearer that participants felt that demonstrating the impact of PPI on 
research outcomes was complex. Ultimately, what the data shows next is that it was only 
possible to evaluate something which had clearly, at a much earlier stage (perhaps before 
a study commences), identified very specific outcomes which are evaluable for certain 
stages of the programme of research. Thus, outcomes may be a mix of: research process 
related outcomes (e.g. winning funding, gaining ethical approval and recruitment 
aspects); outcomes important to patients and public (e.g. improved experience of care or 
comfort); and outcomes important for follow up work (e.g. uptake of research 
recommendations, more funding, policy change etc.). Thus, evaluation for PPI needed to 
consider these smaller steps first to help evaluate it more precisely. The next part of this 
chapter attempts to capture some of these points by describing participants’ thoughts 
about evaluation of PPI and timing.  
Timing evaluation of PPI 
When evaluating the impact of PPI, it is important to acknowledge that PPI is not static. 
It was very much a ‘fluid’ phenomenon. Thus, evaluation of PPI needed to acknowledge 
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timeliness of certain outcomes, a point raised by eight participants. Evaluation of PPI 
could take place pre-implementation, partial-implementation, during-implementation and 
post-implementation. It seemed, during analysis of the current study, that the impact of 
PPI on research outcomes was an amassing of knowledge about a body of information 
being researched, and how patients and the public could influence the growing knowledge 
at different stages. Therefore, Helen and Robert said that questions important to patients 
today will typically take a few years to develop into specific health research questions, 
then a few more years to fund and carry out the research, therefore impact from the work 
will take time. 
You have to remember that for an awful lot of research it takes three or four 
years of writing something, getting the questions right, then getting funding 
takes a couple of years, then five years to run it.... so impact will take time. 
(Helen, cancer patient, IP3) 
 
Robert’s perception, which conflated impact of research with the impact of PPI stated 
that evidence formulation takes too much time. Often by the time the course of the study 
has finished, and safety checks have been carried out, the impact of the research may have 
faded: 
…people understand there has to be certain checks and balances and that takes 
time. But equally there are sometimes when it’s just far too long and the impact 
is going to be diminished.  
(Robert, GP and professor, IR5) 
 
Helen and Robert’s excerpts link to the ‘Resources and the political context’ because as 
one researcher raised in chapter five, research priorities often change, and this affects the 
overall direction of impact. However, the data suggest that evaluation strategies for PPI 
in the way proposed at PPI at pre-implementation, partial implementation, during 
implementation and post implementation, could work. 
 
Pre-implementation stage evaluation of impact of PPI 
 
On three occasions researchers and stakeholders said that before funding is obtained for 
a study, ‘at pre-funding stage’ the impact of PPI could be assessed via a table of ‘you said 
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- we did’, which would also indicate how PPI work influenced the overall application. In 
another example, Katy discussed some work she had been doing within her organisation 
to identify the impact of her research work. The entire portfolio of work carried out 
required involvement from patients and the public affected by cancer. Katy discussed that 
an audit trail was kept which captured the impact of early discussions concerning the 
prioritising of research questions that were developed by patients: 
I’ve just been doing some case studies, …looking at, small examples of the 
impact of PPI on the design of the research, and, some of that links into 
identifying the topics, because it might be that the researcher then uses the topics 
that have been identified by service users, patients, carers, … explores an audit 
trail of what difference those processes are making, and patients are involved in 
those processes all along the chain. So yes, there is definitely documentary 
evidence about how we have improved or changed our performance and patients 
and carers are directly involved in all of those decision-making processes.  
(Katy, national cancer policy staff, IS7) 
 
Similarly, three researchers suggested that the impact of PPI could be assessed through 
looking at how well trials recruited patients, and then scaling the figures against the 
previous years, in a trial without PPI: 
… you could easily look at getting stakeholders involved to try and increase 
recruitment. And actually, benchmark that against previous years’ accruals and 
see if that makes a difference.  
(Priscilla, oncology professor, IR1). 
 
David had a similar view concerning the recruitment stage of trials, but he proposed a 
study where PPI would ‘step in’ mid-way through studies which were not recruiting so 
well. The PPI would be the intervention and this may lead to some thought-provoking 
information about PPI and its impact:   
We know what our recruitment figures are, we have to produce them …And 
what would be interesting to see would be to look at a group of studies, …where 
we think actually they are probably not recruiting to their potential, they plan to 
run over five years, and we can then do some sort of intervention with using 
patient involvement and then just look at numbers at the end of that. That would 
be a really straightforward thing to do, and you might learn some really helpful 
strategies there.  
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(David, geneticist doctor, IR6) 
 
Along similar lines, patient information sheets were mentioned. Janine commented that 
two information sheets for a trial could be compared, one developed by patients and the 
public, and the other developed by the professionals. It could be possible to see which of 
the information sheets recruited better:  
You could [have two information sheets the same, and] set two groups, one for 
the original information sheet and the other with a PPI group and then see how 
the sheet gets modified and after that which sheet recruits better. You could look 
at two studies, one with and one without PPI and see which trial is more 
acceptable to patients.  
(Janine, palliative care professor, IR3) 
 
Katy stated that impact of PPI was most notable on recruitment and also whether a study 
wins the funding or not: 
There are two different measures: recruitment uptake and getting funding. Both 
of those measures are greatly increased through involving people.  
(Katy, national cancer policy staff, IS7) 
 
But for Patsy, she believed that impact of PPI was more possible to demonstrate via an 
RCT as the outcomes would be clearer: 
…impact on the quality of the research and…degree to which that research 
influences ….audiences are the two obvious ones. How can you evidence 
…measure …evaluate it? It is obviously difficult. I think it’s more difficult in 
some research fields than others.  I think certain kinds of clinical research …it’s 
probably much more obvious. I don’t think it would be easy but it’s more 
possible than it would be with certain kinds of research….  
(Patsy, hospice senior staff, IS8) 
 
These ideas suggest that there are ways to evaluate PPI at the pre-implementation stage. 
The prostate cancer and the oncology consultation tool examples demonstrate that these 
types of strategies could work because both studies had ended and no further work was 
planned. 
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Partial, During or Post implementation stage of evaluating impact of PPI 
Other than keeping an audit trail, which four researchers mentioned, another researcher 
suggested that developing a focus on very specific issues concerned with PPI impact 
would be more appropriate to help evaluate it. For example, Dennis spoke of CLAHRC 
funded studies as an example when he was explaining his idea. At the time of interview, 
CLAHRC had 25 projects on their database, all of which had some degree of PPI: 
…[focusing]…on one particular area as a group across [the name of UK region] 
…would it then give us a bit more focus. Yes we want everyone involved all the 
way through the process but rather than trying to do that in 25 projects and 
getting dissipated, if we particularly focused on one particular aspect of PP that 
could actually then help target …[data collected]…  
(Dennis, implementation science lead, IS1) 
 
Dennis was offering insights into precise areas for evaluable outcomes. He then suggested 
that other CLAHRC units across the country could focus on other aspects. He said that 
trying to understand the entirety of impact of PPI on all of these projects would lose focus 
of purpose on evaluating impact of PPI. However, if a researcher focused on a few areas 
such as ‘dissemination’ or ‘mutual relationships’, then a richer understanding of impact 
on those particular aspects could be generated for each project: 
So for me the two big things that we have really gone after, one would be setting 
direction and my main second hope is the dissemination. I suppose the third one 
is about a mutual relationship of asking and improving what we are developing 
all the time in a monitoring and advisory process.   
(Dennis, implementation science lead, IS1) 
 
Often when participants described evaluating impact they suggested that the process was 
uncontainable with too many variables, but Dennis’ understanding (above) illustrates that 
those who evaluate impact must think carefully about particular evaluable aspects of PPI.  
 
Two researchers believed that the impact of PPI could be something that could potentially 
be better understood by applying a ‘realist evaluation’: 
Qualitatively, it’s a bit more feasible especially if you’re doing …theory-based 
evaluation or realist evaluation or something like that.  
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(Robert, GP and professor, IR5) 
 
Other than Dennis and Robert’s pointers, no other suggestions about how impact of PPI 
could be evaluated for outcomes, were offered.  
 
Summary 
From re-examining the data, the six examples of PPI on research outcomes were found. 
It became clearer that understanding the impact of PPI was affected by: 1) the nine factors 
of PPI; 2) whether these were direct or indirect; and 3) the time/stage the study was at. 
 
The second half of this chapter has presented data which complements the six examples 
because the perceptions about the relationship between process and outcomes of PPI were 
shared. There was strong feeling amongst participants that the relationship was not linear, 
that outcomes needed to be precise and evaluable, and that somehow that evaluation 
needed to take consideration of the broader, context, mechanisms and outcomes. There 
were also some examples offered that might encourage new approaches to assessing and 
evaluating the impact of PPI on research outcomes.  
 
The final point to acknowledge, which perhaps is not clearly embedded in the six 
examples or quotations, is that the very essence of evaluation relies on having pre-set 
outcomes, yet often as data in chapter five showed, sometimes PPI is carried out 
tokenistically and without a strong purpose. Thus, evaluating something without clear 
purpose becomes difficult. For example, Robert argued that: ‘…it much harder to 
evaluate things that are less well defined such as PPI and its impact as they are more 
diffuse than those things that are kind of containable’. The definition of the impact of PPI 
which was developed during the Delphi study also reflected this point. Similarly, Patsy 
said that perhaps the important deciding factor about the impact of PPI was teasing out 
understandings of how the newly generated research adds value across the rest of the 
body of available knowledge. Patsy: ‘The question is: what is their [PPI] impact in the 
existing body of knowledge concerning the research?’ These pointers suggest that the 
impact of PPI is complex and tricky to trace/audit. Without favourable values, context 
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and processes the impact of PPI would be less achievable. In the discussion chapter these 
points will be explored in depth. 
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  End user involvement influencing this stage 
 
May 2017 – To help discover the original contribution to this work. Two 
theoretical clarity workshops took place after data collection was complete. 
Involvement in the form of consultation occurred at De Montfort University (n=9 
researchers and stakeholders) and at the University of Leicester (n=15 researchers 
and stakeholders). At these workshops data were presented using interpretations 
and conceptualisations derived from critical theory. Feedback from participants 
suggested that critical theory failed to offer a pragmatic solution and that an 
alternative model may be more suitable. This influenced the researcher to focus 
subsequently on using the CFIR model (Damschroder et al. 2009).  
 
The running of these workshops was made possible due to the research networks 
at the two institutions and the good will and interest of existing contacts to help in 
the capacity of end users. See chapter nine for more details on the limitations of 
this approach  
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Chapter Eight: Discussion 
Introduction  
The aim of this study was to advance knowledge about the impact of PPI on research 
outcomes. It did so through two phases of work. In the first phase, qualitative interviews 
were used to generate new data on the perceptions of the impact of PPI on research 
outcomes amongst patients, researchers and stakeholders. In the second phase, a Delphi 
study was used to refine interview data to produce a common understanding of the impact 
of PPI on research outcomes.  
 
This chapter presents the original contribution to knowledge in the thesis by:  
• arguing first, that PPI can be considered as a complex intervention (Craig et al. 
2008); 
• secondly, that as a complex intervention, the impact of PPI on research outcomes 
can therefore be evaluated using the Consolidated Framework for Implementation 
Research (CFIR) (Damschroder et al. 2009) by demonstrating evaluable PPI 
outcomes; 
• thirdly, using the CFIR, particularly the domain of ‘Process of implementation’, 
helps to draw out new theoretical insights about the evaluation of impact of PPI 
on research outcomes by enhancing understandings about PPI implementation and 
evaluation theory relating to complex interventions such as PPI. 
 
The chapter is organised in two parts. The first part considers how the impact of PPI on 
research outcomes can be considered for evaluation in terms of a complex intervention 
evaluation. It draws on the components of complex interventions as set out by Craig et 
al. (2008) and uses data from the study to illustrate these components. In the second part, 
it is argued that PPI is evaluable using the five domains and 36 constructs of the CFIR 
(Damschroder et al. 2009). This part of the chapter is organised theoretically using the 
domains of the CFIR (Damschroder et al. 2009) to structure the discussion. As the main 
aim of the current study was to address how the impact of PPI on research outcomes 
might be understood, the domain of the ‘process of implementation’ is key, although the 
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other four domains are also relevant to understanding PPI being a complex intervention 
because they help to consider process, mechanisms and outcomes (Staley et al. 2014).  
 
The CFIR was selected due to its flexibility of applicability towards approaching PPI in 
research evaluation and implementation, something which has not yet been achieved in 
the literature. Thus, in the absence of other evaluation tools available for understanding 
specifically the impact of PPI on research outcomes (not just processes), the effects of 
context and mechanisms on outcomes is considered within the CFIR, to help gain a more 
sophisticated understanding of the impact of PPI on research outcomes. At the end of 
each domain of the CFIR, a summary table is presented to demonstrate evaluable 
outcomes of PPI.  
 
Whilst the CFIR was not designed for PPI evaluation purposes it goes further than most 
other tools for evaluating PPI because it offers a common and transferable framework. 
The justification therefore for using the CFIR is that it offers tractability for evaluating 
complex interventions, i.e. when several aspects need considering together. Also, when 
using the CFIR to evaluate PPI, a chronology is inherently present which allows 
flexibility for evaluation to suit pre-implementation, partial implementation, during-
implementation, and post-implementation focused PPI evaluations; the chronology point 
will be discussed throughout this chapter. This point also links to Craig et al.’s. (2008) 
component four about complex interventions having varied outcomes, and component 
five about there being flexibility in how the intervention evaluation can suit particular 
situations.  
 
At the very end of the chapter a conclusion is offered about how this discussion makes an 
original contribution to knowledge to the evidence base of PPI evaluation and 
implementation theory. 
 
Part 1. PPI as a complex intervention 
Complex interventions offer a way of thinking about inherent aspects and features to 
consider when developing, evaluating and implementing health and social care (Craig et 
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al. 2008). The boundary between a complex and a simple intervention is not clear but 
according to Craig et al. (2008) a complex intervention has five aspects that set it apart 
from a simple intervention: 
  
1) the intervention will have a number of interacting components within it; 
2) the intervention which is complex would normally experience difficulty in 
eliciting the behaviours required by those delivering or receiving the intervention;  
3) in a complex intervention there will be a number of groups or organisations 
targeted by the intervention;  
4) there will be a number of varied outcomes;  
5) a complex intervention will offer flexibility in shaping the intervention to suit 
particular situations.  
 
As outlined in chapter 3, the evaluation of PPI in research has been suggested as having 
the characteristics of a complex intervention, (Farrell 2004). This point has also been 
made by others in the field of PPI, e.g. in operational PPI research (Pearson et al. 2013), 
PPI in systematic reviews (Harris et al. 2015) and PPI with hard-to-reach groups (Morgan 
et al. 2016). However, to date, authors who have suggested that PPI could be thought of 
as a complex intervention have focused on PPI in research processes. In this thesis, the 
aim was to consider evaluating the impact of PPI on research outcomes. It could be argued 
that if we think about PPI as a complex intervention, the components set out by Craig et 
al. (2008) would also therefore apply to attempts to understand the impact of PPI in 
research and translational work (the outcomes). This means that in considering PPI as a 
complex intervention we must consider PPI in research processes and on outcomes in 
conjunction because they interact. 
 
It must be acknowledged that there are alternative views about whether PPI can be  
considered a complex intervention. Some scholars argue for example, that PPI is not a 
complex intervention and rather, that PPI is itself an integral part of the research process 
which helps ensure that the research is patient centred. This argument forms the normative 
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argument for PPI (Elderman and Barron 2016) or as what Snape et al. (2014) refer to as 
the intrinsic values of PPI (discussed in the introduction). 
 
The normative argument for PPI considers PPI to be part of the research process, the same 
way that statisticians are needed to calculate the statistics, or clinicians and others on the 
research team are needed for other aspects integral to the research process. Elderman and 
Barron (2016) argue that PPI in research helps to ensure that the voice of the researched 
is taken on board and therefore considering PPI in research to be a complex intervention, 
loses PPI’s purpose and the values that underpin it. 
 
One study which supports Elderman and Barron’s view explored major system change in 
stroke care (Mc Kevitt et al. 2018). The authors argued that PPI in research in the NHS 
required direct invitation from researchers for lay people to be involved in activities that 
were already planned. They suggested that this type of ‘invited involvement’ was 
different from patient movements which concerned social justice and emancipation, and 
which usually arose from outside of such structures. These different purposes of PPI 
therefore invite different approaches to evaluation as McKevitt et al (2018). 
 
The central point here is that PPI serves different purposes in different research projects. 
The findings from the present study which evaluated other studies’ PPI demonstrate how 
PPI can be considered a complex intervention because they show that a variety of 
contextual aspects affect the impact of PPI in research for example: funding supporting 
PPI in a research project; the attitudes of people conducting the PPI (researchers and 
patients) and their commitment levels to PPI; the individual and organisational values 
placed on PPI and; the systems in place to support PPI. 
 
Thus, whilst studies by Pearson et al. (2013), Harris et al. (2015) and Morgan (2016) 
might help us to understand the specific processes of PPI as a complex intervention, none 
of these studies specifically explore the implications of how we might measure the impact 
of that intervention (PPI) in research outcomes. There is a particular gap when evaluating 
how PPI shapes outcomes using the components of a complex intervention set by Craig 
et al. (2008). Most importantly these authors do not explain that when a study has ended, 
how that study might go on to be evaluated at the implementation and translational phases 
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of the work. They simply, and rightfully, argue that PPI context, PPI mechanisms (PPI 
processes) and PPI outcomes need considering together and point to realist evaluation 
ideas about what works for whom and when (Pawson and Tilley 1997). The focus on 
process centres on the level of involvement - consultation, collaboration and user control 
or stage of research cycle (Brett et al. (2010). For PPI context - it is usually described as 
the nature of the research project as aims and design (Staley et al. 2012). ‘PPI outcomes’ 
according to Staley et al. (2012) refer to the outcomes the involvement made to the project 
itself, not specifically the translational and implementation phases (i.e. the focus of the 
current study). Hence what the current study proposes is an intervention evaluation 
approach to understanding the impact of PPI on research outcomes. 
 
Table 24 shows how might we understand the impact of PPI on research outcomes as a 
complex intervention by applying the five components of Craig et al. (2008). Throughout, 
the author draws on examples from the data to illustrate how each component relates 
specifically to the evaluation of the impact of PPI on research outcomes. 
 
Table 24 - The impact of PPI as a complex intervention 
Complex intervention 
characteristic set by 
Craig et al. (2008) 
 
PPI as a complex intervention (with an added emphasis on 
the impact of PPI on research outcomes)  
1. a number of 
interacting 
components  
 
Brett et al. 2010 argue the architecture for PPI as a 
complex intervention has three interacting components, 
these are context, mechanism and outcomes. 
 
PPI Context - would concern national strategies for PPI 
and resource allocation. Example 2, the National Cancer 
Experience Survey showed that the government in power 
supported the work. This would be a favourable context. In 
contrast, in Example 6, the LGBT Cancer study, 
government support for Joanne’s work had eroded as a 
result of government changes, thus, the context acted 
unfavourably towards PPI on research outcomes. The 
factors of PPI found in chapter five, ‘Resources and the 
political context’ and ‘Significance of power and 
leadership’, demonstrate the PPI context affecting the PPI 
outcomes. 
 
 225 
PPI Mechanisms - these might be the locally available 
resources for PPI and the values of people engaging in PPI. 
Example 2, the Cancer Survey, demonstrated that having 
trained PPI in the design of the cancer survey was 
important. PPI mechanisms are different for every research 
project using PPI. Chapter five demonstrated a range of 
mechanisms including: ‘PPI in commissioning’, ‘PPI 
processes’ and ‘PPI in dissemination’. It is reminded here 
to the reader that mechanisms are generally process issues 
and that the relationship here is that data also demonstrated 
that good PPI processes were highly influential for the 
impact of PPI on research outcomes. 
 
PPI outcomes varied from project to project in the data 
from the current study. PPI outcomes ranged from securing 
further funding for follow up work with PPI, policy 
attention with PPI help, policy change with PPI help and a 
new campaign designed by patients (example two).  
 
Thus, the interacting components here found from data in 
the current study are:  
 
PPI context (factors of PPI ‘Resources and the political 
context’ and ‘Significance of Power and Leadership’)  
 
+ PPI mechanisms (‘PPI in commissioning’ and ‘PPI 
processes’)  
 
= PPI outcomes (‘PPI in dissemination’ and ‘PPI in 
implementation’) which might be those listed above for 
PPI outcomes.  
 
2. difficulty eliciting 
required behaviours 
This could include the problem points for PPI on research 
outcomes, resulting in a combination of problems from 
different stakeholders. In example 4, the Prostate Cancer 
study, Dennis and Robert said that a quality of life 
questionnaire for men with prostate cancer was not adopted 
in the NHS after it was developed through the research 
study with PPI. The difficulty of eliciting behaviours can 
therefore mean that policy makers and/or senior leaders may 
not accept a new intervention, despite good PPI. Secondly, 
mandatory expectations about PPI from funders in studies 
may lead researchers to carry out PPI purely to secure 
funds, rather than meaningfully, thus potentially asking the 
wrong question in the study with PPI leading to unusable 
findings. The third difficulty may be that patients and the 
public might have had their own agendas. A fourth, may be 
to convince those who hold budgets to allocate resources for 
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PPI and the fifth may be not knowing how to do PPI in 
research well. Finally, there are effects of bureaucracy on 
PPI on research outcomes. 
 
The factors of PPI ‘Wanting to make a difference’, 
‘Resources and the political context’ and ‘Significance of 
power and leadership’ particularly relate to this 
component of complex interventions. 
 
3. a number of groups 
or organisations 
targeted by the 
intervention  
This applies to how we capture the various views of the 
different people and organisations affected by PPI and 
how these affect the overall outcomes of PPI. Targeted 
groups are the patients and the public (people like Ben and 
Steven), researchers (Joanne and Janine), charities (Katy 
and Patsy), higher education systems (Robert), scientists, 
INVOLVE/NIHR, funded research schemes and research 
council PPI leads. 
 
The PPI factor of ‘Networks’ particularly relates to this 
point. 
 
4. a number of varied 
outcomes 
This component is about how we can measure that the 
PPI on research outcomes has worked. For the current 
study this component of the complex intervention is central 
for the current study and the focus of the question. Four 
stages of evaluation were found in chapter seven. 
 
These stages were pre-implementation (i.e. PPI were part 
of the study’s commissioning and research processes. But 
after the study no further work has happened in relation to 
that study since it finished, and the PPI group has 
dissolved). Partial-implementation (concerned were some 
recommendations from the research had been taken up 
during dissemination. The study had ended and no further 
implementation work was planned. The PPI group has 
dissolved). During implementation (was when the 
researchers with PPI were planning the next stage of the 
work). The last was Post implementation (i.e. the 
researchers with PPI were actively working on the next 
phase of the work). 
 
Aside from those listed above, outcomes may also be 
general or specific aspects such as the increased use of PPI 
in research nationally and how these may be counted, 
capturing the increased knowledge about PPI and what it 
can add, amongst stakeholders. It may be about the 
increased numbers of funders implementing PPI in their 
schemes or how much funding is annually offered for PPI in 
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research. It could also mean how clearly PPI is reported in 
journals using tools such as GRIPP 2 (Staniszewska et al. 
2017). Or how it is assessed in PPI in research 
dissemination work - e.g. who was present at an event and 
how the dissemination event has broadened somebody’s 
thinking about PPI and the usability of the findings 
presented. As Patsy said that when she heard Janine’s case 
at a conference she held a meeting at her hospice about the 
potential of using the findings from Janine’s research.  
 
In the data the six examples demonstrate the reported role 
of PPI in shaping the outcome of the research – evaluation 
of outcomes of PPI can therefore consider all of these 
reported roles of PPI securing the impact. 
 
5. flexibility in 
shaping the 
intervention to suit 
particular situations 
Together the four points above demonstrate that PPI is a 
complex intervention because there is flexibility and scope 
on what aspects to evaluate and when if we consider the pre, 
partial, during and post implementation stages. This allows 
the evaluator some options on what to include and what not 
to whilst being mindful of the impact of context and 
mechanisms on outcomes. 
 
In chapter seven, Robert made an interesting point about the 
appropriateness of PPI and its connection to the link 
between process and outcomes of PPI. He believed that PPI 
only works well if patient experience is at the centre of the 
research study. Similarly, others felt that an RCT would 
help to establish the impact of PPI on research outcomes. 
Others raised that when evaluating the impact of PPI, it is 
important to acknowledge that PPI is not static and therefore 
is timing sensitive. 
 
Thus, the flexibility and scope for evaluating the impact of 
PPI on research outcomes is highly sensitive to both context 
and mechanism. 
 
Based on the defining characteristics of a complex intervention offered by Craig et al. 
(2008) it can be argued by referring to table 24, that PPI in research is a complex 
intervention and therefore can be evaluated as such. To understand the impact of PPI on 
research outcomes, in the context of recognising it as complex intervention, requires us 
to utilise a framework that considers all interacting components. For this, we turn now to 
implementation science and specifically to the work of Damschroder et al. (2009).  
 
 228 
Part 2. The Consolidated Framework for Implementation Research  
The Consolidated Framework for Implementation Research (CFIR) developed by 
Damschroder et al. (2009) reviewed 19 implementation theories and amalgamated them 
into one meta framework. They found five domains which reflected all of the 19 theories 
these were: 
6. Intervention characteristics – which are the core components of an intervention; 
7. Inner setting which recognise that people on the ground will be affected by the 
issue, therefore policies must be ready for change; 
8. Outer setting which are the contextual aspects e.g. politico-social issues with need 
to be aligned to the inner setting; 
9. Characteristics of individuals involved in making the change e.g. must include all 
‘end users’ including patients, public and stakeholders; and  
10. Process by which implementation is accomplished needs careful planning and 
executing.  
(Damschroder et al. 2009) 
 
A domain may be defined as: ‘a pragmatic structure for approaching complex, 
interacting, multi-level, and transient states of constructs in the real world’ (p1). The five 
domains identified under CFIR are: Intervention characteristics; outer setting; inner 
setting; characteristics of the individuals involved; and the process of implementation. 
The constructs within the domains interact in rich and complex ways to influence 
implementation effectiveness. Damschroder et al. (2009) selected constructs based on:  
‘conceptual or evidential support in the literature for influencing 
implementation, high consistency in definitions, alignment with our own 
experience, and potential for operationalisation as measures.’  
(p3)  
 
Table 25, below, identifies the constructs and domains within the framework. The rest of 
this section draws on the entire dataset from the current study and the literature to 
demonstrate how the domains and constructs relate to understanding the impact of PPI 
on research outcomes and its evaluation. Exploring each domain and construct in turn 
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will demonstrate how it can advance PPI implementation and evaluation theory. In each 
case, the domain is first defined and explained and then the focus is given to the specific 
case of PPI impact on research outcomes; which is the focus of this thesis. Based on Craig 
et al. (2008) the outcomes of PPI being a complex intervention are a mixture of contextual 
and mechanistic aspects, linking to outcomes. Therefore, various outcomes of PPI on 
research can be generated by considering the different values (characteristics of the 
intervention and individuals involved), different processes (inner setting and processes of 
implementation) from the different people (e.g. patients, leaders, researchers, 
stakeholders, policy makers) and the variable outcomes that range from securing further 
funding for follow up work with PPI, achieving  policy attention with the PPI help, policy 
change with PPI help or even a new campaign designed by patients.  
 
In evaluation terms, what the description above implies is that whilst the CFIR can be 
used to evaluate PPI more generally, this thesis is only concerned with the outcomes of 
PPI, which is an important point. The constructs may interact in rich ways with each 
other. The characteristics of an individual’s domain (i.e. a domain which could be 
described as a domain about values and norms people have) will be influenced by the 
outer setting domain (i.e. a domain about socio political and economic context at the time 
of the study). This may mean, for example, that patients and researchers may hold strong 
values about PPI but that does not guarantee impact on outcomes if the overall political 
culture of a country does not value or fund resources to support PPI efforts in research. 
So, the CFIR can help to consider these aspects of PPI on research outcomes within one 
interacting model.  
 
Damschroder et al. (2009) list 36 constructs and it is argued in this discussion that each 
of these constructs can offer insights into the evaluation of the impact of PPI on research 
outcomes. However, the domain of significant interest in this study is the ‘Process of 
Implementation’ (the fifth domain in the model) as this is where evaluation theory in 
relation to the impact of PPI on research outcomes can enhance new knowledge. To show 
how each domain advances thinking about evaluation of impact of PPI on research 
outcomes, a summary box is provided after the discussion of each domain.  
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Table 25 – The five CFIR domains and their respective constructs identified by Damschroder et al. 2009. 
Five Domains descriptions 
1.Intervention 
characteristics  
Adaptation is key, without 
this there will be a poor fit, 
resisted by individuals who 
will be affected by the 
intervention. 
 
The core components are the 
indispensable elements 
which make the intervention 
unique. 
2.Outer setting 
Economic and political 
context within which the 
organisation resides. 
 
 
3.Inner setting 
These are the structural, political and 
cultural contexts through which the 
implementation process will 
proceed. 
 
The line between inner and outer 
setting is not always clear. The 
interface is dynamic and sometimes 
precarious. 
 
Readiness for implementation = RFI 
Implementation climate = IC 
4.Characteristics of 
individuals 
Individuals have agency, can 
make choices and can wield 
power on others with 
predictable and unpredictable 
consequences. 
 
Individuals are carriers of 
cultural, organisational, 
professional, and individual 
mind-sets, norms interests 
and affiliations. 
5.Process of implementation 
This is the active change 
process aimed to achieve 
individual and organisational 
level use of the intervention. 
 
Individuals may actively 
promote the implementation 
process and may come from 
inner or Outer setting. 
 
 
 
Engaging = E 
The constructs below each domain 
1. Adaptability 
2. Complexity 
3. Evidence strength 
and quality 
4. Trialability  
5. Cost 
6. Intervention source 
7. Design and quality 
packaging 
8. Relative advantage  
 
1. Patient needs 
and resources 
2. Cosmopolitanism 
3. Peer pressure 
4. External policies 
and incentives 
 
1. Structural characteristics 
2. Networks and 
communications  
3. (RFI)- access to 
knowledge/information  
4. (RFI)- Available resources 
5. (RFI)-Leadership 
6. (IC)- Tension for change 
7. (IC)- Compatibility of fit 
8. (IC)- Relative priority 
9. (IC)- Incentives and 
rewards 
10. (IC)- Goals and feedback 
11. (IC)- Learning climate 
12. Culture 
1. Knowledge and 
beliefs about the 
intervention  
2. Self-efficacy 
3. Individual stage of 
change  
4. Individual 
identification with 
organisation 
5. Other personal 
attributes 
 
 
1. Planning  
2. Executing 
3. E- Opinion leaders 
4. E- Formally 
appointed internal 
implementation 
leaders  
5. E- Champions 
6. E-External change 
agents 
7. Reflecting and 
evaluating 
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Domain 1: Intervention characteristics of impact of PPI on research outcomes 
Damschroder et al. (2009) identified Intervention characteristics as ‘the 
characteristics of the intervention being implemented into a particular organisation 
(p.3). For understanding the impact of PPI on research outcomes this might include 
the goal to reduce the research and practice gap (Savory 2010) or enabling ‘bench to 
bedside’ alignment (Callard et al. 2011) for an organisation. The eight constructs of 
intervention characteristics will now be argued to show fit for PPI impact on research 
outcomes.  
 
Damschroder et al. (2009) suggest an intervention characteristic must have 
Adaptability to suit the setting: 
The intervention is often complex and multi-faceted, with many interacting 
components. Interventions can be conceptualized as having 'core 
components' (the essential and indispensable elements of the intervention) 
and an 'adaptable periphery'. 
(Damschroder et al. 2009, p5). 
 
The intervention characteristic in this work concerns the evaluation of PPI impact on 
research outcomes. Data from the current study in chapter seven show that PPI 
outcomes can be adaptable to any study trying to understand the translational phase. 
In the current study these phases were found to be evaluable at:  
• Pre-implementation (i.e. Example 1: Oncology Consultation Tool) where 
PPI was part of the study’s commissioning, research and dissemination processes, but 
after the study, no further work had happened and the PPI group had dissolved.  
• Partial-implementation (i.e. Example 4: Prostate Cancer study) where some 
recommendations from the research had been taken up but others had not. The study 
had ended, and no further implementation work was planned. The PPI group had 
dissolved.  
• During implementation (Example 5: Cancer Genetics and Example 6: the 
LBGT Cancer study) was when the researchers with PPI were planning the next stage 
of the work.  
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• Post implementation (impact Example 2: Cancer Survey and Example 3: 
Palliative Care) where researchers with PPI were actively working on the next phase 
of the work.  
 
The adaptability aspect of the intervention characteristic links back to the introduction 
to this study which detailed the intrinsic values associated with PPI. Snape et al. 
(2014a) found consensus that these intrinsic values included consideration of: what 
research is undertaken, and how it is used; that different types of knowledge are 
important, and that members of the public have a unique knowledge (Snape et al. 
2014). These values were significant for the current study, because participants 
explained that the values had adaptability across research planning and the application 
of PPI views to research, and that PPI knowledge was a vital ingredient in successful 
implementation.  
 
The literature showed that involvement took place across a spectrum of consultative, 
collaborative and user-controlled involvement (Fleming and Hudson 2009). The 
literature also demonstrated that there was a growing field of spectra (Hanley et al. 
2005), frameworks (Shippee et al. 2013) and models (Forbat et al. 2009) to help 
understand characteristics of PPI in research. Thus, the adaptability element suggested 
by Damschroder et al. (2009) is observable in PPI as a complex intervention. Data 
from the interviews and the Delphi reflected this point well as each study cited by 
participants was different and demonstrated stark contrasts in how they had adapted 
the principles of PPI to suit their work. The six examples (chapter seven) further 
demonstrate that outcomes can be highly subjective. 
 
However, the diversity and adaptability of PPI, added to its ‘complexity’, affecting its 
evaluation. Damschroder et al. (2009) articulated that intervention characteristics 
needed to address the ‘perceived difficulty of implementation, reflected by duration, 
scope, radicalness, disruptiveness, centrality, and intricacy and number of steps 
required to implement’ (p6). This point links to the evidence base of PPI. Participants 
in the current study provided details about PPI processes, for example, the number of 
meetings, number of patients and the public involved in a study, the payments offered, 
training for PPI, managing patient agendas and other process factors. The literature 
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pointed out that PPI characteristics have highly subjective ways in which the evidence 
base is understood. Damschroder et al.’s (2009) construct of ‘evidence strength and 
quality’ was defined as: ‘stakeholders' perceptions of the quality and validity of 
evidence supporting the belief that the intervention will have desired outcomes’ (p6). 
This point is important because it also links to the evidence base of PPI. In the 
literature, the impact of PPI on research outcomes was sensitive to barriers and 
facilitators. PPI was documented in a variety of ways in healthcare research to have 
positive outcomes on different stages of the research, for example: winning funding 
for the research, designing a study, recruitment in a study, and selecting outcomes of 
a study (Domecq et al. 2014). But collectively, the literature showed that the impact 
of PPI on the processes of research was understood better than impact of PPI on the 
outcomes of research. Poor quality reporting was a possible reason for the lack of 
literature on the topic of the impact of PPI on research outcomes (Staniszewska et al. 
2011).  
 
Furthermore, there was no consistent language to identify what was meant by the 
impact of PPI on research processes or outcomes (Brett et al. 2010; Mockford et al. 
2011; Staley 2009). Data from the Delphi study showed that the concept formation of 
impact of PPI in language is achievable by synthesis and trialability. But ‘trialability’ 
for Damschroder et al. (2009) concerned the ‘trialability and usability testing (with 
staff and patients) [which] promotes successful adaptation of the intervention’ (p6). 
And yet this point is sensitive to the ‘cost’ of PPI. The costs to trial PPI as an 
intervention at research design stage or pre-implementation stage, for example, has to 
be set against the funding for PPI, an issue raised by participants in this study. 
Damschroder et al. (2009) highlight a number of costs including those of: ‘the 
intervention and costs associated with implementing that intervention, including 
investment, supply, and opportunity costs’ (p7).  
 
Snape et al. (2014b) found consensus in their work on impact barriers and drivers that 
are central components to implementation work with PPI, arguing that PPI work 
required research team cohesion and most importantly here, suitable resources (i.e. 
funds). Data from the current study reflected this point too: impact was noticeable in 
example 3: Palliative Care and example 2: Cancer Survey where researchers had an 
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existing PPI group and this group kept the research-related understandings at an 
implementable level i.e. the messages that the field of palliative care needed to know. 
Similarly, in example 2, Katy asked trusts to consider how they could deal with 
addressing local anomalies.  
 
Damschroder et al. (2009, p6) describe ‘Intervention source’ as whether the 
‘intervention is internally or externally developed… as a good idea […] solution to 
problem’ (p6). In chapter two, it was highlighted that PPI in healthcare was 
rationalised in two ways: democratic in that it is an attempt to legitimise services, and 
technocratic which related to attempts to improve services. Neoliberal governments 
have placed value on PPI as a solution to the perceived democratic deficit (Florin and 
Dixon 2004).  
 
For the ‘Design quality and packaging’, PPI has been presented as potentially 
achieving better research outcomes. Damschroder et al. (2009) suggest when 
packaging an intervention, there needs to be ‘perceived excellence in how the 
intervention is bundled, presented, and assembled’ (p7). Much of the literature on PPI 
suggested it was fashionable to conduct research with PPI, with scholars adopting, en 
masse, the INVOLVE definition of ‘Doing research ‘with’ or ‘by people’, not ‘to’ 
‘about’ or ‘for them’’ (INVOLVE 2018). Similarly, the ‘Going the Extra Mile’ (GEM 
2015) review had packaged PPI in research to have a new vision, mission and set of 
goals for the next ten years specifically to address research-related PPI complexities 
(NIHR 2015). Thus, PPI is positioned as being innately good and packaged as 
resulting in better research outcomes.  
 
However, the problem of this uniformity in how PPI is sold to researchers is that it 
can mask what good/bad PPI looks like. Poor PPI can lead to poorer outcomes of PPI. 
Data reflected this point. In James’ interview, he said that too much value was placed 
on PPI itself, which made him doubtful of its real effectiveness. These points from the 
literature and data relate to the ‘relative advantage’ of having PPI in a study. Relative 
advantage concerns: ‘stakeholders perception of the advantage of implementing the 
intervention versus an alternative solution’ (p6), for example, a study without PPI. 
The literature reviewed in this thesis identified that, in healthcare, the choice of 
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method and the approach used needed to be aligned to the particular aims of specific 
health initiatives (Anderson et al. 2002). Without this link (of the method to the 
approach), the initiative would fail at being meaningful and relevant to the needs of 
patients and the public, which would potentially later affect outcomes. Thus, funders 
making PPI mandatory supposedly helped alignment of method to health initiative, 
making researchers believe that PPI is a good idea to resolve the problem (whatever 
the research intervention) (Harrison and Mort 1998).  
 
Relative advantage is an important construct for PPI on research outcomes because as 
Abelson et al. (2003) argued, the trend of PPI in research governance suggested that 
policymakers wanted a more sceptical and critical public, and PPI provided a way of 
self-governing. PPI in research initiatives speaks to sceptical publics, as in the case of 
example 1, the Oncology Consultation Tool, where patient Ben wanted to challenge 
medical professionals for his poor experience at the start of his cancer treatment. 
  
Thus, considering PPI as a complex intervention, the characteristics of the 
intervention allow us to think of PPI in research outcomes to be a combination of 
foundational aspects for assessment.  The outcomes may be assessed as summarised 
in table 26.  
 
Table 26 - Evaluable characteristics of intervention characteristics  
Intervention 
characteristics 
Evaluable outcomes  
Adaptability 1)Pre, partial, during or post implementation 
2)Values 
3)Spectrum of involvement 
Complexity Number of: 
a) pre /partial/during and post implementation meetings,  
b) with patients/public involved  
c) whether payments were offered to patients and public 
d) whether training was offered on for e.g. what 
dissemination and implementation processes are and why 
they are important for PPI on research outcomes. 
Evidence strength 
and quality 
Use of consistent language, winning further funding, co-
authoring a paper  
Trialability  Evaluation concept testing 
Cost Resources made available for PPI on research outcomes  
Intervention source What was its purpose of PPI? has it achieved its purpose? 
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Design quality and 
packaging 
Does the PPI work reflect national/local policy ideas and 
recommendations? How? 
Relative advantage What is the alternative solution to implementation if PPI 
was not part of it? 
What is the distinctive advantage of PPI? 
Domain 2: Outer setting of impact of PPI on research outcomes 
The outer setting concerns the political and cultural context within which 
organisations are situated. Changes in the outer setting can influence changes in the 
inner setting, and the boundary between the outer and the inner setting is often not 
clear cut. However, the domain was defined as follows: 
Generally, the outer setting includes the economic, political, and social 
context within which an organization resides, and the inner setting includes 
features of structural, political, and cultural contexts through which the 
implementation process will proceed [22]. However, the line between inner 
and outer setting is not always clear and the interface is dynamic and 
sometimes precarious. The specific factors considered 'in' or 'out' will depend 
on the context of the implementation effort.  
(Damschroder et al. 2009 p7) 
 
Two impact examples help us to make sense of the outer setting. Example 1: The 
Oncology Consultation Tool and Example 4: The Prostate Cancer study, both 
demonstrated that the questionnaires developed within one hospital (inner setting) 
were not taken up outside of the setting (the outer setting). The implementation efforts 
made in these examples were not entirely successful. The constructs will help to 
unpack why this was so. 
 
There were four constructs to the outer setting. For the construct of ‘patient needs and 
resources’ Damschroder et al. (2009) argued these concern: ‘the extent to which 
patient needs, as well as barriers and facilitators to meet those needs, are accurately 
known and prioritized by the organization’ (p7). The literature on research impact 
context demonstrated that generally there seemed to be a failure to connect how PPI 
interventions affected the context of research. This resulted in a mismatched 
alignment from ‘bench to bedside’ (Callard et al. 2011). Furthermore, if a dialogue 
between researchers and patients was not kept alive concerning what was needed from 
research findings, implementation efforts could fail (Morris et al. 2011). In the data, 
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researchers and patients discussed efforts they had made to engage with 
commissioners, and participants discussed how they used their networks to ensure that 
research reflected what patients wanted. This point linked to Damschroder et al.’s 
(2009) construct of cosmopolitanism:  
the degree to which an organization is networked with other external 
organizations. …Social capital is one term used to describe the quality and 
the extent of those relationships and includes …shared vision and 
information sharing. …[including] external bridging between people or 
groups outside the organization  
(Damschroder et al. 2009 p7) 
 
The literature demonstrated that NIHR-funded organisations were supported by 
recommendations made in the GEM report. One such piece of work was the 
documentation of values, principles and standards for PPI, which were co-produced 
with the public and other partners (GEM 2015). GEM outlined six principles covering: 
respect, support, transparency, responsiveness, diversity and accountability, and six 
standards which comprised: inclusive opportunities, working together, support and 
learning, communications, impact and governance (NIHR 2017). These standards of 
working will potentially offer leverage to articulate common goals of PPI in research 
outcomes (e.g. to achieve the working together principle). The point of 
cosmopolitanism links highly to two of the other constructs under this domain of 
Outer setting, ‘Peer pressure’ and ‘External policies and incentives’. Discussing peer 
pressure, Damschroder et al. (2009) explained the construct as follows:  
'peers' can refer to any outside entity with which the organization feels some 
degree of affinity or competition at some level within their organization  
(p7) 
 
And external policies and incentives as: 
 External policies and incentives concern the ‘broad constructs that 
encompass external strategies to spread interventions, including policy and 
regulations …external mandates, recommendations and guidelines…’  
(p7)  
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Both of these constructs within the literature concern long-term investment, leadership 
and co-ordination, which were recommended in the GEM report. The outer setting 
echoes the general concerns about leadership found in wider research impact and 
implementation literature (e.g. Kuruvilla et al. 2006) as well as in the PPI literature 
(e.g. Jinks et al. 2016). The building of trust between researchers, patients and the 
public, and staff in PPI leadership roles requires investment. Learning about what 
approaches in PPI work best, in different healthcare research settings, requires 
detailed understandings about the complex interplay of involvement dynamics, here 
the blurring of the boundary between inner and outer setting. PPI interventions 
concern: clarity of purpose, defined roles and relationships, organised support and a 
strongly funded infrastructure, which are all components believed to create the spaces 
for strong and supported PPI in research endeavours (Jinks et al. 2016). The data on 
networks (researcher, stakeholder and patient) links here because without strong 
networks, relationships will struggle to materialise.  
 
In the data, relationship building was a key component for which resources and 
political backing for PPI work were vital. Janine’s study, Example 3: Palliative Cancer 
Care demonstrated this point well. She described how PPI in research work relied on 
strong relationships and these built up a rich tapestry of information. The impact of 
PPI on research outcomes needed these strong networks to share information 
generated from PPI-informed research. The data across the six examples reflected that 
at a commissioning level and research process level active efforts were being made 
by researchers to suitably meet the needs of those involved. However, this point was 
highly sensitive to funding for PPI. If an organisation was not awarded any PPI funds, 
then the efforts they made for PPI were vulnerable. Joanne, the researcher in LGBT 
work (Example: 6), explained in her interview how she used her own money to pay 
for flowers to thank PPI members. Impact in her work had stalled because the 
government context was chaotic and hindered her research plans. The more 
established PPI groups performed much better, such as in the PPI group working on 
the Example 2: Cancer Survey conducted by a cancer network and Example 3: 
Palliative Care, where trained and well-resourced PPI groups were part of the 
organisational infrastructure. Of note, these examples demonstrated better PPI-related 
outcomes than the others set out in chapter seven.  
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The outer setting for shaping the impact of PPI on research outcomes therefore 
concerns patient needs and resources, cosmopolitanism, peer pressure and external 
policies as investments for PPI, and these are all channelled as a form of PPI 
leadership and strategic direction. Without resources, political backing, and power and 
leadership, PPI efforts are sensitive to failure and tokenism.  
 
Table 27 - Evaluable characteristics of outer settings 
Outer setting Evaluable outcomes 
Patient needs and 
resources 
Understanding how dialogue kelp alive pre, partial, during 
and post implementation.  
Listing the ways that patients could request needs and 
resources 
Cosmopolitanism  Listing networks that have been involved and how the 
national standards for PPI have been assessed across the 
networks?  
Peer pressure How are other well performing research groups researching 
similar areas achieving their implementation plans for PPI? 
Can learning be achieved?  
External policies 
and incentives 
What PPI guidelines, and recommendations are in place for 
PPI on research outcomes and implementation?  
 
 
Domain 3: Inner setting of impact of PPI on research outcomes 
The domain of inner setting concerns the internal issues faced by organisations during 
implementation. Damschroder et al. (2009) argued that a there is a complexity in 
describing how the constructs identified under the inner setting are related. They 
found that there was very little systematic research addressing how the constructs 
related to each other or which of the constructs was most important. Damschroder et 
al. (2009) argued that the inner setting ‘Contribute[d] to the complexity inherent in 
describing the many constructs related to the inner setting.’(p7) and that in particular 
it: 
may be composed of tightly or loosely coupled entities […] tangible and 
intangible manifestation of structural characteristics, networks and 
communications, culture, climate, and readiness all interrelate and influence 
implementation.  
(Damschroder et al. 2009 p5). 
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Example 6: LGBT Cancer study demonstrated strong networks internally but 
struggled as the outer setting, via the resources and political context, was not fully 
responsive to Joanne’s policy recommendations. This was despite the evidence of 
adequate PPI processes being in place.  
 
The domain of inner setting for Damschroder et al. (2009) has 12 constructs. The 
‘structural characteristics’ construct, Damschroder et al. (2009) demarcate as: ‘the 
social architecture, age, maturity, and size of an organization. … The number of units 
or departments represents diversity of knowledge in an organization [show 
importance]’ (p7). In this context, it could concern the organisation needing to adopt 
the ethos of PPI. But to do this it would also require leadership and the other constructs 
in favour of the implementation effort. In Example 3: Palliative Care study, Janine 
commented on the location the study was situated within (a palliative care research 
wing, within a university hospital). This positioning of her research centre, she argued, 
provided her study with a strong culture embracing the values and ethos of PPI. This 
example demonstrated flourishing impact of PPI on research outcomes because 
further funding and policy attention to her research findings were achieved, and there 
was presence of an ‘implementation climate’ for PPI. Damschroder et al. (2009) 
identifies the implementation climate as:  
the absorptive capacity for change, shared receptivity of involved individuals 
to an intervention…, and the extent to which use of that intervention will be 
'rewarded, supported, and expected within their organization.  
(p8)  
 
All of Janine’s research studies had PPI within them and many of her studies were 
follow on studies – this work was mature and reinforced over time, as were her 
relationships with the people involved. Therefore, PPI relies on networks and 
collaborations, a central theme in the current study. The ‘networks and 
communication’ of PPI concerned relationships and positioning of how powerful 
interventions such as PPI could be. Damschroder et al. (2009) outline that:  
the nature and quality of webs of social networks and the nature and quality 
of formal and informal communications within an organization. Research on 
organisational change has moved beyond reductionist measures of 
organizational structures and increasingly embraces the complex role that 
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networks and communications have on implementation of change 
interventions 
(Damschroder et al. 2009, p8)  
 
The data demonstrated the cancer network was at the centre of the success of the 
Cancer Survey (Example 2). They had the infrastructure and commitment to help lead 
findings into the implementation phase. The PPI factor of ‘ICT’ also links to this 
domain’s construct as ICT provided a visible profile outside of the groups about how 
PPI outcomes were to be used.  
 
But for PPI work to flourish, access to information and knowledge about PPI was 
necessary. For Damschroder et al. (2009, p9) this point offers the inner setting ‘ease 
of access to digestible information and knowledge about the intervention’. In the data 
to reflect this point, the issue of training was mentioned in almost every dataset. 
Connected to this was ‘available resources’ to help achieve good PPI. According to 
Damschroder et al. (2009, p9) available resources include: ‘the level of resources 
dedicated for implementation and ongoing operations including money, training, 
education, physical space, and time’. Not having this kind of support can lead to 
negative effects, as Barry mentioned in his interview when he described how easily 
values for PPI can ebb away if strong leadership was lacking. ‘Leadership’ for PPI 
values was important: ‘commitment, involvement, and accountability of leaders and 
managers…[…]with the implementation’ (p9). Government leadership (in support for 
the findings) was not observable in the Example 1: Oncology Consultation Tool, 
Example 4: Prostate Cancer study or Example 6: LGBT Cancer Study, even though 
these studies had PPI in the commissioning and research processes. 
 
Damschroder et al. (2009) observed ‘tension for change’ as: ‘the degree to which 
stakeholders perceived the current situation as intolerable or needing change’ (p8). 
Katy and Steven independently spoke of Example 2: Cancer Survey and how its 
results were challenging for underperforming healthcare trusts. There was also 
evidence of ‘compatibility’ of PPI plans between partners. Compatibility for 
Damschroder et al. (2009) was expressed as:  
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The degree of tangible fit between meaning and values attached to the 
intervention by involved individuals, how those align with individuals' own 
norms, values, and perceived risks and needs, and how the intervention fits 
with existing workflows and systems.  
(Damschroder et al. 2009, p8) 
 
Again, in the data this point was reflected in Example 2: The Cancer Survey, 
explaining how underperforming organisations would tackle the results of the survey.  
 
The compatibility element links to the ‘relative priority’ of PPI within an organisation. 
The term relative priority for Damschroder et al. (2009) concerns how: ‘individuals' 
shared perception of the importance of the implementation [in this case the 
implementation of the PPI] within the organization’ (p8). But these shared 
understandings need organisational ‘incentives and rewards’, i.e. rewarding good 
quality PPI. Damschroder et al. (2009, p8) refers to ‘rewards and incentives’ as: 
‘extrinsic incentives such as goal-sharing awards, performance reviews, promotions, 
and raises in salary, as well as less tangible incentives such as increased stature or 
respect’. In the data, cancer networks were praised for their quality work and co-
ordinated efforts towards achieving good services and progress for patients. 
 
‘Goals and feedback’ for Damschroder et al. (2009) concern ‘the degree to which 
goals are clearly communicated, acted upon, and fed back to staff…’(p9), which links 
back to the ‘learning climate’ about harnessing openness about concerns about PPI. 
A learning climate for Damschroder et al. (2009) proposes to be a climate where:  
leaders express their own fallibility and need for team members' assistance 
and input; team members feel … essential, valued, and knowledgeable 
partners in the change process; individuals feel psychologically safe to try 
new methods; [with]time and space for reflective thinking and evaluation.  
(Damschroder et al. 2009p9)  
 
There was a presence of a learning climate in impact examples 2, 3, 5, 6 but not in 
examples 1 and 4. Interestingly these two latter examples were the only studies which 
were not showing signs of PPI in implementation (these studies fell under pre-
implementation and partial implementation stages). In the literature, there were 
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examples offered by Brett et al. (2014b) reporting positive impacts of PPI on the 
patients and public, who felt valued and gained confidence and life skills. They 
reported that researchers found that involvement led to greater understandings and 
insights into their research area, gaining respect and a good rapport with the 
community. However, building links with the community also takes time and 
commitment. Thus, outcomes here may be whether an existing PPI group is in place 
for scrutinising the implementation efforts. Learning climate links to culture, and 
there was a belief that PPI interventions were not always embraced in academia, an 
‘ivory tower’ culture that promoted writing journal papers over organising community 
talks and events. This would suggest the need for cultural change to enable the impact 
of PPI on research outcomes. Damschroder et al. (2009) propose that culture in the 
inner setting concerns ‘norms, values, and basic assumptions of a given 
organization’(p8). 
 
On several occasions the point was made that incentive structures in academia are 
designed unfavourably away from PPI and that the REF is designed to maintain the 
ivory towers culture. For academics, research impact for REF was defined as ‘any 
identifiable benefit to, or positive influence on, the economy, society, public policy or 
services, health, the environment, quality of life, or academia’ (HEFCE 2014p. 26). 
But evaluating this type of impact is complicated. Rivera et al. (2017) found five tiers 
of impact across short- medium- and long-term time periods, although they do not 
explicitly state how many years each tier could take. The first tier proposed by Rivera 
et al. (2017) was primary-research-related impact, which the authors argued were 
immediate research outcomes such as journal papers. Their second category focused 
on influencing policy; the third tier involved health systems impact; the fourth tier 
was health-related and societal impact; and the fifth tier was broader economic impact. 
Based on these categories offered by Rivera et al. (2017), third-tier impact was 
observable in Example 2: Cancer Survey and second-tier impact for Example 3: 
Palliative Care. 
 
The twelve constructs of the inner setting offer ideas about what can and might be 
suitable for evaluating the impact of PPI on research outcomes.  Special attention 
needs to focus on PPI in leadership work, the use of ICT in PPI work (presenting the 
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outward-facing PPI via social networks and online platforms) and how various 
different PPI-focused networks (used by patients, researchers, charities and 
stakeholder) enable inner setting to be more effective.  
 
Table 28 - Evaluable characteristics of inner settings 
Inner setting Evaluable outcomes 
Structural 
characteristics 
Age of organisation? 
PPI in research history? (for example, is there an active 
PPI group?) 
Staffing levels? 
Networks and 
communication 
Which networks are working with the setting where 
translational work (pre, partial, during and post)/ 
implementation work has happened? 
What are the goals of the organisation around outcomes of 
PPI being met and how are these communicated with staff 
and those involved in the process. 
(RFI)  
- Access to 
information and 
knowledge 
Those who will be part of translational work, how are they 
being trained and how easily is training, or knowledge 
needed made available? Who will they go to if they need 
support? 
(RFI)  
- Available resources  
(RFI)- Leadership  How are leaders, managers and seniors committed to the 
work, what is their long, medium and short term 
commitment and understandings about the 
implementation/translational work plans  
(IC)- Tension for 
change 
How tolerable is the current situation? What will happen if 
the desired PPI outcome does not materialise?  
(IC)- Compatibility  What are the pros and cons of the PPI outcome and how 
easily can actions be taken on to help the PPI outcome 
take shape.  
(IC)- Relative 
priority 
Does everyone involved understand why the outcome is so 
necessary? 
Incentives and 
rewards 
How will success and good practice about the intervention 
be praised to help keep motivations alive about moving 
towards the PPI outcomes (the intervention) 
(IC)- Goals/feedback To what extent have goals been achieved about the 
implementation and how is this feedback to help the 
implementation plans internally? 
(IC)- Learning 
climate 
How are people able to express their self-doubts and how 
supported do they feel afterwards? 
Culture Are PPI involved in developing the intervention with the 
organisation, subconsciously does the organisation 
attempting the intervention with PPI, value community 
input or does the research organisation value publications 
and academic impact? 
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Domain 4: Characteristics of individuals of impact of PPI on research 
outcomes 
As the title suggests, this domain focuses on the people involved in carrying out an 
intervention. Damschroder et al. (2009) describe this domain thus: 
 
Individuals have agency; they make choices and can wield power and 
influence on others with predictable or unpredictable consequences for 
implementation. Individuals are carriers of cultural, organizational, 
professional, and individual mindsets, norms, interests, and affiliations. 
Greenhalgh et al. [2004] . describe the significant role of individuals: 'People 
are not passive recipients of innovations. Rather...they seek innovations, 
experiment…, evaluate…, find (or fail to find) meaning…, develop feelings 
(positive or negative) …, challenge…, worry…, complain…, 'work 
around'…, gain experience…, modify… to fit particular tasks, and try to 
improve or redesign them–often through dialogue with other users.  
(Damschroder et al. 2009, p5) 
 
In the six examples a strong cross cutting PPI factor was ‘Wanting to make a 
difference’. Damschroder et al. (2009) stated that there was little research focusing on 
the interplay between individuals involved in research and the organisation that they 
are part of. With patients and the public being the nucleus of what PPI concerns, this 
domain of the CFIR is highly influential, because here the characteristics of those 
involved will fuse between the patients and the public, researchers carrying out the 
PPI intervention, and other stakeholders affected by the research.  
 
There were five constructs offered under this domain, the first was ‘knowledge and 
beliefs about the intervention’. For Damschroder et al. (2009) this point relates to:  
individuals' attitudes toward and value placed on the intervention, as well as 
familiarity with facts, truths, and principles related to the intervention. Skill 
in using the intervention is a primarily cognitive function how-to knowledge 
and knowledge of underlying principles or rationale for adopting the 
intervention.  
(Damschroder et al. 2009, p9) 
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In the introduction to the study PPI was contextualised as a global policy imperative 
set by the World Health Organisation (WHO). Clinical breakdowns in the UK 
suggested that PPI could be a way of delivering safer care and a method of improving 
health services’ accountability, moving from paternalism towards patient 
empowerment (Ocloo and Fulop 2012). The UK government embraced the following 
principle from the NHS constitution: ‘The patient will be at the heart of everything 
the NHS does’ (Department of Health 2009). Arguably the link here to research 
outcomes is made logically, that health research will ultimately translate into the NHS, 
if done well. Thus, the knowledge and beliefs about the intervention require conveying 
eloquently and in a tailored way by those involved. In Example 3, Palliative Care 
study, Janine spoke of how she went to a conference to disseminate her research. In 
the audience was Patsy who worked in a hospice. Patsy was not convinced of Janine’s 
research. Although she praised the findings, her hospice was not heightened to change 
their practice. 
 
Damschroder et al. (2009, p9) state that ‘self-efficacy’ involves ‘individual belief in 
their own capabilities to execute courses of action to achieve implementation goals’ 
and linked to this is an ‘individual stage of change’. These are the ‘characterization 
of the phase an individual is in, as he or she progresses toward skilled, enthusiastic, 
and sustained use of the intervention’ (p9). The data found that the sentiment behind 
PPI in research concerned hope for change, the idea of democracy, equality, pragmatic 
insights into disease, and accountability.  
 
It is important to consider here the professional researchers who are part of the 
implementation process (professionally and in the PPI roles) because in the literature 
it was found that involvement opportunities were often undermined or controlled by 
the powerful (Beresford and Campbell 1994) and as a result involvement could end 
up being tokenistic or manipulative to advance professional interests (Milewa et al. 
1999). Martin (2008b) argued that because involvement initiatives were not 
representative, involvement was contingent on micro-level negotiations. Here the 
problem of legitimacy of knowledge arguments could be formed because involvement 
relies on self-selection as those that come forward for PPI roles are often from middle-
class cross-sections of society (Church et al. 2002). In the data there was striking 
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information about this point. Several patients spoke of how there were not enough 
patients and public for the growing demands of PPI work, and one patient was working 
out a strategy for removing those who had been involved for too many years.  
 
Furthermore, in this study, the entire patient group was white, nine of the 13 patients 
were women and all of the patients were over the age of 60. The researchers spoke 
during their interviews of how they found it hard to engage BME groups in cancer 
research for PPI activity (the point was raised in four separate interviews with 
researchers). What this suggests is that there is a huge barrier for BME groups to 
engage in PPI in research endeavours and that more work is needed to understand this 
anomaly. Dawson et al.’s (2017) review found that despite the widespread promotion 
and inclusion of PPI in the last ten years, involvement is limited in scope as to who is 
involved, with PPI activity not mirroring the diversity of the population. Perhaps the 
point of BME groups not engaging in PPI activity is rooted in some of the ‘other 
personal attributes’ mentioned by Damschroder et al. (2009), who argue that the 
characteristics of those involved need to include traits such as ‘tolerance of ambiguity, 
intellectual ability, motivation, values, competence, capacity [and] innovativeness’ 
(p10). People in BME communities, like others, may well have all of these traits, but 
the bigger issue for PPI work involving people with cancer might concern the stigma 
associated with the disease in BME communities (Elkan et al. 2007). 
 
Finally, the broad construct of ‘individual identification with organization’ concerns:  
how individuals perceive the organization and their relationship and degree 
of commitment to that organization. These attributes may affect the 
willingness of staff to fully engage in implementation efforts or use the 
intervention.  
(Damschroder et al. 2009, p10) 
 
Within the literature there was a strong case demonstrating a neoliberal agenda in 
healthcare. This point is relevant because the literature on healthcare demonstrated 
that rapid reshuffles of PPI structures were interpreted as an indication that something 
unclear was steering involvement initiatives. The changes also destabilised people’s 
understandings of what government was trying to do, by diverting attention away from 
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universal healthcare and its collectivist origins. The GEM report (2015) however, has 
shown how the agenda for PPI in research is strong and has a clear sense of direction. 
Thus, the effect on the ground for those conducting research, those engaging in PPI 
work and importantly those involved in developing PPI on research outcomes feeds 
off this strong steer and helps to generate a common starting point for everyone 
involved. The only data which reflected this was the work of Example 2: Cancer 
Survey. Steven described how he was invited through his network to attend an All 
Party Parliamentary Group on Cancer to discuss what the survey had generated. He 
discussed how satisfied he felt about the work and also of the network organisation 
which he belonged to. 
 
The effect of the domain of individuals involved, for understanding the impact of PPI 
on research outcomes, is complex. The meshing of values, pragmatic knowledge, the 
case of representation, the problem of stigma and clarity of involvement efforts all fall 
within this domain.  
 
 
 
 
Table 29 - Evaluable characteristics of the individuals involved 
Characteristics of 
individuals involved 
Evaluable outcomes 
Knowledge and beliefs 
about the intervention 
What are the intrinsic values of PPI on research 
outcomes? 
Who is selling the intervention and who is listening? 
How did the dissemination event broaden somebody’s 
thinking about PPI and the usability of the findings 
presented? 
Self-efficacy  Who is involved? What is their background on PPI on 
research outcomes? how representative do they feel to 
meet the outcome? How confident are they that they 
are the right person for the role to reach the PPI 
outcome? 
Individual stage of 
change 
What training is needed for the individual to make the 
PPI outcomes flourish? How enthusiastic are they 
about the outcome? 
Individual identification 
with organisation 
How willing are people to represent the organisation? 
What effort are they actively putting in to achieve the 
outcome of PPI? 
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Other personal attributes How tolerant/competent/innovative are people towards 
change? 
 
Domain 5: Process of implementation 
As mentioned above, the main aim of the current study was to consider how the impact 
of PPI on research outcomes might be better understood. Thus, the domain of the 
Process of Implementation is highly relevant. For Damschroder et al. (2009) it 
concerned four ingredients, planning, engaging, executing, and reflecting and 
evaluating. The latter point being significant for the current study as it concerns 
recognising the impact of PPI on research outcomes. They argued that: 
Successful implementation usually requires an active change process aimed 
to achieve individual and organizational level use of the intervention as 
designed. Individuals may actively promote the implementation process and 
may come from the inner or outer setting … The implementation process 
may be an interrelated series of sub-processes that do not necessarily occur 
sequentially. There are often related processes progressing simultaneously at 
multiple levels within the organization [Pettigrew et al. 2001]. These sub-
processes may be formally planned or spontaneous; conscious or 
subconscious; linear or nonlinear, but ideally are all aimed in the same 
general direction: effective implementation.  
(Damschoder et al. 2009 p5) 
 
Damschroder et al. (2009) state that for the ‘planning’ construct it is concerned with:  
the degree to which a scheme or method of behaviour and tasks for 
implementing an intervention are developed in advance and the quality of 
those schemes or methods. … The plan can be formal or informal but should 
consider all salient contextual factors–both modifiable and non-modifiable.  
(Damschroder et al. 2009, p10) 
 
Planning links to the factors of PPI concerning ‘PPI in dissemination’ and ‘PPI in 
implementation’ found in the data. These two factors were the only two themes which 
appeared to have a direct impact on research outcomes. They were both linked by the 
participants to tailoring messages and all people affected needing to work together. 
Linked to this construct was ‘executing’, which for Damschroder et al. (2009, p10) 
signalled ‘carrying out or accomplishing the implementation according to plan’. 
Existing research also suggest that this is a challenge in PPI. In the literature, Graham 
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et al. (2006) found at least 29 terms that refer to acting on findings; this presented a 
challenge for researchers and policy makers in applying new knowledge and how the 
terms differed slightly in meaning. For example, knowledge transfer represented the 
process of moving research-based knowledge or ideas from one area to another, 
supporting a culture of evidence-based decision making in healthcare (LoBiondo-
Wood and Haber 2005), suggesting that knowledge can be ‘rolled out’. But the 
knowledge-base for healthcare is diverse; from health management, health policy 
makers, through to clinicians, patients and the public, and the nature of these ‘agents’ 
is fragmented across healthcare (Walker 2007). There were reasons offered about why 
knowledge transfer presented difficulties. Including, knowledge being ‘sticky’ or 
difficult to share beyond the immediate setting (Szulanski 1996; 2000). The 
knowledge may also lead to problems associated with ‘absorptive capacity’ when 
trying to transfer it to healthcare staff (Cohen and Levinthal 1990), implying the new 
knowledge may not suit the staff or the setting in which it is being offered.  
 
The data reflected these points in places. The six impact examples in chapter seven 
demonstrated what change had taken place as a result of the PPI in the research study. 
It was striking that (in the PPI factor of ‘dissemination’) participants described the 
limits of academic dissemination in all of these studies (i.e. ‘planning’ versus ‘actual 
executing’). They stated that journal papers made very little impact but preparing 
information widely for a variety of people and using the help of patients and the public 
in the dissemination process did make an impact.  
 
This point was also made by Delphi panellists. Clarity between dissemination and 
implementation was achieved via these examples, which show that dissemination was 
seen to be about reporting and planning what to do next, whilst the implementation 
factor of PPI concerned action and actual change – research outcomes. In chapter five, 
Janine (a researcher) spoke about how her Palliative Care study (Example 3) work 
was making good progress with major policy attention, yet Patsy (a stakeholder 
working in a hospice) argued that, for her, it was one study and that was not enough 
to change practice in her hospice. Thus, the idea of knowledge transfer is sensitive to 
wider research in the field: only when there was evidence of alignment (in this case, 
the alignment of highly sensitive issues to their practice), would Patsy’s hospice adopt 
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Janine’s findings. Whilst these examples demonstrate that PPI was part of the study it 
also demonstrates that PPI had little influence over practice change because ultimately 
knowledge needs to be assessed against other salient issues.  
 
Damschroder et al. (2009) state that ‘engaging’ concerned:  
Attracting and involving appropriate individuals in the implementation and 
use of the intervention through a combined strategy of social marketing, 
education, role modelling, training, and other similar activities. Engaging 
members of teams tasked with implementing an intervention (or to be 'first 
users') is an often overlooked part of implementation… It is vital that early 
members are carefully and thoughtfully selected or allowed to rise naturally.  
(Damschroder et al. 2009 p11)  
 
They identified four types of leaders to engage: opinion leaders, formally appointed 
leaders, champions and external change agents. Opinion leaders for Damschroder et 
al. (2009, p11) are: ‘formal or informal influence on the attitudes and beliefs of their 
colleagues with respect to implementing the intervention … experts and peers’. The 
formally appointed leaders are: ‘Individuals from within the organization who have 
been appointed with responsibility for implementing an intervention’ (p11). Engaging 
champions concerns:  
Individuals who dedicate themselves to supporting, marketing, and driving 
through an [implementation]…A defining characteristic of champions is 
their willingness to risk informal status and reputation because they believe 
so strongly in the intervention 
(Damschroder et al. 2009 p11). 
 
Lastly, external change agents are: people from outside the organisation ‘who formally 
influence or facilitate intervention decisions in a desirable direction’ (p11).  
 
Not surprisingly, collectively there was a feeling across the participants that the 
‘significance of power and leadership’, or input from particularly influential 
individuals, could enhance the likelihood of achieving research impact. The data 
confirmed that leaders were thought to be a variety of different types of individuals 
ranging from expert cancer patient ambassadors, to cancer charity patrons, as well as 
celebrities living with cancer. The more conventional ‘top-down’ leaders readily 
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associated with healthcare change were also discussed, such as: cancer ‘tsars’, 
government health officials, cancer policy-makers, cancer researchers and NHS 
cancer service managers. However, the former group (expert cancer patient 
ambassadors, cancer charity patrons and celebrities living with cancer) can be 
identified as ‘new leaders’ in implementation, a term borrowed and adapted from 
Kelleher’s work on ‘new social movements’ (2001).  
 
It seemed that several patient participants aspired to and took steps to become these 
new leaders; they discussed how they regularly checked their smartphones for 
requests to join new research trials as co-applicants. They had technology savoir-faire. 
Some even wrote their own personal blogs about their input in health research. Some 
were avid Tweeters using the social network Twitter and had a large group of 
followers (people who had chosen to read their Tweets). In some examples, they had 
enlisted mass media support. They had highly visible profiles in PPI work, often 
supporting several studies at one time, and had enthusiasm and support to influence 
decision-making. One patient described how he had successfully influenced decisions 
as he was invited on more than one occasion to speak at the All Party Parliamentary 
Group on Cancer.  
 
New leaders have emerged from outside of the traditional forms of management and 
leadership found in the public sector. These opinion-formers showed strong 
personalities after their cancer treatment had finished. Perceptions of patients and 
policy makers suggested that powerful and high-profile personalities like expert 
cancer patients/carers had a role in policy making but it is difficult to draw any 
concluding ideas about PPI activities that are appropriate and effective for policy 
development (Conklin et al. 2012).  
 
The construct of ‘reflection and evaluation’ for Damschroder et al. (2009) was about 
being on top of:  
quantitative and qualitative feedback about the progress and quality of 
implementation accompanied with regular personal and team debriefing 
about progress and experience. 
(Damschroder et al. 2009 p11).  
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A major gap in information about the evidence base concerning the impact of PPI on 
research outcomes was identified about reflection more specifically by Wilson et al. 
(2015). Furthermore, Wilson et al. (2015) and Daykin et al. (2007) identified that a 
longer time period was needed to understand and assess the impact related to PPI on 
research outcomes. 
 
In relation to the evaluation point by Damchroder et al. (2009), one distinctive aspect 
of PPI as a complex intervention is that it could help bring a unique focus to 
implementation work, as patients and the public remain patients and the public, even 
when researchers move on to new ventures, thus the current author proposes 
evaluation for PPI to be carried out at different stages. Brocklehurst et al. (2017) 
argued that:  
...[guidelines and frameworks] can help to understand the conditions or 
features which support intervention effectiveness, its implementation and 
ideally, how to achieve sustained practice change  
(Brocklehurst et al. 2017, p333).  
 
This could mean that by following implementation guidelines during research conduct 
(pre-implementation stage) there are opportunities for up-to-date knowledge and the 
iterative application of information about knowledge translation, exchange and 
transfer. Therefore, impact can be assessed and traced more easily as the impacts 
emerge over time and the perspectives remain fresh.  In the current study, data 
demonstrated that the impact of PPI on research outcomes is assessable in at least four 
stages.  
 
Following Rivera et al. (2017) who suggest that impact of research in general can be 
assessed in the short, medium and longer term, the impact of PPI could also be mapped 
against a similar time line. ‘Pre-implementation’ could be a suitable first point to 
assess the impact of PPI on research outcomes i.e. studies which are presenting similar 
outcomes to Example 1: Oncology Consultation Tool study where a PPI group has 
dissolved and the study has ended. Further evaluation of PPI on research outcomes 
could be formed when partial implementation is observed, e.g. when some 
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recommendations of a study have been taken up but other recommendations have not 
i.e. the Example 4: Prostate Cancer study. Then more evaluation can be carried out 
when new implementation work is being achieved i.e. the Example 5: Cancer Genetics 
study and Example 6: LGBT Cancer study both of these groups had an active group 
of patients supporting the implementation work – this would fall under the ‘during 
implementation stage’. Finally, to consider the contribution post-implementation, 
longitudinal work could allow PPI to be assessed as impacts emerge over time (Rivera 
et al. 2017). This was the stage Example 2: Cancer Survey and Example 3: Palliative 
Care was at and these studies had with their PPI groups moved into a new phase of 
work. 
 
There are obvious aspects attached to CFIR model of evaluation proposed that need 
careful consideration, such as who would conduct the evaluations, who would fund 
the evaluation, and for how long the evaluations on PPI would continue. However, 
currently, with the duty and ambivalence placed on PPI, the idea of the evaluation of 
PPI and its outcomes as a complex intervention requires resources, commitment and 
time. The domain of Process of Implementation is therefore highly important for the 
study of PPI (as a complex intervention) for achieving understandings about the 
impact of PPI on research outcomes.  
 
 
 
 
 
Table 30 - Evaluable characteristics of process 
Process Evaluable outcomes 
Planning How messages have been tailored for implementing PPI on 
research outcomes 
Knowing the timing for evaluation 
How needs have been met 
How goal have been achieved  
Executing  Should executors of change be direct/indirect 
(E)- Opinion 
leaders 
Blogging, tweeting about the intervention, How many 
tweets/retweets have occurred. 
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Conclusion 
The discussion in this chapter offered an original contribution to knowledge in three 
ways: 1) demonstrating that PPI can be considered as a complex intervention (Craig 
et al. 2008); 2) therefore, as a complex intervention, PPI can be evaluated using the 
CFIR (Damschroder et al. 2009) and showing evaluable PPI outcomes; and 3), by 
focusing specifically on the domain of process of implementation, we can develop 
improved understandings about the impact of PPI on research outcomes. In turn, this 
allows the advancement of PPI and implementation theory in new directions; 
specifically, in terms of impact of PPI on research outcomes. 
 
Using mixed methods data about perceptions of impact of PPI on research outcomes, 
the thesis shows in principle, how PPI can be evaluated using the CFIR model. Given 
the aim of this PhD was to consider PPI on research outcomes specifically, the 
discussion here draws attention to PPI on research outcomes which can be 
obtainable/observable via the domains of intervention characteristics (outcomes listed 
in table 26); outer setting (outcomes listed in table 27); inner setting (outcomes listed 
in table 28); characteristics of individuals involved (outcomes listed in table 29); and 
process (outcomes listed in table 30). The third original contribution concerns the fifth 
domain of process of implementation. This study has found that to evaluate the impact 
of PPI on research outcomes, evaluators need to be sensitised to chronology because 
the very nature of research is ongoing, thus context will change and may become 
favourable or unfavourable towards implementation efforts, and the outcomes of PPI 
are changeable because they respond to context. The essence of PPI on research 
outcomes concerns this domain more than the other domains because currently there 
(E)- Formally 
appointed leaders 
What is the style of leader, the method of leading and sharing 
success. 
What authority/credibility do they have? 
What risks they are willing to take/have they taken for the 
intervention? 
Balancing a space for working in and yet being physically 
close enough to the implementation process 
(E)- Champions 
(E)- External 
change agents 
Reflections and 
evaluations 
Is the evaluation pre, partial, during or post implementation 
evaluation. Where on Rivera et al. (2017) table do the 
outcomes sit? 
Goal progress 
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are no tools for specifically assessing the impact of PPI on research outcomes and this 
domain of the CFIR draws attention to how context, mechanism and outcomes 
interact. 
 
The CFIR offers insights into PPI-related expectations and outcomes for those who 
are carrying out the intervention and evaluation and of those affected, such as end 
users involved and patients and the public. Thus, the CFIR provides a comprehensive 
taxonomy of influences which might affect how complex interventions such as PPI 
might be assessed for evaluation.  
 
The caveat to PPI being a complex intervention and applying the CFIR is that PPI 
aims and objectives must be explicitly and specifically defined from the outset. This 
is raised here as a caveat because it is acknowledged that PPI is sometimes carried out 
for its own sake rather than as an intervention with intended outcomes. Thus, point 
four about what outcomes the evaluation is assessing raised by Craig et al. (2009) will 
need careful thought if adopting PPI as a complex intervention. 
 
Although PPI as a complex intervention suggests a macro-level identity, at a closer 
level of scrutiny, the analysis demonstrates highly sensitive micro-level cohesion, and 
meso-level logistics. The macro factors at a deeper level concern: the values placed 
on PPI by government and funders; how PPI is sold as the answer; the relative 
advantage placed on PPI; how adaptable the PPI plans are to suit and trial PPI work; 
having the funds to pay for it in the first place; and managing it in a cohesive way.  
 
At an outcomes level, the ability to assess the impact of PPI becomes complex because 
sometimes the intervention is not defined, and assessment becomes weak. 
Damschroder et al.’s (2009) constructs of adaptability, complexity and trialability 
helps PPI to be recognised as a complex intervention and complements Craig et al.’s 
(2009) definition of complex interventions. The participants did not mention complex 
interventions explicitly but judging by how they have described PPI and its tricky 
strategies, mixed values, influential components, needs and problems, they do all 
imply the hallmarks of a complex intervention. These points lead (or not) to impact 
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(the outcomes). Undoubtedly logic tells us that the CFIR suits complex intervention 
evaluation ideas because PPI is confounded by context process-and outcomes-related-
aspects. 
 
The outer setting for PPI as a complex intervention in research can be summarised as 
external issues which are outside of the control of implementers. Patient needs and 
resources, cosmopolitanism, peer pressure and external policies are investments for 
PPI. These investments are channelled in the form of PPI leadership and strategic 
direction holding onto PPI’s values as an anchor for its investment efforts. Without 
resources and political backing, and power and leadership, PPI efforts are sensitive to 
failure and tokenism.  
 
The twelve constructs of the inner setting for PPI as a complex intervention in research 
offered reflections of individuals involved and the mixing of values and pragmatic 
knowledge, the issue of representation, the problem of stigma and clarity of 
involvement efforts all affect this domain.  
 
Lastly, the domain of process of implementation is highly important for the current 
study of PPI as a complex intervention for achieving research impact. When research 
ends and implementation begins, resource allocation is a sensitive topic. The 
consideration of impact of PPI on research outcomes could send a beacon of 
confidence to all involved in the process, because the public and patients have been 
engaged/involved in the design of implementation plans. Boutin et al. (2017) argues 
that a number one priority for culture change requires stakeholder organisations to 
effectively communicate change messages, whether positive or negative. This 
includes whether the issues of change concern addressing a waste of resources or 
endorsing a message, a particular new policy or a research study offering investment. 
There are no doubt many professed benefits associated with the assessment of research 
impact more generally, including: (1) assessing the quality of the research and its 
subsequent benefits to society; (2) informing and influencing optimal policy and 
funding allocation; (3) demonstrating accountability, and the value of research in 
terms of efficiency and effectiveness to the government, stakeholders, and society; 
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and (4) maximising impact through better understanding the concept of, and pathways 
to, impact (Rivera et al. 2017).  
 
However, this research was specifically about the contribution that patients and the 
public made to research impact. The lack of clarity in this area has given rise to a 
poorly monitored and complex fields of activity, leading to unclear expectations from 
research funders, policy makers, host organisations, researchers, health activists and 
volunteers (Madden and Speed 2017). This poses a threat to the impact of PPI on 
research outcomes because if the field is not carefully monitored, PPI efforts will fail. 
In this study, Damschroder et al’s (2009) framework was used retrospectively. There 
are some limitations to using the CFIR retrospectively and two criticisms are offered 
here. 
 
First, it has been suggested that the CFIR model does not help researchers decide or 
prioritise which aspects of an interventions to evaluate (Williams 2011). Instead, the 
model suggests that equal importance is placed on all domains and constructs, leaving 
the researcher to approach the CFIR in a ‘pic ‘n’ mix style’, which Williams suggests 
is therefore a limitation of CFIR. 
 
The second, related criticism concerns questions of transparency and the justifications 
used for adopting specific CFIR constructs and domains. In a review looking at the 
ways in which the model has been used, it was found that researchers had used a 
variety of constructs for evaluation (Kirk et al. 2015). Furthermore, they found that 
these researchers often offered little description of methods or logic for selecting 
particular CFIR constructs or domains. Thus, the reasoning behind use of specific 
domains and constructs is sometimes lacking and needs to be made explicit (Kirk et 
al. 2015). 
 
This should not necessarily be seen as an inherent flaw of the model itself, however, 
and Damschroder et al. (2009) recommend and invite discretion in the selection of 
domains and that researchers using the model should explicitly report the decision and 
rationale for selecting domains and constructs. This suggests that the omission of 
reporting noted by Williams (2011) sits with individual researchers applying the CIFR 
and not within the CFIR model itself.  
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In the current study it has been made clear that for PPI in research, the CFIR domain 
of ‘process of implementation’ is highly important to help with evaluating the impact 
of PPI on research outcomes and hence to be prioritised.  
 
We now know, through accounts and perceptions of the participants from this study, 
to what extent PPI made a difference to research outcomes, which was initially a gap 
in knowledge (Mockford et al. 2011). We also now know, through the participants’ 
accounts, the extent and types of factors which have affected the implementation of 
research findings into policy and practice, which the literature review had also 
highlighted as absent (Staniszewska, 2011). Furthermore, we now understand at an 
implementation level, what and why difficulties are present for PPI evaluation. This 
study was designed to address these knowledge gaps and to some extent has now 
revealed new information about how to evaluate the contribution of PPI to research 
outcomes. The final two chapters offer a conclusion, starting with a reflective account 
of PPI in this present PhD study. 
 
  End user involvement influencing this stage 
 
September 2018 raising awareness of the current study and its findings. After submitting 
the PhD and before the viva, involvement in the form of consultation and engagement 
with an existing Leicester, Leicestershire and Rutland PPI group of older people at the 
University of Leicester occurred, 10 patients and the public were present. 
 
The overall idea of using Damschroder et al. (2009) was presented to the group, and a 
general discussion about the domains and constructs was offered. The group were invited 
to constructively critique the model for evaluation purposes. They were enthused by the 
idea of how helpful the CFIR was and agreed that the model works as a way to evaluate 
PPI generally. They discussed other ideas for disseminating this research study including a 
public lecture on the topic and academic publications. 
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Chapter Nine: Reflections on end user involvement in this PhD 
 
This chapter reflects on the end user involvement in this PhD study. As a reminder, in 
the critical narrative review (chapter three), the Guidelines for Reporting Involvement 
of Patients and the Public 2 (GRIPP2) (Staniszewska et al. 2017) was described as a 
way forward for helping to achieve better quality in the reporting of PPI in studies. 
GRIPP2 was developed to help researchers to report on how PPI worked, in what 
context, for whom and why and is itself based on some very recent understandings 
that have emerged in published research. Whilst the majority of this present study was 
completed prior to the publication of GRIPP2, deploying it as an assessment tool 
following the research does provide a helpful way to evaluate how involvement has 
shaped the present study.  
 
In the critical reflection section of their paper, Staniszewska et al. (2017) invite 
researchers to: ‘Comment critically on the study, reflecting on the things that went 
well and those that did not, so others can learn from this experience’ (p.4). Taking 
this steer, the author has decided to use this present chapter to explore some of her 
own questions in relation to PhD involvement in this study: 
 
1. What is role of ‘PPI’ in a PhD?  
2. Who are the people involved in a PhD study and can a mix of lay and 
professional knowledge work?  
3. Where - how did I find the people to take part in this PhD study? 
4. Managing - how is PPI in a PhD managed when there are resource 
implications?  
5. When - the frequency of PPI encounters in a PhD study and the implications 
of time.  
6. How was my experience unique? 
 
The chapter is organised around these questions, outlining the issues faced, resolutions 
taken and offering suggestions for how PPI might further be improved. 
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Before commencing this process of reflection, it is worth restating how involvement 
has shaped this research and the nature of the impact of PPI on this study. Table 6 in 
chapter four demonstrates that the involvement of end users has had an impact on the 
current study in a number of ways, notably through the research design, 
methodological decision making and to aid conceptual clarity. Involvement occurred 
during key phases including: study aims development; research design for both 
phases; piloting questions for fieldwork in both phases; analysis in both phases; and 
discussion planning. Involvement encounters occurred mostly in the form of face-to-
face meetings and sometimes remotely (over email and telephone). Overall, 13 
involvement events occurred over the course of the study (on average, twice yearly). 
All involvement was at a consultative level (Hanley 2005). 
What is the role of ‘PPI’ in a PhD?  
By its very nature a PhD requires researchers to work independently (Dunleavy 2003). 
Yet PPI in research is about working with people (INVOLVE 2012). From an 
epistemological point, this can result in a difficult balance between the process of 
independent thinking whilst working with end users. Linked to this were questions 
about who the genuine end users were i.e. patients and the public using services and 
those working in organisation (Tarpey 2013) and how they could shape this work 
without compromising the need for independent doctoral research. As Dunleavy 
(2003) reminds us:  
‘Independent critical power’ is almost as vague a criterion as ‘originality’… 
presumably the idea here is that the thesis author shows … some significant 
theoretical or thematical argument …from a perspective of her own. 
(Dunleavy 2003, p23) 
 
Liabo et al. (2018) argue that PPI has inherent power imbalances and that to begin to 
solve these requires patient partners to be made more than mere data providers. 
Instead, ‘patient partners are included at all stages of the research’ (p1). In this study, 
this presented particular challenges because originality required independence, yet 
involvement required levels of co-dependence. There is no guidance about how to 
resolve this, so the idea of what constitutes ‘meaningful and relevant’ involvement 
was considered here (Wright et al. 2010). Thus, information that was provided about 
this PhD at involvement events needed be concise with a focus about the purpose. It 
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was explained at the beginning that in this study ‘PPI is not like involvement in funded 
research studies because it is a PhD research study and today help is needed to 
understand your thoughts on…’. This approach worked mostly for the current study. 
But there were times when influential thoughts became difficult to disentangle 
because many ideas were discussed at involvement workshops and how some of these 
ideas could shape the thesis. For example, when data collection phase 1 was 
completed, three ‘making sense of the data’ workshops were run. The sole purpose 
was to offer an opportunity for people to comment on the early development of codes 
formed (see Appendix 7 and pg. 97-99) and these workshops helped me to analyse 
and interpret what the data meant. However, when the data were presented to end 
users (researchers and academics), it became quickly apparent that the data were too 
broad, which would not help in evaluating of impact of PPI.  
 
Having been immersed in data until that point, some questions triggered a discussion 
amongst academic end users which later led to ideas about regarding PPI as a complex 
intervention (Craig et al 2008), but at the time, complex interventions were not 
considered in the discussion explicitly. On reflection these workshops helped with 
conceptual mapping. The idea of balancing ‘independent thought’ and PPI in PhDs 
requires some attention, as the number of PhD studies featuring involvement 
continues to grow (e.g. Thompson 2009 and Robinson 2015). In the case of both 
Thompson and Robinson’s studies, the same group of people remained throughout as 
part of the involvement process, so input was described as tense at times, and perhaps 
even harder to balance than for the current study. In the current study, as end users 
were potential patients, researchers and stakeholders, there needed to be balance of 
perspectives, thus it was less of a difficult issue to manage, but for PhDs with 
considerably more involvement, this may become a more complex challenge. 
However, mixing lay and professional views brought its own challenges, discussed 
next. 
Who are the ‘PPI’ in a PhD study and can a mix of lay and professional 
knowledge work? 
An end user can be someone who is likely to make use of the study results. These are 
people who are often most affected by the research, including patients and healthcare 
professionals (Farrington 2016). Therefore, for the current study the people most 
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likely to be affected ranged from academics to patients and the public. But the problem 
with the former group at an involvement level meant there was danger that 
‘involvement’ could be misunderstood as a ‘research seminar’ where academics 
would attend the workshop with a set of expectations different to my own. Despite 
explaining in emails that the workshop was about addressing the involvement element 
to the PhD, there would be conversations with colleagues about what they had thought 
the workshop was about and what it was actually about. Therefore, it was sometimes 
difficult to explain to colleagues with mutual interest on the topic that their input was 
at an involvement consultation level inviting deliberation on whatever was planned. 
Consultation concerns asking people for their views and using these views to inform 
your own decision making (INVOLVE 2012). This differs from a traditional research 
seminar and reconceptualises the role of an academic as an ‘end-user’.  
 
Similarly, patients and members of the public where also confused when they would 
hear that academic researchers were part of the involvement process for this work 
because it was sometimes questioned how professionals could offer an ‘end user’ view 
about a topic which broadly affected PPI, because in their minds involvement was 
about patients and the public contributing and not ‘professionals’. Here the arguments 
of lay verses scientific knowledge arise (Popay et al. 2003) and feature within the PhD 
study – another point not recorded anywhere in the literature. More work is needed to 
establish the challenges relating to this point.  
Where did I find ‘PPI’ for this PhD study? 
As no guidance is available on where to find suitable end users for a PhD study, the 
following initiatives were taken. Before involvement was planned with patients and 
the public, the opportunity to input this work was made possible by a patient forum 
the researcher had set up for her professional work as PPI adviser. Thus, patients and 
the public were already interested in the impact of PPI and this research. Some were 
affected by cancer research themselves, they were all geographically close in 
proximity, willing to help, interested in the study and available to offer comments at 
a given time (Dörnyei 2007). In research terms this approach matches convenience 
sampling ideas (Taub et al. 2014). Over the course of the study over 70 patients and 
members of the public have been part of involvement processes but for resource and 
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time constraints, most participants have come from one region - the East Midlands. 
Thus, a criticism of this approach may concern how representative these people are 
(or not) (Martin 2008b) and their involvement is therefore highly likely to generate 
localised understandings (Veronesi and Keasey 2015). Despite this, localised 
knowledge can be beneficial. INVOLVE itself recognises the importance of local 
level work: ‘INVOLVE takes forward its work by: working with others at a national 
and local [level]…’ (NIHR 2016). For the current study this suggests that even highly 
localised involvement is useful and important because it offers some perspectives 
beyond the researcher’s. 
 
Similarly, ‘end users’ were also academics who were also found locally, via university 
research networks across the two local universities (DMU and University of 
Leicester). Over the course of the study around 45 academic researchers have attended 
workshops (in addition to those who featured as researcher interviewees in the current 
study). Many end users were already known professionally to the researcher and 
therefore professional contacts offering an ‘end user’ perspective may have been as a 
result of people feeling obliged to help by attending out of goodwill and collegiate 
support rather than them being genuine ‘end users’ of cancer research. But academic 
discussions did extend the scope of the study through insightful contributions, e.g. 
especially how the REF impact definition was of primary concern for those working 
in academia. Therefore, these types of contributions were valuable despite localised 
input for a study which potentially has national relevance. 
Managing PPI in a PhD when there are resource implications?  
Managing a PPI process in this PhD concerned thinking creatively with the resources 
available. Involvement in this work was carried out without a tight budget. This meant 
that university rooms were hired for free and involvement sessions often ran during 
lunchtime when workshops were taking place within the university setting. 
 
Where possible ‘piggy-backing’ on existing PPI events was carried out (Parker and 
Tritter 2006). For example, the patient and public ‘making sense of data workshop’ 
was a final afternoon session at a pre-existing PPI event that the researcher had co-
convened. As the workshop was not part of the official event, in the event email 
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correspondence sent out to people who had said they were attending, it was explained 
that a workshop was taking place after the event and people could leave after the 
session before the workshop. But most people stayed and because the event covered 
their expenses, the workshop was made possible. No refreshments were provided at 
any time of the involvement during the PhD. The lack of resources argument is well 
grounded in the PPI literature (Florin and Dixon 2004). Based on this experience it 
would be recommended that higher education institutions consider setting up 
resources for PhD students to cover the costs of PPI. PPI is increasingly being taught 
in HE degrees at graduate and post-graduate levels (Fundamentals of Research 
Module handbook (UOL) 2018) with a central message that research must have PPI, 
yet the lack of resources to support PPI work is commonplace. 
When – the frequency of PPI encounters in a PhD study and the implications 
of time? 
Without the PPI in this study – the study would have been submitted earlier. The 
implications of the time that PPI takes, must not be taken lightly. Time pressures faced 
by researchers is a well-known barrier for PPI (Florin and Dixon 2004; Pandya-Wood 
et al. 2017). It is important to note that the length of time taken to complete the current 
study has been eight and a half years. Having taken two maternity breaks (2012 and 
in 2015, 27 months in total) contributed to a feeling that inviting input from end users 
was a burden on me as a researcher (RDS PPI handbook 2014). This was especially 
the case after the second period of leave.  
 
However, having committed to the process, PPI needed to be carried out. I would 
argue that research institutions need to fully consider how the PPI in the research 
agenda links within the Athena Swan charter. Athena Swan is an equality challenge 
that UK universities are embracing (Athena Swan 2018). If research is increasingly 
expected to have PPI, then women researchers will have extra challenges. A genuine 
problem I experienced was managing this research with PPI and balancing career 
breaks to have children. The institution I am part of was accommodating towards this, 
but PPI does exacerbate the time pressures already placed on women having career 
breaks and conducting research. Supervision notes from November 2016, March 2017 
and June 2017 discuss involvement and maternity breaks and the added implications 
of time. 
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How was my experience unique - a symbiotic relationship? 
An important issue which was raised in GRIPP 2 concerned the ‘context’ of the study 
(Staniszewska et al 2017). When the study started in 2009, very little was known about 
the impact of PPI. But particularly after the phase 2 data were collected, PPI in 
research was becoming well-grounded in the literature. New publications were more 
frequent and funded national studies about PPI and impact were starting to publish. 
All of these aspects were exacerbating the pressures of a part-time nature of the PhD. 
But the involvement workshops needed to happen and required careful planning in 
personal PhD time. However, on a positive note as more PPI related publications were 
coming out, interest in this study was also growing. At the last two involvement 
workshops entitled ‘the discussion – seeing the wood from the trees’, 24 people 
attended, which suggested increasing interest. 
 
End-user involvement in research helped to heighten researcher awareness and 
organise the ‘messy data’ in a useful way. Certain aspects could only be dealt with at 
the right times (after ‘end user’ involvement had taken place). For example, there were 
times when I wanted to make my own research judgements but having committed to 
end-user involvement and its values, certain tasks could only be dealt with after a 
discussion with people who were likely to use the work.  
 
Therefore, I argue that being a PhD student researcher studying PPI and working as a 
research practitioner advocating for PPI in research studies, combines to make a 
unique experience. It was clear that there was a symbiosis of the two roles relying on 
each other. i.e. PPI with patients and the public being made possible at workshops, as 
a result of my role as PPI lead, and the role of PPI lead allowing me to ask the question 
in the PhD which mattered to those on the ground conducting studies. This is a highly 
privileged and unique position for a PhD study. 
Summary 
In this chapter I have described a reflective account of how PPI has affected the 
research process and how PPI problems in this study have been and could be further 
addressed, so that future PhD researchers can consider how PPI can feature in their 
own PhDs and how HE can support this. By answering some pertinent questions, I 
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have reflected on my unique experience. Firstly, a reflection is offered about 
independent study of a PhD on PPI which required a level of co-dependence. 
Guidance is lacking and is needed to help future PhD students on how to achieve a 
balance of independent thinking but also to consider what is meaningful and relevant 
in a PhD about ‘PPI’. I also argue that in a PhD a mix of lay and professional 
knowledge from PPI is helpful as it offered insights about different end users views. 
It is clear that scientific and lay knowledge differences may arise as a result. I argue 
that highly localised ‘PPI’ for this PhD study was suitable despite its national 
relevance. I also reflected on how to manage PPI in a PhD when there are no resources. 
By thinking creatively, I was able to overcome challenges about expenses which 
meant that patients and the public were not left out of pocket. A part time PhD on PPI 
studied by women who take career breaks demonstrates that universities need to 
carefully consider how PPI efforts are encouraged within their institution’s Athena 
Swan equality challenge. Finally, I argue that my experience was unique because of 
practicing and studying PPI simultaneously. In the next chapter, a conclusion of the 
study is offered. 
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Chapter Ten: Conclusion 
Introduction 
This concluding chapter will consider how the current study has achieved its aim of 
advancing knowledge about how to evaluate the impact of PPI on cancer research 
outcomes. It will also consider ways that the study can be used and applied to build 
further knowledge. The aims of the study are re-stated, followed by a summary of how 
these aims have been met. A discussion is offered about key findings and their 
implications for future research and governance. The limitations of the study are 
considered concerning the location, methods and the lack of BME participants. The 
future directions of publications and further research recommendations from this work 
are mapped out. Lastly, an autobiographical account is presented considering how this 
present doctoral experience has shaped the identity of the author, as an independent 
researcher and as a person. 
How the aims and objectives have been met 
Knowledge about how to evaluate the impact of PPI has been gaining momentum 
across healthcare (Mockford et al. 2011). However, whilst some progress has been 
made to understand the impact of PPI on research processes (Staley 2009), little work 
has considered the effects of PPI on shaping the outcomes (Staniszewska et al. 2011). 
Some authors suggest that PPI has the traits of a complex intervention because PPI 
has various contexts, mechanisms and outcomes which require simultaneous 
evaluation (Brett et al 2014a). But at a research outcomes level, there are insufficient 
understandings about longer-term effects of PPI on research outcomes (Wilson et al. 
2015). This study set out to explore these gaps. Specifically, this exploratory and 
inductive social science research study aimed to advance knowledge about how to 
evaluate the impact of PPI on cancer research outcomes. The objectives were: 
1. To explore perceptions of and experiences relating to the impact of PPI on 
research outcomes amongst patients, researchers and stakeholders involved in cancer 
research  
2. To identify factors which affect the implementation of PPI informed research 
findings in policy and practice 
3. To enhance and refine understandings of factors that shape the impact of PPI 
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4. To enhance knowledge and understanding about the link between 
implementation theory and how evaluation of impact of PPI on research outcomes 
might be achieved. 
 
Data from 23 interviews and a Delphi survey identified common factors which acted 
as barriers or facilitators towards PPI having an impact on research outcomes: 1. 
‘Wanting to make a difference’; 2. ‘PPI in research processes’; 3. ‘Information and 
Communication Technology (ICT)’; 4. ‘Networks’; 5. ‘Dissemination’; 6. ‘The 
significance of power and leadership’; and 7. ‘Resources and the political context’; 8. 
‘PPI in commissioning’; and 9. ‘PPI in implementation’. The data demonstrated that 
PPI context and PPI processes were vital components towards achieving PPI 
outcomes.  
 
Following the interviews and Delphi, the identification of these contributory ‘factors 
of PPI’ were further analysed which resulted in six examples of PPI. These six 
examples offered insights into how such impact can be evaluated at different stages 
across different research studies. Across the six examples a journey was observable 
for stages of when evaluation of PPI may be possible. This helped to consider the 
evaluation of impact of PPI in four distinct ways, these were: pre-implementation, 
partial-implementation, during-implementation and post-implementation-evaluation. 
Thus, the adoption of a mixed method, sequential design, contributed significantly 
towards the staged evaluation of PPI because the factors of PPI were combined from 
interviews and the Delphi survey, suggesting that mixed methods were necessary to 
gain a stronger insight into what can be evaluable about PPI on research outcomes. 
The six examples from Phase 1 only became notable once data from Phase 2 were 
found to feedback into Phase 1 analysis.  
 
To offer an original contribution to knowledge, this study has argued first that PPI can 
be considered as a complex intervention (Craig et al. 2008). Secondly, that as a 
complex intervention, the impact of PPI on research outcomes can be evaluated using 
the Consolidated Framework for Implementation Research (CFIR) (Damschroder et 
al. 2009). Thirdly, using the CFIR, particularly the domain of ‘Process of 
implementation’, helps to draw out new theoretical insights about the evaluation of 
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impact of PPI on research outcomes by enhancing understandings about PPI 
implementation and evaluation theory.  
Implications of the current study on future researchers 
PPI has been characterised as a complex intervention (Brett et al. 2014, Wilson et al. 
2015) This thesis has extended this idea to consider how we might evaluate the impact 
of PPI on research outcomes by applying it to the characteristics of complex 
interventions set out by Craig et al (2008). In this respect, evaluating PPI outcomes 
then allows for external issues (such as the funding made available for PPI) to be taken 
into account. However, in order to evaluate complex interventions, a framework is 
required that will take account of the many different interacting components. Whilst 
conceptual tools such as Normalisation Process Theory (NPT) have been suggested 
for its evaluation (Wilson et al. 2015), no previous study has used the CFIR as a tool 
for evaluating PPI. 
 
The CFIR (Damschroder et al. 2009) is appropriate for the task of evaluation as it 
provides a taxonomy of evaluable phenomena which can be applied to PPI. The 
flexibility of CFIR is expanding and the CFIR is being adopted to study 
implementation science across healthcare more generally (Kirk et al. 2015). But its 
use as a tool for evaluation is still relatively new. Whilst the CFIR was not designed 
for evaluation, more recently, the utility of CFIR for rapid evaluation has been adopted 
(Keith et al. 2017) as well as for studying barriers and facilitators for collaborative 
work in care (Wood et al 2017). These two studies lend insights which further suggests 
its extended suitability for posing original ideas for PPI evaluation.  
 
The evaluation of PPI using CFIR has flexibility and the component of flexibility is 
inherently present in the ideas of PPI being a complex intervention (Craig et al. 2008). 
Flexibility could concern exploring each domain and construct in turn, or it may 
involve using just a single domain, to help develop highly specialised knowledge 
about PPI. It may involve using a combination of pertinent constructs, depending on 
the PPI evaluation study focus. But according to the current study the CFIR will only 
be applicable if ideas of a complex intervention are applied first. This is because 
complex interventions, such as PPI, are a mixture of contextual and mechanistic 
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aspects that link to outcomes. Therefore, various outcomes of PPI can be generated 
by considering how the different domains influence each other. 
 
In evaluation terms, whilst the CFIR can be used to evaluate PPI more generally, this 
thesis was only concerned with the outcomes of PPI. Despite this, constructs in the 
CFIR interact in rich ways and this means that PPI processes can also be evaluated 
within this model. For example, the ‘characteristics of individuals involved’ domain 
(i.e. a domain which could be described about values and norms people have) will be 
influenced by the ‘outer setting’ domain (i.e. a domain about socio political and 
economic context). Thus, whilst patients and researchers may hold strong values about 
PPI during a study, the impact of PPI is not guaranteed if the political culture of a 
country does not value or fund further resources to support PPI efforts. Thus, whilst 
outcomes of PPI might be limited, an understanding can still be formed about why the 
impact of PPI was favourable or poor. The CFIR can help to consider these aspects of 
PPI evaluation within one interacting framework. 
 
Within the CFIR, the ‘process of implementation’ domain relates to the active change 
process where individuals interested in PPI may actively promote the implementation 
of PPI knowledge through planning and engaging with opinion leaders, change agents 
and champions of PPI to execute implementation outcomes. During this process, they 
would continually reflect and evaluate at different stages of the study. This is where 
evaluation theory in relation to the impact of PPI on research outcomes can enhance 
new knowledge by considering stages of evaluation and what might be achievable e.g. 
winning new funding because PPI was invested in even after an initial study might 
have ended. 
 
In sum, if future researchers regard PPI as a complex intervention, then they will be 
able to evaluate PPI using the CFIR (Damschroder et al. 2009). But by focusing 
particularly on the domain of ‘process of implementation’, we can develop improved 
understandings about the impact of PPI on research outcomes specifically. In turn, 
this allows the advancement of PPI and implementation theory to take new directions; 
specifically, in terms of the impact of PPI on research outcomes.  
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Future researchers will need to fully consider before evaluation, what stages the 
studies needing evaluation are at, e.g. what previous work has already been carried 
out in line of the study being evaluated. If an entirely new area with PPI is being 
studied, researchers could plan when evaluation should occur before a study starts, as 
this will offer insights into the points of time where outcomes may be observable – 
this approach can help prospective planning too (Moore et al. 2015). 
 
Future researchers also need to consider that staged evaluation of PPI in the way 
proposed here will have a further cost (Pizzo et al. 2014) and time implication already 
known (Ocloo and Matthews 2016). This study found four stages where evaluation 
could occur and in the real-world evaluation of PPI at different stages may not always 
be achievable because studies end, and researchers move on to new studies. Similarly, 
PPI groups might dissipate or for long period of time, there may not be any 
involvement (Evans et al. 2014) after a study. 
 
But if cost and time are not an issue and if a PPI group is still active, then the 
evaluation process proposed in stages may help to distinguish the smaller 
achievements at suitable set points of evaluation. Researchers may be able to see, for 
example, that if a PPI group remains active even after the study ends, new outcomes 
of PPI may become observable, such as: developing a new research grant for further 
research; obtaining further funding; achieving policy attention; and ultimately seeing 
actual change. As Mc Kenna (2015) argues there is a reciprocal relationship between 
research impact and PPI, and increasingly with dominant systems such as REF, the 
impact of PPI on research outcomes needs to be made more visible.  
 
Generally, PPI evaluations occur once at the end of an intervention study due to 
restraints on funding and time (e.g. Pizzo et al 2014), but PPI as an intervention needs 
to be understood as a unique intervention which requires commitment of multiple 
stages of evaluations, despite it adding further complexity to the intervention 
evaluation (Petticrew et al. 2015). As Petticrew et al. state, pragmatic solutions such 
as the one proposed in this study are worthy of full consideration in the absence of 
other suitable tools, especially given the overwhelming emphasis placed on the need 
for PPI in research (Madden and Speed 2017). 
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Future directions – facing forward 
During the course of this study, PPI in health research has seen significant and 
sometimes serendipitous change. This section draws together some of the key future 
challenges and opportunities for PPI in health research by considering recent political 
and economic shifts, particularly in the context of neoliberalism, the integration of 
health and social care, financial austerity in the UK and Brexit.  
 
PPI, both in the delivery of services and in research, takes shape within an NHS which 
continues to embody collectivist principles, but which is increasingly shaped by 
neoliberal notions of market competition, individualism and reduced government 
accountability (Baggott 2011). Neoliberalism, therefore, continues to be an important 
component in understanding PPI and its impact, because it shapes the social and 
political context within which PPI operates. As chapter two illustrated, the perceived 
‘democratic deficit’ was one primary driver for an increase in PPI initiatives, with the 
accompanying argument that too many healthcare decisions were made in the absence 
of input from patients and the public. As a result, social movements and state 
structures, designed to help people become more engaged in shaping healthcare were 
catalysed (de Frietas 2017). However, as that chapter demonstrated, PPI was also seen 
as a way of legitimising a number of policy reforms that reflected neoliberal principles 
– the patient as a ‘consumer’ being a case in point. 
 
Throughout recent history, UK governments have embodied varying degrees of faith 
in the power of localism to fulfil democratic engagement in healthcare. In neoliberal 
terms, this ostensible shift from central state to local decision making has been 
underpinned by a belief that individuals want freedom from the so-called ‘nanny state’ 
and the reduction in state interference in individual lives. However, these moves invite 
criticism from a number of perspectives, notably the absence of genuine power to 
affect change. For example, critics have pointed out that neoliberalism transfers the 
responsibility for entrenched and enduring social and health problems to individuals 
and away from the state (Kemshall and Wood 2007). Genuine democratic 
involvement is reduced, in favour of more narrow technocratic ideals, with the 
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government inviting people to provide insights into their health needs in order to shape 
services, without being able to shape strategy or priorities. This poses enduring 
questions about the purpose and impact of PPI more generally. Are patients and the 
public genuinely empowered to challenge health services, health inequalities and 
health priorities? Or are they merely 'accountable' agents, increasingly responsible for 
their own 'good' health behaviour and tackling social problems, without the 
corresponding power to do so (Feiler 2018)?  
 
These questions hold resonance for PPI in research. It raises questions about whether 
people involved in research are really helping to challenge health services and health 
inequalities or are they simply justifying pre-defined health priorities (Bissell et al. 
2018; Maguire and Britten 2017). The currently fashionable agenda relating to co-
production in research allows patients and the public to understand that there are 
power sharing opportunities in shaping healthcare research, but without evaluating 
PPI in research it is difficult to know what impact this has.  
 
Another development that warrants future attention is the increasing integration of 
social care and health at local and national government level. Health researchers are 
now likely to expand on their domain of study to embrace social care, and PPI will 
potentially therefore also become increasingly prominent in social care research. The 
joining of health and social care may change their relative status (perhaps by 
increasing the relative status of social care) and will allow for greater PPI 
opportunities. Mental health, social work and youth and community care are already 
becoming more pronounced in NIHR research. The new Department of Health and 
Social Care means that healthcare professionals and researchers may consider patient 
views in a more integrated way, for example delivering and evaluating social work 
interventions in primary care settings (McGregor et al. 2018).  
 
These reforms also fit the recent government promises to increase NHS budgets in 
times of austerity, with its focus on health and social care. The government has set out 
a 10-year plan to improve services within the NHS with an increasing focus on 
technological innovation and preventative medicine (NHS England 2019). Ham and 
Murray (2018) argue that the focus of NHS reform should be kept on improving 
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population health in a measurable way and to reduce health inequalities through better 
stakeholder and public involvement. The issue of representation once again becomes 
important here. If the 10-year plan is to incorporate better public and stakeholder 
involvement, then the question of who is involved needs to be at the centre stage. As 
discussed in the early part of this thesis, PPI policies, especially in terms of holding 
healthcare to account, have been prone to almost constant upheaval and flux. One 
challenge for government in ensuring PPI representation might to embrace and 
enhance existing structures (such as Healthwatch) rather than destabilise them, unless 
there is a case for replacing them with something stronger and more representative. 
These debates also apply to PPI in research. As we have seen throughout the thesis, 
there has been a gradual shift towards the inclusion of the public and patients within 
established peer reviewed health research funding awards. As research priorities shift 
towards better understanding and evaluating preventative approaches and integrative 
healthcare, models for PPI will need to keep apace. 
 
Of most importance in the current context is the looming challenge of Brexit. At the 
time of writing, the UK heads towards exit from the European Union with 
questionable clarity about our future relationship with the bloc. The challenges for 
healthcare, healthcare research and the role of PPI are bound up in this uncertainty, 
and it makes predictions of the future direction all the more difficult.  
 
It is perhaps easy, in these macro debates, to lose sight of the importance of the voice 
of patients and the public. Yet, as has been argued throughout this thesis, these voices 
might be instrumental in helping to democratise and improve healthcare and 
healthcare research. Therefore, understanding how PPI in healthcare research works, 
and why it matters, remain central questions. These are the questions that have shaped 
this thesis and have guided its contribution to future research that seeks to evaluate 
the impact of PPI on outcomes. 
Limitations of the study  
Methodological limitations 
Purposive sampling had advantages for phase 1 and the researcher’s work within a 
Research Design Service offered a unique position from which to conduct this work. 
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All interviews were carried out regionally in phase 1. The researcher’s professional 
knowledge and networks helped to find suitable national participants for phase 2 by 
targeting recruitment information. Thus, potentially suitable participants outside of 
these networks may not have engaged in study materials. To widen reach, the study 
materials were circulated by INVOLVE and CHAIN networks to achieve national 
publicity. 
 
Links within the research field meant that some of those with whom there was contact 
with through work became participants, and their participation sometimes resulted 
into snowballing (Noy 2008). This was particularly the case with stakeholders. It 
needs to be acknowledged therefore that there may have been the potential for the 
obligation on people to participate (Feeley 2002). However, an environment was 
created which tried to ensure that participants felt comfortable with withdrawing from 
the study. In the Delphi survey a panellist who was expert patient did indeed leave the 
study after round 1. In an email correspondence outside of the Delphi process, he felt 
that the current study was not about cancer as he had thought initially and the focus 
around impact was too abstract for him. This was despite the attempts to ensure that 
the study information sheet was clear about the aims and focus. His experiences of 
cancer research were linked to very specific understandings about cancer trials and 
finding a cure. This example illustrates that patients did feel able to withdraw from 
the study.  
  
There was one qualitative researcher in the Delphi survey who raised that they had 
found the process of the Delphi useful and successful, but interaction not fulfilling 
enough. This panellist would have preferred face-to-face consensus-forming. This 
point demonstrates that at least one person did feel able to voice criticism during data 
collection, putting aside the current researcher’s relationship to them. In this situation, 
it was explained why the Delphi was selected, grounding the answer in the Delphi’s 
cost effectiveness suitability and strengths, i.e. panellists being anonymous and not 
feeling pressured to answer in a particular way.  
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Diversity-related limitations 
The researcher is a black woman with an Indian heritage. During the recruitment stage, 
active efforts were made to find participants from BME backgrounds to help 
understand if there were any different experiences amongst the participants based on 
their ethnicity (Dawson et al. 2018). No participants came forward from this group. 
One reason for the lack of BME patient and public participants might be because 
cancer can be stigmatised in BME communities (Jones et al. 2015) and because of this 
stigma they may participate less in PPI roles. In phase 1, all six patient participants 
came from a white background, and in phase 2, once again, all seven expert patient 
panellists identified as white, thus the sample does not reflect the various different 
subgroups of populations living in the UK.  
 
Geographical limitations  
Phase 1 of the study was designed to be East Midlands focused but phase 2, the Delphi 
survey, was national with a diverse mix amongst the 10 regions represented in the 
sample. Whilst the findings therefore present a valuable and valid account, the work 
was limited to England. Those working in the field of PPI evaluation elsewhere will 
find inevitable differences in the ‘outer settings’ of Damschroder et al.’s (2009) 
framework. 
 
Despite these limitations to the work, the findings from this study have implications 
for further work. This next section explains some of these next steps. 
Next steps and recommendations for future research 
Dissemination is planned as follows:  
 
Develop five journal papers: 1) an original contribution paper, advancing the field, 
which will apply the thinking of complex interventions and the CFIR (Damschroder 
et al 2009) and particularly how domain five process of implementation helps to focus 
understanding about the impact of PPI on research outcomes; 2) an epistemological 
paper on the tensions associated with conducting this study with end user involvement 
3) a paper on PPI in research policy and GEM’s critique and implications for 
addressing impact; 4) a methodological paper on the Delphi approach addressing 
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specifically the use of stimulus material; and 5) A paper on the synthesised definition 
of impact formed from the Delphi. 
 
The findings from this study will be presented in print and oral form at local meetings 
and conferences to patients and researchers: local and regional organisations such as 
Collaborative Leadership of Applied Health Research and Care (CLAHRC and soon 
to be ARCs) and cancer charities. National audiences such as the NIHR impact 
working group, INVOLVE, funders, The GEM Review panel (at the Department of 
Health and Social Care), the National Institute for Health and Care Excellence (NICE) 
and Clinical Commissioning Groups (CCGs). International conferences will be 
targeted to generate international perspectives on the evaluation of PPI. 
 
Recommendations for further research 
Four new ideas for further research have been considered: 
• Forming a definition of the impact of PPI for usability in the field was beyond 
the scope of the current study and therefore did not allow a determination of the 
applicability of the Delphi synthesised definition of impact (chapter six). However, 
there is potential for further study to develop a shorter definition of impact of PPI 
combined with the recent work of Hughs and Duffy (2018) in order to gain consensus 
on the concept of the impact of PPI. 
• Exploring new methods for developing a PPI impact framework by breaking 
down the different types of PPI roles, in different studies for example health services, 
health policy, clinical trial design, genomic/genetic research and community work. 
Thus, some practical guidance/toolkit for researchers about the nine PPI factors could 
also be developed considering the complex intervention of PPI (Craig et al 2008).  
• Evaluating the impact of REF requirements and its connections to PPI. This 
would be a multi-site mixed method study of universities assessing how university 
researchers negotiate PPI work (Caress 2013). Using understandings generated from 
the current study, it would apply the CFIR to help understand tensions researchers 
face in academia around PPI and how the REF guides what university researchers do, 
data from the current study has found that ivory tower culture may hinder the impact 
of PPI.  
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• This study has focused evaluation ideas using the CFIR and complex 
interventions specifically on the impact of PPI on research outcomes, but a study could 
be carried out across the entire PPI journey – in the form of longitudinal work. This 
study would be wholly concerned with context, mechanism and outcomes of PPI, 
using the CFIR along with insights from NPT (Wilson et al. 2015; Wilson et al 2018). 
• More work could explicitly examine the role of PPI in a PhD study. Here the 
arguments of lay verses scientific knowledge can be formed applying Popay et al. 
(2003) about how a PhD study requiring independent thought and health research 
applying PPI principles can be better understood.  
Autobiographical critical reflection 
A reflexive researcher is one who considers how their own influences (such as their 
age, race, gender, ability, social class, professional status and distance) affects 
research work (Mays and Pope 2008). Whilst carrying out this study, wherever 
possible, disclosure of race, gender and professional status has been made to 
participants so that participants can see why there is interest from the researcher about 
the topic. Serrant-Green (2002) argues that all researchers fall somewhere between 
complete insiders and complete outsiders, occupying different spaces which affect the 
research process and research outcomes. Thus, conducting this doctoral research study 
shows that research is a ‘messy’ process which sometimes blurred intellectual, 
personal, social and at times emotional boundaries.  
 
There are many acknowledged skills acquired over the last eight and a half years. 
From reading some of the best works available in the field of PPI in research and 
impact, it has been made possible to grasp what experts are raising and how to 
consider these arguments in different ways and across disciplines. Other skills 
cultivated have been in writing and publishing resulting in being able to critically 
examine and communicate knowledge and awareness of PPI (see Appendix 16 for a 
list if outputs influenced through this PhD). The skills of communicating publicly, and 
how to have frequent, and private contact with a range of groups from patients through 
to high-profile politicians, have been developed through this study. These experiences 
have enhanced fieldwork confidence skills, but also away from the field have taught 
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how to confidently commit pen to paper and write the thesis, despite being diagnosed 
with dyslexia (very early on in the PhD journey).  
 
Lastly, whilst undertaking this research study some invaluable life skills have been 
gained, not least in how to overcome self-doubt and become emotionally resilient 
when coping with shifts in research directions. That self-discipline has been necessary 
to survive the endurance of a PhD journey whilst balancing the role of parenting to a 
young family as well as holding down a demanding job. These skills go beyond 
academia because, ultimately, they teach the meaning of patience and keeping the 
drive and determination as a focus to complete something that is worthy and important 
to me. 
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Appendix 11 - Delphi Process Phase 2 
  
 
 
 
 
 
 
 
 
 
 
Start Date: Monday 15th September 2014 
Participants will be asked to read the stimulus paper 
about key themes that have emerged from data in 
phase one. There will be three questions about the 
paper. Participants will be asked to send their 
      
Collate last set of comments offer a summary by the 27th October 2014 on the range of 
convergence/divergence of opinions and close Delphi. 
Delphi Round 3 
Delphi Round 
 
Start Date: Monday 13th October 2014 
Round 2 will be summarised and participants will be 
offered further controlled feedback. The final three 
questions will be sent. Participants will be asked to send 
their comments by Friday 17th October 2014. 
Delphi Round 
2 
Start Date: Monday 29th September 2014 
Round 1 will be summarised and controlled feedback 
will be offered on issues raised by the participants. A 
further three questions will be sent. Participants will be 
asked to send their comments by Friday 3rd October 
 
Open the Delphi survey - a six-week process from start to finish 
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Appendix 12 - Consent Phase 2 
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Appendix 13 - Coding Frameworks Phase 2 
 
 
 
 
 
 
 
 
 
 
  
Impact 
of PPI
degress of 
involvement
qual and 
quant
strong and 
subtle
process and 
outcomes
policy, theory 
and practice
barriers and 
facilitators
layers of 
impact
context and 
circumstance
transparency
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Appendix 14 - Delphi Questions Rounds 1-3 - Phase 2 
 
Delphi Round 1  
Monday 15th – Friday 19th September 
 
Question 1. 
 
Based on the stimulus paper that you have just read, please rank the seven factors in order of importance 
(‘1’ being most and ‘7’ being least important, using each number only once).  
Your ranking should be guided by how important you feel each factor is for generating impact from 
research that has included PPI. You should also base your answers on your own professional/personal 
experience as appropriate. Place your ranking in the boxes provided. 
Successful PPI processes as a foundation for the production of  
impact  
  
Wanting to make a difference 
 
 
The significance of power and leadership   
 
 
Networks (non-virtual)  
 
 
Resources and the political context 
 
 
Dissemination  
 
 
Information and communication technology 
 
 
Question 2.  
 
Using the expandable box below, please explain the reasoning for your ranking, why the issues are ranked 
in the order they appear? (Particularly, offering thought to any significant issues or challenges associated 
with the factor) applying your professional/personal expertise to the answer. 
 
Question 3.  
 
Using the expandable box below, please explain, did you sense that there was anything missing in the 
findings presented that you would have expected to see?  
 
 
Delphi Round 2 
Monday 29th September – Friday 3rd October 
 
You are asked to revise your earlier ranking in light of two new themes as well as categorising your 
answers according to whether they reflect: 
 
Micro issues – small-scale interactions on individual projects, such as conversations, between 
individuals, or group dynamics that influence something. 
Meso issues – (the middle of micro and macro) which includes the consideration of organisations and 
communities. For example hospitals, care settings and health education settings which may be the 
structures that influence something. 
Macro level – These are large-scale social processes, such as social change, political movements, 
patterns and trends that are influential. 
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Question 1 a. 
From what you have just read, please rank the nine factors (seven factors brought forward from the first 
round and two new ones**) ranking them in order of importance (‘1’ being most and ‘9’ being least 
important, using each number only once). 
As previously, your ranking should be guided by how important you feel each factor is for generating 
impact from research that has included PPI. You should also base your answers on your own 
professional/ personal experience as appropriate. Place your ranking in the left-hand row of boxes 
provided.  
Successful PPI processes as a foundation for the production of  
impact  (this came 1st in the previous round)  
  
Wanting to make a difference 
(this came 5th in the previous round) 
 
The significance of power and leadership   
(this came 4th in the previous round) 
 
Networks (non-virtual, includes collaborative working)  
(this came 6th in the previous round) 
 
Resources and the political context 
(this came 3rd in the previous round) 
 
Dissemination  
(this came 2nd in the previous round) 
 
Information and Communication Technology  
(this came 7th in the previous round) 
 
**Commissioning of research 
(new theme) 
 
**PPI in implementation  
(new theme) 
  
Question 1 b. 
Based the above ranking, please indicate in the right-hand row of boxes which factors you would 
categorise as a ‘micro’, ‘meso’ or ‘macro’ level factors: by placing a ‘MI’ for micro, a ‘ME’ for meso 
and a ‘MA’ for macro in the box.  
 
Question 2. 
Using the expandable box below please make any other comments concerning your thoughts about new 
items ‘H’ - Commissioning of research and ‘I’ - PPI in implementation in support of your ranking.  
 
. 
Question 3.  
You now have the opportunity to consider the issue of defining ‘PPI impact’. Please give me your 
definition of this in the box below.  
 
 
 
 
Delphi Round 3 
Monday 13th October – Friday 17th October 2014 
 
To what extent does the PPI impact definition capture/include your submitted definition and or your view 
of what PPI impact is (keeping in mind the 9 factors and their levels of complexity)  
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 Completely  [  ]   
 Mostly     [  ]   
 Slightly    [  ]  
 Not at all [  ] 
 
Any other comments about this: 
 
 
 
Which of the nine factors are unique to the topic of cancer and can and should they be transferable to 
other areas of health/illness research with PPI? 
 
Factors that shape the impact 
of PPI in research outcomes 
Unique to cancer 
research with 
PPI? 
Yes/No/Maybe 
Transferability beyond cancer 
Please explain:  
Successful PPI processes   
Dissemination   
Resources and the political 
context  
  
PPI in implementation   
The significance of power and 
leadership  
  
PPI in commissioning research   
Wanting to make a difference    
Networks   
Information and 
Communication Technology 
  
 
There are three emerging findings from this Delphi study: A) the nine complex and interrelated factors 
that shape the impact of PPI in research outcomes; B) the factors exist at micro, meso and macro level(s); 
and C) a collective definition of PPI impact. I would like your views about what the next steps for this 
work might look like. Please explain your answer in the box below, thinking about people/groups and 
organisations that might benefit from knowing about these findings, any recommendations you have, any 
unanswered questions this work raises for you etc.   
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Appendix 16 - Summary of research outputs generated  
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